diff --git a/.github/workflows/build-docs.yml b/.github/workflows/build-docs.yml index 11bb2ac7d..7c03f7039 100644 --- a/.github/workflows/build-docs.yml +++ b/.github/workflows/build-docs.yml @@ -15,6 +15,8 @@ jobs: steps: - name: Checkout code uses: actions/checkout@v4 + with: + submodules: recursive - name: Setup Ruby uses: ruby/setup-ruby@v1 @@ -26,6 +28,9 @@ jobs: gem install asciidoctor gem install asciidoctor-diagram + - name: Install Python dependencies + run: pip install pyyaml jinja2 + - name: Set output directory based on branch id: set-output-dir run: | @@ -37,45 +42,14 @@ jobs: echo "base_url=/dev" >> $GITHUB_OUTPUT fi - - name: Create output directory - run: mkdir -p ${{ steps.set-output-dir.outputs.output_dir }} - - - name: Build AsciiDoc documentation - run: | - chmod +x scripts/build-asciidoc.sh - ./scripts/build-asciidoc.sh ${{ steps.set-output-dir.outputs.output_dir }} - - - name: Copy static assets - run: | - chmod +x scripts/copy-assets.sh - ./scripts/copy-assets.sh ${{ steps.set-output-dir.outputs.output_dir }} - - - name: Build SDRF Explorer index - run: | - python3 site/build-sdrf-index.py - cp site/sdrf-data.json ${{ steps.set-output-dir.outputs.output_dir }}/ - - - name: Inject navigation headers - run: | - python3 scripts/inject-headers.py ${{ steps.set-output-dir.outputs.output_dir }} - - - name: Transform SDRF links to viewer - run: | - python3 scripts/transform-links.py ${{ steps.set-output-dir.outputs.output_dir }} - - - name: Transform SDRF example tables - run: | - python3 scripts/transform-sdrf-tables.py ${{ steps.set-output-dir.outputs.output_dir }} - - - name: Build search index + - name: Build documentation site run: | - python3 site/build-search-index.py . ${{ steps.set-output-dir.outputs.output_dir }}/search-index.json - - - name: Add version banner for dev branch - if: github.ref_name == 'dev' - run: | - chmod +x scripts/add-dev-banner.sh - ./scripts/add-dev-banner.sh ${{ steps.set-output-dir.outputs.output_dir }} + chmod +x scripts/build-docs.sh + if [ "${{ github.ref_name }}" == "dev" ]; then + ./scripts/build-docs.sh ${{ steps.set-output-dir.outputs.output_dir }} --dev + else + ./scripts/build-docs.sh ${{ steps.set-output-dir.outputs.output_dir }} + fi - name: Checkout gh-pages branch for merging if: github.ref_name == 'dev' diff --git a/CHANGELOG.md b/CHANGELOG.md index 788edfd5e..3e7ac85a2 100644 --- a/CHANGELOG.md +++ b/CHANGELOG.md @@ -43,7 +43,16 @@ and this project adheres to [Semantic Versioning](https://semver.org/spec/v2.0.0 ### Changed +- **Template architecture refactoring**: Introduced `sample-metadata` intermediate template between `base` and technology/organism templates. Columns `organism`, `organism part`, `cell type`, `biological replicate`, and `pooled sample` moved from `base` to `sample-metadata`. Columns `disease` and `biosample accession number` consolidated from organism templates into `sample-metadata` (RECOMMENDED and OPTIONAL respectively; organism templates override disease to REQUIRED). All technology templates (`ms-proteomics`, `affinity-proteomics`) and organism templates (`human`, `vertebrates`, `invertebrates`, `plants`) now extend `sample-metadata` instead of `base`. No change to effective validation for any template combination. - **Version bump to v1.1.0**. +- **BREAKING: `comment[technical replicate]`** changed from RECOMMENDED to REQUIRED in base template. All inheriting templates now require a technical replicate column. Existing SDRF files without this column will fail validation -- add the column with value `1` for single-run samples. +- **BREAKING: Immunopeptidomics field renames**: `characteristics[MHC class]` → `characteristics[MHC protein complex]` (GO:0042611), `characteristics[MHC allele]`/`characteristics[HLA typing]` → `characteristics[MHC typing]` (PRIDE:0000893), `characteristics[HLA typing method]` → `characteristics[MHC typing method]` (PRIDE:0000894). Values updated to use MRO/GO ontology terms. Existing datasets must update column names and values. +- **Organism templates**: `developmental stage` and `strain/breed` changed to REQUIRED in invertebrates, vertebrates, and plants. `sex` changed to RECOMMENDED in vertebrates. `growth conditions` and `treatment` changed to RECOMMENDED in plants. +- **Human template**: `age` and `sex` changed to REQUIRED. Age pattern now allows standalone month/week/day values (e.g. `6M`, `3W`, `14D`). +- **BioSample accession**: regex fixed from `^SAM[NED]A?\d+$` to `^SAM(N|EA|D)\d+$` to reject invalid prefixes. +- **Affinity proteomics**: version set to 1.0.0. `comment[instrument]` renamed to `comment[platform]` (REQUIRED); new `comment[instrument]` added as OPTIONAL for actual sequencer/reader. Sample type values normalized to use spaces (`sample control`, `negative control`, etc.). +- **Cell-lines**: added PATO ontology to disease field for `normal` (PATO:0000461). Added `characteristics[culture medium]` (RECOMMENDED) and `characteristics[storage temperature]` (RECOMMENDED). +- **MS-proteomics/DDA**: mass tolerance patterns updated to accept `not available`/`not applicable` when those flags are set. DDA mass tolerance kept as RECOMMENDED. - **Specification restructured** with clearer organization: Quick Start → Validation → Specification Structure → Notational Conventions → Sample Metadata → Data File Metadata → Templates → Factor Values. - **Column naming**: `fileformat` changed to `file_format` for consistency with underscore convention. - **Ontology recommendations**: added NCIT and PRIDE to general purpose; added PATO for healthy samples (`normal` = PATO:0000461). diff --git a/DEVELOPMENT.md b/DEVELOPMENT.md index d72ac4fe0..362370791 100644 --- a/DEVELOPMENT.md +++ b/DEVELOPMENT.md @@ -8,34 +8,30 @@ This guide explains how to build and maintain the SDRF-Proteomics documentation proteomics-metadata-standard/ ├── scripts/ # Build and utility scripts │ ├── build-docs.sh # Main build script (local & CI/CD) -│ ├── build-asciidoc.sh # AsciiDoc build helper -│ ├── copy-assets.sh # Asset copying helper +│ ├── build_template_pages.py # Generate per-template HTML from YAML +│ ├── build_index_templates.py # Generate index.html template section +│ ├── resolve_templates.py # Template inheritance resolver │ ├── inject-headers.py # Navigation header injection -│ ├── transform-links.py # SDRF link transformation +│ ├── transform-links.py # .adoc→.html link transformation │ ├── transform-sdrf-tables.py # SDRF example table styling +│ ├── build_sdrf_builder_data.py # SDRF builder JSON data compiler │ └── add-dev-banner.sh # Dev version banner ├── sdrf-proteomics/ # Main specification source │ ├── README.adoc # Main specification (AsciiDoc) -│ ├── tool-support.adoc # Tool support page -│ ├── metadata-guidelines/ # General metadata guidelines -│ │ ├── sample-metadata.adoc +│ ├── TOOLS.adoc # Tool support page +│ ├── TEMPLATES.adoc # Templates guide +│ ├── SAMPLE-GUIDELINES.adoc # Sample metadata guidelines +│ ├── metadata-guidelines/ # Detailed metadata guidelines +│ │ ├── data-analysis-metadata.adoc │ │ └── sdrf-terms.tsv -│ ├── templates/ # All templates (core + specialized) -│ │ ├── human/ # Human template (includes clinical metadata) -│ │ ├── vertebrates/ # Non-human vertebrates -│ │ ├── invertebrates/ # Invertebrates (Drosophila, C. elegans) -│ │ ├── plants/ # Plant organisms -│ │ ├── ms-proteomics/ # MS proteomics template (base for MS experiments) -│ │ ├── cell-lines/ # Cell line experiments -│ │ ├── crosslinking/ # XL-MS experiments -│ │ ├── immunopeptidomics/ # Immunopeptidomics -│ │ └── ... +│ ├── sdrf-templates/ # YAML template definitions (submodule) │ └── images/ # Specification images ├── site/ # Website assets and build scripts │ ├── css/style.css # Main stylesheet │ ├── js/search.js # Search functionality +│ ├── js/sdrf-builder.js # Interactive SDRF builder logic │ ├── index.html # Homepage -│ ├── quickstart.html # Quick start guide +│ ├── quickstart.html # Quick start guide + interactive builder │ ├── sdrf-explorer.html # SDRF dataset explorer │ ├── sdrf-terms.html # Terms reference page │ ├── build-sdrf-index.py # Builds dataset index @@ -88,7 +84,7 @@ The easiest way to build the documentation is using the provided build script. T 1. **Converts AsciiDoc to HTML** using Asciidoctor with proper styling options 2. **Copies static assets** (CSS, JavaScript, images) -3. **Copies static HTML pages** (index.html, quickstart.html, sdrf-explorer.html, sdrf-terms.html) +3. **Copies static HTML pages** (index.html, quickstart.html, sdrf-explorer.html, sdrf-editor.html, sdrf-terms.html) 4. **Builds SDRF Explorer index** from annotated-projects 5. **Injects navigation headers** into all generated HTML pages 6. **Transforms SDRF links** to use the SDRF Explorer viewer @@ -345,7 +341,6 @@ To force an immediate update, the specification website needs to be rebuilt: | File | Purpose | |------|---------| | `site/sdrf-editor.html` | Editor page (loads Angular app from jsDelivr) | -| `scripts/copy-assets.sh` | Copies editor page during build | | `scripts/inject-headers.py` | Adds Editor link to navigation | ### Testing Editor Changes Locally @@ -361,6 +356,32 @@ npm run build -- --configuration=production # (temporarily change jsDelivr URLs to local paths for testing) ``` +## Interactive SDRF Builder + +The quickstart page (`/quickstart.html`) includes an interactive SDRF template builder that helps users create custom SDRF templates by answering questions. + +### How It Works + +1. **Build time:** `scripts/build_sdrf_builder_data.py` resolves all YAML templates and sdrf-terms.tsv into `sdrf-builder-data.json` +2. **Runtime:** `site/js/sdrf-builder.js` loads the JSON and renders a branching questionnaire +3. Users select technology, organism, experiment type, review columns, and download a TSV + +### Builder Files + +| File | Purpose | +|------|---------| +| `scripts/build_sdrf_builder_data.py` | Compiles YAML templates + terms into JSON | +| `site/js/sdrf-builder.js` | Builder UI logic (vanilla JS) | +| `site/quickstart.html` | Page with simplified intro + builder scaffold | +| `site/css/style.css` | Builder-specific styles (`.builder-*`, `.option-*`) | + +### Updating the Builder + +When templates change (new columns, new templates): +1. The build script automatically recompiles `sdrf-builder-data.json` +2. No JS changes needed unless new template layers or combination rules are added +3. New templates appear automatically in the appropriate step + ## Contributing 1. Make changes to the appropriate AsciiDoc or HTML files diff --git a/annotated-projects/PMID33086064/PMID33086064.sdrf.tsv b/annotated-projects/PMID33086064/PMID33086064.sdrf.tsv index d0b0d7cf0..d3dcde37a 100644 --- a/annotated-projects/PMID33086064/PMID33086064.sdrf.tsv +++ b/annotated-projects/PMID33086064/PMID33086064.sdrf.tsv @@ -1,3121 +1,3121 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[cell line] characteristics[developmental stage] characteristics[disease] characteristics[ancestry category] characteristics[sex] characteristics[anatomic site tumor] characteristics[origin site disease] characteristics[age] characteristics[biological replicate] characteristics[tumor cellularity] characteristics[tumor grade] characteristics[tumor stage ovary figo] characteristics[individual] characteristics[material type] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[file uri] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[dissociation method] comment[collision energy] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[sdrf version] comment[sdrf template] factor value[disease] -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 005 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 071 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 002 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 102 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 032 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 104 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 092 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample2 Homo sapiens ovary not applicable not applicable adult not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 012 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC5 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 010 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 099 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 105 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 076 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 064 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 025 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 031 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 001 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 066 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -QC6 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 017 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 033 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 034 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 018 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 006 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 011 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 075 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 013 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 079 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 019 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 027 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC4 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 093 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 021 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 004 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 077 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 009 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 072 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 007 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 020 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 100 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 073 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 081 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 068 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 015 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 087 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 074 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 103 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC8 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 080 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 026 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 085 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 069 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 016 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 014 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 094 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 097 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -QC7 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 035 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 028 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 023 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 003 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 067 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 098 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 089 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 106 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 084 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 109 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 082 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 101 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC1 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 008 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 086 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 030 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 037 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC9 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 107 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 029 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 088 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 083 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 108 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 078 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC3 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 036 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 024 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 070 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -SPL 091 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -QC2 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 022 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 090 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 096 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 095 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 065 Homo sapiens ovary not applicable not applicable adult high-grade serous ovarian adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 high-grade serous ovarian adenocarcinoma -SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor -SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161209_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample1 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample1 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 005 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 528D 1 75 G3 IIIC 15OV001 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 071 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 792D 1 70 G2 IC 11OV009 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 002 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 802D 1 60 not available IIIC 17OV014 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 102 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 720D 1 70 G3 IIIC 04OV048 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 047 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 782D 1 not applicable G3 IIIC 02OV001 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 043 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 528D 1 not applicable G3 IIIC 15OV001 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 032 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV008 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 104 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 656D 1 60 G3 IIIC 17OV039 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 092 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 762D 1 70 G3 IIIC 04OV044 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/01CPTAC_OVprospective_Proteome_JHU_20161209/01CPTAC_OVprospective_Proteome_JHU_20161209_raw/01CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample2 Homo sapiens ovary not applicable not applicable adult not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample2 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 012 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 614D 1 95 G3 IIIC 01OV039 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC5 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 059 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 665D 1 not applicable G3 IIIC 01OV008 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 010 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 849D 1 70 G3 IIIC 01OV041 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 099 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 733D 1 75 G2 IC 18OV001 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 105 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 840D 1 70 G3 IIIC 04OV040 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 076 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 663D 1 60 G3 IIIC 04OV045 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 049 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 849D 1 not applicable G3 IIIC 01OV041 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 064 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 887D 1 65 G3 IIIB 04OV050 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/02CPTAC_OVprospective_Proteome_JHU_20161104/02CPTAC_OVprospective_Proteome_JHU_20161104_raw/02CPTAC_OVprospective_W_JHUZ_20161104_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample3 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample3 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 025 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 600D 1 80 G3 IIIC 02OV008 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 031 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 870D 1 90 G3 IV 04OV005 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 041 Homo sapiens ovary not applicable not applicable adult Non-Tumor American Indian or Alaska Native Female not applicable not applicable 753D 1 not applicable not available not available 17OV004 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 001 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 759D 1 60 not available IIIC 17OV015 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 066 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 606D 1 75 G3 IV 04OV063 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 056 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 672D 1 not applicable G3 IIIC 01OV017 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +QC6 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available not available not available not available not available 1 not available not available not available Sample 5776 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 017 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 672D 1 90 G3 IIIC 01OV017 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 033 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 1031D 1 90 G3 IIIC 04OV011 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/03CPTAC_OVprospective_Proteome_JHU_20161110/03CPTAC_OVprospective_Proteome_JHU_20161110_raw/03CPTAC_OVprospective_W_JHUZ_20161110_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample4 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample4 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 034 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Fallopian tube 701D 1 90 G3 IIIC 04OV012 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 018 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 535D 1 98 G3 IIIC 01OV018 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 006 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 717D 1 65 G3 IV 04OV028 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 011 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 707D 1 60 not available IIIC 14OV011 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 075 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 741D 1 80 G3 IIIC 02OV035 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 013 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 687D 1 65 G3 IIIC 04OV021 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 046 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable Ovary 789D 1 not applicable G2 IIIC 11OV002 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 079 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 673D 1 80 G3 IIIC 02OV042 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 044 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 707D 1 not applicable not available IIIC 14OV011 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/04CPTAC_OVprospective_Proteome_JHU_20161111/04CPTAC_OVprospective_Proteome_JHU_20161111_raw/04CPTAC_OVprospective_W_JHUZ_20161111_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample5 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample5 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 019 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 90 G3 IIIC 01OV019 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 027 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Ovary Ovary 706D 1 80 G3 IIIC 02OV022 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC4 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 040 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 861D 1 not applicable not available not available 17OV005 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 093 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 802D 1 75 G3 IIIC 17OV034 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 021 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Peritoneum 932D 1 90 G3 IIIC 01OV026 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 053 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 932D 1 not applicable G3 IIIC 01OV026 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 004 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 687D 1 80 G3 IIIC 02OV032 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 077 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 686D 1 90 G3 IIIB 26OV010 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/05CPTAC_OVprospective_Proteome_JHU_20161115/05CPTAC_OVprospective_Proteome_JHU_20161115_raw/05CPTAC_OVprospective_W_JHUZ_20161115_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample6 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample6 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 055 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 707D 1 not applicable G3 IIIC 01OV023 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 009 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 448D 1 65 G3 IV 04OV023 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 072 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 827D 1 65 G3 IIIC 04OV041 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 007 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 712D 1 70 G3 IV 04OV027 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 020 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 707D 1 90 G3 IIIC 01OV023 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 100 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 747D 1 60 G3 IIIC 04OV055 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 073 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 863D 1 90 G3 IV 04OV037 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 081 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 712D 1 75 G3 IIIC 04OV031 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 054 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Fallopian tube 693D 1 not applicable G3 III 01OV024 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/06CPTAC_OVprospective_Proteome_JHU_20161216/06CPTAC_OVprospective_Proteome_JHU_20161216_raw/06CPTAC_OVprospective_W_JHUZ_20161216_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample7 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample7 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 038 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 729D 1 not applicable G3 IIIC 22OV001 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 039 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available not available 720D 1 not applicable not available not available 17OV012 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 068 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 729D 1 75 G3 IIIC 22OV001 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 015 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 790D 1 85 G3 IIIC 04OV017 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 087 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Ovary 762D 1 65 not available not available 17OV036 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 074 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 529D 1 90 not available not available 17OV029 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 103 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 639D 1 75 G3 IIIC 02OV045 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC8 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 080 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 790D 1 70 G3 IIIC 02OV040 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/07CPTAC_OVprospective_Proteome_JHU_20161121/07CPTAC_OVprospective_Proteome_JHU_20161121_raw/07CPTAC_OVprospective_W_JHUZ_20161121_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample8 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample8 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 026 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Peritoneum 898D 1 90 G3 IIIC 02OV015 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 085 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 695D 1 65 G3 IV 04OV051 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 069 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Asian Female Omentum Ovary 472D 1 85 G3 IV 04OV036 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 045 Homo sapiens ovary not applicable not applicable adult Non-Tumor Asian Female not applicable not applicable 634D 1 not applicable not applicable not applicable 11OV010 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 016 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 820D 1 70 G3 IV 01OV007 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 060 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 820D 1 not applicable G3 IV 01OV007 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 014 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 761D 1 65 G3 IIIC 04OV018 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 094 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 765D 1 60 G3 IIIC 04OV049 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 097 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 694D 1 75 G2 IIIB 17OV019 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/08CPTAC_OVprospective_Proteome_JHU_20161213/08CPTAC_OVprospective_Proteome_JHU_20161213_raw/08CPTAC_OVprospective_W_JHUZ_20161213_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample9 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample9 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +QC7 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 051 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 886D 1 not available G3 IIIC 01OV030 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 035 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 637D 1 90 G3 IIIC 04OV013 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 028 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 559D 1 90 G3 IIIC 02OV023 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 023 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 886D 1 95 G3 IIIC 01OV030 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 003 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 753D 1 70 G2 IIIC 17OV018 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 067 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Fallopian tube 552D 1 65 G3 IIIC 04OV039 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 061 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 688D 1 not available not available IIB 14OV029 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 098 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Fallopian tube 854D 1 65 G3 IIIC 04OV058 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/09CPTAC_OVprospective_Proteome_JHU_20161123/09CPTAC_OVprospective_Proteome_JHU_20161123_raw/09CPTAC_OVprospective_W_JHUZ_20161123_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample10 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample10 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 089 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Pelvic mass Ovary 652D 1 70 G3 IV 01OV046 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 048 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Ovary 612D 1 not applicable G3 IIIC 01OV045 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 106 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 612D 1 65 G3 IIIC 01OV045 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 084 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female Omentum Ovary 692D 1 65 G3 IV 04OV033 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 109 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 695D 1 90 G3 IIIC 26OV002 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 058 Homo sapiens ovary not applicable not applicable adult Non-Tumor Black or African American Female not applicable Fallopian tube 625D 1 not applicable G3 IIIC 01OV010 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 082 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female not applicable Peritoneum 801D 1 70 G3 IIIA 17OV025 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 101 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 688D 1 90 G3 IIIC 17OV028 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC1 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/10CPTAC_OVprospective_Proteome_JHU_20161128/10CPTAC_OVprospective_Proteome_JHU_20161128_raw/10CPTAC_OVprospective_W_JHUZ_20161128_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample11 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample11 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 008 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Fallopian tube 580D 1 80 G3 IIIC 04OV024 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 086 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 522D 1 65 G3 IV 04OV054 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 030 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Peritoneum 650D 1 90 G3 IV 04OV004 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 037 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 583D 1 90 G3 IIIC 17OV002 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC9 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 062 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 583D 1 not applicable G3 IIIC 17OV002 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 107 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 75 not available not available 17OV011 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 029 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 605D 1 90 G3 IIIC 04OV001 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 088 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 653D 1 75 G3 IIIC 01OV049 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/11CPTAC_OVprospective_Proteome_JHU_20161201/11CPTAC_OVprospective_Proteome_JHU_20161201_raw/11CPTAC_OVprospective_W_JHUZ_20161201_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample12 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample12 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 083 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 763D 1 65 G3 IIIC 04OV057 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 108 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma Black or African American Female Ovary Ovary 591D 1 75 not available IIIA 17OV013 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 078 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 728D 1 85 G3 IIIC 26OV009 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC3 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 057 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 828D 1 not applicable G3 IIIC 01OV013 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 063 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not available Ovary 679D 1 not applicable G2 III 17OV001 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 036 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 679D 1 80 G2 III 17OV001 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 024 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 933D 1 90 G3 IIIC 02OV005 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 070 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 842D 1 70 G3 IIIC 13OV004 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/12CPTAC_OVprospective_Proteome_JHU_20161202/12CPTAC_OVprospective_Proteome_JHU_20161202_raw/12CPTAC_OVprospective_W_JHUZ_20161202_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f01.raw 1 1 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f02.raw 1 2 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f03.raw 1 3 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f04.raw 1 4 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f05.raw 1 5 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f06.raw 1 6 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f07.raw 1 7 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f08.raw 1 8 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f09.raw 1 9 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f10.raw 1 10 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f11.raw 1 11 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f12.raw 1 12 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f13.raw 1 13 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f14.raw 1 14 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f15.raw 1 15 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f16.raw 1 16 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f17.raw 1 17 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f18.raw 1 18 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f19.raw 1 19 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f20.raw 1 20 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f21.raw 1 21 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f22.raw 1 22 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f23.raw 1 23 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +pooled sample13 Homo sapiens ovary not applicable not applicable not applicable not applicable not applicable not applicable not applicable not applicable not available 1 not applicable not applicable not applicable pooled sample13 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT126 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +SPL 091 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 782D 1 75 G3 IV 26OV008 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT127N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +QC2 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma not available Female not available not available not available 1 not available not available not available Sample 5776 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT127C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 022 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Peritoneum Peritoneum 585D 1 80 G3 IIIA 01OV029 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT128N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 090 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 527D 1 80 G3 IIIB 17OV030 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT128C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 096 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 954D 1 90 not available IIIC 17OV017 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT129N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 095 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Ovary Ovary 843D 1 70 G3 IIIC 20OV005 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT129C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 065 Homo sapiens ovary not applicable not applicable adult ovarian high grade serous adenocarcinoma White Female Omentum Ovary 762D 1 65 G3 IV 04OV053 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT130N NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 ovarian high grade serous adenocarcinoma +SPL 052 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable Peritoneum 585D 1 not applicable G3 IIIA 01OV029 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT130C NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor +SPL 042 Homo sapiens ovary not applicable not applicable adult Non-Tumor White Female not applicable not applicable 668D 1 not applicable not applicable not applicable 17OV003 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/S059_Ovarian_Cancer_Glycoproteome_Cell2020/13CPTAC_OVprospective_Proteome_JHU_20161206/13CPTAC_OVprospective_Proteome_JHU_20161206_raw/13CPTAC_OVprospective_W_JHUZ_20161206_QE_f24.raw 1 24 TMT131 NT=Q Exactive;AC=MS:1001911 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=TMT6plex;AC=UNIMOD:737;PP=Protein N-term;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT=Trypsin;AC=MS:1001251 NT=HCD;AC=PRIDE:0000590 31% NCE 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Non-Tumor diff --git a/annotated-projects/PXD000527/PXD000527.sdrf.tsv b/annotated-projects/PXD000527/PXD000527.sdrf.tsv index c76b5990c..d575696ad 100644 --- a/annotated-projects/PXD000527/PXD000527.sdrf.tsv +++ b/annotated-projects/PXD000527/PXD000527.sdrf.tsv @@ -1,241 +1,241 @@ source name characteristics[organism] characteristics[organism part] characteristics[sex] characteristics[cell type] characteristics[developmental stage] characteristics[disease] characteristics[genotype] characteristics[phenotype] characteristics[biological replicate] assay name technology type comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[technical replicate] comment[fraction identifier] comment[instrument] comment[cleavage agent details] comment[number of missed cleavages] comment[proteomics data acquisition method] comment[data file] comment[file uri] comment[sdrf version] comment[sdrf template] -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS1_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A1 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E1 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F1 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C1 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B1 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D1 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E2 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS2_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B2 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A2 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B3 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F2 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D2 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C2 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A3 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_1 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_10 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_2 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_3 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_4 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_5 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_6 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_7 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_8 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -IS3_pool Citrus maxima floral bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C3 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -C4 Citrus maxima floral bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -E3 Citrus maxima floral bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -D3 Citrus maxima floral bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -A4 Citrus maxima floral bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -F3 Citrus maxima floral bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -B4 Citrus maxima floral bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_9 proteomic profiling by mass spectrometry iTRAQ reagent 121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_1 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_1 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_1 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_1 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_1 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_1 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_1 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_1 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_10 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_10 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_10 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_10 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_10 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_10 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_10 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_10 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_2 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_2 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_2 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_2 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_2 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_2 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_2 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_2 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_3 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_3 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_3 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_3 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_3 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_3 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_3 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_3 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_4 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_4 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_4 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_4 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_4 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_4 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_4 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_4 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_5 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_5 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_5 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_5 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_5 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_5 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_5 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_5 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_6 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_6 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_6 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_6 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_6 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_6 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_6 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_6 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_7 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_7 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_7 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_7 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_7 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_7 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_7 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_7 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_8 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_8 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_8 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_8 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_8 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_8 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_8 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_8 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS1_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 1 run_1_fraction_9 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A1 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 1 run_1_fraction_9 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E1 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 1 run_1_fraction_9 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F1 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 1 run_1_fraction_9 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C1 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 1 run_1_fraction_9 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B1 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 1 run_1_fraction_9 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D1 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 1 run_1_fraction_9 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E2 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 2 run_1_fraction_9 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_1_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_1_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_1 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_1 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_1 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_1 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_1 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_1 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_1 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_1 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_10 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_10 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_10 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_10 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_10 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_10 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_10 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_10 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_2 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_2 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_2 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_2 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_2 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_2 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_2 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_2 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_3 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_3 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_3 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_3 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_3 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_3 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_3 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_3 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_4 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_4 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_4 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_4 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_4 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_4 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_4 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_4 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_5 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_5 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_5 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_5 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_5 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_5 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_5 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_5 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_6 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_6 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_6 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_6 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_6 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_6 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_6 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_6 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_7 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_7 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_7 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_7 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_7 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_7 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_7 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_7 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_8 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_8 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_8 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_8 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_8 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_8 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_8 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_8 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS2_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 2 run_2_fraction_9 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B2 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 2 run_2_fraction_9 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A2 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 2 run_2_fraction_9 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B3 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 3 run_2_fraction_9 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F2 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 2 run_2_fraction_9 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D2 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 2 run_2_fraction_9 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C2 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 2 run_2_fraction_9 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A3 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 3 run_2_fraction_9 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_2_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_2_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_1 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_1 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_1 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_1 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_1 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_1 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_1 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_1 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 1 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_10 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_10 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_10 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_10 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_10 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_10 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_10 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_10 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 10 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F10.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_2 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_2 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_2 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_2 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_2 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_2 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_2 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_2 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 2 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_3 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_3 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_3 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_3 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_3 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_3 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_3 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_3 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 3 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F3.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_4 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_4 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_4 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_4 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_4 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_4 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_4 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_4 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 4 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F4.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_5 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_5 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_5 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_5 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_5 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_5 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_5 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_5 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 5 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F5.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_6 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_6 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_6 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_6 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_6 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_6 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_6 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_6 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 6 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F6.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_7 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_7 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_7 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_7 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_7 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_7 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_7 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_7 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 7 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F7.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_8 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_8 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_8 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_8 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_8 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_8 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_8 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_8 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 8 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F8.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +IS3_pool Citrus maxima flower bud male not applicable not applicable not applicable not applicable not applicable 3 run_3_fraction_9 proteomic profiling by mass spectrometry itraq113 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C3 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 3 run_3_fraction_9 proteomic profiling by mass spectrometry itraq114 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +C4 Citrus maxima flower bud male not applicable stage 2 not applicable G1+HBP sterile 4 run_3_fraction_9 proteomic profiling by mass spectrometry itraq115 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +E3 Citrus maxima flower bud male not applicable stage 3 not applicable G1+HBP sterile 3 run_3_fraction_9 proteomic profiling by mass spectrometry itraq116 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +D3 Citrus maxima flower bud male not applicable stage 2 not applicable HBP fertile 3 run_3_fraction_9 proteomic profiling by mass spectrometry itraq117 NT=iTRAQ8plex;PP=Any N-term;TA=K;AC=UNIMOD:730;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +A4 Citrus maxima flower bud male not applicable stage 1 not applicable G1+HBP sterile 4 run_3_fraction_9 proteomic profiling by mass spectrometry itraq118 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +F3 Citrus maxima flower bud male not applicable stage 3 not applicable HBP fertile 3 run_3_fraction_9 proteomic profiling by mass spectrometry itraq119 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +B4 Citrus maxima flower bud male not applicable stage 1 not applicable HBP fertile 4 run_3_fraction_9 proteomic profiling by mass spectrometry itraq121 NT=iTRAQ8plex:13C(6)15N(2) ;PP=Any N-term;TA=K;AC=UNIMOD:731;MT=fixed NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable 1 9 NT=Q Exactive;AC=MS:1001911 NT=Trypsin;AC=MS:1001251 2 NT=Data-dependent acquisition;AC=PRIDE:0000627 P12162_3_F9.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD000527/P12162_3_F9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/annotated-projects/PXD000793/PXD000793.sdrf.tsv b/annotated-projects/PXD000793/PXD000793.sdrf.tsv index d35b0e044..0e4222029 100644 --- a/annotated-projects/PXD000793/PXD000793.sdrf.tsv +++ b/annotated-projects/PXD000793/PXD000793.sdrf.tsv @@ -1,117 +1,117 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[developmental stage] characteristics[biological replicate] characteristics[disease] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[file uri] comment[fractionation method] comment[technical replicate] comment[fraction identifier] comment[sample volume] comment[label] comment[cleavage agent details] comment[instrument] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[sdrf version] comment[sdrf template] -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl AC=MS:1002624;NT=iTRAQ reagent 114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl AC=MS:1002625;NT=iTRAQ reagent 115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl AC=MS:1002626;NT=iTRAQ reagent 116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl AC=MS:1002627;NT=iTRAQ reagent 117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 1 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 01 CEX1 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/01 CEX1 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 2 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 02 CEX1 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/02 CEX1 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 3 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 03 CEX1 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/03 CEX1 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX1 5 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 4 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 04 CEX2 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/04 CEX2 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 5 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 05 CEX2 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/05 CEX2 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 6 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 06 CEX2 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/06 CEX2 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX2 5 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 7 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 07 CEX3 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/07 CEX3 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 8 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 08 CEX3 3uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/08 CEX3 3uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 9 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 09 CEX3 5uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/09 CEX3 5uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX3 5 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 10 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 10 CEX4 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/10 CEX4 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 11 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 11 CEX4 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/11 CEX4 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 5 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 12 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 12 CEX4 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/12 CEX4 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX4 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 13 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 13 CEX5 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/13 CEX5 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 14 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 14 CEX5 5uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/14 CEX5 5uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 5 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 15 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 15 CEX5 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/15 CEX5 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX5 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 16 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 16 CEX6 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/16 CEX6 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 17 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 17 CEX6 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/17 CEX6 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 18 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 18 CEX6 6uL DBS EMC 2ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/18 CEX6 6uL DBS EMC 2ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX6 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 19 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 19 CEX7 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/19 CEX7 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 20 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 20 CEX7 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/20 CEX7 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX7 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 21 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 21 CEX8 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/21 CEX8 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 22 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 22 CEX8 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/22 CEX8 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX8 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 23 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 23 CEX9 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/23 CEX9 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 24 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 24 CEX9 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/24 CEX9 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX9 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 25 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 25 CEX10 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/25 CEX10 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 26 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 26 CEX10 6uL DBS EMC 1ex.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/26 CEX10 6uL DBS EMC 1ex.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX10 6 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 27 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 27 CEX11 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/27 CEX11 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX11 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 28 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 28 CEX12 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/28 CEX12 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX12 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-114 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl itraq114 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-115 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl itraq115 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-116 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl itraq116 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +iPRG2008-iTRAQ4plex-117 Mus musculus not available not available not available 1 not available 29 proteomic profiling by mass spectrometry NT=selected reaction monitoring;AC=MS:1000206 29 CEX13 3uL DBS EMC.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2015/05/PXD000793/29 CEX13 3uL DBS EMC.wiff NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 1 CEX13 3 µl itraq117 NT=Trypsin;AC=MS:1001251 NT=3200 QTRAP;AC=MS:1000651 0.45 Da 0.45 Da NT=Acetyl; MT=variable; PP=Protein N-Term;AC=Unimod:1; TA=.; MM=42 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Methylthio; MT=fixed; PP=Anywhere;AC=Unimod:39; TA=.; MM=45.98772 v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/annotated-projects/PXD003539/PXD003539.sdrf.tsv b/annotated-projects/PXD003539/PXD003539.sdrf.tsv index 2a9ab2328..3f71271c7 100644 --- a/annotated-projects/PXD003539/PXD003539.sdrf.tsv +++ b/annotated-projects/PXD003539/PXD003539.sdrf.tsv @@ -27,14 +27,14 @@ ME_UACC62_a Homo sapiens skin not available UACC-62 not available skin cutaneous RE_ACHN_a Homo sapiens kidney not available ACHN not available renal adenocarcinoma caucasian Male 22Y cell 1 Run 26 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130615_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 ACHN ME_MALME3M_a Homo sapiens skin not available MALME3M not available malignant melanoma caucasian Male 43Y cell 1 Run 27 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130615_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 MALME3M OV_OVCAR4_a Homo sapiens ovary not available OVCAR4 not available ovarian serous cystadenocarcinoma caucasian Female 42Y cell 1 Run 28 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130615_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 OVCAR4 -LE_RPMI8226_a Homo sapiens blood not available RPMI8226 not available B-cell plasmacytoma; myeloma caucasian Male 61Y cell 1 Run 29 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130615_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 RPMI8226 +LE_RPMI8226_a Homo sapiens blood not available RPMI8226 not available plasmacytoma caucasian Male 61Y cell 1 Run 29 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130615_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 RPMI8226 BR_T47D_a Homo sapiens breast not available T47D not available breast ductal adenocarcinoma caucasian Female 54Y cell 1 Run 30 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130615_006_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130615_006_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 T47D LC_A549_a Homo sapiens lung not available A549 not available lung carcinoma caucasian Male 58Y cell 1 Run 31 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130616_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 A549 BR_BT549_a Homo sapiens breast not available BT549 not available breast ductal adenocarcinoma caucasian Female 72Y cell 1 Run 32 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130616_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 BT549 LC_NCIH522_a Homo sapiens lung not available NCI-H522 not available non-small cell lung carcinoma caucasian Male 58Y cell 1 Run 33 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130616_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NCI-H522 RE_TK10_a Homo sapiens kidney not available TK-10 not available renal cell adenocarcinoma caucasian Male 43Y cell 1 Run 34 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130616_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 TK-10 ME_UACC257_a Homo sapiens skin not available UACC-257 not available skin cutaneous melanoma caucasian not available not available cell 1 Run 35 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130616_006_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130616_006_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 UACC-257 -PR_DU145_a Homo sapiens prostate not available DU 145 not available prostate adenocarcinoma caucasian Male 69Y cell 1 Run 36 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130617_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 DU 145 +PR_DU145_a Homo sapiens prostate gland not available DU 145 not available prostate adenocarcinoma caucasian Male 69Y cell 1 Run 36 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130617_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 DU 145 CO_HCT15_a Homo sapiens large intestine not available HCT15 not available colon adenocarcinoma caucasian Male not available cell 1 Run 37 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130617_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT15 LE_MOLT4_a Homo sapiens blood not available MOLT4 not available acute T lymphoblastic leukaemia caucasian Male 19Y cell 1 Run 38 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130617_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 MOLT4 LC_NCIH460_a Homo sapiens lung not available NCI-H460 not available large cell lung carcinoma caucasian Male not available cell 1 Run 39 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130617_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130617_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NCI-H460 @@ -54,7 +54,7 @@ OV_OVCAR5_a Homo sapiens ovary not available OVCAR5 not available ovarian adenoc LE_SR_a Homo sapiens blood not available SR not available immunoblastic large cell lymphoma caucasian Male 11Y cell 1 Run 53 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130620_006_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130620_006_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 SR LC_HOP92_a Homo sapiens lung not available HOP-92 not available large cell lung carcinoma caucasian Male 62Y cell 1 Run 54 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130621_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 HOP-92 ME_LOXIMVI_a Homo sapiens skin not available LOX IMVI not available skin cutaneous melanoma caucasian Male 58Y cell 1 Run 55 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130621_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 LOX IMVI -PR_PC3_a Homo sapiens prostate not available PC-3 not available prostate adenocarcinoma caucasian Male 62Y cell 1 Run 56 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130621_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 PC-3 +PR_PC3_a Homo sapiens prostate gland not available PC-3 not available prostate adenocarcinoma caucasian Male 62Y cell 1 Run 56 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130621_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 PC-3 RE_SN12C_a Homo sapiens kidney not available SN12C not available renal cell carcinoma caucasian Male not available cell 1 Run 57 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130621_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130621_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 SN12C LE_CCRFCEM_b Homo sapiens blood not available CCRFCEM not available acute lymphoblastic leukemia caucasian Female 3Y11M cell 2 Run 58 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130622_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130622_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 CCRFCEM LC_EKVX_b Homo sapiens lung not available EKVX not available non-small cell lung carcinoma caucasian Male not available cell 2 Run 59 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130622_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130622_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 EKVX @@ -84,14 +84,14 @@ ME_UACC62_b Homo sapiens skin not available UACC-62 not available skin cutaneous RE_ACHN_b Homo sapiens kidney not available ACHN not available renal adenocarcinoma caucasian Male 22Y cell 2 Run 83 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130627_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 ACHN ME_MALME3M_b Homo sapiens skin not available MALME3M not available malignant melanoma caucasian Male 43Y cell 2 Run 84 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130627_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 MALME3M OV_OVCAR4_b Homo sapiens ovary not available OVCAR4 not available ovarian serous cystadenocarcinoma caucasian Female 42Y cell 2 Run 85 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130627_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 OVCAR4 -LE_RPMI8226_b Homo sapiens blood not available RPMI8226 not available B-cell plasmacytoma; myeloma caucasian Male 61Y cell 2 Run 86 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130627_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 RPMI8226 +LE_RPMI8226_b Homo sapiens blood not available RPMI8226 not available plasmacytoma caucasian Male 61Y cell 2 Run 86 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130627_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 RPMI8226 BR_T47D_b Homo sapiens breast not available T47D not available breast ductal adenocarcinoma caucasian Female 54Y cell 2 Run 87 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130627_006_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130627_006_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 T47D LC_A549_b Homo sapiens lung not available A549 not available lung carcinoma caucasian Male 58Y cell 2 Run 88 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130628_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 A549 BR_BT549_b Homo sapiens breast not available BT549 not available breast ductal adenocarcinoma caucasian Female 72Y cell 2 Run 89 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130628_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 BT549 LC_NCIH522_b Homo sapiens lung not available NCI-H522 not available non-small cell lung carcinoma caucasian Male 58Y cell 2 Run 90 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130628_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NCI-H522 RE_TK10_b Homo sapiens kidney not available TK-10 not available renal cell adenocarcinoma caucasian Male 43Y cell 2 Run 91 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130628_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 TK-10 ME_UACC257_b Homo sapiens skin not available UACC-257 not available skin cutaneous melanoma caucasian not available not available cell 2 Run 92 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130628_006_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130628_006_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 UACC-257 -PR_DU145_b Homo sapiens prostate not available DU 145 not available prostate adenocarcinoma caucasian Male 69Y cell 2 Run 93 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130629_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 DU 145 +PR_DU145_b Homo sapiens prostate gland not available DU 145 not available prostate adenocarcinoma caucasian Male 69Y cell 2 Run 93 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130629_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 DU 145 CO_HCT15_b Homo sapiens large intestine not available HCT15 not available colon adenocarcinoma caucasian Male not available cell 2 Run 94 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130629_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT15 LE_MOLT4_b Homo sapiens blood not available MOLT4 not available acute T lymphoblastic leukaemia caucasian Male 19Y cell 2 Run 95 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130629_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 MOLT4 LC_NCIH460_b Homo sapiens lung not available NCI-H460 not available large cell lung carcinoma caucasian Male not available cell 2 Run 96 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130629_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130629_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NCI-H460 @@ -111,7 +111,7 @@ OV_OVCAR5_b Homo sapiens ovary not available OVCAR5 not available ovarian adenoc LE_SR_b Homo sapiens blood not available SR not available immunoblastic large cell lymphoma caucasian Male 11Y cell 2 Run 110 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130702_006_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130702_006_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 SR LC_HOP92_b Homo sapiens lung not available HOP-92 not available large cell lung carcinoma caucasian Male 62Y cell 2 Run 111 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130703_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 HOP-92 ME_LOXIMVI_b Homo sapiens skin not available LOX IMVI not available skin cutaneous melanoma caucasian Male 58Y cell 2 Run 112 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130703_003b_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_003b_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 LOX IMVI -PR_PC3_b Homo sapiens prostate not available PC-3 not available prostate adenocarcinoma caucasian Male 62Y cell 2 Run 113 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130703_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 PC-3 +PR_PC3_b Homo sapiens prostate gland not available PC-3 not available prostate adenocarcinoma caucasian Male 62Y cell 2 Run 113 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130703_004_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_004_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 PC-3 RE_SN12C_b Homo sapiens kidney not available SN12C not available renal cell carcinoma caucasian Male not available cell 2 Run 114 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130703_005_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130703_005_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 SN12C CNS_SNB75_a Homo sapiens brain not available SNB75 not available astrocytoma caucasian Female 74Y cell 1 Run 115 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130719_002_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130719_002_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 SNB75 CNS_SNB75_b Homo sapiens brain not available SNB75 not available astrocytoma caucasian Female 74Y cell 2 Run 116 proteomic profiling by mass spectrometry data-dependent acquisition guot_L130719_003_SW.wiff https://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD003539/guot_L130719_003_SW.wiff PXD003539 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin NT=TripleTOF 5600;AC=MS:1000932 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 400 1200 v1.1.0 NT=ms-proteomics;VV=v1.1.0 SNB75 diff --git a/annotated-projects/PXD005163/PXD005163.sdrf.tsv b/annotated-projects/PXD005163/PXD005163.sdrf.tsv index 0cff9e044..eb7c98de2 100644 --- a/annotated-projects/PXD005163/PXD005163.sdrf.tsv +++ b/annotated-projects/PXD005163/PXD005163.sdrf.tsv @@ -1,73 +1,73 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[ancestry category] characteristics[age] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[biological replicate] characteristics[phenotype] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[fractionation method] comment[file uri] comment[sdrf version] comment[sdrf template] -Sample 1 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr1.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr1.raw 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr2.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr2.raw 1 2 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr3.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr3.raw 1 3 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr4.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr4.raw 1 4 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr5.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr5.raw 1 5 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr6.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr6.raw 1 6 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr7.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr7.raw 1 7 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr8.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr8.raw 1 8 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr9.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr9.raw 1 9 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr10.raw 1 10 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr11.raw 1 11 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr12.raw 1 12 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr13.raw 1 13 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr14.raw 1 14 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr15.raw 1 15 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr16.raw 1 16 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr17.raw 1 17 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr18.raw 1 18 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr19.raw 1 19 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr20.raw 1 20 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr21.raw 1 21 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr22.raw 1 22 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr23.raw 1 23 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr24.raw 1 24 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr25.raw 1 25 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr26.raw 1 26 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr27.raw 1 27 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr28.raw 1 28 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr29.raw 1 29 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr30.raw 1 30 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 31 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr31.raw 1 31 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 31 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr31.raw 1 31 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 32 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr32.raw 1 32 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 32 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr32.raw 1 32 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 33 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr33.raw 1 33 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 33 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr33.raw 1 33 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 34 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr34.raw 1 34 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 34 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr34.raw 1 34 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 35 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr35.raw 1 35 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 35 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr35.raw 1 35 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 36 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr36.raw 1 36 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 36 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr36.raw 1 36 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr1.raw 1 1 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr1.raw 1 1 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr2.raw 1 2 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr2.raw 1 2 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr3.raw 1 3 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr3.raw 1 3 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr3.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr4.raw 1 4 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr4.raw 1 4 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr5.raw 1 5 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr5.raw 1 5 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr5.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr6.raw 1 6 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr6.raw 1 6 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr6.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr7.raw 1 7 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr7.raw 1 7 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr7.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr8.raw 1 8 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr8.raw 1 8 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr8.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr9.raw 1 9 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr9.raw 1 9 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr9.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr10.raw 1 10 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr10.raw 1 10 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr11.raw 1 11 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr11.raw 1 11 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr12.raw 1 12 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr12.raw 1 12 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr13.raw 1 13 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr13.raw 1 13 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr14.raw 1 14 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr14.raw 1 14 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr15.raw 1 15 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr15.raw 1 15 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr16.raw 1 16 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr16.raw 1 16 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr17.raw 1 17 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr17.raw 1 17 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr18.raw 1 18 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr18.raw 1 18 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr19.raw 1 19 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr19.raw 1 19 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr20.raw 1 20 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr20.raw 1 20 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr21.raw 1 21 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr21.raw 1 21 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr22.raw 1 22 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr22.raw 1 22 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr23.raw 1 23 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr23.raw 1 23 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr24.raw 1 24 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr24.raw 1 24 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr25.raw 1 25 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr25.raw 1 25 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr26.raw 1 26 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr26.raw 1 26 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr27.raw 1 27 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr27.raw 1 27 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr28.raw 1 28 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr28.raw 1 28 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr29.raw 1 29 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr29.raw 1 29 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr30.raw 1 30 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr30.raw 1 30 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 31 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr31.raw 1 31 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 31 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr31.raw 1 31 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 32 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr32.raw 1 32 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 32 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr32.raw 1 32 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 33 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr33.raw 1 33 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 33 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr33.raw 1 33 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 34 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr34.raw 1 34 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 34 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr34.raw 1 34 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 35 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr35.raw 1 35 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 35 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr35.raw 1 35 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 36 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with high-risk MammaPrint breast cancer run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr36.raw 1 36 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 36 Homo sapiens Breast not available not available not available not available Breast cancer not available 1 18 patients with with low-risk MammaPrint breast cancer run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 BreastCancerMem_Fr36.raw 1 36 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Lys-C;AC=MS:1001309 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000201.0/BreastCancerMem_Fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/annotated-projects/PXD005171/PXD005171.sdrf.tsv b/annotated-projects/PXD005171/PXD005171.sdrf.tsv index bf6d9d3a3..f509220ba 100644 --- a/annotated-projects/PXD005171/PXD005171.sdrf.tsv +++ b/annotated-projects/PXD005171/PXD005171.sdrf.tsv @@ -1,101 +1,101 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[ancestry category] characteristics[age] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[biological replicate] characteristics[phenotype] assay name technology type comment[data file] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[proteomics data acquisition method] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[fractionation method] comment[fractionation method] comment[file uri] comment[sdrf version] comment[sdrf template] -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 1 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_01.raw 1 1 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 2 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_02.raw 1 2 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 3 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_03.raw 1 3 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 4 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_04.raw 1 4 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 5 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_05.raw 1 5 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 6 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_06.raw 1 6 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 7 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_07.raw 1 7 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 8 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_08.raw 1 8 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 9 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_09.raw 1 9 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 10 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_10.raw 1 10 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 11 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_11.raw 1 11 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 12 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_12.raw 1 12 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 13 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_13.raw 1 13 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 14 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_14.raw 1 14 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 15 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_15.raw 1 15 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 16 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_16.raw 1 16 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 17 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_17.raw 1 17 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 18 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_18.raw 1 18 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 19 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_19.raw 1 19 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 20 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_20.raw 1 20 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 21 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_21.raw 1 21 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 22 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_22.raw 1 22 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 23 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_23.raw 1 23 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 24 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_24.raw 1 24 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with no metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 patients with metastasis run 25 proteomic profiling by mass spectrometry CRC_phospho_iTRAQ_25.raw 1 25 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000204.0/CRC_phospho_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/annotated-projects/PXD005174/PXD005174.sdrf.tsv b/annotated-projects/PXD005174/PXD005174.sdrf.tsv index 13548371b..3dd57d370 100644 --- a/annotated-projects/PXD005174/PXD005174.sdrf.tsv +++ b/annotated-projects/PXD005174/PXD005174.sdrf.tsv @@ -1,129 +1,129 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[cell line] characteristics[ancestry category] characteristics[age] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[biological replicate] characteristics[phenotype] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[fractionation method] comment[fractionation method] comment[file uri] comment[sdrf version] comment[sdrf template] factor value[phenotype] -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 AC=MS:1002625;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 AC=MS:1002626;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone -phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 AC=MS:1002627;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_1.raw 1 1 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_2.raw 1 2 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_3.raw 1 3 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_4.raw 1 4 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_5.raw 1 5 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_6.raw 1 6 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_7.raw 1 7 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_8.raw 1 8 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_9.raw 1 9 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_10.raw 1 10 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_11.raw 1 11 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_12.raw 1 12 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_13.raw 1 13 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_14.raw 1 14 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_15.raw 1 15 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_16.raw 1 16 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_17.raw 1 17 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_18.raw 1 18 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_19.raw 1 19 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_20.raw 1 20 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_21.raw 1 21 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_22.raw 1 22 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_23.raw 1 23 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_24.raw 1 24 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_25.raw 1 25 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_26.raw 1 26 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_27.raw 1 27 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_28.raw 1 28 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_29.raw 1 29 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_30.raw 1 30 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_31.raw 1 31 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +phospho_1 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_2 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +phospho_3 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT115 metastatic clone run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT115 metastatic clone +phospho_4 Homo sapiens Colorectum not available HCT116 not available not available not available Colorectal cancer not available 1 HCT116 metastatic clone run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 120404_mHCT116_phospho_32.raw 1 32 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Trypsin/P;AC=MS:1001313 NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=IMAC;AC=PRIDE:0000587 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000206.0/120404_mHCT116_phospho_35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone diff --git a/annotated-projects/PXD005175/PXD005175.sdrf.tsv b/annotated-projects/PXD005175/PXD005175.sdrf.tsv index 370bdf87c..5948bdf2c 100644 --- a/annotated-projects/PXD005175/PXD005175.sdrf.tsv +++ b/annotated-projects/PXD005175/PXD005175.sdrf.tsv @@ -1,121 +1,121 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[ancestry category] characteristics[age] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[biological replicate] characteristics[phenotype] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[fractionation method] comment[file uri] comment[sdrf version] comment[sdrf template] -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001743 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001773 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001803 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001744 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001774 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001804 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001745 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001775 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001805 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001746 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001776 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001806 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001747 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001777 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001807 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001748 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001778 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001808 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001749 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001779 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001809 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001750 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001780 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001810 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001751 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001781 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001811 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001752 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001782 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001812 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001753 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001783 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001813 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001754 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001784 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001814 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001755 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001785 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001815 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001756 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001786 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001816 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001757 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001787 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001817 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001758 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001788 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001818 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001759 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001789 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001819 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001760 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001790 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001820 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001761 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001791 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001821 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001762 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001792 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001822 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001763 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001793 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001823 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001764 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001794 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001824 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001765 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001795 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001825 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001766 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001796 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001826 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001767 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001797 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001827 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001768 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001798 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001828 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001769 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001799 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001829 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001770 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001800 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001830 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001771 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001801 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001831 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001772 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001802 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001832 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001743 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001773 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_01.raw 1 1 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001803 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001744 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001774 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_02.raw 1 2 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001804 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001745 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001775 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_03.raw 1 3 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001805 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001746 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001776 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_04.raw 1 4 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001806 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001747 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001777 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_05.raw 1 5 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001807 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001748 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001778 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_06.raw 1 6 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001808 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001749 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001779 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_07.raw 1 7 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001809 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001750 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001780 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_08.raw 1 8 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001810 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001751 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001781 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_09.raw 1 9 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001811 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001752 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001782 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_10.raw 1 10 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001812 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001753 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001783 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_11.raw 1 11 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001813 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001754 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001784 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_12.raw 1 12 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001814 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001755 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001785 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_13.raw 1 13 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001815 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001756 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001786 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_14.raw 1 14 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001816 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001757 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001787 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_15.raw 1 15 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001817 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001758 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001788 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_16.raw 1 16 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001818 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001759 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001789 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_17.raw 1 17 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001819 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001760 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001790 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_18.raw 1 18 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001820 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001761 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001791 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_19.raw 1 19 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001821 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001762 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001792 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_20.raw 1 20 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001822 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001763 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001793 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_21.raw 1 21 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001823 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001764 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001794 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_22.raw 1 22 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001824 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001765 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001795 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_23.raw 1 23 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001825 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001766 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001796 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_24.raw 1 24 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001826 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001767 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001797 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_25.raw 1 25 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001827 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001768 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001798 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_26.raw 1 26 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001828 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001769 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001799 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_27.raw 1 27 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001829 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001770 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001800 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_28.raw 1 28 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001830 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001771 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001801 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_29.raw 1 29 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001831 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001772 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with no metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001802 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Colorectum not available not available not available not available Colorectal cancer not available 1 12 colorectal cancer patients with metastasis run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 CRC_iTRAQ_30.raw 1 30 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001832 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000203.0/CRC_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/annotated-projects/PXD005177/PXD005177.sdrf.tsv b/annotated-projects/PXD005177/PXD005177.sdrf.tsv index 4c56c852c..23f867e5f 100644 --- a/annotated-projects/PXD005177/PXD005177.sdrf.tsv +++ b/annotated-projects/PXD005177/PXD005177.sdrf.tsv @@ -1,137 +1,137 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell line] characteristics[cell type] characteristics[ancestry category] characteristics[age] characteristics[developmental stage] characteristics[sex] characteristics[disease] characteristics[individual] characteristics[biological replicate] characteristics[phenotype] assay name technology type comment[data file] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[proteomics data acquisition method] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[fractionation method] comment[file uri] comment[sdrf version] comment[sdrf template] factor value[phenotype] -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 AC=MS:1002624;NT=iTRAQ reagent 114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 AC=MS:1002624;NT=iTRAQ reagent 115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 AC=MS:1002624;NT=iTRAQ reagent 116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone -mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 AC=MS:1002624;NT=iTRAQ reagent 117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 itraq114 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 parent clone without metastasis run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 itraq115 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 parent clone without metastasis +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 itraq116 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 1 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_01.raw 1 1 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 2 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_02.raw 1 2 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 3 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_03.raw 1 3 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 4 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_04.raw 1 4 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 5 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_05.raw 1 5 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 6 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_06.raw 1 6 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 7 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_07.raw 1 7 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 8 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_08.raw 1 8 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 9 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_09.raw 1 9 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 10 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_10.raw 1 10 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 11 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_11.raw 1 11 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 12 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_12.raw 1 12 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 13 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_13.raw 1 13 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 14 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_14.raw 1 14 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 15 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_15.raw 1 15 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 16 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_16.raw 1 16 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 17 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_17.raw 1 17 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 18 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_18.raw 1 18 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 19 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_19.raw 1 19 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 20 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_20.raw 1 20 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 21 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_21.raw 1 21 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 22 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_22.raw 1 22 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 23 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_23.raw 1 23 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 24 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_24.raw 1 24 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 25 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_25.raw 1 25 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 26 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_26.raw 1 26 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 27 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_27.raw 1 27 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 28 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_28.raw 1 28 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 29 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_29.raw 1 29 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 30 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_30.raw 1 30 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 31 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_31.raw 1 31 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 32 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_32.raw 1 32 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 33 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_33.raw 1 33 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone +mHCT116_iTRAQ Homo sapiens Colorectum HCT116 epithelial not available not available adult Male Colorectal cancer not available 1 HCT116 metastatic clone run 34 proteomic profiling by mass spectrometry 120307_mHCT116_iTRAQ_34.raw 1 34 itraq117 NT=LTQ Orbitrap Velos;AC=MS:1001742 NT=Data-dependent acquisition;AC=PRIDE:0000627 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=iTRAQ4plex; MT=fixed; PP=Anywhere;AC=Unimod:214; TA=K; MM=144 NT=iTRAQ4plex; MT=fixed; PP=Any N-Term;AC=Unimod:214; TA=.; MM=144 NT=iTRAQ4plex; MT=variable; PP=Anywhere;AC=Unimod:214; TA=Y; MM=144 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 https://repository.jpostdb.org/data/JPST000205.0/120307_mHCT116_iTRAQ_34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HCT116 metastatic clone diff --git a/annotated-projects/PXD008841/PXD008841.sdrf.tsv b/annotated-projects/PXD008841/PXD008841.sdrf.tsv index 046e03384..49ead851f 100644 --- a/annotated-projects/PXD008841/PXD008841.sdrf.tsv +++ b/annotated-projects/PXD008841/PXD008841.sdrf.tsv @@ -8,7 +8,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -18,7 +18,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -28,7 +28,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -38,7 +38,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -48,7 +48,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -58,7 +58,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -68,7 +68,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -78,7 +78,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -88,7 +88,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -98,7 +98,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -108,7 +108,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -118,7 +118,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -128,7 +128,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -138,7 +138,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -148,7 +148,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -158,7 +158,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -168,7 +168,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -178,7 +178,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -188,7 +188,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -198,7 +198,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -208,7 +208,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -218,7 +218,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -228,7 +228,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -238,7 +238,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -248,7 +248,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -258,7 +258,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -268,7 +268,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -278,7 +278,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -288,7 +288,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -298,7 +298,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -308,7 +308,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -318,7 +318,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -328,7 +328,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -338,7 +338,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -348,7 +348,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -358,7 +358,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -368,7 +368,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -378,7 +378,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -388,7 +388,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -398,7 +398,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -408,7 +408,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -418,7 +418,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -428,7 +428,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -438,7 +438,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -448,7 +448,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -458,7 +458,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -468,7 +468,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -478,7 +478,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -488,7 +488,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -498,7 +498,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -508,7 +508,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -518,7 +518,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -528,7 +528,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -538,7 +538,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -548,7 +548,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -558,7 +558,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -568,7 +568,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -578,7 +578,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -588,7 +588,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -598,7 +598,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -608,7 +608,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -618,7 +618,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -628,7 +628,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -638,7 +638,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -648,7 +648,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -658,7 +658,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -668,7 +668,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -678,7 +678,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -688,7 +688,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -698,7 +698,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -708,7 +708,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.53E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.567 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.3FF Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma @@ -718,7 +718,7 @@ OSL.4B0 Homo Sapiens breast not available not available female malignant cell 1 OSL.4D6 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.485 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.41B Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 1, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -728,7 +728,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -738,7 +738,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -748,7 +748,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -758,7 +758,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -768,7 +768,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -778,7 +778,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -788,7 +788,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -798,7 +798,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -808,7 +808,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -818,7 +818,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -828,7 +828,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -838,7 +838,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -848,7 +848,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -858,7 +858,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -868,7 +868,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -878,7 +878,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -888,7 +888,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -898,7 +898,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -908,7 +908,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -918,7 +918,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -928,7 +928,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -938,7 +938,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -948,7 +948,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -958,7 +958,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -968,7 +968,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -978,7 +978,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -988,7 +988,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -998,7 +998,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1008,7 +1008,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1018,7 +1018,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1028,7 +1028,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1038,7 +1038,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1048,7 +1048,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1058,7 +1058,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1068,7 +1068,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1078,7 +1078,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1088,7 +1088,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1098,7 +1098,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1108,7 +1108,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1118,7 +1118,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1128,7 +1128,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1138,7 +1138,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1148,7 +1148,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1158,7 +1158,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1168,7 +1168,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1178,7 +1178,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1188,7 +1188,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1198,7 +1198,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1208,7 +1208,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1218,7 +1218,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1228,7 +1228,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1238,7 +1238,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1248,7 +1248,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1258,7 +1258,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1268,7 +1268,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1278,7 +1278,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1288,7 +1288,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1298,7 +1298,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1308,7 +1308,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1318,7 +1318,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1328,7 +1328,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1338,7 +1338,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1348,7 +1348,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1358,7 +1358,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1368,7 +1368,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1378,7 +1378,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1388,7 +1388,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1398,7 +1398,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1408,7 +1408,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1418,7 +1418,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1428,7 +1428,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.4AF Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.46E Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma OSL.494 Homo Sapiens breast not available not available female malignant cell 1 not pooled luminal A breast carcinoma pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 luminal A breast carcinoma @@ -1438,7 +1438,7 @@ OSL.4B4 Homo Sapiens breast not available not available female malignant cell 1 OSL.449 Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.44E Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma OSL.3EB Homo Sapiens breast not available not available female malignant cell 1 not pooled basal-like breast carcinoma pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 basal-like breast carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 2, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1448,7 +1448,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1458,7 +1458,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1468,7 +1468,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1478,7 +1478,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1488,7 +1488,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1498,7 +1498,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1508,7 +1508,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1518,7 +1518,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1528,7 +1528,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1538,7 +1538,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1548,7 +1548,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1558,7 +1558,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1568,7 +1568,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1578,7 +1578,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1588,7 +1588,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1598,7 +1598,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1608,7 +1608,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1618,7 +1618,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1628,7 +1628,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1638,7 +1638,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1648,7 +1648,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1658,7 +1658,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1668,7 +1668,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1678,7 +1678,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1688,7 +1688,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1698,7 +1698,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1708,7 +1708,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1718,7 +1718,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1728,7 +1728,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1738,7 +1738,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1748,7 +1748,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1758,7 +1758,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1768,7 +1768,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1778,7 +1778,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1788,7 +1788,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1798,7 +1798,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1808,7 +1808,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1818,7 +1818,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1828,7 +1828,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1838,7 +1838,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1848,7 +1848,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1858,7 +1858,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1868,7 +1868,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1878,7 +1878,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1888,7 +1888,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1898,7 +1898,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1908,7 +1908,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1918,7 +1918,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1928,7 +1928,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1938,7 +1938,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1948,7 +1948,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1958,7 +1958,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1968,7 +1968,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1978,7 +1978,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1988,7 +1988,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -1998,7 +1998,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2008,7 +2008,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2018,7 +2018,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2028,7 +2028,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2038,7 +2038,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2048,7 +2048,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2058,7 +2058,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2068,7 +2068,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2078,7 +2078,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2088,7 +2088,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2098,7 +2098,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2108,7 +2108,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2118,7 +2118,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2128,7 +2128,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2138,7 +2138,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2148,7 +2148,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.493 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.4D9 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2158,7 +2158,7 @@ OSL.49E Homo Sapiens breast not available not available female malignant cell 1 OSL.441 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.430 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.4FA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 3, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2168,7 +2168,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2178,7 +2178,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2188,7 +2188,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2198,7 +2198,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2208,7 +2208,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2218,7 +2218,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2228,7 +2228,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2238,7 +2238,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2248,7 +2248,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2258,7 +2258,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2268,7 +2268,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2278,7 +2278,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2288,7 +2288,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2298,7 +2298,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2308,7 +2308,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2318,7 +2318,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2328,7 +2328,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2338,7 +2338,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2348,7 +2348,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2358,7 +2358,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2368,7 +2368,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2378,7 +2378,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2388,7 +2388,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2398,7 +2398,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2408,7 +2408,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2418,7 +2418,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2428,7 +2428,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2438,7 +2438,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2448,7 +2448,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2458,7 +2458,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2468,7 +2468,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2478,7 +2478,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2488,7 +2488,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2498,7 +2498,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2508,7 +2508,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2518,7 +2518,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2528,7 +2528,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2538,7 +2538,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2548,7 +2548,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2558,7 +2558,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2568,7 +2568,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2578,7 +2578,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2588,7 +2588,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2598,7 +2598,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2608,7 +2608,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2618,7 +2618,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2628,7 +2628,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2638,7 +2638,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2648,7 +2648,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2658,7 +2658,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2668,7 +2668,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2678,7 +2678,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2688,7 +2688,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2698,7 +2698,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2708,7 +2708,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2718,7 +2718,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2728,7 +2728,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2738,7 +2738,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2748,7 +2748,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2758,7 +2758,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2768,7 +2768,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2778,7 +2778,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2788,7 +2788,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2798,7 +2798,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2808,7 +2808,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2818,7 +2818,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2828,7 +2828,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2838,7 +2838,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2848,7 +2848,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2858,7 +2858,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2868,7 +2868,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.43A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.406 Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.47C Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2878,7 +2878,7 @@ OSL.458 Homo Sapiens breast not available not available female malignant cell 1 OSL.53D Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.540 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.42E Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 4, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2888,7 +2888,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw 1 1 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2898,7 +2898,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw 1 2 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2908,7 +2908,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw 1 3 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2918,7 +2918,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw 1 4 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2928,7 +2928,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw 1 5 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2938,7 +2938,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw 1 6 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2948,7 +2948,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw 1 7 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2958,7 +2958,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw 1 8 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2968,7 +2968,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw 1 9 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2978,7 +2978,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw 1 10 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2988,7 +2988,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw 1 11 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -2998,7 +2998,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw 1 12 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3008,7 +3008,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw 1 13 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3018,7 +3018,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw 1 14 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3028,7 +3028,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw 1 15 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3038,7 +3038,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw 1 16 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3048,7 +3048,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw 1 17 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3058,7 +3058,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw 1 18 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3068,7 +3068,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw 1 19 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3078,7 +3078,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw 1 20 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3088,7 +3088,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw 1 21 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3098,7 +3098,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw 1 22 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3108,7 +3108,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw 1 23 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3118,7 +3118,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw 1 24 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3128,7 +3128,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw 1 25 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3138,7 +3138,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw 1 26 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3148,7 +3148,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw 1 27 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3158,7 +3158,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw 1 28 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3168,7 +3168,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw 1 29 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3178,7 +3178,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw 1 30 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3188,7 +3188,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw 1 31 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3198,7 +3198,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw 1 32 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3208,7 +3208,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw 1 33 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3218,7 +3218,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw 1 34 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3228,7 +3228,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw 1 35 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3238,7 +3238,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw 1 36 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3248,7 +3248,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw 1 37 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3258,7 +3258,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw 1 38 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3268,7 +3268,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw 1 39 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3278,7 +3278,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw 1 40 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3288,7 +3288,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw 1 41 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3298,7 +3298,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw 1 42 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3308,7 +3308,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw 1 43 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3318,7 +3318,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw 1 44 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3328,7 +3328,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw 1 45 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3338,7 +3338,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw 1 46 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3348,7 +3348,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw 1 47 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3358,7 +3358,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw 1 48 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3368,7 +3368,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw 1 49 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3378,7 +3378,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw 1 50 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3388,7 +3388,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw 1 51 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3398,7 +3398,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw 1 52 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3408,7 +3408,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw 1 53 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3418,7 +3418,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw 1 54 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3428,7 +3428,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw 1 55 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3438,7 +3438,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw 1 56 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3448,7 +3448,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw 1 57 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3458,7 +3458,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw 1 58 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3468,7 +3468,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw 1 59 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3478,7 +3478,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw 1 60 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3488,7 +3488,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw 1 61 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3498,7 +3498,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw 1 62 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3508,7 +3508,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw 1 63 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3518,7 +3518,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw 1 64 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3528,7 +3528,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw 1 65 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3538,7 +3538,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw 1 66 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3548,7 +3548,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw 1 67 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3558,7 +3558,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw 1 68 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3568,7 +3568,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw 1 69 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3578,7 +3578,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw 1 70 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3588,7 +3588,7 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw 1 71 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer OSL.40A Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT126 Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.40E Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma OSL.3FA Homo Sapiens breast not available not available female malignant cell 1 not pooled HER2 Positive Breast Carcinoma pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT127C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 HER2 Positive Breast Carcinoma @@ -3598,4 +3598,4 @@ OSL.54D Homo Sapiens breast not available not available female malignant cell 1 OSL.4BA Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT129C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.579 Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma OSL.57B Homo Sapiens breast not available not available female malignant cell 1 not pooled Normal Breast-Like Subtype of Breast Carcinoma pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT130C Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 Normal Breast-Like Subtype of Breast Carcinoma -pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B breast cancer pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer +pool Homo Sapiens breast not available not available female malignant cell 1 SN=OSL.53E;SN=OSL.567;SN=OSL.3FF;SN=OSL.55F;SN=OSL.46A;SN=OSL.4B0;SN=OSL.4D6;SN=OSL.485;SN=OSL.41B;SN=OSL.4AF;SN=OSL.46E;SN=OSL.494;SN=OSL.457;SN=OSL.48B;SN=OSL.4B4;SN=OSL.449;SN=OSL.44E;SN=OSL.3EB;SN=OSL.43C;SN=OSL.493;SN=OSL.4D9;SN=OSL.56F;SN=OSL.405;SN=OSL.49E;SN=OSL.441;SN=OSL.430;SN=OSL.4FA;SN=OSL.43A;SN=OSL.406;SN=OSL.47C;SN=OSL.524;SN=OSL.443;SN=OSL.458;SN=OSL.53D;SN=OSL.540;SN=OSL.42E;SN=OSL.40A;SN=OSL.40E;SN=OSL.3FA;SN=OSL.521;SN=OSL.46D;SN=OSL.54D;SN=OSL.4BA;SN=OSL.579;SN=OSL.57B breast cancer pool 5, fraction 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw 1 72 TMT131N Q Exactive 20.0 ppm 5.0 ppm NT=Trypsin/P;CS=(?<=[KR]) NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490 NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060 NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293 NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293 NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146 NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293 https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 breast cancer diff --git a/annotated-projects/PXD010429/PXD010429.sdrf.tsv b/annotated-projects/PXD010429/PXD010429.sdrf.tsv index bedc1d0ce..e0a802f8b 100644 --- a/annotated-projects/PXD010429/PXD010429.sdrf.tsv +++ b/annotated-projects/PXD010429/PXD010429.sdrf.tsv @@ -1,4177 +1,4177 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[cell line] characteristics[developmental stage] characteristics[disease] characteristics[ancestry category] characteristics[sex] characteristics[age] characteristics[subtype] characteristics[biological replicate] characteristics[individual] characteristics[material type] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[file uri] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[sdrf version] comment[sdrf template] factor value[subtype] -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A -Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed -Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B -Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable -Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 m/z v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 16 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 17 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 18 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 19 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 20 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 21 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 22 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 1 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-126 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 2 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT01-127 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 3 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC015 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 4 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC047 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 5 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC024 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 6 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC050 tissue run 23 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 7 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-126 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 8 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT01-127 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 9 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC015 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 10 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC047 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 11 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC024 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 12 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC050 tissue run 24 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT01-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 25 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 26 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 27 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 28 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 29 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 30 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 31 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 32 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 33 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 34 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 35 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 36 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 37 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 38 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 39 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 40 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 41 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 42 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 43 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 44 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 45 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 46 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 13 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-126 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 14 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC071 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 15 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT02-128 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 16 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC045 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 17 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC037 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 18 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC034 tissue run 47 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 19 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-126 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 20 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC071 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 21 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT02-128 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 22 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC045 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 23 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC037 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 24 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC034 tissue run 48 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT02-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 49 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 50 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 51 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 52 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 53 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 54 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 55 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 56 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 57 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 58 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 59 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 60 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 61 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 62 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 63 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 64 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 65 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 66 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 67 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 68 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 69 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 70 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 25 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-126 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 26 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC097 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 27 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC041 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 28 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT03-129 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 29 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC096 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 30 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC039 tissue run 71 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 31 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-126 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 32 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC097 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 33 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC041 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 34 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT03-129 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 35 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC096 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 36 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC039 tissue run 72 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT03-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 73 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 74 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 75 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 76 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 77 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 78 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 79 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 80 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 81 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 82 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 83 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 84 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 85 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 86 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 87 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 88 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 89 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 90 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 91 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 92 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 93 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 94 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 37 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-126 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 38 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC038 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 39 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC020 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 40 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC065 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 41 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT04-130 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 42 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC025 tissue run 95 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 43 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-126 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 44 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC038 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 45 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC020 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 46 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC065 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 47 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT04-130 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 48 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC025 tissue run 96 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT04-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 97 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 98 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 99 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 100 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 101 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 102 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 103 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 104 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 105 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 106 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 107 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 108 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 109 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 110 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 111 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 112 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 113 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 114 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 115 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 116 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 117 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 118 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 49 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-126 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 50 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC031 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 51 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC032 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 52 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC070 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 53 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC029 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 54 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT05-131 tissue run 119 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 55 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-126 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 56 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC031 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 57 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC032 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 58 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC070 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 59 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC029 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 60 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT05-131 tissue run 120 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT05-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 121 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 122 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 123 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 124 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 125 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 126 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 127 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 128 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 129 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 130 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 131 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 132 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 133 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 134 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 135 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 136 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 137 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 138 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 139 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 140 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 141 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 142 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 61 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-126 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 62 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT06-127 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 63 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC101 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 64 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC081 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 65 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC008 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 66 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC022 tissue run 143 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 67 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-126 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 68 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT06-127 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 69 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC101 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 70 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC081 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 71 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC008 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 72 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC022 tissue run 144 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT06-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 145 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 146 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 147 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 148 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 149 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 150 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 151 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 152 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 153 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 154 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 155 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 156 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 157 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 158 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 159 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 160 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 161 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 162 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 163 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 164 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 165 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 166 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 73 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-126 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 74 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC107 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 75 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT07-128 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 76 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC088 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 77 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC108 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 78 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC042 tissue run 167 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 79 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-126 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 80 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC107 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 81 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT07-128 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 82 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC088 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 83 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC108 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 84 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC042 tissue run 168 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT07-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 169 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 170 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 171 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 172 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 173 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 174 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 175 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 176 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 177 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 178 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 179 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 180 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 181 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 182 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 183 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 184 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 185 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 186 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 187 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 188 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 189 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 190 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 85 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-126 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 86 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC076 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 87 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC075 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 88 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT08-129 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 89 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC018 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 90 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC080 tissue run 191 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 91 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-126 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 92 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC076 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 93 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC075 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 94 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT08-129 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 95 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC018 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 96 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC080 tissue run 192 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT08-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 193 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 194 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 195 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 196 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 197 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 198 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 199 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 200 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 201 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 202 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 203 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 204 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 205 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 206 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 207 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 208 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 209 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 210 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 211 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 212 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 213 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 214 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 97 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-126 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 98 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC046 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 99 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC048 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 100 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC044 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 101 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT09-130 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 102 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC053 tissue run 215 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 103 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-126 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 104 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC046 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 105 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC048 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 106 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC044 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 107 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT09-130 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 108 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC053 tissue run 216 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT09-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 217 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 218 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 219 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 220 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 221 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 222 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 223 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 224 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 225 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 226 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 227 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 228 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 229 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 230 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 231 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 232 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 233 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 234 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 235 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 236 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 237 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 109 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-126 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 110 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC005 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 111 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC011 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 112 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC049 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 113 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-130 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 114 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT10-131 tissue run 238 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 239 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 115 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-126 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 116 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC005 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 117 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC011 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 118 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC049 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 119 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-130 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 120 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT10-131 tissue run 240 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT10-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT10-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 241 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 242 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 243 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 244 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 245 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 246 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 247 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 248 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 249 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 250 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 251 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 252 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 253 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 254 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 255 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 256 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 257 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 258 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 259 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 260 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 261 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 262 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 121 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-126 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 122 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT11-127 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 123 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC040 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 124 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC069 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 125 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC095 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 126 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC035 tissue run 263 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 127 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-126 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 128 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT11-127 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 129 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC040 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 130 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC069 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 131 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC095 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 132 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC035 tissue run 264 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT11-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT11-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 265 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 266 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 267 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 268 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 269 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 270 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 271 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 272 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 273 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 274 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 275 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 276 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 277 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 278 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 279 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 280 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 281 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 282 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 283 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 284 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 285 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 286 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 133 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-126 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 134 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC102 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 135 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-128 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 136 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC007 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 137 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT12-130 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 138 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC086 tissue run 287 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 139 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-126 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 140 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC102 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 141 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-128 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 142 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC007 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 143 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT12-130 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 144 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC086 tissue run 288 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT12-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 289 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 290 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx01-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 291 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 292 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx02-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 293 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 294 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx03-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 295 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 296 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx04-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 297 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 298 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx05-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 299 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 300 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx06-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 301 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 302 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx07-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 303 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 304 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx08-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 305 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 306 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx09-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 307 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 308 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx10-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 309 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 310 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx11-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 145 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-126 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 146 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC064 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 147 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC062 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 148 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT13-129 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 149 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC093 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 150 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC103 tissue run 311 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 151 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-126 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 152 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC064 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 153 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC062 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 154 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT13-129 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 155 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC093 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 156 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC103 tissue run 312 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT13-2_fx12-Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 313 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 314 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 315 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 316 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 317 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 318 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 319 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 320 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 321 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 322 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 323 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 324 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 325 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 326 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 327 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 328 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 329 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 330 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 331 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 332 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 333 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 334 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 157 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-126 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 158 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC014 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 159 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC066 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 160 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC012 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 161 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT14-130 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 162 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC051 tissue run 335 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 163 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-126 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 164 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC014 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 165 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC066 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 166 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC012 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 167 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT14-130 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 168 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC051 tissue run 336 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT14-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 337 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 338 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 339 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 340 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 341 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 342 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 343 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 344 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 345 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 346 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 347 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 348 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 349 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 350 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 351 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 352 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 353 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 354 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 355 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 356 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 357 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 358 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 169 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-126 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 170 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC087 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 171 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC092 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 172 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC009 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 173 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC074 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 174 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT15-131 tissue run 359 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 175 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-126 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 176 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC087 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 177 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC092 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 178 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC009 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 179 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC074 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 180 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT15-131 tissue run 360 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT15-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 361 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 362 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 363 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 364 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 365 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 366 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 367 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 368 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 369 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 370 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 371 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 372 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 373 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 374 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 375 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 376 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 377 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 378 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 379 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 380 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 381 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 382 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 181 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-126 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 182 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT16-127 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 183 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC063 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 184 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC052 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 185 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC013 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 186 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC043 tissue run 383 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 187 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-126 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 188 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT16-127 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 189 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC063 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 190 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC052 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 191 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC013 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 192 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC043 tissue run 384 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT16-2-Fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 385 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 386 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 387 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 388 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 389 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 390 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 391 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 392 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 393 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 394 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 395 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 396 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 397 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 398 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 399 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 400 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 401 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 402 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 403 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 404 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 405 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 406 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 193 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-126 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 194 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC104 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 195 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-128 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 196 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT17-129 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 197 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC006 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 198 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC019 tissue run 407 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 199 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-126 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 200 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC104 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 201 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-128 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 202 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT17-129 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 203 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC006 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 204 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC019 tissue run 408 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT17-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 409 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 410 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 411 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 412 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 413 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 414 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 415 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 416 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 417 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 418 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 419 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 420 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 421 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 422 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 423 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 424 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 425 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 426 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 427 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 428 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 429 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 430 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 205 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-126 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 206 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC089 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 207 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC021 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 208 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT18-129 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 209 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC090 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 210 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC099 tissue run 431 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 211 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-126 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 212 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC089 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 213 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC021 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 214 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT18-129 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 215 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC090 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 216 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC099 tissue run 432 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT18-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 433 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 434 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx01_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 435 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 436 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx02_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 437 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 438 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx03_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 439 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 440 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx04_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 441 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 442 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx05_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 443 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 444 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx06_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 445 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 446 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx07_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 447 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 448 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx08_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 449 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 450 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx09_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 451 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 452 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx10_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 453 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 454 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx11_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 217 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-126 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 218 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC023 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 219 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC017 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 220 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC079 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 221 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT19-130 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 222 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC084 tissue run 455 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 223 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-126 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 224 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC023 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 225 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC017 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 226 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC079 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 227 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT19-130 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 228 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC084 tissue run 456 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT19-2_fx12_Run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 457 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 458 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 459 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 460 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 461 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 462 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 463 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 464 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 465 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 466 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 467 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 468 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 469 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 470 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 471 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 472 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 473 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 474 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 475 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 476 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 477 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 478 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 229 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-126 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 230 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC100 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 231 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC073 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 232 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC098 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 233 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC055 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 234 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT20-131 tissue run 479 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 235 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-126 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 236 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC100 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 237 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC073 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 238 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC098 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 239 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC055 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 240 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT20-131 tissue run 480 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT20-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT20-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 481 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 482 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 483 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 484 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 485 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 486 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 487 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 488 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 489 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 490 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 491 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 492 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 493 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 494 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 495 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 496 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 497 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 498 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 499 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 500 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 501 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 502 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 241 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-126 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 242 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-127 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 243 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC083 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 244 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT21-129 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 245 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC036 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 246 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC057 tissue run 503 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 247 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-126 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 248 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-127 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 249 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC083 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 250 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT21-129 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 251 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC036 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 252 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC057 tissue run 504 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT21-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 505 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 506 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 507 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 508 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 509 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 510 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 511 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 512 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 513 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 514 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 515 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 516 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 517 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 518 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 519 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 520 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 521 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 522 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 523 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 524 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 525 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 526 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 253 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-126 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 254 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC026 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 255 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT22-128 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 256 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC082 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 257 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC105 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 258 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC058 tissue run 527 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 259 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-126 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 260 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC026 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 261 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT22-128 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 262 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC082 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 263 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC105 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 264 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC058 tissue run 528 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT22-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 529 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 530 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 531 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 532 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 533 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 534 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 535 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 536 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 537 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 538 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 539 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 540 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 541 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 542 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 543 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 544 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 545 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 546 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 547 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 548 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 549 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 550 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 265 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-126 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 266 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC004 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 267 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC059 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 268 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-129 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 269 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT23-130 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 270 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC002 tissue run 551 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 271 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-126 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 272 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC004 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 273 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC059 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 274 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-129 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 275 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT23-130 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 276 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC002 tissue run 552 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT23-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 553 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 554 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 555 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 556 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 557 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 558 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 559 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 560 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 561 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 562 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 563 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 564 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 565 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 566 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 567 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 568 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 569 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 570 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 571 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 572 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 573 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 574 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 277 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-126 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 278 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC027 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 279 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC003 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 280 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-129 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 281 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT24-130 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 282 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC028 tissue run 575 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 283 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-126 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 284 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC027 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 285 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC003 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 286 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-129 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 287 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT24-130 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 288 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC028 tissue run 576 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT24-2-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 577 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 578 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 579 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 580 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 581 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 582 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 583 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 584 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 585 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 586 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 587 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 588 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 589 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 590 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 591 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 592 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 593 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 594 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 595 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 596 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 597 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 598 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 289 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-126 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 290 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC072 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 291 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC016 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 292 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC030 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 293 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC010 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 294 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT25-131 tissue run 599 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 295 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-126 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 296 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC072 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 297 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC016 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 298 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC030 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 299 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC010 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 300 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT25-131 tissue run 600 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT25-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT25-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 601 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 602 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 603 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 604 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 605 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 606 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 607 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 608 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 609 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 610 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 611 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 612 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 613 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 614 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 615 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 616 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 617 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 618 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 619 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 620 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 621 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 622 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 301 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-126 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 302 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-127 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 303 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT26-128 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 304 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC060 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 305 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 1 SCC001 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 306 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 1 SCC033 tissue run 623 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 307 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-126 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 308 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-127 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 309 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT26-128 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 310 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC060 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 311 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed A 2 SCC001 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed A +Sample 312 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Inflamed B 2 SCC033 tissue run 624 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT26-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT26-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Inflamed B +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 625 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 626 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 627 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 628 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 629 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 630 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 631 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 632 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 633 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 634 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 635 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 636 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 637 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 638 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 639 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 640 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 641 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 642 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 643 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 644 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 645 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 646 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 313 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-126 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 314 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC078 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 315 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-128 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 316 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC085 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 317 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT27-130 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 318 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 1 SCC054 tissue run 647 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 319 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-126 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 320 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC078 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 321 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-128 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 322 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC085 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 323 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT27-130 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 324 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox A 2 SCC054 tissue run 648 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT27-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT27-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox A +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 649 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 650 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 651 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 652 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 653 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 654 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx03-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 655 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 656 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx04-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 657 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 658 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx05-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 659 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 660 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx06-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 661 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 662 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx07-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 663 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 664 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx08-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 665 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 666 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx09-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 667 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 668 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx10-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 669 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 670 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx11-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 325 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-126 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 326 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC061 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 327 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC091 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 328 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT28-129 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 329 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 1 SCC106 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 330 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC067 tissue run 671 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 331 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-126 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 332 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC061 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 333 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC091 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 334 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT28-129 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 335 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Mixed 2 SCC106 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Mixed +Sample 336 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC067 tissue run 672 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT28-fx12-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT28-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 673 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 674 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx01-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx01-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 675 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 676 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx02-run2.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx02-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 677 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 678 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx03-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx03-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 679 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 680 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx04-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx04-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 681 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 682 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx05-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx05-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 683 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 684 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx06-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx06-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 685 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 686 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx07-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx07-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 687 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 688 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx08-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx08-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 689 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 690 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx09-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx09-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 691 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 692 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx10-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx10-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 693 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 694 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx11-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx11-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 337 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-126 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 338 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC094 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 339 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC068 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 340 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC056 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 341 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 1 Pool_TMT29-130 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 342 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 1 SCC077 tissue run 695 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run1.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run1.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 343 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-126 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT126 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 344 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC094 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT127 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 345 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC068 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT128 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 346 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC056 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT129 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B +Sample 347 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available not applicable 2 Pool_TMT29-130 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT130 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable +Sample 348 Homo sapiens lung not available not applicable adult squamous cell lung cancer not available not available not available Redox B 2 SCC077 tissue run 696 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 20160609_Haura-SCC-PG_TMT29-fx12-run2.raw https://ftp.ebi.ac.uk/pride-archive/2019/05/PXD010429/20160609_Haura-SCC-PG_TMT29-fx12-run2.raw 1 1 TMT131 NT=Q Exactive Plus;AC=MS:1001911 AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=Gln->pyro-Glu;AC=UNIMOD:28;PP=Any N-term;MT=variable NT= TMT6plex;AC=UNIMOD:737;TA=K;MT=Fixed NT= TMT6plex;AC=UNIMOD:737;PP=Any N-term;MT=Fixed 10 ppm 0.5 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 Redox B diff --git a/annotated-projects/PXD010705/PXD010705.sdrf.tsv b/annotated-projects/PXD010705/PXD010705.sdrf.tsv index 4b03978eb..0bb181556 100644 --- a/annotated-projects/PXD010705/PXD010705.sdrf.tsv +++ b/annotated-projects/PXD010705/PXD010705.sdrf.tsv @@ -1,4 +1,4 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[ancestry category] characteristics[age] characteristics[sex] characteristics[disease] characteristics[biological replicate] characteristics[individual] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[technical replicate] comment[fraction identifier] comment[file uri] comment[label] comment[instrument] comment[cleavage agent details] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[modification parameters] comment[modification parameters] comment[sdrf version] comment[sdrf template] -Sample 1 Homo sapiens Cerebrospinal fluid (CSF) not applicable not available 40Y-85Y not available hydrocephalus 1 not available replicate1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 DIA replicate1.raw 1 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010705/DIA%20replicate1.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 NT=Trypsin;AC=MS:1001251 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15.994915 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Cerebrospinal fluid (CSF) not applicable not available 40Y-85Y not available hydrocephalus 1 not available replicate2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 DIA replicate2.raw 1 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010705/DIA%20replicate2.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 NT=Trypsin;AC=MS:1001251 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15.994915 v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Cerebrospinal fluid (CSF) not applicable not available 40Y-85Y not available hydrocephalus 1 not available replicate3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 DIA replicate3.raw 1 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010705/DIA%20replicate3.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 NT=Trypsin;AC=MS:1001251 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15.994915 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available replicate1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 DIA replicate1.raw 1 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010705/DIA%20replicate1.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 NT=Trypsin;AC=MS:1001251 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15.994915 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available replicate2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 DIA replicate2.raw 1 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010705/DIA%20replicate2.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 NT=Trypsin;AC=MS:1001251 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15.994915 v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available replicate3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 DIA replicate3.raw 1 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010705/DIA%20replicate3.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 NT=Trypsin;AC=MS:1001251 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15.994915 v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/annotated-projects/PXD010708/PXD010708.sdrf.tsv b/annotated-projects/PXD010708/PXD010708.sdrf.tsv index 8cc911609..c1bda249e 100644 --- a/annotated-projects/PXD010708/PXD010708.sdrf.tsv +++ b/annotated-projects/PXD010708/PXD010708.sdrf.tsv @@ -1,16 +1,16 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[ancestry category] characteristics[age] characteristics[sex] characteristics[disease] characteristics[biological replicate] characteristics[individual] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[technical replicate] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[modification parameters] comment[modification parameters] comment[fraction identifier] comment[sdrf version] comment[sdrf template] factor value[organism part] -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21818_F15.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21818_F15.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21286_F1.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21286_F1.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21794_F12.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21794_F12.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21292_F4.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21292_F4.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 4 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21304_F10.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21304_F10.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 5 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21816_F14.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21816_F14.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 6 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21288_F2.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21288_F2.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 7 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21290_F3.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21290_F3.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 8 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21298_F7.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21298_F7.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 9 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21300_F8.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21300_F8.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 10 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21302_F9.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21302_F9.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 11 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21296_F6.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21296_F6.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 12 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21820_F16.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21820_F16.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 13 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21796_F13.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21796_F13.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 14 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 -Sample 1 Homo Sapiens NT=Cerebrospinal Fluid,AC=NCIT:C12692 not appicable not available 40Y-85Y not available NT:hydrocephalus,AC:DOID:10908 1 not available Run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21294_F5.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21294_F5.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 15 v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=Cerebrospinal Fluid,AC=NCIT:C12692 +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21818_F15.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21818_F15.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21286_F1.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21286_F1.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21794_F12.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21794_F12.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21292_F4.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21292_F4.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 4 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21304_F10.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21304_F10.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 5 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21816_F14.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21816_F14.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 6 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21288_F2.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21288_F2.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 7 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21290_F3.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21290_F3.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 8 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21298_F7.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21298_F7.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 9 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21300_F8.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21300_F8.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 10 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21302_F9.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21302_F9.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 11 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21296_F6.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21296_F6.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 12 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 13 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21820_F16.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21820_F16.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 13 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 14 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21796_F13.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21796_F13.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 14 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid +Sample 1 Homo Sapiens cerebrospinal fluid not applicable not available 40Y-85Y not available hydrocephalus 1 not available Run 15 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 QEXI21294_F5.raw 1 https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010708/QEXI21294_F5.raw AC=MS:1002038;NT=label free sample NT=Q Exactive; AC = MS:1001911 trypsin 5 ppm 20 mmu NT= Carbamidomethyl; MT=variable; PP=Anywhere;AC=Unimod:4; TA=.; MM=57 NT=Oxidation; MT=variable; PP=Anywhere;AC=Unimod:35; TA=M; MM=15 15 v1.1.0 NT=ms-proteomics;VV=v1.1.0 cerebrospinal fluid diff --git a/annotated-projects/PXD010981/PXD010981.sdrf.tsv b/annotated-projects/PXD010981/PXD010981.sdrf.tsv index 60b454324..75a3578e5 100644 --- a/annotated-projects/PXD010981/PXD010981.sdrf.tsv +++ b/annotated-projects/PXD010981/PXD010981.sdrf.tsv @@ -1,13 +1,13 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[cell line] characteristics[disease] characteristics[mass] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[biological replicate] characteristics[material type] assay name technology type comment[proteomics data acquisition method] comment[data file] comment[file uri] comment[technical replicate] comment[fraction identifier] comment[label] comment[cleavage agent details] comment[instrument] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[dissociation method] comment[collision energy] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[sdrf version] comment[sdrf template] factor value[spiked compound] -Sample 1 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=55 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=15 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=2 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=11 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=10 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample1-A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample1-A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin -Sample 1 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=55 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=15 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=2 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=11 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=10 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample1_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample1_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin -Sample 1 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=55 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=15 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=2 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=11 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=10 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample1_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample1_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin -Sample 2 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=15 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=2 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=65 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=0.6 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=500 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample2_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample2_A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin -Sample 2 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=15 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=2 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=65 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=0.6 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=500 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample2_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample2_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin -Sample 2 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=15 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=2 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=65 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=0.6 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=500 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample2_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample2_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin -Sample 3 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=2 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=65 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=55 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=10 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=11 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample3_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample3_A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin -Sample 3 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=2 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=65 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=55 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=10 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=11 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample3_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample3_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin -Sample 3 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=2 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=65 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=55 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=10 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=11 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample3_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample3_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin -Sample 4 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=65 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=55 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=15 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=500 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=0.6 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample4-A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample4-A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin -Sample 4 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=65 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=55 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=15 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=500 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=0.6 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample4_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample4_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin -Sample 4 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=65 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=55 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=15 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=500 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=0.6 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample4_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample4_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Th v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin +Sample 1 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=55 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=15 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=2 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=11 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=10 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 1 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample1-A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample1-A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin +Sample 1 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=55 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=15 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=2 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=11 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=10 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 2 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample1_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample1_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin +Sample 1 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=55 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=15 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=2 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=11 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=10 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 3 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample1_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample1_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=65 ng;AC=P01012;CN=Ovalbumin +Sample 2 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=15 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=2 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=65 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=0.6 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=500 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 4 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample2_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample2_A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin +Sample 2 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=15 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=2 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=65 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=0.6 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=500 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 5 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample2_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample2_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin +Sample 2 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=15 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=2 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=65 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=0.6 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=500 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 6 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample2_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample2_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=55 ng;AC=P01012;CN=Ovalbumin +Sample 3 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=2 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=65 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=55 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=10 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=11 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 7 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample3_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample3_A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin +Sample 3 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=2 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=65 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=55 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=10 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=11 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 8 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample3_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample3_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin +Sample 3 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=2 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=65 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=55 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=10 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=11 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 9 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample3_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample3_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=15 ng;AC=P01012;CN=Ovalbumin +Sample 4 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=65 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=55 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=15 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=500 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=0.6 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 10 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample4-A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample4-A.raw 1 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin +Sample 4 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=65 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=55 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=15 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=500 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=0.6 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 11 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample4_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample4_B.raw 2 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin +Sample 4 Saccharomyces cerevisiae not applicable not available not applicable not available 200 ng CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin CT=Protein;QY=65 ng;AC=P68082;CN=Myoglobin CT=Protein;QY=55 ng;AC=PHKA1;CN=Phosphorylase b CT=Protein;QY=15 ng;AC=P00722;CN=Beta-Galactosidase CT=Protein;QY=500 ng;AC=P02769;CN=Bovine Serum Albumin CT=Protein;QY=0.6 ng;AC=P00921;CN=Carbonic Anhydrase 1 lysate run 12 proteomic profiling by mass spectrometry NT=Data-dependent acquisition;AC=PRIDE:0000627 JD_06232014_sample4_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2018/09/PXD010981/JD_06232014_sample4_C.raw 3 1 AC=MS:1002038;NT=label free sample AC=MS:1001251;NT=Trypsin AC=MS:1001911;NT=Q Exactive NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=variable NT=Cyclization;PP=Protein N-term;TA=Q,E;MT=variable AC=MS:1000422;NT=HCD 27% NCE 10 ppm 0.01 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 CT=Protein;QY=2 ng;AC=P01012;CN=Ovalbumin diff --git a/annotated-projects/PXD012203/PXD012203.sdrf.tsv b/annotated-projects/PXD012203/PXD012203.sdrf.tsv index 6af0c620c..7766c1774 100644 --- a/annotated-projects/PXD012203/PXD012203.sdrf.tsv +++ b/annotated-projects/PXD012203/PXD012203.sdrf.tsv @@ -1,241 +1,241 @@ source name characteristics[organism] characteristics[disease] characteristics[organism part] characteristics[organism part] characteristics[cell type] characteristics[ancestry category] characteristics[age] characteristics[sex] characteristics[individual] characteristics[developmental stage] characteristics[biological replicate] characteristics[material type] assay name technology type comment[technical replicate] comment[fraction identifier] comment[label] comment[proteomexchange accession number] comment[proteomics data acquisition method] comment[data file] comment[file uri] comment[instrument] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[sdrf version] comment[sdrf template] -Sample 1 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 1 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 2 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 3 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 4 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 5 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 6 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 7 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 8 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 9 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 10 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 11 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 12 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 13 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 14 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 15 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 16 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 17 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 18 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 19 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 5 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 20 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 21 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 22 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 23 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 6 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 24 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 25 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 26 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 27 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 7 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 28 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 29 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 30 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 31 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 8 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 32 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 33 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 34 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 35 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 9 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 36 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 37 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 38 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 39 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 10 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 40 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 41 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 42 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 43 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 11 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 44 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 45 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 46 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 47 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 12 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 48 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 49 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 50 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 51 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 13 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 52 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 53 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 54 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 55 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 14 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 56 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 57 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 58 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 59 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 15 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 60 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 61 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 62 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 63 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 16 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 64 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 65 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 66 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 67 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 17 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 68 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 69 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 70 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 71 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 18 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 72 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 73 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 74 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 75 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 19 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 76 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 77 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 78 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 79 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 20 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 80 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 81 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 82 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 83 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 21 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 84 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 85 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 86 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 87 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 22 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 88 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 89 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 90 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 91 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 23 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 92 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 93 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 94 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 95 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 24 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 96 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 97 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 98 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 99 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 25 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 100 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 101 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 102 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 103 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 26 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 104 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 105 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 106 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 107 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 27 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 108 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 109 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 110 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 111 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 28 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 112 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 113 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 114 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 115 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 29 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 116 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 117 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 118 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 119 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 30 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 120 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 31 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 121 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 31 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 122 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 31 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 123 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 31 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 124 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 32 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 125 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 32 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 126 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 32 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 127 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 32 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 128 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 33 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 129 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 33 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 130 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 33 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 131 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 33 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 132 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 34 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 133 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 34 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 134 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 34 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 135 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 34 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 136 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 35 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 137 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 35 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 138 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 35 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 139 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 35 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 140 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 36 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 141 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 36 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 142 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 36 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 143 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 36 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 144 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 37 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 145 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 37 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 146 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 37 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 147 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 37 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 148 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 38 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 149 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 38 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 150 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 38 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 151 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 38 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 152 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 39 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 153 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 39 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 154 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 39 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 155 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 39 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 156 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 40 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 157 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 40 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 158 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 40 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 159 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 40 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 160 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 41 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 161 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 41 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 162 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 41 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 163 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 41 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 164 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 42 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 165 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 42 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 166 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 42 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 167 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 42 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 168 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 43 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 169 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 43 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 170 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 43 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 171 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 43 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 172 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 44 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 173 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 44 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 174 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 44 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 175 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 44 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 176 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 45 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 177 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 45 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 178 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 45 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 179 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 45 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 180 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 46 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 181 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 46 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 182 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 46 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 183 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 46 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 184 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 47 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 185 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 47 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 186 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 47 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 187 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 47 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 188 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 48 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 189 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 48 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 190 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 48 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 191 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 48 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 192 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 49 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 193 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 49 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 194 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 49 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 195 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 49 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 196 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 50 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 197 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 50 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 198 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 50 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 199 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 50 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 200 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 51 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 201 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 51 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 202 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 51 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 203 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 51 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 204 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 52 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 205 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 52 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 206 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 52 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 207 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 52 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 208 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 53 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 209 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 53 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 210 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 53 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 211 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 53 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 212 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 54 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 213 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 54 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 214 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 54 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 215 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 54 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 216 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 55 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 217 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 55 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 218 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 55 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 219 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 55 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 220 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 56 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 221 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 56 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 222 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 56 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 223 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 56 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 224 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 57 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 225 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 57 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 226 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 57 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 227 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 57 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 228 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 58 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 229 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 58 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 230 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 58 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 231 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 58 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 232 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 59 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 233 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 59 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 234 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 59 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 235 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 59 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 236 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 60 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 237 proteomic profiling by mass spectrometry 1 1 AC=MS:1002624;NT=iTRAQ reagent 114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 60 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 238 proteomic profiling by mass spectrometry 1 1 AC=MS:1002625;NT=iTRAQ reagent 115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 60 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 239 proteomic profiling by mass spectrometry 1 1 AC=MS:1002626;NT=iTRAQ reagent 116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 60 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 240 proteomic profiling by mass spectrometry 1 1 AC=MS:1002627;NT=iTRAQ reagent 117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 1 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 2 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 3 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 4 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 5 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 6 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 7 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 8 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 9 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 10 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 11 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 12 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_01_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_01_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 13 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 14 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 15 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 16 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 17 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 18 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 19 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 5 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 20 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 21 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 22 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 23 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 6 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 24 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_02_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_02_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 25 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 26 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 27 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 7 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 28 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 29 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 30 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 31 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 8 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 32 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 33 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 34 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 35 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 9 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 36 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_03_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_03_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 37 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 38 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 39 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 10 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 40 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 41 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 42 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 43 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 11 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 44 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 45 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 46 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 47 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 12 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 48 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_04_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_04_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 49 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 50 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 51 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 13 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 52 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 53 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 54 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 55 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 14 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 56 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 57 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 58 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 59 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 15 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 60 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_05_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_05_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 61 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 62 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 63 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 16 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 64 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 65 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 66 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 67 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 17 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 68 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 69 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 70 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 71 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 18 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 72 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_06_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_06_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 73 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 74 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 75 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 19 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 76 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 77 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 78 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 79 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 20 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 80 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 81 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 82 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 83 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 21 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 84 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_07_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_07_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 85 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 86 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 87 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 22 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 88 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 89 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 90 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 91 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 23 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 92 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 93 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 94 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 95 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 24 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 96 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_08_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_08_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 97 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 98 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 99 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 25 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 100 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 101 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 102 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 103 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 26 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 104 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 105 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 106 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 107 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 27 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 108 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_09_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_09_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 109 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 110 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 111 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 28 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 112 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 113 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 114 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 115 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 29 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 116 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 117 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 118 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 119 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 30 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 120 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_10_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_10_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 31 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 121 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 31 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 122 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 31 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 123 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 31 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 124 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 32 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 125 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 32 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 126 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 32 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 127 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 32 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 128 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 33 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 129 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 33 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 130 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 33 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 131 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 33 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 132 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_11_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_11_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 34 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 133 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 34 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 134 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 34 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 135 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 34 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 136 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 35 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 137 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 35 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 138 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 35 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 139 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 35 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 140 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 36 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 141 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 36 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 142 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 36 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 143 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 36 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 144 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_12_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_12_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 37 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 145 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 37 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 146 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 37 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 147 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 37 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 148 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 38 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 149 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 38 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 150 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 38 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 151 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 38 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 152 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 39 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 153 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 39 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 154 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 39 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 155 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 39 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 156 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_13_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_13_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 40 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 157 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 40 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 158 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 40 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 159 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 40 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 160 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 41 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 161 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 41 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 162 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 41 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 163 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 41 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 164 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 42 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 165 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 42 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 166 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 42 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 167 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 42 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 168 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_14_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_14_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 43 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 169 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 43 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 170 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 43 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 171 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 43 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 172 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 44 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 173 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 44 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 174 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 44 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 175 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 44 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 176 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 45 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 177 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 45 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 178 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 45 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 179 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 45 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 180 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_15_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_15_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 46 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 181 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 46 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 182 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 46 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 183 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 46 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 184 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 47 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 185 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 47 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 186 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 47 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 187 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 47 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 188 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 48 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 189 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 48 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 190 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 48 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 191 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 48 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 192 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_16_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_16_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 49 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 193 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 49 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 194 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 49 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 195 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 49 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 196 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 50 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 197 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 50 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 198 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 50 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 199 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 50 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 200 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 51 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 201 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 51 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 202 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 51 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 203 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 51 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 204 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_17_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_17_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 52 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 205 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 52 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 206 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 52 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 207 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 52 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 208 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 53 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 209 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 53 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 210 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 53 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 211 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 53 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 212 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 54 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 213 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 54 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 214 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 54 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 215 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 54 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 216 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_18_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_18_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 55 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 217 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 55 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 218 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 55 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 219 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 55 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 220 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 56 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 221 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 56 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 222 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 56 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 223 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 56 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 224 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 57 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 225 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 57 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 226 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 57 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 227 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 57 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 228 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_19_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_19_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 58 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 229 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 58 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 230 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 58 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 231 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 58 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 1 tissue run 232 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_A.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_A.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 59 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 233 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 59 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 234 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 59 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 235 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 59 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 2 tissue run 236 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_B.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_B.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 60 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 237 proteomic profiling by mass spectrometry 1 1 itraq114 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 60 Homo sapiens Alzheimer's diseasemedial brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 238 proteomic profiling by mass spectrometry 1 1 itraq115 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 60 Homo sapiens Non-demented control brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 239 proteomic profiling by mass spectrometry 1 1 itraq116 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 60 Homo sapiens Alzheimer's disease brain medial frontal gyrus not available not available not available not available not available not available 3 tissue run 240 proteomic profiling by mass spectrometry 1 1 itraq117 PXD012203 NT=Data-dependent acquisition;AC=PRIDE:0000627 140725_Sunil_iTRAQ_AD_20_C.raw https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203/140725_Sunil_iTRAQ_AD_20_C.raw AC=MS:1001911;NT=Q Exactive NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Fixed NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed AC=MS:1001251;NT=Trypsin 0.6 Da 20 ppm v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/annotated-projects/PXD012986/PXD012986.sdrf.tsv b/annotated-projects/PXD012986/PXD012986.sdrf.tsv index 8ec4edefd..2bfa1d9a1 100644 --- a/annotated-projects/PXD012986/PXD012986.sdrf.tsv +++ b/annotated-projects/PXD012986/PXD012986.sdrf.tsv @@ -1,16 +1,16 @@ source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell type] characteristics[cell line] characteristics[biological replicate] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] characteristics[spiked compound] assay name technology type comment[fraction identifier] comment[label] comment[instrument] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[dissociation method] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[file uri] comment[proteomics data acquisition method] comment[data file] comment[technical replicate] comment[sdrf version] comment[sdrf template] factor value[phenotype] -PXD012986-Sample-1 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=0.5 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=0.1 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=5 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=1 pmol;AC=P68082 run 1 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04026.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04026.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-1 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=0.5 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=0.1 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=5 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=1 pmol;AC=P68082 run 2 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04036.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04036.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-1 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=0.5 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=0.1 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=0.1 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=5 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=1 pmol;AC=P68082 run 3 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04046.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04046.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-2 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=0.1 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=1 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=10 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=0.1 pmol;AC=P68082 run 4 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04028.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04028.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-2 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=0.1 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=1 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=10 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=0.1 pmol;AC=P68082 run 5 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04038.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04038.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-2 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=0.1 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=1 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=0.5 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=10 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=0.1 pmol;AC=P68082 run 6 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04048.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04048.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-3 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=5 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=10 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=0.1 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=5 pmol;AC=P68082 run 7 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04030.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04030.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-3 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=5 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=10 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=0.1 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=5 pmol;AC=P68082 run 8 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04040.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04040.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-3 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=5 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=10 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=10 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=1 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=0.1 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=5 pmol;AC=P68082 run 9 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04050.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04050.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-4 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=10 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=5 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=0.5 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=10 pmol;AC=P68082 run 10 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04032.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04032.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-4 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=10 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=5 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=0.5 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=10 pmol;AC=P68082 run 11 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04042.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04042.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-4 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=10 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=0.5 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=5 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=1 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=5 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=0.5 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=10 pmol;AC=P68082 run 12 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04052.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04052.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-5 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=1 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=0.5 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=1 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=0.5 pmol;AC=P68082 run 13 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04034.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04034.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-5 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=1 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=0.5 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=1 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=0.5 pmol;AC=P68082 run 14 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04044.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04044.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal -PXD012986-Sample-5 Mus musculus not applicable not available Myoblast C2C12 1 SP=Homo sapiens;CT=protein;QY=5 pmol;AC=P37840 SP=Bos taurus;CT=protein;QY=1 pmol;AC=P02754 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02671 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02675 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P02679 SP=Aspergillus niger;CT=protein;QY=0.5 pmol;AC=P13006 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P69905 SP=Homo sapiens;CT=protein;QY=0.1 pmol;AC=P68871 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P20261 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P32946 SP=Diutina rugosa;CT=protein;QY=10 pmol;AC=P32947 SP=Gallus gallus;CT=protein;QY=1 pmol;AC=P00698 SP=Equus caballus;CT=protein;QY=0.5 pmol;AC=P68082 run 15 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04054.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04054.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-1 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=0.5 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=0.1 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=5 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=1 pmol;AC=P68082 run 1 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04026.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04026.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-1 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=0.5 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=0.1 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=5 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=1 pmol;AC=P68082 run 2 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04036.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04036.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-1 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=0.5 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=0.1 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=0.1 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=5 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=1 pmol;AC=P68082 run 3 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04046.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04046.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-2 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=0.1 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=1 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=10 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=0.1 pmol;AC=P68082 run 4 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04028.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04028.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-2 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=0.1 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=1 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=10 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=0.1 pmol;AC=P68082 run 5 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04038.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04038.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-2 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=0.1 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=1 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=0.5 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=10 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=0.1 pmol;AC=P68082 run 6 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04048.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04048.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-3 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=5 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=10 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=0.1 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=5 pmol;AC=P68082 run 7 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04030.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04030.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-3 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=5 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=10 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=0.1 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=5 pmol;AC=P68082 run 8 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04040.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04040.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-3 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=5 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=10 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=10 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=1 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=0.1 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=5 pmol;AC=P68082 run 9 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04050.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04050.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-4 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=10 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=5 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=0.5 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=10 pmol;AC=P68082 run 10 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04032.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04032.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-4 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=10 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=5 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=0.5 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=10 pmol;AC=P68082 run 11 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04042.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04042.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-4 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=10 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=0.5 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=5 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=1 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=5 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=0.5 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=10 pmol;AC=P68082 run 12 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04052.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04052.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-5 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=1 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=0.5 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=1 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=0.5 pmol;AC=P68082 run 13 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04034.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04034.raw 1 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-5 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=1 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=0.5 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=1 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=0.5 pmol;AC=P68082 run 14 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04044.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04044.raw 2 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal +PXD012986-Sample-5 Mus musculus not applicable not available Myoblast C2C12 1 CT=protein;SP=Homo sapiens;QY=5 pmol;AC=P37840 CT=protein;SP=Bos taurus;QY=1 pmol;AC=P02754 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02671 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02675 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P02679 CT=protein;SP=Aspergillus niger;QY=0.5 pmol;AC=P13006 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P69905 CT=protein;SP=Homo sapiens;QY=0.1 pmol;AC=P68871 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P20261 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P32946 CT=protein;SP=Diutina rugosa;QY=10 pmol;AC=P32947 CT=protein;SP=Gallus gallus;QY=1 pmol;AC=P00698 CT=protein;SP=Equus caballus;QY=0.5 pmol;AC=P68082 run 15 proteomic profiling by mass spectrometry 1 AC=MS:1002038;NT=label free sample AC=MS:1002523;NT=Q Exactive HF 5 ppm 0.02 Da AC=MS:1000422;NT=HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Deamidated;TA=N,Q;AC=UNIMOD:7;MT=variable NT=Glu->pyro-Glu;MT=variable;PP=Any N-term;TA=Q;AC=Unimod:27 NT=Ammonium;TA=D,E;AC=UNIMOD:989;MT=variable NT=Ammonia-loss;TA=C;PP=Any N-term;AC=UNIMOD:385;MT=variable NT=Ammonia-loss;TA=N;AC=UNIMOD:385;MT=variable https://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012986/QExHF04054.raw NT=Data-dependent acquisition;AC=PRIDE:0000627 QExHF04054.raw 3 v1.1.0 NT=ms-proteomics;VV=v1.1.0 normal diff --git a/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv b/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv index bd6e528bf..124fd6741 100644 --- a/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv +++ b/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv @@ -1,14 +1,14 @@ source name characteristics[biological replicate] characteristics[organism] characteristics[organism part] characteristics[age] characteristics[ancestry category] characteristics[cell type] characteristics[disease] characteristics[cell line] characteristics[phenotype] characteristics[genetic modification] characteristics[individual] characteristics[sex] characteristics[pooled sample] characteristics[xenograft] characteristics[enrichment process] assay name technology type comment[proteomexchange accession number] comment[cleavage agent details] comment[cleavage agent details] comment[cleavage agent details] comment[fraction identifier] comment[fragment mass tolerance] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[precursor mass tolerance] comment[technical replicate] comment[tool metadata] comment[proteomics data acquisition method] comment[data file] comment[sdrf version] comment[sdrf template] factor value[genetic modification] factor value[phenotype] -D-HEp3 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 1 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_D1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 2 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_D2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -T-HEp3 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 3 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_T1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=proliferating cells;AC=CMPO:0000241 -T-HEp3 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 4 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_T2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=proliferating cells;AC=CMPO:0000241 -T-HEp3 #4 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 5 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_T4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=proliferating cells;AC=CMPO:0000241 -D-HEp3 shCTRL #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 6 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaC0-2-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shCTRL #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 7 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaC1-1-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shCTRL #3 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 8 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-1-10x_180123194318.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shCTRL #4 4 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 9 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-2-10x.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #1 1 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 10 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaSh2-4-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #2 2 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 11 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaSh3-2-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #3 3 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 12 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-3-10x.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 -D-HEp3 shDDR1 #4 4 homo sapiens NT=head and neck;AC=MA:0000006 62Y african american squamous epitheliel cells squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice NT=Extraction purification;AC=NCIT:C113061 run 13 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-4-10x.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 #1 1 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice extraction purification run 1 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_D1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 #2 2 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available pooled cancer cell line grown in mice extraction purification run 2 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_D2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +T-HEp3 #1 1 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice extraction purification run 3 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_T1.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=proliferating cells;AC=CMPO:0000241 +T-HEp3 #2 2 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice extraction purification run 4 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_T2.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=proliferating cells;AC=CMPO:0000241 +T-HEp3 #4 3 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=proliferating cells;AC=CMPO:0000241 not applicable not applicable not available not pooled cancer cell line grown in mice extraction purification run 5 proteomic profiling by mass spectrometry PXD036453 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.015 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M', 'K', 'P NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N,Q NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N NT=Carbamyl;AC=Unimod:5;MT=Variable;PP=Any N-term;TA=Y', 'S', 'T not applicable 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 180615_554_AN_T4.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=proliferating cells;AC=CMPO:0000241 +D-HEp3 shCTRL #1 1 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice extraction purification run 6 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaC0-2-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shCTRL #2 2 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice extraction purification run 7 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaC1-1-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shCTRL #3 3 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice extraction purification run 8 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-1-10x_180123194318.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shCTRL #4 4 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 not applicable not applicable not available not pooled cancer cell line grown in mice extraction purification run 9 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-2-10x.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 not applicable NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #1 1 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice extraction purification run 10 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaSh2-4-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #2 2 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice extraction purification run 11 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 NabaSh3-2-10X.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #3 3 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice extraction purification run 12 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-3-10x.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 +D-HEp3 shDDR1 #4 4 homo sapiens head and neck 62Y african american squamous epithelial cell squamous cell carcinoma NT=HEp-3 cell;AC=BTO:0005139 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 NT=gene knockdown;AC=OBI:0002625 not applicable not available not pooled cancer cell line grown in mice extraction purification run 13 proteomic profiling by mass spectrometry PXD018883 NT=Trypsin;AC=MS:1001251 NT=Lys-C;AC=MS:1001309 NT=N-glycosidase F;AC=CHMO:0002922 1 0.1 Da NT=LTQ Orbitrap Velos;AC=MS:1001742 label free sample NT=Carbamidomethyl;AC=Unimod:4;MT=Fixed;PP=Anywhere;TA=C NT=Oxidation;AC=Unimod:35;MT=Variable;PP=Anywhere;TA=M NT=Deamidated;AC=Unimod:7;MT=Variable;PP=Anywhere;TA=N NT=Gln->pyro-Glu;AC=Unimod:28;MT=Variable;PP=Any N-term;TA=N not applicable NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=K,P 10 ppm 1 lesSDRF v0.1.0 NT=Data-dependent acquisition;AC=PRIDE:0000627 Naba-4-10x.raw v1.1.0 NT=ms-proteomics;VV=v1.1.0 NT=gene knockdown;AC=OBI:0002625 NT=cell cycle arrest in mitotic G1 phase;AC=FYPO:0000445 diff --git a/annotated-projects/PXD023158/PXD023158.sdrf.tsv b/annotated-projects/PXD023158/PXD023158.sdrf.tsv index b154723a8..19f925803 100644 --- a/annotated-projects/PXD023158/PXD023158.sdrf.tsv +++ b/annotated-projects/PXD023158/PXD023158.sdrf.tsv @@ -1,91 +1,91 @@ source name characteristics[biological replicate] characteristics[cell type] characteristics[disease] characteristics[organism part] characteristics[organism] characteristics[strain/breed] characteristics[treatment] characteristics[medium] characteristics[temperature] characteristics[growth phase] characteristics[optical density] assay name technology type comment[alkylation reagent] comment[cleavage agent details] comment[collision energy] comment[proteomics data acquisition method] comment[data file] comment[dissociation method] comment[fraction identifier] comment[fragment mass tolerance] comment[instrument] comment[label] comment[modification parameters] comment[modification parameters] comment[precursor mass tolerance] comment[reduction reagent] comment[technical replicate] comment[tool metadata] comment[sdrf version] comment[sdrf template] factor value[treatment] -TMT_Fraction1_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction2_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction3_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction4_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction5_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction6_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction7_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction8_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction9_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction10_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction11_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction12_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction13_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction14_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction15_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive TMT reagent 126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction1_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction2_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction3_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction4_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction5_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction6_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction7_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction8_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction9_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction10_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction11_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction12_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction13_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction14_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction15_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive TMT reagent 127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction1_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction2_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction3_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction4_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction5_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction6_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction7_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction8_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction9_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction10_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction11_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction12_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction13_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction14_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction15_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive TMT reagent 128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight -TMT_Fraction1_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction2_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction3_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction4_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction5_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction6_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction7_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction8_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction9_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction10_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction11_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction12_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction13_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction14_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction15_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive TMT reagent 129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction1_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction2_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction3_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction4_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction5_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction6_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction7_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction8_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction9_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction10_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction11_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction12_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction13_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction14_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction15_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive TMT reagent 130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction1_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction2_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction3_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction4_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction5_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction6_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction7_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction8_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction9_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction10_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction11_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction12_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction13_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction14_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control -TMT_Fraction15_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive TMT reagent 131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction1_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction2_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction3_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction4_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction5_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction6_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction7_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction8_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction9_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction10_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction11_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction12_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction13_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction14_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction15_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive tmt126 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction1_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction2_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction3_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction4_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction5_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction6_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction7_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction8_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction9_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction10_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction11_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction12_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction13_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction14_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction15_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive tmt127 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction1_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction2_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction3_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction4_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction5_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction6_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction7_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction8_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction9_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction10_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction11_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction12_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction13_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction14_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction15_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Spaceflight LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive tmt128 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Spaceflight +TMT_Fraction1_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction2_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction3_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction4_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction5_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction6_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction7_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction8_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction9_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction10_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction11_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction12_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction13_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction14_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction15_Repeat1.raw 1 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive tmt129 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction1_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction2_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction3_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction4_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction5_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction6_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction7_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction8_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction9_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction10_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction11_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction12_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction13_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction14_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction15_Repeat1.raw 2 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive tmt130 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction1_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 1 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction1_Repeat1.raw NT=HCD; AC=MS:1002481 1 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction2_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 2 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction2_Repeat1.raw NT=HCD; AC=MS:1002481 2 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction3_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 3 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction3_Repeat1.raw NT=HCD; AC=MS:1002481 3 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction4_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 4 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction4_Repeat1.raw NT=HCD; AC=MS:1002481 4 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction5_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 5 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction5_Repeat1.raw NT=HCD; AC=MS:1002481 5 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction6_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 6 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction6_Repeat1.raw NT=HCD; AC=MS:1002481 6 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction7_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 7 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction7_Repeat1.raw NT=HCD; AC=MS:1002481 7 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction8_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 8 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction8_Repeat1.raw NT=HCD; AC=MS:1002481 8 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction9_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 9 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction9_Repeat1.raw NT=HCD; AC=MS:1002481 9 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction10_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 10 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction10_Repeat1.raw NT=HCD; AC=MS:1002481 10 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction11_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 11 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction11_Repeat1.raw NT=HCD; AC=MS:1002481 11 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction12_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 12 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction12_Repeat1.raw NT=HCD; AC=MS:1002481 12 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction13_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 13 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction13_Repeat1.raw NT=HCD; AC=MS:1002481 13 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction14_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 14 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction14_Repeat1.raw NT=HCD; AC=MS:1002481 14 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control +TMT_Fraction15_Repeat1.raw 3 Prokaryotic cell Not applicable Cell lysate Escherichia coli Escherichia coli str. K-12 Control LB medium 37°C Exponential phase 1 run 15 Proteomic profiling by mass spectrometry IAA NT=Trypsin;AC=1001251 32% NCE NT=Data-dependent acquisition;AC=PRIDE:0000627 TMT_Fraction15_Repeat1.raw NT=HCD; AC=MS:1002481 15 Not available NT=Q Exactive tmt131 NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C'] NT=TMT6plex;AC=737;CF=H(20) C(8) 13C(4) N 15N O(2);MM=229.162932;MT=Variable;PP=Anywhere;TA=['K'] Not available DTT 1 lesSDRF v0.1.0 v1.1.0 NT=ms-proteomics;VV=v1.1.0 Control diff --git a/annotated-projects/PXD026474/PXD026474.sdrf.tsv b/annotated-projects/PXD026474/PXD026474.sdrf.tsv index c718fbf21..66e2574bf 100644 --- a/annotated-projects/PXD026474/PXD026474.sdrf.tsv +++ b/annotated-projects/PXD026474/PXD026474.sdrf.tsv @@ -1,9 +1,9 @@ source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[disease] characteristics[phenotype] characteristics[biological replicate] assay name technology type comment[plasmodium strain] comment[proteomexchange accession number] comment[proteomics data acquisition method] comment[data file] comment[file uri] comment[fraction identifier] comment[technical replicate] comment[label] comment[instrument] comment[dissociation method] comment[cleavage agent details] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[precursor mass tolerance] comment[fragment mass tolerance] comment[sdrf version] comment[sdrf template] -Sample 1_frac_1_run_1 plasmodium falciparum not available gametocytes;schizonts not applicable knockout 1 run 1 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200624_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2_frac_1_run_1 plasmodium falciparum not available gametocytes;schizonts not applicable knockout 1 run 2 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200624_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3_frac_1_run_1 plasmodium falciparum not available gametocytes;schizonts not applicable knockout 1 run 3 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200709_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4_frac_1_run_1 plasmodium falciparum not available gametocytes;schizonts not applicable knockout 1 run 4 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200709_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 1_frac_1_run_2 plasmodium falciparum not available gametocytes;schizonts not applicable wild 1 run 1 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200624_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 2_frac_1_run_2 plasmodium falciparum not available gametocytes;schizonts not applicable wild 1 run 2 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200624_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 3_frac_1_run_2 plasmodium falciparum not available gametocytes;schizonts not applicable wild 1 run 3 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200709_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 -Sample 4_frac_1_run_2 plasmodium falciparum not available gametocytes;schizonts not applicable wild 1 run 4 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200709_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1_frac_1_run_1 plasmodium falciparum not available gametocyte not applicable knockout 1 run 1 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200624_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2_frac_1_run_1 plasmodium falciparum not available gametocyte not applicable knockout 1 run 2 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200624_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3_frac_1_run_1 plasmodium falciparum not available gametocyte not applicable knockout 1 run 3 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200709_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4_frac_1_run_1 plasmodium falciparum not available gametocyte not applicable knockout 1 run 4 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_KO_20200709_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 1_frac_1_run_2 plasmodium falciparum not available gametocyte not applicable wild 1 run 1 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200624_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 2_frac_1_run_2 plasmodium falciparum not available gametocyte not applicable wild 1 run 2 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200624_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 3_frac_1_run_2 plasmodium falciparum not available gametocyte not applicable wild 1 run 3 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200709_phospho_4h_A.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 +Sample 4_frac_1_run_2 plasmodium falciparum not available gametocyte not applicable wild 1 run 4 proteomic profiling by mass spectrometry 3D7 PXD026474 NT=Data-dependent acquisition;AC=PRIDE:0000627 LUMOS_2020-09-29_KES_PfGams_WT_20200709_phospho_4h_B.raw ftp://massive.ucsd.edu/MSV000087569/ 1 1 label free sample AC=MS:1002732;NT=Orbitrap Fusion Lumos HCD AC=MS:1001251;NT=Trypsin NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;AC=UNIMOD:35;TA=M,W,H;MT=Variable NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable NT=Acetyl;AC=UNIMOD:1;TA=K;MT=Variable NT=Ammonia-loss;AC=UNIMOD:385;TA=Q,C;MT=Variable NT=Glu->pyro-Glu;AC=UNIMOD:27;TA=E;MT=Variable NT=Deamidated;AC=UNIMOD:7;PP=Protein N-term;MT=Variable NT=Phospho;AC=UNIMOD:21;TA=S,T,Y,A;MT=Variable 20 ppm 0.02 Da v1.1.0 NT=ms-proteomics;VV=v1.1.0 diff --git a/examples/core/PDC000126/PDC000126.sdrf.tsv b/examples/PDC000126/PDC000126.sdrf.tsv similarity index 100% rename from examples/core/PDC000126/PDC000126.sdrf.tsv rename to examples/PDC000126/PDC000126.sdrf.tsv diff --git a/examples/core/PXD002137/PXD002137.sdrf.tsv b/examples/PXD002137/PXD002137.sdrf.tsv similarity index 100% rename from examples/core/PXD002137/PXD002137.sdrf.tsv rename to examples/PXD002137/PXD002137.sdrf.tsv diff --git a/examples/PXD003772/PXD003772.sdrf.tsv b/examples/PXD003772/PXD003772.sdrf.tsv new file mode 100644 index 000000000..8ecc53ea7 --- /dev/null +++ b/examples/PXD003772/PXD003772.sdrf.tsv @@ -0,0 +1,13 @@ +source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell line] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[developmental stage] characteristics[sex] characteristics[treatment] characteristics[biological replicate] material type assay name technology type comment[instrument] comment[label] comment[fraction identifier] comment[proteomics data acquisition method] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[collision energy] comment[dissociation method] comment[file uri] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[data file] factor value[treatment] +Sample 1 Mus musculus blood plasma none not available not available not available not available not available not available NI 1 fluid run 1 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT126 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_1_240m_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_1_240m_1pt5.raw NI +Sample 2 Mus musculus blood plasma none not available not available not available not available not available not available NI 1 fluid run 1 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT127 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_1_240m_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_1_240m_1pt5.raw NI +Sample 3 Mus musculus blood plasma none not available not available not available not available not available not available d3 pi 1 fluid run 1 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT128 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_1_240m_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_1_240m_1pt5.raw d3 pi +Sample 4 Mus musculus blood plasma none not available not available not available not available not available not available d3 pi 1 fluid run 1 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT129 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_1_240m_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_1_240m_1pt5.raw d3 pi +Sample 5 Mus musculus blood plasma experimental cerebral malaria not available not available not available not available not available not available ECM 1 fluid run 1 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT130 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_1_240m_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_1_240m_1pt5.raw ECM +Sample 6 Mus musculus blood plasma experimental cerebral malaria not available not available not available not available not available not available ECM 1 fluid run 1 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT131 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_1_240m_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_1_240m_1pt5.raw ECM +Sample 7 Mus musculus blood plasma experimental cerebral malaria not available not available not available not available not available not available ECM 1 fluid run 2 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT126 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_2_240min_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_2_240min_1pt5.raw ECM +Sample 8 Mus musculus blood plasma experimental cerebral malaria not available not available not available not available not available not available ECM 1 fluid run 2 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT127 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_2_240min_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_2_240min_1pt5.raw ECM +Sample 9 Mus musculus blood plasma none not available not available not available not available not available not available NI 1 fluid run 2 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT128 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_2_240min_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_2_240min_1pt5.raw NI +Sample 10 Mus musculus blood plasma none not available not available not available not available not available not available NI 1 fluid run 2 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT129 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_2_240min_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_2_240min_1pt5.raw NI +Sample 11 Mus musculus blood plasma none not available not available not available not available not available not available d3 pi 1 fluid run 2 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT130 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_2_240min_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_2_240min_1pt5.raw d3 pi +Sample 12 Mus musculus blood plasma none not available not available not available not available not available not available d3 pi 1 fluid run 2 proteomic profiling by mass spectrometry NT=Q Exactive Plus;AC=MS:1002634 TMT131 1 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737 NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737 AC=MS:1001251;NT=Trypsin 30 NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD003772/Natalia_TMT6_2_240min_1pt5.raw 0.05 Da 10 ppm 1 Natalia_TMT6_2_240min_1pt5.raw d3 pi diff --git a/examples/PXD003791/PXD003791.sdrf.tsv b/examples/PXD003791/PXD003791.sdrf.tsv new file mode 100644 index 000000000..5bb7d30fb --- /dev/null +++ b/examples/PXD003791/PXD003791.sdrf.tsv @@ -0,0 +1,109 @@ +source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell type] characteristics[age] characteristics[developmental stage] characteristics[individual] characteristics[sex] characteristics[biological replicate] assay name technology type comment[instrument] comment[label] comment[fraction identifier] comment[proteomics data acquisition method] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[bmi] comment[file uri] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[proteomexchange accession number] comment[ptm] comment[technical replicate] comment[data file] factor value[sex] +PXD003791-Sample-1 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27672-12-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 26 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27672-12-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27672-12-ATH-F01.raw female +PXD003791-Sample-1 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27672-12-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 26 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27672-12-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27672-12-ATH-F02.raw female +PXD003791-Sample-1 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27672-12-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 26 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27672-12-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27672-12-ATH-F03.raw female +PXD003791-Sample-2 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27673-12-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 26 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27673-12-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27673-12-ATH-F01.raw female +PXD003791-Sample-2 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27673-12-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 26 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27673-12-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27673-12-ATH-F02.raw female +PXD003791-Sample-2 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27673-12-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 26 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27673-12-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27673-12-ATH-F03.raw female +PXD003791-Sample-3 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27674-12-ATH-F01_57f2f93a9b47b05ab013_ proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin not available ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27674-12-ATH-F01_57f2f93a9b47b05ab013_.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27674-12-ATH-F01_57f2f93a9b47b05ab013_.raw female +PXD003791-Sample-3 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27674-12-ATH-F02_e930a4087ef89bc7d1d9_ proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin not available ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27674-12-ATH-F02_e930a4087ef89bc7d1d9_.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27674-12-ATH-F02_e930a4087ef89bc7d1d9_.raw female +PXD003791-Sample-3 human gut metagenome not applicable normal not available 60 adult 1 female 1 130729-27674-12-ATH-F03_ca2be5839b2b08651f24_ proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin not available ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/130729-27674-12-ATH-F03_ca2be5839b2b08651f24_.raw 0.05 Da 5 ppm PXD003791 not applicable 1 130729-27674-12-ATH-F03_ca2be5839b2b08651f24_.raw female +PXD003791-Sample-4 human gut metagenome not applicable type 1 diabetes mellitus not available 62 adult 2 male 1 131211-28623-12-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 25 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28623-12-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28623-12-ATH-F01.raw male +PXD003791-Sample-4 human gut metagenome not applicable type 1 diabetes mellitus not available 62 adult 2 male 1 131211-28623-12-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 25 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28623-12-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28623-12-ATH-F02.raw male +PXD003791-Sample-4 human gut metagenome not applicable type 1 diabetes mellitus not available 62 adult 2 male 1 131211-28623-12-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 25 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28623-12-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28623-12-ATH-F03.raw male +PXD003791-Sample-5 human gut metagenome not applicable type 1 diabetes mellitus not available 62 adult 2 male 1 131211-28624-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 27 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28624-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28624-13-ATH-F01.raw male +PXD003791-Sample-5 human gut metagenome not applicable type 1 diabetes mellitus not available 62 adult 2 male 1 131211-28624-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 27 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28624-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28624-13-ATH-F02.raw male +PXD003791-Sample-5 human gut metagenome not applicable type 1 diabetes mellitus not available 62 adult 2 male 1 131211-28624-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 27 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28624-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28624-13-ATH-F03.raw male +PXD003791-Sample-6 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28626-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28626-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28626-13-ATH-F01.raw female +PXD003791-Sample-6 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28626-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28626-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28626-13-ATH-F02.raw female +PXD003791-Sample-6 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28626-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28626-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28626-13-ATH-F03.raw female +PXD003791-Sample-7 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28627-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28627-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28627-13-ATH-F01.raw female +PXD003791-Sample-7 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28627-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28627-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28627-13-ATH-F02.raw female +PXD003791-Sample-7 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28627-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28627-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28627-13-ATH-F03.raw female +PXD003791-Sample-8 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28628-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28628-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28628-13-ATH-F01.raw female +PXD003791-Sample-8 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28628-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28628-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28628-13-ATH-F02.raw female +PXD003791-Sample-8 human gut metagenome not applicable normal not available 57 adult 3 female 1 131211-28628-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28628-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28628-13-ATH-F03.raw female +PXD003791-Sample-9 human gut metagenome not applicable type 1 diabetes mellitus not available 37 adult 4 female 1 131211-28630-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 36 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28630-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28630-13-ATH-F01.raw female +PXD003791-Sample-9 human gut metagenome not applicable type 1 diabetes mellitus not available 37 adult 4 female 1 131211-28630-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 36 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28630-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28630-13-ATH-F02.raw female +PXD003791-Sample-9 human gut metagenome not applicable type 1 diabetes mellitus not available 37 adult 4 female 1 131211-28630-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 36 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28630-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28630-13-ATH-F03.raw female +PXD003791-Sample-10 human gut metagenome not applicable type 1 diabetes mellitus not available 37 adult 4 female 1 131211-28631-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28631-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28631-13-ATH-F01.raw female +PXD003791-Sample-10 human gut metagenome not applicable type 1 diabetes mellitus not available 37 adult 4 female 1 131211-28631-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28631-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28631-13-ATH-F02.raw female +PXD003791-Sample-10 human gut metagenome not applicable type 1 diabetes mellitus not available 37 adult 4 female 1 131211-28631-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 37 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28631-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28631-13-ATH-F03.raw female +PXD003791-Sample-11 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28635-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28635-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28635-13-ATH-F01.raw male +PXD003791-Sample-11 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28635-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28635-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28635-13-ATH-F02.raw male +PXD003791-Sample-11 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28635-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28635-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28635-13-ATH-F03.raw male +PXD003791-Sample-12 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28636-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28636-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28636-13-ATH-F01.raw male +PXD003791-Sample-12 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28636-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28636-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28636-13-ATH-F02.raw male +PXD003791-Sample-12 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28636-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28636-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28636-13-ATH-F03.raw male +PXD003791-Sample-13 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28637-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28637-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28637-13-ATH-F01.raw male +PXD003791-Sample-13 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28637-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28637-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28637-13-ATH-F02.raw male +PXD003791-Sample-13 human gut metagenome not applicable type 1 diabetes mellitus not available 58 adult 5 male 1 131211-28637-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 23 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28637-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28637-13-ATH-F03.raw male +PXD003791-Sample-14 human gut metagenome not applicable type 1 diabetes not available 24 adult 6 female 1 131211-28639-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 19 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28639-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28639-13-ATH-F01.raw female +PXD003791-Sample-14 human gut metagenome not applicable type 1 diabetes not available 24 adult 6 female 1 131211-28639-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 19 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28639-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28639-13-ATH-F02.raw female +PXD003791-Sample-14 human gut metagenome not applicable type 1 diabetes not available 24 adult 6 female 1 131211-28639-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 19 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28639-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28639-13-ATH-F03.raw female +PXD003791-Sample-15 human gut metagenome not applicable type 1 diabetes not available 24 adult 6 female 1 131211-28640-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 19 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28640-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28640-13-ATH-F01.raw female +PXD003791-Sample-15 human gut metagenome not applicable type 1 diabetes not available 24 adult 6 female 1 131211-28640-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 19 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28640-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28640-13-ATH-F02.raw female +PXD003791-Sample-15 human gut metagenome not applicable type 1 diabetes not available 24 adult 6 female 1 131211-28640-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 19 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28640-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28640-13-ATH-F03.raw female +PXD003791-Sample-16 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28641-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28641-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28641-13-ATH-F01.raw male +PXD003791-Sample-16 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28641-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28641-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28641-13-ATH-F02.raw male +PXD003791-Sample-16 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28641-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28641-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28641-13-ATH-F03.raw male +PXD003791-Sample-17 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28642-17-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28642-17-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28642-17-ATH-F01.raw male +PXD003791-Sample-17 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28642-17-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28642-17-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28642-17-ATH-F02.raw male +PXD003791-Sample-17 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28642-17-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28642-17-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28642-17-ATH-F03.raw male +PXD003791-Sample-18 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28643-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28643-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28643-13-ATH-F01.raw male +PXD003791-Sample-18 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28643-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28643-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28643-13-ATH-F02.raw male +PXD003791-Sample-18 human gut metagenome not applicable type 1 diabetes not available 30 adult 7 male 1 131211-28643-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28643-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28643-13-ATH-F03.raw male +PXD003791-Sample-19 human gut metagenome not applicable normal not available 58 adult 8 female 1 131211-28644-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28644-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28644-13-ATH-F01.raw female +PXD003791-Sample-19 human gut metagenome not applicable normal not available 58 adult 8 female 1 131211-28644-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28644-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28644-13-ATH-F02.raw female +PXD003791-Sample-19 human gut metagenome not applicable normal not available 58 adult 8 female 1 131211-28644-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28644-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28644-13-ATH-F03.raw female +PXD003791-Sample-20 human gut metagenome not applicable normal not available 58 adult 8 female 1 131211-28646-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28646-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28646-13-ATH-F01.raw female +PXD003791-Sample-20 human gut metagenome not applicable normal not available 58 adult 8 female 1 131211-28646-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28646-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28646-13-ATH-F02.raw female +PXD003791-Sample-20 human gut metagenome not applicable normal not available 58 adult 8 female 1 131211-28646-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28646-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28646-13-ATH-F03.raw female +PXD003791-Sample-21 human gut metagenome not applicable type 1 diabetes not available 28 adult 9 female 1 131211-28647-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28647-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28647-13-ATH-F01.raw female +PXD003791-Sample-21 human gut metagenome not applicable type 1 diabetes not available 28 adult 9 female 1 131211-28647-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28647-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28647-13-ATH-F02.raw female +PXD003791-Sample-21 human gut metagenome not applicable type 1 diabetes not available 28 adult 9 female 1 131211-28647-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28647-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28647-13-ATH-F03.raw female +PXD003791-Sample-22 human gut metagenome not applicable type 1 diabetes not available 28 adult 9 female 1 131211-28648-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28648-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28648-13-ATH-F01.raw female +PXD003791-Sample-22 human gut metagenome not applicable type 1 diabetes not available 28 adult 9 female 1 131211-28648-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28648-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28648-13-ATH-F02.raw female +PXD003791-Sample-22 human gut metagenome not applicable type 1 diabetes not available 28 adult 9 female 1 131211-28648-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28648-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28648-13-ATH-F03.raw female +PXD003791-Sample-23 human gut metagenome not applicable normal not available 14 not available 10 female 1 131211-28652-17-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28652-17-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28652-17-ATH-F01.raw female +PXD003791-Sample-23 human gut metagenome not applicable normal not available 14 not available 10 female 1 131211-28652-17-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28652-17-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28652-17-ATH-F02.raw female +PXD003791-Sample-23 human gut metagenome not applicable normal not available 14 not available 10 female 1 131211-28652-17-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 20 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28652-17-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28652-17-ATH-F03.raw female +PXD003791-Sample-24 human gut metagenome not applicable type 1 diabetes not available 17 not available female 1 131211-28654-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28654-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28654-13-ATH-F01.raw female +PXD003791-Sample-24 human gut metagenome not applicable type 1 diabetes not available 17 not available female 1 131211-28654-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28654-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28654-13-ATH-F02.raw female +PXD003791-Sample-24 human gut metagenome not applicable type 1 diabetes not available 17 not available female 1 131211-28654-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28654-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28654-13-ATH-F03.raw female +PXD003791-Sample-25 human gut metagenome not applicable type 1 diabetes not available 19 not available female 1 131211-28656-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 25 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28656-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28656-13-ATH-F01.raw female +PXD003791-Sample-25 human gut metagenome not applicable type 1 diabetes not available 19 not available female 1 131211-28656-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 25 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28656-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28656-13-ATH-F02.raw female +PXD003791-Sample-25 human gut metagenome not applicable type 1 diabetes not available 19 not available female 1 131211-28656-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 25 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28656-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28656-13-ATH-F03.raw female +PXD003791-Sample-26 human gut metagenome not applicable normal not available 34 adult female 1 131211-28659-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 38 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28659-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28659-13-ATH-F01.raw female +PXD003791-Sample-26 human gut metagenome not applicable normal not available 34 adult female 1 131211-28659-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 38 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28659-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28659-13-ATH-F02.raw female +PXD003791-Sample-26 human gut metagenome not applicable normal not available 34 adult female 1 131211-28659-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 38 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28659-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28659-13-ATH-F03.raw female +PXD003791-Sample-27 human gut metagenome not applicable type 1 diabetes not available 5 not available male 1 131211-28661-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 15 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28661-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28661-13-ATH-F01.raw male +PXD003791-Sample-27 human gut metagenome not applicable type 1 diabetes not available 5 not available male 1 131211-28661-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 15 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28661-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28661-13-ATH-F02.raw male +PXD003791-Sample-27 human gut metagenome not applicable type 1 diabetes not available 5 not available male 1 131211-28661-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 15 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28661-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28661-13-ATH-F03.raw male +PXD003791-Sample-28 human gut metagenome not applicable type 1 diabetes not available 5 not available male 1 131211-28662-12-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 15 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28662-12-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28662-12-ATH-F01.raw male +PXD003791-Sample-28 human gut metagenome not applicable type 1 diabetes not available 5 not available male 1 131211-28662-12-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 15 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28662-12-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28662-12-ATH-F02.raw male +PXD003791-Sample-28 human gut metagenome not applicable type 1 diabetes not available 5 not available male 1 131211-28662-12-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 15 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28662-12-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28662-12-ATH-F03.raw male +PXD003791-Sample-29 human gut metagenome not applicable normal not available 12 not available female 1 131211-28667-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 30 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28667-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28667-13-ATH-F01.raw female +PXD003791-Sample-29 human gut metagenome not applicable normal not available 12 not available female 1 131211-28667-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 30 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28667-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28667-13-ATH-F02.raw female +PXD003791-Sample-29 human gut metagenome not applicable normal not available 12 not available female 1 131211-28667-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 30 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28667-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28667-13-ATH-F03.raw female +PXD003791-Sample-30 human gut metagenome not applicable normal not available 16 not available female 1 131211-28669-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 29 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28669-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28669-13-ATH-F01.raw female +PXD003791-Sample-30 human gut metagenome not applicable normal not available 16 not available female 1 131211-28669-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 29 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28669-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28669-13-ATH-F02.raw female +PXD003791-Sample-30 human gut metagenome not applicable normal not available 16 not available female 1 131211-28669-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 29 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28669-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28669-13-ATH-F03.raw female +PXD003791-Sample-31 human gut metagenome not applicable normal not available 43 not available male 1 131211-28671-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 35 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28671-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28671-13-ATH-F01.raw male +PXD003791-Sample-31 human gut metagenome not applicable normal not available 43 not available male 1 131211-28671-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 35 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28671-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28671-13-ATH-F02.raw male +PXD003791-Sample-31 human gut metagenome not applicable normal not available 43 not available male 1 131211-28671-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 35 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28671-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28671-13-ATH-F03.raw male +PXD003791-Sample-32 human gut metagenome not applicable normal not available 43 not available male 1 131211-28672-13-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 36 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28672-13-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28672-13-ATH-F01.raw male +PXD003791-Sample-32 human gut metagenome not applicable normal not available 43 not available male 1 131211-28672-13-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 36 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28672-13-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28672-13-ATH-F02.raw male +PXD003791-Sample-32 human gut metagenome not applicable normal not available 43 not available male 1 131211-28672-13-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 36 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/131211-28672-13-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 131211-28672-13-ATH-F03.raw male +PXD003791-Sample-33 human gut metagenome not applicable type 1 diabetes mellitus not available 62 not available male 1 140108-28625-17-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin not available ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140108-28625-17-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140108-28625-17-ATH-F01.raw male +PXD003791-Sample-33 human gut metagenome not applicable type 1 diabetes mellitus not available 62 not available male 1 140108-28625-17-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin not available ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140108-28625-17-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140108-28625-17-ATH-F02.raw male +PXD003791-Sample-33 human gut metagenome not applicable type 1 diabetes mellitus not available 62 not available male 1 140108-28625-17-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin not available ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140108-28625-17-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140108-28625-17-ATH-F03.raw male +PXD003791-Sample-34 human gut metagenome not applicable normal not available 58 not available female 1 140113-28645-17-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28645-17-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28645-17-ATH-F01.raw female +PXD003791-Sample-34 human gut metagenome not applicable normal not available 58 not available female 1 140113-28645-17-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28645-17-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28645-17-ATH-F02.raw female +PXD003791-Sample-34 human gut metagenome not applicable normal not available 58 not available female 1 140113-28645-17-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 21 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28645-17-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28645-17-ATH-F03.raw female +PXD003791-Sample-35 human gut metagenome not applicable type 1 diabetes not available 9 not available male 1 140113-28663-17-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 24 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28663-17-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28663-17-ATH-F01.raw male +PXD003791-Sample-35 human gut metagenome not applicable type 1 diabetes not available 9 not available male 1 140113-28663-17-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 24 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28663-17-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28663-17-ATH-F02.raw male +PXD003791-Sample-35 human gut metagenome not applicable type 1 diabetes not available 9 not available male 1 140113-28663-17-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 24 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28663-17-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28663-17-ATH-F03.raw male +PXD003791-Sample-36 human gut metagenome not applicable normal not available 12 not available female 1 140113-28665-17-ATH-F01 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 1 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 30 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28665-17-ATH-F01.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28665-17-ATH-F01.raw female +PXD003791-Sample-36 human gut metagenome not applicable normal not available 12 not available female 1 140113-28665-17-ATH-F02 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 2 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 30 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28665-17-ATH-F02.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28665-17-ATH-F02.raw female +PXD003791-Sample-36 human gut metagenome not applicable normal not available 12 not available female 1 140113-28665-17-ATH-F03 proteomic profiling by mass spectrometry AC=MS:1001911;NT=Q Exactive NT=label free sample;AC=MS:1002038 3 Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35 NT=Acetyl;MT=Variable;PP=Protein N-term;AC=UNIMOD:1 NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7 AC=MS:1001251;NT=Trypsin 30 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/08/PXD003791/140113-28665-17-ATH-F03.raw 0.05 Da 5 ppm PXD003791 not applicable 1 140113-28665-17-ATH-F03.raw female diff --git a/examples/core/PXD004684/PXD004684.sdrf.tsv b/examples/PXD004684/PXD004684.sdrf.tsv similarity index 100% rename from examples/core/PXD004684/PXD004684.sdrf.tsv rename to examples/PXD004684/PXD004684.sdrf.tsv diff --git a/examples/PXD006439/PXD006439.sdrf.tsv b/examples/PXD006439/PXD006439.sdrf.tsv new file mode 100644 index 000000000..20f45ca01 --- /dev/null +++ b/examples/PXD006439/PXD006439.sdrf.tsv @@ -0,0 +1,68 @@ +source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell line] characteristics[cell type] characteristics[age] characteristics[developmental stage] characteristics[phenotype] characteristics[sample type] characteristics[sex] characteristics[strain] characteristics[biological replicate] material type assay name technology type comment[instrument] comment[label] comment[fraction identifier] comment[proteomics data acquisition method] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[collision energy] comment[dissociation method] comment[file uri] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[data file] factor value[cell line] +PXD006439-Sample-1 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 1 cell run 1 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_A1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_A1.raw B16-F1 +PXD006439-Sample-1 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 1 cell run 2 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_A2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_A2.raw B16-F1 +PXD006439-Sample-1 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 1 cell run 3 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_A3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_A3.raw B16-F1 +PXD006439-Sample-1 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 1 cell run 4 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_A4_160202090357.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_A4_160202090357.raw B16-F1 +PXD006439-Sample-1 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 1 cell run 5 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_A5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_A5.raw B16-F1 +PXD006439-Sample-2 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 2 cell run 6 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_C1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_C1.raw B16-F1 +PXD006439-Sample-2 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 2 cell run 7 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_C2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_C2.raw B16-F1 +PXD006439-Sample-2 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 2 cell run 8 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_C3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_C3.raw B16-F1 +PXD006439-Sample-2 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 2 cell run 9 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_C4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_C4.raw B16-F1 +PXD006439-Sample-2 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 2 cell run 10 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_C5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_C5.raw B16-F1 +PXD006439-Sample-3 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 3 cell run 11 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_E1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_E1.raw B16-F1 +PXD006439-Sample-3 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 3 cell run 12 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_E2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_E2.raw B16-F1 +PXD006439-Sample-3 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 3 cell run 13 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_E3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_E3.raw B16-F1 +PXD006439-Sample-3 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 3 cell run 14 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_E4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_E4.raw B16-F1 +PXD006439-Sample-3 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign Cell Lysate not available C57BL/6J 3 cell run 15 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_E5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_E5.raw B16-F1 +PXD006439-Sample-4 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 1 cell run 16 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_B1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_B1.raw B16-F10 +PXD006439-Sample-4 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 1 cell run 17 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_B2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_B2.raw B16-F10 +PXD006439-Sample-4 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 1 cell run 18 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_B3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_B3.raw B16-F10 +PXD006439-Sample-4 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 1 cell run 19 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_B4_160202110509.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_B4_160202110509.raw B16-F10 +PXD006439-Sample-4 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 1 cell run 20 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_B5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_B5.raw B16-F10 +PXD006439-Sample-5 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 2 cell run 21 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_D1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_D1.raw B16-F10 +PXD006439-Sample-5 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 2 cell run 22 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_D2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_D2.raw B16-F10 +PXD006439-Sample-5 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 2 cell run 23 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_D3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_D3.raw B16-F10 +PXD006439-Sample-5 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 2 cell run 24 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_D4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_D4.raw B16-F10 +PXD006439-Sample-5 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 2 cell run 25 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_D5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_D5.raw B16-F10 +PXD006439-Sample-6 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 3 cell run 26 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_F1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_F1.raw B16-F10 +PXD006439-Sample-6 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 3 cell run 27 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_F2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_F2.raw B16-F10 +PXD006439-Sample-6 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 3 cell run 28 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_F3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_F3.raw B16-F10 +PXD006439-Sample-6 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 3 cell run 29 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_F4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_F4.raw B16-F10 +PXD006439-Sample-6 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant Cell Lysate not available C57BL/6J 3 cell run 30 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_F5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_F5.raw B16-F10 +PXD006439-Sample-7 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 1 cell run 31 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_G1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_G1.raw B16-F1 +PXD006439-Sample-7 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 1 cell run 32 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_G2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_G2.raw B16-F1 +PXD006439-Sample-7 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 1 cell run 33 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_G3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_G3.raw B16-F1 +PXD006439-Sample-7 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 1 cell run 34 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_G4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_G4.raw B16-F1 +PXD006439-Sample-7 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 1 cell run 35 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_G5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_G5.raw B16-F1 +PXD006439-Sample-8 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 2 cell run 36 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_I1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_I1.raw B16-F1 +PXD006439-Sample-8 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 2 cell run 37 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_I2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_I2.raw B16-F1 +PXD006439-Sample-8 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 2 cell run 38 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_I3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_I3.raw B16-F1 +PXD006439-Sample-8 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 2 cell run 39 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_I4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_I4.raw B16-F1 +PXD006439-Sample-8 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 2 cell run 40 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_I5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_I5.raw B16-F1 +PXD006439-Sample-9 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 3 cell run 41 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_K1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_K1.raw B16-F1 +PXD006439-Sample-9 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 3 cell run 42 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_K2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_K2.raw B16-F1 +PXD006439-Sample-9 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 3 cell run 43 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_K3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_K3.raw B16-F1 +PXD006439-Sample-9 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 3 cell run 44 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_K4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_K4.raw B16-F1 +PXD006439-Sample-9 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 16K EV not available C57BL/6J 3 cell run 45 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_K5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_K5.raw B16-F1 +PXD006439-Sample-10 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 1 cell run 46 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_H1.raw B16-F10 +PXD006439-Sample-10 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 1 cell run 47 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_H2.raw B16-F10 +PXD006439-Sample-10 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 1 cell run 48 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_H3.raw B16-F10 +PXD006439-Sample-10 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 1 cell run 49 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_H4.raw B16-F10 +PXD006439-Sample-10 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 1 cell run 50 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_H5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_H5.raw B16-F10 +PXD006439-Sample-11 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 2 cell run 51 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_J1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_J1.raw B16-F10 +PXD006439-Sample-11 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 2 cell run 52 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_J2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_J2.raw B16-F10 +PXD006439-Sample-11 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 2 cell run 53 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_J3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_J3.raw B16-F10 +PXD006439-Sample-11 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 2 cell run 54 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_J4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_J4.raw B16-F10 +PXD006439-Sample-11 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 2 cell run 55 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_J5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_J5.raw B16-F10 +PXD006439-Sample-12 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 3 cell run 56 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_L1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_L1.raw B16-F10 +PXD006439-Sample-12 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 3 cell run 57 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_L2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_L2.raw B16-F10 +PXD006439-Sample-12 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 3 cell run 58 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_L3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_L3.raw B16-F10 +PXD006439-Sample-12 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 3 cell run 59 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_L4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_L4.raw B16-F10 +PXD006439-Sample-12 Mus musculus skin high metastatic potential B16-F10 not available not available not available Malignant 16K EV not available C57BL/6J 3 cell run 60 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_L5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_L5.raw B16-F10 +PXD006439-Sample-13 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 100K EV not available C57BL/6J 1 cell run 61 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_M1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_M1.raw B16-F1 +PXD006439-Sample-13 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 100K EV not available C57BL/6J 1 cell run 62 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 2 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_M2.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_M2.raw B16-F1 +PXD006439-Sample-13 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 100K EV not available C57BL/6J 1 cell run 63 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 3 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_M3.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_M3.raw B16-F1 +PXD006439-Sample-13 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 100K EV not available C57BL/6J 1 cell run 64 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 4 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_M4.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_M4.raw B16-F1 +PXD006439-Sample-13 Mus musculus skin low metastatic potential B16-F1 not available not available not available Benign 100K EV not available C57BL/6J 1 cell run 65 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 5 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_M5.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_M5.raw B16-F1 +PXD006439-Sample-14 Mus musculus skin low metastatic potential B16-F10 not available not available not available Malignant 100K EV not available C57BL/6J 1 cell run 66 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_N1.raw 20 ppm 4.5 ppm 1 QE2_160128_OPL4022_SCS_EVs_and_LYS_N1.raw B16-F10 +PXD006439-Sample-14 Mus musculus skin low metastatic potential B16-F10 not available not available not available Malignant 100K EV not available C57BL/6J 1 cell run 67 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Any N-term;MT=Variable AC=MS:1001313;NT=Trypsin 25% NCE NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/06/PXD006439/QE2_160128_OPL4022_SCS_EVs_and_LYS_R5.raw 20 ppm 4.5 ppm 2 QE2_160128_OPL4022_SCS_EVs_and_LYS_R5.raw B16-F10 diff --git a/examples/core/PXD006482/PXD006482.sdrf.tsv b/examples/PXD006482/PXD006482.sdrf.tsv similarity index 100% rename from examples/core/PXD006482/PXD006482.sdrf.tsv rename to examples/PXD006482/PXD006482.sdrf.tsv diff --git a/examples/core/PXD008934/PXD008934.sdrf.tsv b/examples/PXD008934/PXD008934.sdrf.tsv similarity index 100% rename from examples/core/PXD008934/PXD008934.sdrf.tsv rename to examples/PXD008934/PXD008934.sdrf.tsv diff --git a/examples/PXD012667/PXD012667.sdrf.tsv b/examples/PXD012667/PXD012667.sdrf.tsv new file mode 100644 index 000000000..77777219e --- /dev/null +++ b/examples/PXD012667/PXD012667.sdrf.tsv @@ -0,0 +1,49 @@ +source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[depletion] characteristics[developmental stage] characteristics[individual] characteristics[sampling time] characteristics[sex] characteristics[biological replicate] assay name technology type comment[instrument] comment[label] comment[fraction identifier] comment[fractionation method] comment[proteomics data acquisition method] comment[modification parameter] comment[modification parameter] comment[cleavage agent details] comment[biological replicate] comment[collision energy] comment[dissociation method] comment[file uri] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[proteomics data adquisition method] comment[separation] comment[technical replicate] comment[data file] value[organism part] +PXD012667-Sample-1 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 69 not available no depletion not available 1 not applicable Male 1 171031_TTSH_Disease1_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 1 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease1_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease1_A1.raw blood plasma +PXD012667-Sample-2 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 69 not available no depletion not available 1 not applicable Male 1 171031_TTSH_Disease1_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 1 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease1_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease1_B1.raw blood plasma +PXD012667-Sample-3 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 69 not available no depletion not available 1 not applicable Male 1 171031_TTSH_Disease1_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 1 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease1_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease1_C1.raw blood plasma +PXD012667-Sample-4 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 67 not available no depletion not available 2 not applicable Male 1 171031_TTSH_Disease2_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 2 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease2_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease2_A1.raw blood plasma +PXD012667-Sample-5 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 67 not available no depletion not available 2 not applicable Male 1 171031_TTSH_Disease2_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 2 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease2_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease2_B1.raw blood plasma +PXD012667-Sample-6 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 67 not available no depletion not available 2 not applicable Male 1 171031_TTSH_Disease2_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 2 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease2_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease2_C1.raw blood plasma +PXD012667-Sample-7 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 65 not available no depletion not available 3 not applicable Male 1 171031_TTSH_Disease3_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 3 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease3_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease3_A1.raw blood plasma +PXD012667-Sample-8 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 65 not available no depletion not available 3 not applicable Male 1 171031_TTSH_Disease3_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 3 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease3_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease3_B1.raw blood plasma +PXD012667-Sample-9 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 65 not available no depletion not available 3 not applicable Male 1 171031_TTSH_Disease3_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 3 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease3_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease3_C1.raw blood plasma +PXD012667-Sample-10 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 59 not available no depletion not available 4 not applicable Male 1 171031_TTSH_Disease4_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 4 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease4_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease4_A1.raw blood plasma +PXD012667-Sample-11 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 59 not available no depletion not available 4 not applicable Male 1 171031_TTSH_Disease4_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 4 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease4_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease4_B1.raw blood plasma +PXD012667-Sample-12 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 59 not available no depletion not available 4 not applicable Male 1 171031_TTSH_Disease4_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 4 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease4_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease4_C1.raw blood plasma +PXD012667-Sample-13 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 59 not available no depletion not available 5 not applicable Male 1 171031_TTSH_Disease5_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 5 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease5_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease5_A1.raw blood plasma +PXD012667-Sample-14 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 59 not available no depletion not available 5 not applicable Male 1 171031_TTSH_Disease5_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 5 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease5_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease5_B1.raw blood plasma +PXD012667-Sample-15 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 59 not available no depletion not available 5 not applicable Male 1 171031_TTSH_Disease5_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 5 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease5_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease5_C1.raw blood plasma +PXD012667-Sample-16 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 67 not available no depletion not available 6 not applicable Male 1 171031_TTSH_Disease6_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 6 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease6_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease6_A1.raw blood plasma +PXD012667-Sample-17 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 67 not available no depletion not available 6 not applicable Male 1 171031_TTSH_Disease6_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 6 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease6_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease6_B1.raw blood plasma +PXD012667-Sample-18 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 67 not available no depletion not available 6 not applicable Male 1 171031_TTSH_Disease6_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 6 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease6_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease6_C1.raw blood plasma +PXD012667-Sample-19 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 52 not available no depletion not available 7 not applicable Male 1 171031_TTSH_Disease7_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 7 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease7_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease7_A1.raw blood plasma +PXD012667-Sample-20 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 52 not available no depletion not available 7 not applicable Female 1 171031_TTSH_Disease7_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 7 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease7_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease7_B1.raw blood plasma +PXD012667-Sample-21 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 52 not available no depletion not available 7 not applicable Female 1 171031_TTSH_Disease7_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 7 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease7_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease7_C1.raw blood plasma +PXD012667-Sample-22 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 72 not available no depletion not available 8 not applicable Female 1 171031_TTSH_Disease8_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 8 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease8_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease8_A1.raw blood plasma +PXD012667-Sample-23 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 72 not available no depletion not available 8 not applicable Male 1 171031_TTSH_Disease8_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 8 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease8_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease8_B1.raw blood plasma +PXD012667-Sample-24 Homo sapiens blood plasma Type 2 Diabetes Mellitus not applicable 72 not available no depletion not available 8 not applicable Male 1 171031_TTSH_Disease8_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 8 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease8_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Disease8_C1.raw blood plasma +PXD012667-Sample-25 Homo sapiens blood plasma Normal not applicable 54 not available no depletion not available 9 not applicable Male 1 171031_TTSH_Healthy1_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 9 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy1_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy1_A1.raw blood plasma +PXD012667-Sample-26 Homo sapiens blood plasma Normal not applicable 54 not available no depletion not available 9 not applicable Male 1 171031_TTSH_Healthy1_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 9 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy1_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy1_B1.raw blood plasma +PXD012667-Sample-27 Homo sapiens blood plasma Normal not applicable 54 not available no depletion not available 9 not applicable Male 1 171031_TTSH_Healthy1_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 9 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy1_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy1_C1.raw blood plasma +PXD012667-Sample-28 Homo sapiens blood plasma Normal not applicable 53 not available no depletion not available 10 not applicable Male 1 171031_TTSH_Healthy2_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 10 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy2_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy2_A1.raw blood plasma +PXD012667-Sample-29 Homo sapiens blood plasma Normal not applicable 53 not available no depletion not available 10 not applicable Male 1 171031_TTSH_Healthy2_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 10 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy2_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy2_B1.raw blood plasma +PXD012667-Sample-30 Homo sapiens blood plasma Normal not applicable 53 not available no depletion not available 10 not applicable Male 1 171031_TTSH_Healthy2_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 10 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy2_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy2_C1.raw blood plasma +PXD012667-Sample-31 Homo sapiens blood plasma Normal not applicable 56 not available no depletion not available 11 not applicable Male 1 171031_TTSH_Healthy3_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 11 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy3_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy3_A1.raw blood plasma +PXD012667-Sample-32 Homo sapiens blood plasma Normal not applicable 56 not available no depletion not available 11 not applicable Male 1 171031_TTSH_Healthy3_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 11 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy3_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy3_B1.raw blood plasma +PXD012667-Sample-33 Homo sapiens blood plasma Normal not applicable 56 not available no depletion not available 11 not applicable Male 1 171031_TTSH_Healthy3_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 11 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy3_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy3_C1.raw blood plasma +PXD012667-Sample-34 Homo sapiens blood plasma Normal not applicable 53 not available no depletion not available 12 not applicable Male 1 171031_TTSH_Healthy4_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 12 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy4_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy4_A1.raw blood plasma +PXD012667-Sample-35 Homo sapiens blood plasma Normal not applicable 53 not available no depletion not available 12 not applicable Male 1 171031_TTSH_Healthy4_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 12 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy4_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy4_B1.raw blood plasma +PXD012667-Sample-36 Homo sapiens blood plasma Normal not applicable 53 not available no depletion not available 12 not applicable Male 1 171031_TTSH_Healthy4_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 12 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy4_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy4_C1.raw blood plasma +PXD012667-Sample-37 Homo sapiens blood plasma Normal not applicable 55 not available no depletion not available 13 not applicable Male 1 171031_TTSH_Healthy5_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 13 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy5_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy5_A1.raw blood plasma +PXD012667-Sample-38 Homo sapiens blood plasma Normal not applicable 55 not available no depletion not available 13 not applicable Male 1 171031_TTSH_Healthy5_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 13 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy5_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy5_B1.raw blood plasma +PXD012667-Sample-39 Homo sapiens blood plasma Normal not applicable 55 not available no depletion not available 13 not applicable Male 1 171031_TTSH_Healthy5_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 13 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy5_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy5_C1.raw blood plasma +PXD012667-Sample-40 Homo sapiens blood plasma Normal not applicable 68 not available no depletion not available 14 not applicable Female 1 171031_TTSH_Healthy6_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 14 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy6_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy6_A1.raw blood plasma +PXD012667-Sample-41 Homo sapiens blood plasma Normal not applicable 68 not available no depletion not available 14 not applicable Female 1 171031_TTSH_Healthy6_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 14 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy6_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy6_B1.raw blood plasma +PXD012667-Sample-42 Homo sapiens blood plasma Normal not applicable 68 not available no depletion not available 14 not applicable Female 1 171031_TTSH_Healthy6_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 14 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy6_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy6_C1.raw blood plasma +PXD012667-Sample-43 Homo sapiens blood plasma Normal not applicable 55 not available no depletion not available 15 not applicable Male 1 171031_TTSH_Healthy7_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 15 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy7_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy7_A1.raw blood plasma +PXD012667-Sample-44 Homo sapiens blood plasma Normal not applicable 55 not available no depletion not available 15 not applicable Male 1 171031_TTSH_Healthy7_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 15 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy7_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy7_B1.raw blood plasma +PXD012667-Sample-45 Homo sapiens blood plasma Normal not applicable 55 not available no depletion not available 15 not applicable Male 1 171031_TTSH_Healthy7_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 15 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy7_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy7_C1.raw blood plasma +PXD012667-Sample-46 Homo sapiens blood plasma Normal not applicable 50 not available no depletion not available 16 not applicable Male 1 171031_TTSH_Healthy8_A1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 1 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 16 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy8_A1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy8_A1.raw blood plasma +PXD012667-Sample-47 Homo sapiens blood plasma Normal not applicable 50 not available no depletion not available 16 not applicable Male 1 171031_TTSH_Healthy8_B1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 2 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 16 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy8_B1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy8_B1.raw blood plasma +PXD012667-Sample-48 Homo sapiens blood plasma Normal not applicable 50 not available no depletion not available 16 not applicable Male 1 171031_TTSH_Healthy8_C1 proteomic profiling by mass spectrometry AC=MS:1001911 ; NT=Q Exactive AC=MS:1002038;NT=label free sample 3 AC=PRID:0000555; NT=ERLIC Data-Independent Acquisition NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P) 16 28 NCE AC=MS:1000422;NT=HCD https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy8_C1.raw 30 ppm 10 ppm AC=PRIDE:0000627; NT=Data-dependent adquisition AC=PRIDE:0000563;NT=Reversed-phase chromatography 1 171031_TTSH_Healthy8_C1.raw blood plasma diff --git a/examples/PXD013868/PXD013868.sdrf.tsv b/examples/PXD013868/PXD013868.sdrf.tsv new file mode 100644 index 000000000..c0984edb9 --- /dev/null +++ b/examples/PXD013868/PXD013868.sdrf.tsv @@ -0,0 +1,21 @@ +source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell type] characteristics[age] characteristics[enrichment process] characteristics[biological replicate] assay name technology type comment[instrument] comment[label] comment[fraction identifier] comment[fractionation method] comment[proteomics data acquisition method] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[file uri] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[data file] factor value[organism part] +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 1 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 1 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BA2_P026998_S00_X01_R1.raw 20 ppm 5 ppm 1 02444_BA2_P026998_S00_X01_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 2 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 2 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BB2_P026998_S00_X02_R1.raw 20 ppm 5 ppm 1 02444_BB2_P026998_S00_X02_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 3 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 3 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BC2_P026998_S00_X03_R1.raw 20 ppm 5 ppm 1 02444_BC2_P026998_S00_X03_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 4 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 4 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BD2_P026998_S00_X04_R1.raw 20 ppm 5 ppm 1 02444_BD2_P026998_S00_X04_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 5 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 5 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BE2_P026998_S00_X05_R1.raw 20 ppm 5 ppm 1 02444_BE2_P026998_S00_X05_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 6 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 6 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BF2_P026998_S00_X06_R1.raw 20 ppm 5 ppm 1 02444_BF2_P026998_S00_X06_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 7 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 7 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BG2_P026998_S00_X07_R1.raw 20 ppm 5 ppm 1 02444_BG2_P026998_S00_X07_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 8 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 8 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BH2_P026998_S00_X08_R1.raw 20 ppm 5 ppm 1 02444_BH2_P026998_S00_X08_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 9 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 9 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BA3_P026998_S00_X09_R1.raw 20 ppm 5 ppm 1 02444_BA3_P026998_S00_X09_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 10 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 10 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BB3_P026998_S00_X10_R1.raw 20 ppm 5 ppm 1 02444_BB3_P026998_S00_X10_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 11 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 11 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BC3_P026998_S00_X11_R1.raw 20 ppm 5 ppm 1 02444_BC3_P026998_S00_X11_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 12 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 12 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BD3_P026998_S00_X12_R1.raw 20 ppm 5 ppm 1 02444_BD3_P026998_S00_X12_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 13 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 13 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BE3_P026998_S00_X13_R1.raw 20 ppm 5 ppm 1 02444_BE3_P026998_S00_X13_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 14 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 14 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BF3_P026998_S00_X14_R1.raw 20 ppm 5 ppm 1 02444_BF3_P026998_S00_X14_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 15 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 15 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BG3_P026998_S00_X15_R1.raw 20 ppm 5 ppm 1 02444_BG3_P026998_S00_X15_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 16 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 16 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BH3_P026998_S00_X16_R1.raw 20 ppm 5 ppm 1 02444_BH3_P026998_S00_X16_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 17 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 17 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BA4_P026998_S00_X17_R1.raw 20 ppm 5 ppm 1 02444_BA4_P026998_S00_X17_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 18 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 18 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BB4_P026998_S00_X18_R1.raw 20 ppm 5 ppm 1 02444_BB4_P026998_S00_X18_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 19 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 19 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BC4_P026998_S00_X19_R1.raw 20 ppm 5 ppm 1 02444_BC4_P026998_S00_X19_R1.raw flower +PXD013868-Sample 1 Arabidopsis thaliana flower normal plant cell 5W no enrichment 1 run 20 proteomic profiling by mass spectrometry NT=Q Exactive HF;AC=MS:1002523 AC=MS:1002038;NT=label free sample 20 Size-exclusion chromatography (SEC) Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 AC=MS:1001251;NT=Trypsin ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD013868/02444_BD4_P026998_S00_X20_R1.raw 20 ppm 5 ppm 1 02444_BD4_P026998_S00_X20_R1.raw flower diff --git a/examples/PXD013923/PXD013923.sdrf.tsv b/examples/PXD013923/PXD013923.sdrf.tsv new file mode 100644 index 000000000..0f5e91bbe --- /dev/null +++ b/examples/PXD013923/PXD013923.sdrf.tsv @@ -0,0 +1,21 @@ +source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell line] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[developmental stage] characteristics[enrichment method] characteristics[enrichment process] characteristics[sex] characteristics[treatment] characteristics[treatment] characteristics[biological replicate] material type assay name technology type comment[instrument] comment[label] comment[fraction identifier] comment[fractionation method] comment[proteomics data acquisition method] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[cleavage agent details] comment[file uri] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[data file] factor value[enrichment process] factor value[treatment] factor value[treatment] +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none BRAF inhibitor dabrafenib 1 cell run 1 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC heavy 1 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S01.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S01.raw enrichment of phosphorylated Protein none BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female control BRAF inhibitor dabrafenib 1 cell run 1 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC medium 1 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S01.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S01.raw enrichment of phosphorylated Protein control BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none control 1 cell run 1 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC light 1 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S01.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S01.raw enrichment of phosphorylated Protein none control +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none BRAF inhibitor dabrafenib 1 cell run 2 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC heavy 6 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S013_14.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S013_14.raw enrichment of phosphorylated Protein none BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female control BRAF inhibitor dabrafenib 1 cell run 2 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC medium 6 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S013_14.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S013_14.raw enrichment of phosphorylated Protein control BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none control 1 cell run 2 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC light 6 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S013_14.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S013_14.raw enrichment of phosphorylated Protein none control +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none BRAF inhibitor dabrafenib 1 cell run 3 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC heavy 7 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S015.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S015.raw enrichment of phosphorylated Protein none BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female control BRAF inhibitor dabrafenib 1 cell run 3 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC medium 7 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S015.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S015.raw enrichment of phosphorylated Protein control BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none control 1 cell run 3 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC light 7 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S015.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S015.raw enrichment of phosphorylated Protein none control +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none BRAF inhibitor dabrafenib 1 cell run 4 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC heavy 2 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S02_12.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S02_12.raw enrichment of phosphorylated Protein none BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female control BRAF inhibitor dabrafenib 1 cell run 4 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC medium 2 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S02_12.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S02_12.raw enrichment of phosphorylated Protein control BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none control 1 cell run 4 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC light 2 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S02_12.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S02_12.raw enrichment of phosphorylated Protein none control +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none BRAF inhibitor dabrafenib 1 cell run 5 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC heavy 3 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S03_4_5_6.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S03_4_5_6.raw enrichment of phosphorylated Protein none BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female control BRAF inhibitor dabrafenib 1 cell run 5 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC medium 3 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S03_4_5_6.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S03_4_5_6.raw enrichment of phosphorylated Protein control BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none control 1 cell run 5 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC light 3 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S03_4_5_6.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S03_4_5_6.raw enrichment of phosphorylated Protein none control +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none BRAF inhibitor dabrafenib 1 cell run 6 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC heavy 4 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S07_8.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S07_8.raw enrichment of phosphorylated Protein none BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female control BRAF inhibitor dabrafenib 1 cell run 6 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC medium 4 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S07_8.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S07_8.raw enrichment of phosphorylated Protein control BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none control 1 cell run 6 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC light 4 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S07_8.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S07_8.raw enrichment of phosphorylated Protein none control +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female none BRAF inhibitor dabrafenib 1 cell run 7 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC heavy 5 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S09_10_11.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S09_10_11.raw enrichment of phosphorylated Protein none BRAF inhibitor dabrafenib +PXD013923-Sample-1 Homo sapiens not applicable malignant melanoma A375 epithelial 54Y not available not available TIO2 enrichment of phosphorylated Protein female control BRAF inhibitor dabrafenib 1 cell run 7 proteomic profiling by mass spectrometry NT=Q Exactive;AC=MS:1001911 SILAC medium 5 NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561 Data-Dependent Acquisition NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35 NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21 NT=Trypsin; AC=MS:1001251 NT=Lys-C;AC=MS:1001309 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD013923/20131114_CCS_EV_A375_RAFi_30min_S09_10_11.raw not available not available 1 20131114_CCS_EV_A375_RAFi_30min_S09_10_11.raw enrichment of phosphorylated Protein control BRAF inhibitor dabrafenib diff --git a/examples/PXD019515/PXD019515Hela.sdrf.tsv b/examples/PXD019515/PXD019515Hela.sdrf.tsv new file mode 100644 index 000000000..0073ab456 --- /dev/null +++ b/examples/PXD019515/PXD019515Hela.sdrf.tsv @@ -0,0 +1,7 @@ +source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[cell line] characteristics[cell type] characteristics[age] characteristics[ancestry category] characteristics[developmental stage] characteristics[sex] characteristics[biological replicate] material type assay name technology type comment[instrument] comment[label] comment[fraction identifier] comment[proteomics data acquisition method] comment[modification parameters] comment[modification parameters] comment[modification parameters] comment[cleavage agent details] comment[dissociation method] comment[file uri] comment[fragment mass tolerance] comment[precursor mass tolerance] comment[technical replicate] comment[data file] factor value[cell line] +PXD019515-Sample 7 Homo sapiens not applicable not applicable not applicable not applicable not available not applicable not available not applicable 1 cell run 1 proteomic profiling by mass spectrometry NT=Orbitrap Eclipse;AC=MS:1003029 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=Variable AC=MS:1001313;NT=Trypsin NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD019515/FAIMS_2CV_OTIT_HCD_300ITMS2_Blank_1.raw 20 ppm 5 ppm 1 FAIMS_2CV_OTIT_HCD_300ITMS2_Blank_1.raw blank +PXD019515-Sample 7 Homo sapiens not applicable not applicable not applicable not applicable not available not applicable not available not applicable 1 cell run 2 proteomic profiling by mass spectrometry NT=Orbitrap Eclipse;AC=MS:1003029 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=Variable AC=MS:1001313;NT=Trypsin NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD019515/FAIMS_2CV_OTIT_HCD_300ITMS2_Blank_2.raw 20 ppm 5 ppm 2 FAIMS_2CV_OTIT_HCD_300ITMS2_Blank_2.raw blank +PXD019515-Sample 7 Homo sapiens not applicable not applicable not applicable not applicable not available not applicable not available not applicable 1 cell run 3 proteomic profiling by mass spectrometry NT=Orbitrap Eclipse;AC=MS:1003029 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=Variable AC=MS:1001313;NT=Trypsin NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD019515/FAIMS_2CV_OTIT_HCD_300ITMS2_Blank_3.raw 20 ppm 5 ppm 3 FAIMS_2CV_OTIT_HCD_300ITMS2_Blank_3.raw blank +PXD019515-Sample 8 Homo sapiens uterine cervix cervical cancer HeLa epithelial cell 31Y black adult female 1 cell run 4 proteomic profiling by mass spectrometry NT=Orbitrap Eclipse;AC=MS:1003029 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=Variable AC=MS:1001313;NT=Trypsin NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD019515/FAIMS_2CV_OTIT_HCD_300ITMS2_Single_HeLa_1.raw 20 ppm 5 ppm 1 FAIMS_2CV_OTIT_HCD_300ITMS2_Single_HeLa_1.raw HeLa +PXD019515-Sample 8 Homo sapiens uterine cervix cervical cancer HeLa epithelial cell 31Y black adult female 1 cell run 5 proteomic profiling by mass spectrometry NT=Orbitrap Eclipse;AC=MS:1003029 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=Variable AC=MS:1001313;NT=Trypsin NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD019515/FAIMS_2CV_OTIT_HCD_300ITMS2_Single_HeLa_2.raw 20 ppm 5 ppm 2 FAIMS_2CV_OTIT_HCD_300ITMS2_Single_HeLa_2.raw HeLa +PXD019515-Sample 8 Homo sapiens uterine cervix cervical cancer HeLa epithelial cell 31Y black adult female 1 cell run 6 proteomic profiling by mass spectrometry NT=Orbitrap Eclipse;AC=MS:1003029 AC=MS:1002038;NT=label free sample 1 Data-Dependent Acquisition NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35 NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4 NT=Acetyl;AC=UNIMOD:67;PP=Protein N-term;MT=Variable AC=MS:1001313;NT=Trypsin NT=HCD;AC=PRIDE:0000590 ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD019515/FAIMS_2CV_OTIT_HCD_300ITMS2_Single_HeLa_3.raw 20 ppm 5 ppm 3 FAIMS_2CV_OTIT_HCD_300ITMS2_Single_HeLa_3.raw HeLa diff --git a/examples/README.md b/examples/README.md new file mode 100644 index 000000000..b7dc2cdf2 --- /dev/null +++ b/examples/README.md @@ -0,0 +1,18 @@ +# SDRF Example Files + +Curated examples of SDRF files covering different experiment types and organisms. + +| Accession | Description | Organism | Label | Templates | Rows | +|-----------|-------------|----------|-------|-----------|------| +| PXD004684 | Label-free, DDA | Homo sapiens | label free | ms-proteomics, human | 15 | +| PXD008934 | Label-free, human proteome | Homo sapiens | label free | ms-proteomics, human | 35 | +| PXD002137 | Label-free, clinical | Homo sapiens | label free | ms-proteomics, human | 193 | +| PXD006482 | Label-free, renal carcinoma | Homo sapiens | label free | ms-proteomics, human | 193 | +| PXD003772 | TMT labeling | Mus musculus | TMT | ms-proteomics, vertebrates | 13 | +| PDC000126 | TMT labeling, large cohort | Homo sapiens | TMT | ms-proteomics, human | 2041 | +| PXD013923 | SILAC labeling, phosphoproteomics | Homo sapiens | SILAC | ms-proteomics, human | 21 | +| PXD012667 | DIA acquisition | Homo sapiens | label free | ms-proteomics, human, dia-acquisition | 49 | +| PXD019515 | Single-cell proteomics | Homo sapiens | label free | ms-proteomics, human, single-cell | 7 | +| PXD003791 | Metaproteomics, gut | human gut metagenome | label free | metaproteomics | 109 | +| PXD006439 | Label-free, mouse | Mus musculus | label free | ms-proteomics, vertebrates | 68 | +| PXD013868 | Label-free, plant | Arabidopsis thaliana | label free | ms-proteomics, plants | 21 | diff --git a/examples/use-cases/crosslinking.sdrf.tsv b/examples/use-cases/crosslinking.sdrf.tsv deleted file mode 100644 index c3a9ed691..000000000 --- a/examples/use-cases/crosslinking.sdrf.tsv +++ /dev/null @@ -1,2 +0,0 @@ -source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[disease] characteristics[material type] characteristics[crosslinking reagent] characteristics[biological replicate] assay name technology type comment[proteomics data acquisition method] comment[fractionation method] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[technical replicate] comment[data file] comment[sdrf version] comment[sdrf template] comment[sdrf template] comment[sdrf template] -sample1 homo sapiens HEK293 epithelial cell not applicable cell DSS 1 run1 proteomic profiling by mass spectrometry data-dependent acquisition SCX 1 label free sample NT=Orbitrap Fusion Lumos NT=Trypsin;AC=MS:1001251 1 file1.raw v1.1.0 ms-proteomics v1.1.0 human v1.1.0 crosslinking v1.0.0 diff --git a/examples/use-cases/immunopeptidomics.sdrf.tsv b/examples/use-cases/immunopeptidomics.sdrf.tsv deleted file mode 100644 index 58ad6cbd1..000000000 --- a/examples/use-cases/immunopeptidomics.sdrf.tsv +++ /dev/null @@ -1,2 +0,0 @@ -source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[disease] characteristics[material type] characteristics[immunopeptidome enrichment method] characteristics[biological replicate] assay name technology type comment[proteomics data acquisition method] comment[fractionation method] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[technical replicate] comment[data file] comment[sdrf version] comment[sdrf template] comment[sdrf template] comment[sdrf template] -sample1 homo sapiens liver hepatocyte hepatocellular carcinoma cell line MHC-I immunoprecipitation 1 run1 proteomic profiling by mass spectrometry data-dependent acquisition Off-gel electrophoresis 1 label free sample NT=LTQ Orbitrap XL NT=Trypsin;AC=MS:1001251 1 file1.raw v1.1.0 ms-proteomics v1.1.0 human v1.1.0 immunopeptidomics v1.0.0 diff --git a/examples/use-cases/single-cell.sdrf.tsv b/examples/use-cases/single-cell.sdrf.tsv deleted file mode 100644 index f8266912e..000000000 --- a/examples/use-cases/single-cell.sdrf.tsv +++ /dev/null @@ -1,2 +0,0 @@ -source name characteristics[organism] characteristics[organism part] characteristics[cell type] characteristics[disease] characteristics[material type] characteristics[single cell isolation method] characteristics[cell identifier] characteristics[biological replicate] assay name technology type comment[proteomics data acquisition method] comment[fractionation method] comment[fraction identifier] comment[label] comment[instrument] comment[cleavage agent details] comment[technical replicate] comment[data file] comment[sdrf version] comment[sdrf template] comment[sdrf template] comment[sdrf template] -cell1 homo sapiens brain neuron alzheimer's disease cell FACS cell_id_001 1 run1 proteomic profiling by mass spectrometry data-dependent acquisition not applicable 1 label free sample NT=Q Exactive HF-X NT=Trypsin;AC=MS:1001251 1 cell1.raw v1.1.0 ms-proteomics v1.1.0 human v1.1.0 single-cell v1.0.0 diff --git a/llms.txt b/llms.txt index d7b6d72ad..d502861d1 100644 --- a/llms.txt +++ b/llms.txt @@ -7,7 +7,7 @@ - sdrf-proteomics/README.adoc - Core specification: format rules, column headers, cell values, templates, factor values, ontologies - sdrf-proteomics/quickstart.adoc - Quick Start Tutorial (10-15 min) - sdrf-proteomics/metadata-guidelines/sample-metadata.adoc - Sample Metadata Guidelines: age, sex, disease, organism part, cell type - - sdrf-proteomics/metadata-guidelines/template-definitions.adoc - Template Definitions Guide (for developers) + - sdrf-proteomics/TEMPLATES.adoc - Templates Guide: template selection, YAML schema, validators, and developer reference - sdrf-proteomics/metadata-guidelines/sdrf-terms.tsv - SDRF Terms Reference: all column terms with ontology mappings - sdrf-proteomics/VERSIONING.adoc - Versioning and Deprecation Policy: version tracks, template compatibility, deprecation lifecycle, transition timelines @@ -24,10 +24,9 @@ - sdrf-proteomics/templates/invertebrates/README.adoc - Invertebrates: Drosophila, C. elegans - sdrf-proteomics/templates/plants/README.adoc - Plants: Arabidopsis, crops - sdrf-proteomics/templates/cell-lines/README.adoc - Cell Lines: Cellosaurus integration -- sdrf-proteomics/templates/dda-acquisition/README.adoc - DDA Acquisition: dissociation method, collision energy - sdrf-proteomics/templates/dia-acquisition/README.adoc - DIA Acquisition: scan windows, isolation width - sdrf-proteomics/templates/single-cell/README.adoc - Single-Cell Proteomics: cell isolation, carrier proteome -- sdrf-proteomics/templates/immunopeptidomics/README.adoc - Immunopeptidomics: MHC class, HLA typing +- sdrf-proteomics/templates/immunopeptidomics/README.adoc - Immunopeptidomics: MHC protein complex, MHC typing - sdrf-proteomics/templates/crosslinking/README.adoc - Crosslinking MS: crosslinker reagents - sdrf-proteomics/templates/metaproteomics/README.adoc - Metaproteomics: environmental and microbiome samples - sdrf-proteomics/templates/olink/README.adoc - Olink: proximity extension assays @@ -35,34 +34,34 @@ ## Template YAML Schemas (sdrf-templates submodule) -Machine-readable YAML definitions used by sdrf-pipelines for validation. Each template has a `.yaml` schema and an optional `.sdrf.tsv` example file. Templates follow a layered hierarchy: base → technology → sample/experiment. +Machine-readable YAML definitions used by sdrf-pipelines for validation. Each template has a `.yaml` schema and an optional `.sdrf.tsv` example file. Templates follow a layered hierarchy: base → sample-metadata → technology/sample/experiment. - sdrf-proteomics/sdrf-templates/templates.yaml - Template manifest: all templates with latest versions, inheritance, and layer metadata -- sdrf-proteomics/sdrf-templates/base/1.1.0/base.yaml - Base template (internal, not user-facing): shared columns inherited by all templates +- sdrf-proteomics/sdrf-templates/base/1.1.0/base.yaml - Base template (internal, not user-facing): infrastructure columns (source name, assay name, technology type, etc.) - sdrf-proteomics/sdrf-templates/base/1.1.0/base.sdrf.tsv - Base example -- sdrf-proteomics/sdrf-templates/ms-proteomics/1.1.0/ms-proteomics.yaml - MS-Proteomics (technology layer): minimum valid template for any MS experiment +- sdrf-proteomics/sdrf-templates/sample-metadata/1.1.0/sample-metadata.yaml - Sample-metadata template (intermediate, not user-facing): sample columns (organism, organism part, cell type, biological replicate, pooled sample, disease, biosample accession). Extends base. + - sdrf-proteomics/sdrf-templates/sample-metadata/1.1.0/sample-metadata.sdrf.tsv - Sample-metadata example +- sdrf-proteomics/sdrf-templates/ms-proteomics/1.1.0/ms-proteomics.yaml - MS-Proteomics (technology layer): minimum valid template for any MS experiment. Extends sample-metadata. - sdrf-proteomics/sdrf-templates/ms-proteomics/1.1.0/ms-proteomics.sdrf.tsv - MS-Proteomics example -- sdrf-proteomics/sdrf-templates/affinity-proteomics/1.1.0/affinity-proteomics.yaml - Affinity Proteomics (technology layer): Olink, SomaScan base +- sdrf-proteomics/sdrf-templates/affinity-proteomics/1.1.0/affinity-proteomics.yaml - Affinity Proteomics (technology layer): Olink, SomaScan base. Extends sample-metadata. - sdrf-proteomics/sdrf-templates/affinity-proteomics/1.1.0/affinity-proteomics.sdrf.tsv - Affinity Proteomics example -- sdrf-proteomics/sdrf-templates/human/1.1.0/human.yaml - Human (sample layer): disease, age, sex, ancestry +- sdrf-proteomics/sdrf-templates/human/1.1.0/human.yaml - Human (sample layer): disease, age, sex, ancestry. Extends sample-metadata. - sdrf-proteomics/sdrf-templates/human/1.1.0/human.sdrf.tsv - Human example -- sdrf-proteomics/sdrf-templates/vertebrates/1.1.0/vertebrates.yaml - Vertebrates (sample layer): mouse, rat, zebrafish, etc. +- sdrf-proteomics/sdrf-templates/vertebrates/1.1.0/vertebrates.yaml - Vertebrates (sample layer): mouse, rat, zebrafish, etc. Extends sample-metadata. - sdrf-proteomics/sdrf-templates/vertebrates/1.1.0/vertebrates.sdrf.tsv - Vertebrates example -- sdrf-proteomics/sdrf-templates/invertebrates/1.1.0/invertebrates.yaml - Invertebrates (sample layer): Drosophila, C. elegans +- sdrf-proteomics/sdrf-templates/invertebrates/1.1.0/invertebrates.yaml - Invertebrates (sample layer): Drosophila, C. elegans. Extends sample-metadata. - sdrf-proteomics/sdrf-templates/invertebrates/1.1.0/invertebrates.sdrf.tsv - Invertebrates example -- sdrf-proteomics/sdrf-templates/plants/1.1.0/plants.yaml - Plants (sample layer): Arabidopsis, crops +- sdrf-proteomics/sdrf-templates/plants/1.1.0/plants.yaml - Plants (sample layer): Arabidopsis, crops. Extends sample-metadata. - sdrf-proteomics/sdrf-templates/plants/1.1.0/plants.sdrf.tsv - Plants example - sdrf-proteomics/sdrf-templates/cell-lines/1.1.0/cell-lines.yaml - Cell Lines (experiment layer): Cellosaurus integration - sdrf-proteomics/sdrf-templates/cell-lines/1.1.0/cell-lines.sdrf.tsv - Cell Lines example -- sdrf-proteomics/sdrf-templates/dda-acquisition/1.1.0/dda-acquisition.yaml - DDA Acquisition (experiment layer): dissociation method, collision energy - - sdrf-proteomics/sdrf-templates/dda-acquisition/1.1.0/dda-acquisition.sdrf.tsv - DDA example - sdrf-proteomics/sdrf-templates/dia-acquisition/1.1.0/dia-acquisition.yaml - DIA Acquisition (experiment layer): scan windows, isolation width - sdrf-proteomics/sdrf-templates/dia-acquisition/1.1.0/dia-acquisition.sdrf.tsv - DIA example - sdrf-proteomics/sdrf-templates/crosslinking/1.1.0/crosslinking.yaml - Crosslinking MS (experiment layer): crosslinker reagents - sdrf-proteomics/sdrf-templates/crosslinking/1.1.0/crosslinking.sdrf.tsv - Crosslinking example - sdrf-proteomics/sdrf-templates/single-cell/1.0.0/single-cell.yaml - Single-Cell (experiment layer): cell isolation, carrier proteome - sdrf-proteomics/sdrf-templates/single-cell/1.0.0/single-cell.sdrf.tsv - Single-Cell example -- sdrf-proteomics/sdrf-templates/immunopeptidomics/1.0.0-dev/immunopeptidomics.yaml - Immunopeptidomics (experiment layer): MHC class, HLA typing +- sdrf-proteomics/sdrf-templates/immunopeptidomics/1.0.0-dev/immunopeptidomics.yaml - Immunopeptidomics (experiment layer): MHC protein complex, MHC typing - sdrf-proteomics/sdrf-templates/metaproteomics/1.0.0-dev/metaproteomics.yaml - Metaproteomics (experiment layer): environmental and microbiome samples - sdrf-proteomics/sdrf-templates/metaproteomics/1.0.0-dev/metaproteomics.sdrf.tsv - Metaproteomics example - sdrf-proteomics/sdrf-templates/olink/1.0.0/olink.yaml - Olink (experiment layer): proximity extension assays @@ -82,14 +81,18 @@ Machine-readable YAML definitions used by sdrf-pipelines for validation. Each te ## Examples -- examples/core/PXD002137/PXD002137.sdrf.tsv - Core example: label-free -- examples/core/PXD004684/PXD004684.sdrf.tsv - Core example: TMT labeled -- examples/core/PXD006482/PXD006482.sdrf.tsv - Core example: SILAC -- examples/core/PXD008934/PXD008934.sdrf.tsv - Core example: human proteome -- examples/core/PDC000126/PDC000126.sdrf.tsv - Core example: PDC dataset -- examples/use-cases/crosslinking.sdrf.tsv - Use case: crosslinking MS -- examples/use-cases/immunopeptidomics.sdrf.tsv - Use case: immunopeptidomics -- examples/use-cases/single-cell.sdrf.tsv - Use case: single-cell proteomics +- examples/PXD004684/ - Label-free, DDA, human +- examples/PXD008934/ - Label-free, human proteome +- examples/PXD002137/ - Label-free, clinical, human +- examples/PXD006482/ - Label-free, renal carcinoma, human +- examples/PXD003772/ - TMT labeling, mouse +- examples/PDC000126/ - TMT labeling, large cohort, human +- examples/PXD013923/ - SILAC, phosphoproteomics, human +- examples/PXD012667/ - DIA acquisition, human +- examples/PXD019515/ - Single-cell proteomics, human +- examples/PXD003791/ - Metaproteomics, gut +- examples/PXD006439/ - Label-free, mouse +- examples/PXD013868/ - Label-free, plant (Arabidopsis) ## Annotated Projects diff --git a/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf b/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf index efe9fb818..e993c3fc3 100644 Binary files a/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf and b/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf differ diff --git a/psi-document/v1.1.0-dev/supplementary-files/quickstart-v1.1.0-dev.adoc b/psi-document/v1.1.0-dev/supplementary-files/quickstart-v1.1.0-dev.adoc index 1ae5536dc..b26c09a88 100644 --- a/psi-document/v1.1.0-dev/supplementary-files/quickstart-v1.1.0-dev.adoc +++ b/psi-document/v1.1.0-dev/supplementary-files/quickstart-v1.1.0-dev.adoc @@ -79,7 +79,7 @@ Add extra columns for specific experimental workflows: |DIA-specific parameters. link:templates/dia-acquisition/README.adoc[View template] |**immunopeptidomics** -|HLA typing and related metadata. link:templates/immunopeptidomics/README.adoc[View template] +|MHC typing and related metadata. link:templates/immunopeptidomics/README.adoc[View template] |**crosslinking** |XL-MS specific columns. link:templates/crosslinking/README.adoc[View template] diff --git a/psi-document/v1.1.0-dev/supplementary-files/template-definitions-v1.1.0-dev.adoc b/psi-document/v1.1.0-dev/supplementary-files/template-definitions-v1.1.0-dev.adoc index 61114cdbb..6f66b18ea 100644 --- a/psi-document/v1.1.0-dev/supplementary-files/template-definitions-v1.1.0-dev.adoc +++ b/psi-document/v1.1.0-dev/supplementary-files/template-definitions-v1.1.0-dev.adoc @@ -26,26 +26,27 @@ Templates are organized in a layered hierarchy where each layer serves a specifi ---- base (construction artifact - not user-facing) │ -├── TECHNOLOGY LAYER (mutually exclusive) -│ ├── ms-proteomics # Mass spectrometry proteomics -│ │ └── EXPERIMENT LAYER -│ │ ├── dda-acquisition # Data-dependent acquisition -│ │ ├── dia-acquisition # Data-independent acquisition -│ │ ├── single-cell # Single-cell proteomics -│ │ ├── immunopeptidomics # MHC peptide analysis -│ │ ├── crosslinking # XL-MS experiments -│ │ └── metaproteomics # Microbiome proteomics -│ │ -│ └── affinity-proteomics # Affinity-based proteomics -│ └── EXPERIMENT LAYER -│ ├── olink # Olink PEA platform -│ └── somascan # SomaScan aptamer platform -│ -└── SAMPLE LAYER (mutually exclusive) - ├── human # Human samples - ├── vertebrates # Non-human vertebrates (mouse, rat, etc.) - ├── invertebrates # Invertebrates (Drosophila, C. elegans) - └── plants # Plant samples (Arabidopsis, crops) +└── sample-metadata (intermediate - sample columns shared by all templates) + │ + ├── TECHNOLOGY LAYER (mutually exclusive) + │ ├── ms-proteomics # Mass spectrometry proteomics + │ │ └── EXPERIMENT LAYER + │ │ ├── dia-acquisition # Data-independent acquisition + │ │ ├── single-cell # Single-cell proteomics + │ │ ├── immunopeptidomics # MHC peptide analysis + │ │ ├── crosslinking # XL-MS experiments + │ │ └── metaproteomics # Microbiome proteomics + │ │ + │ └── affinity-proteomics # Affinity-based proteomics + │ └── EXPERIMENT LAYER + │ ├── olink # Olink PEA platform + │ └── somascan # SomaScan aptamer platform + │ + └── SAMPLE LAYER (mutually exclusive) + ├── human # Human samples + ├── vertebrates # Non-human vertebrates (mouse, rat, etc.) + ├── invertebrates # Invertebrates (Drosophila, C. elegans) + └── plants # Plant samples (Arabidopsis, crops) cell-lines (EXPERIMENT layer - requires technology + sample) ---- @@ -57,9 +58,13 @@ cell-lines (EXPERIMENT layer - requires technology + sample) | Layer | Purpose | Examples | `base` -| Internal construction artifact with shared columns. Never used directly by users. +| Internal construction artifact with infrastructure columns (source name, assay name, technology type, etc.). Never used directly by users. | base +| `sample-metadata` +| Intermediate template with sample-level columns shared by all templates (organism, organism part, cell type, biological replicate, pooled sample, disease, biosample accession). Extends `base`. Never used directly by users. +| sample-metadata + | `technology` | Defines the proteomics technology. Exactly one required per SDRF. | ms-proteomics, affinity-proteomics @@ -70,7 +75,7 @@ cell-lines (EXPERIMENT layer - requires technology + sample) | `experiment` | Defines methodology-specific columns. Multiple can be combined if not mutually exclusive. -| dda-acquisition, single-cell, olink, cell-lines +| dia-acquisition, single-cell, olink, cell-lines |=== === Mutual Exclusivity @@ -82,7 +87,6 @@ Some templates cannot be combined because they represent mutually exclusive conc | Template A | Template B | Reason | ms-proteomics | affinity-proteomics | Different technologies -| dda-acquisition | dia-acquisition | Different acquisition methods | somascan | olink | Different affinity platforms | human | vertebrates | Different organism types | human | invertebrates | Different organism types @@ -108,9 +112,9 @@ version: 1.1.0 # Semantic version (major.minor.patch) # ============================================================================= # INHERITANCE AND RELATIONSHIPS (optional) # ============================================================================= -extends: base # Parent template to inherit from +extends: sample-metadata # Parent template to inherit from usable_alone: false # Can this template be used without others? -layer: sample # Layer: base, technology, sample, experiment +layer: sample # Layer: base, sample-metadata, technology, sample, experiment # Mutual exclusivity - templates that cannot be combined with this one mutually_exclusive_with: @@ -476,7 +480,7 @@ When multiple templates are combined: **Example valid combination:** [source] ---- -ms-proteomics + human + dda-acquisition + cell-lines +ms-proteomics + human + dia-acquisition + cell-lines ↓ ↓ ↓ ↓ technology sample experiment experiment ---- @@ -576,10 +580,10 @@ parse_sdrf validate-sdrf --sdrf_file file.sdrf.tsv --template ms-proteomics parse_sdrf validate-sdrf --sdrf_file file.sdrf.tsv \ --template ms-proteomics \ --template human \ - --template dda-acquisition + --template dia-acquisition # Check template compatibility -parse_sdrf check-templates --templates ms-proteomics,human,dda-acquisition +parse_sdrf check-templates --templates ms-proteomics,human,dia-acquisition ---- == References diff --git a/scripts/build-asciidoc.sh b/scripts/build-asciidoc.sh deleted file mode 100755 index 763210bf0..000000000 --- a/scripts/build-asciidoc.sh +++ /dev/null @@ -1,83 +0,0 @@ -#!/bin/bash -# Build AsciiDoc documentation files -# Usage: ./build-asciidoc.sh - -set -e - -OUTPUT_DIR="${1:-docs}" - -echo "Building AsciiDoc documentation to: $OUTPUT_DIR" - -# Create output directories -mkdir -p "$OUTPUT_DIR" -mkdir -p "$OUTPUT_DIR/metadata-guidelines" -mkdir -p "$OUTPUT_DIR/templates" - -# Common asciidoctor options -ASCIIDOCTOR_OPTS="-a linkcss -a toc=left -a toclevels=3 -a sectanchors -a sectlinks -a source-highlighter=highlight.js --backend=html5" - -# Build main specification -echo "Building main specification..." -asciidoctor \ - -D "$OUTPUT_DIR" \ - -a stylesheet=css/style.css \ - $ASCIIDOCTOR_OPTS \ - -o specification.html \ - sdrf-proteomics/README.adoc - -# Build tool support page -echo "Building tool support page..." -asciidoctor \ - -D "$OUTPUT_DIR" \ - -a stylesheet=css/style.css \ - $ASCIIDOCTOR_OPTS \ - -o tool-support.html \ - sdrf-proteomics/tool-support.adoc - -# Build sample metadata guidelines -echo "Building sample metadata guidelines..." -asciidoctor \ - -D "$OUTPUT_DIR/metadata-guidelines" \ - -a stylesheet=../css/style.css \ - $ASCIIDOCTOR_OPTS \ - -o sample-metadata.html \ - sdrf-proteomics/metadata-guidelines/sample-metadata.adoc - -# Build template definitions guide -if [ -f "sdrf-proteomics/metadata-guidelines/template-definitions.adoc" ]; then - echo "Building template definitions guide..." - asciidoctor \ - -D "$OUTPUT_DIR/metadata-guidelines" \ - -a stylesheet=../css/style.css \ - $ASCIIDOCTOR_OPTS \ - -o template-definitions.html \ - sdrf-proteomics/metadata-guidelines/template-definitions.adoc -fi - -# Build data analysis metadata guide -if [ -f "sdrf-proteomics/metadata-guidelines/data-analysis-metadata.adoc" ]; then - echo "Building data analysis metadata guide..." - asciidoctor \ - -D "$OUTPUT_DIR/metadata-guidelines" \ - -a stylesheet=../css/style.css \ - $ASCIIDOCTOR_OPTS \ - -o data-analysis-metadata.html \ - sdrf-proteomics/metadata-guidelines/data-analysis-metadata.adoc -fi - -# Build template documentation -echo "Building template documentation..." -for dir in sdrf-proteomics/templates/*/; do - if [ -f "${dir}README.adoc" ]; then - template_name=$(basename "$dir") - echo " Building template: $template_name" - asciidoctor \ - -D "$OUTPUT_DIR/templates" \ - -a stylesheet=../css/style.css \ - $ASCIIDOCTOR_OPTS \ - -o "${template_name}.html" \ - "${dir}README.adoc" - fi -done - -echo "AsciiDoc build complete!" diff --git a/scripts/build-docs.sh b/scripts/build-docs.sh index 0e1a21466..3f84efbd7 100755 --- a/scripts/build-docs.sh +++ b/scripts/build-docs.sh @@ -109,54 +109,25 @@ echo "Building tool support page..." asciidoctor \ -D "$OUTPUT_DIR" \ $ASCIIDOCTOR_OPTS \ - -o tool-support.html \ - sdrf-proteomics/tool-support.adoc + -o tools.html \ + sdrf-proteomics/TOOLS.adoc -# Build metadata guidelines -echo "Building metadata guidelines..." +# Build sample guidelines page +echo "Building sample guidelines page..." asciidoctor \ - -D "$OUTPUT_DIR/metadata-guidelines" \ - -a stylesheet=../css/style.css \ - -a linkcss \ - -a toc=left \ - -a toclevels=3 \ - -a sectanchors \ - -a sectlinks \ - --backend=html5 \ - -o sample-metadata.html \ - sdrf-proteomics/metadata-guidelines/sample-metadata.adoc + -D "$OUTPUT_DIR" \ + $ASCIIDOCTOR_OPTS \ + -o sample-guidelines.html \ + sdrf-proteomics/SAMPLE-GUIDELINES.adoc -# Check if human-sample-metadata.adoc exists and build it -if [ -f "sdrf-proteomics/metadata-guidelines/human-sample-metadata.adoc" ]; then - echo "Building human sample metadata guidelines..." +# Build templates guide +if [ -f "sdrf-proteomics/TEMPLATES.adoc" ]; then + echo "Building templates guide..." asciidoctor \ - -D "$OUTPUT_DIR/metadata-guidelines" \ - -a stylesheet=../css/style.css \ - -a linkcss \ - -a toc=left \ - -a toclevels=3 \ - -a sectanchors \ - -a sectlinks \ - --backend=html5 \ - -o human-sample-metadata.html \ - sdrf-proteomics/metadata-guidelines/human-sample-metadata.adoc -fi - -# Build template definitions guide -if [ -f "sdrf-proteomics/metadata-guidelines/template-definitions.adoc" ]; then - echo "Building template definitions guide..." - asciidoctor \ - -D "$OUTPUT_DIR/metadata-guidelines" \ - -a stylesheet=../css/style.css \ - -a linkcss \ - -a toc=left \ - -a toclevels=3 \ - -a sectanchors \ - -a sectlinks \ - -a source-highlighter=highlight.js \ - --backend=html5 \ - -o template-definitions.html \ - sdrf-proteomics/metadata-guidelines/template-definitions.adoc + -D "$OUTPUT_DIR" \ + $ASCIIDOCTOR_OPTS \ + -o templates.html \ + sdrf-proteomics/TEMPLATES.adoc fi # Build data analysis metadata guide @@ -176,25 +147,10 @@ if [ -f "sdrf-proteomics/metadata-guidelines/data-analysis-metadata.adoc" ]; the sdrf-proteomics/metadata-guidelines/data-analysis-metadata.adoc fi -# Build template documentation -echo "Building templates..." -for dir in sdrf-proteomics/templates/*/; do - if [ -f "${dir}README.adoc" ]; then - template_name=$(basename "$dir") - echo " Building template: $template_name" - asciidoctor \ - -D "$OUTPUT_DIR/templates" \ - -a stylesheet=../css/style.css \ - -a linkcss \ - -a toc=left \ - -a toclevels=3 \ - -a sectanchors \ - -a sectlinks \ - --backend=html5 \ - -o "${template_name}.html" \ - "${dir}README.adoc" - fi -done +# Build template pages from YAML definitions +echo "Building template pages from YAML..." +python3 scripts/build_template_pages.py \ + sdrf-proteomics/sdrf-templates "$OUTPUT_DIR/templates" # Copy assets echo "Copying assets..." @@ -204,6 +160,7 @@ cp site/css/style.css "$OUTPUT_DIR/css/" # Copy JavaScript cp site/js/search.js "$OUTPUT_DIR/js/" +cp site/js/sdrf-builder.js "$OUTPUT_DIR/js/" # Copy images cp -r sdrf-proteomics/images/* "$OUTPUT_DIR/images/" 2>/dev/null || true @@ -215,9 +172,16 @@ cp site/index.html "$OUTPUT_DIR/" cp site/sdrf-terms.html "$OUTPUT_DIR/" cp site/quickstart.html "$OUTPUT_DIR/" cp site/sdrf-explorer.html "$OUTPUT_DIR/" +cp site/sdrf-editor.html "$OUTPUT_DIR/" + +# Copy SDRF terms TSV (if present) — also create TERMS.tsv alias for AsciiDoc links +cp sdrf-proteomics/metadata-guidelines/sdrf-terms.tsv "$OUTPUT_DIR/" 2>/dev/null || true +cp sdrf-proteomics/TERMS.tsv "$OUTPUT_DIR/TERMS.tsv" 2>/dev/null || true -# Copy SDRF terms TSV -cp sdrf-proteomics/metadata-guidelines/sdrf-terms.tsv "$OUTPUT_DIR/" +# Auto-generate index.html template section from YAML +echo "Updating index template section..." +python3 scripts/build_index_templates.py \ + sdrf-proteomics/sdrf-templates "$OUTPUT_DIR/index.html" # Build SDRF Explorer index echo "Building SDRF Explorer index..." @@ -236,6 +200,11 @@ python3 scripts/transform-links.py "$OUTPUT_DIR" echo "Transforming SDRF example tables..." python3 scripts/transform-sdrf-tables.py "$OUTPUT_DIR" +# Build SDRF builder data +echo "Building SDRF builder data..." +python3 scripts/build_sdrf_builder_data.py \ + sdrf-proteomics/sdrf-templates "$OUTPUT_DIR/sdrf-builder-data.json" + # Build search index echo "Building search index..." python3 site/build-search-index.py . "$OUTPUT_DIR/search-index.json" diff --git a/scripts/build_index_templates.py b/scripts/build_index_templates.py new file mode 100644 index 000000000..d7b292424 --- /dev/null +++ b/scripts/build_index_templates.py @@ -0,0 +1,99 @@ +#!/usr/bin/env python3 +"""Generate the template section for index.html from resolved templates. + +Usage: + python3 scripts/build_index_templates.py + +The script resolves all templates, filters out internal ones, +renders a Jinja2 snippet, and replaces the content inside +
...
in the target HTML file. +""" + +from __future__ import annotations + +import re +import sys +from pathlib import Path + +from jinja2 import Environment, FileSystemLoader + +# Allow importing resolve_templates from scripts/ +sys.path.insert(0, str(Path(__file__).resolve().parent)) +from resolve_templates import resolve_all # noqa: E402 + +# Display order for layers +LAYER_ORDER = {"technology": 0, "sample": 1, "experiment": 2} + + +def filter_and_sort_templates(all_resolved: dict[str, dict]) -> list[dict]: + """Filter out internal templates and sort by layer then name.""" + templates = [] + for name, tpl in all_resolved.items(): + layer = tpl.get("layer") + usable_alone = tpl.get("usable_alone", False) + # Exclude internal templates (layer is None and not usable alone) + if layer is None and not usable_alone: + continue + templates.append(tpl) + + templates.sort( + key=lambda t: ( + LAYER_ORDER.get(t.get("layer") or "", 99), + t["name"], + ) + ) + return templates + + +def render_section(templates: list[dict]) -> str: + """Render the index-templates Jinja2 snippet.""" + templates_dir = Path(__file__).resolve().parent.parent / "site" / "templates" + env = Environment( + loader=FileSystemLoader(str(templates_dir)), + autoescape=False, + keep_trailing_newline=True, + ) + template = env.get_template("index-templates.html.j2") + return template.render(all_templates=templates) + + +def inject_section(html: str, section_html: str) -> str: + """Replace content inside
...
.""" + pattern = r'(]*>)(.*?)()' + replacement = rf"\1\n{section_html}\n \3" + result, count = re.subn(pattern, replacement, html, count=1, flags=re.DOTALL) + if count == 0: + raise ValueError('Could not find
in HTML') + return result + + +def main() -> None: + if len(sys.argv) != 3: + print( + f"Usage: {sys.argv[0]} ", + file=sys.stderr, + ) + sys.exit(1) + + templates_dir = Path(sys.argv[1]) + index_path = Path(sys.argv[2]) + + # Resolve all templates + all_resolved = resolve_all(templates_dir) + + # Filter and sort + templates = filter_and_sort_templates(all_resolved) + + # Render the Jinja2 snippet + section_html = render_section(templates) + + # Read, inject, clean up, write + html = index_path.read_text() + html = inject_section(html, section_html) + index_path.write_text(html) + + print(f"Injected {len(templates)} templates into {index_path}") + + +if __name__ == "__main__": + main() diff --git a/scripts/build_sdrf_builder_data.py b/scripts/build_sdrf_builder_data.py new file mode 100644 index 000000000..41c07daea --- /dev/null +++ b/scripts/build_sdrf_builder_data.py @@ -0,0 +1,190 @@ +#!/usr/bin/env python3 +"""Build JSON data file for the interactive SDRF builder UI. + +Compiles YAML template definitions into a single JSON file containing +resolved templates, combination rules, and term definitions. + +Usage: + python3 build_sdrf_builder_data.py +""" + +import csv +import json +import sys +from pathlib import Path +from typing import Any + +sys.path.insert(0, str(Path(__file__).parent)) +from resolve_templates import resolve_all + +# Fallback example values for well-known column names +FALLBACK_EXAMPLES: dict[str, str] = { + "source name": "sample_1", + "assay name": "run_1", + "comment[data file]": "sample1.raw", + "comment[fraction identifier]": "1", + "comment[technical replicate]": "1", + "comment[label]": "label free sample", +} + + +def _compact_validators(validators: list[dict] | None) -> list[dict]: + """Return a compact representation of validators.""" + if not validators: + return [] + result = [] + for v in validators: + compact: dict[str, Any] = {"type": v.get("validator_name", "")} + params = v.get("params", {}) + if params: + compact["params"] = params + result.append(compact) + return result + + +def _example_value(column: dict) -> str: + """Derive an example value for a column from validators or fallbacks.""" + validators = column.get("validators") or [] + for v in validators: + params = v.get("params", {}) + if params.get("examples"): + return str(params["examples"][0]) + if params.get("values"): + return str(params["values"][0]) + return FALLBACK_EXAMPLES.get(column.get("name", ""), "") + + +def _serialize_column(col: dict) -> dict: + """Serialize a single column dict for JSON output.""" + return { + "name": col.get("name", ""), + "requirement": col.get("requirement", "optional"), + "description": col.get("description", ""), + "ontology_accession": col.get("ontology_accession", ""), + "cardinality": col.get("cardinality", "single"), + "allow_not_applicable": col.get("allow_not_applicable", False), + "allow_not_available": col.get("allow_not_available", False), + "source_template": col.get("source_template", ""), + "validators": _compact_validators(col.get("validators")), + "example_value": _example_value(col), + } + + +def _extract_combination_rules( + all_templates: dict[str, dict], +) -> dict[str, Any]: + """Extract combination rules from all resolved templates.""" + # Deduplicate mutually_exclusive groups (stored as frozensets) + exclusive_groups: set[frozenset[str]] = set() + requires: dict[str, list[str]] = {} + excludes: dict[str, list[str]] = {} + + for name, tpl in all_templates.items(): + me = tpl.get("mutually_exclusive_with") or [] + if me: + group = frozenset([name] + list(me)) + exclusive_groups.add(group) + + req = tpl.get("requires") + if req: + requires[name] = list(req) if isinstance(req, list) else [req] + + exc = tpl.get("excludes") + if exc: + excludes[name] = list(exc) if isinstance(exc, list) else [exc] + + return { + "mutually_exclusive": [sorted(g) for g in exclusive_groups], + "requires": requires, + "excludes": excludes, + } + + +def _load_terms(repo_root: Path) -> list[dict]: + """Load sdrf-terms.tsv from known locations.""" + candidates = [ + repo_root / "sdrf-proteomics" / "metadata-guidelines" / "sdrf-terms.tsv", + repo_root / "local-info" / "demo_web" / "sdrf-terms.tsv", + ] + terms_path = None + for p in candidates: + if p.exists(): + terms_path = p + break + + if terms_path is None: + print("Warning: sdrf-terms.tsv not found, terms list will be empty.") + return [] + + terms: list[dict] = [] + with open(terms_path, newline="") as f: + reader = csv.DictReader(f, delimiter="\t") + for row in reader: + terms.append( + { + "term": row.get("term", ""), + "type": row.get("type", ""), + "description": row.get("description", ""), + "values": row.get("values", ""), + "ontology_accession": row.get("ontology_term_accession", ""), + "allow_not_available": row.get("allow_not_available", "false") + == "true", + "allow_not_applicable": row.get("allow_not_applicable", "false") + == "true", + } + ) + print(f"Loaded {len(terms)} terms from {terms_path}") + return terms + + +def main() -> None: + if len(sys.argv) < 3: + print( + "Usage: python3 build_sdrf_builder_data.py " + " " + ) + sys.exit(1) + + templates_dir = Path(sys.argv[1]) + output_path = Path(sys.argv[2]) + output_path.parent.mkdir(parents=True, exist_ok=True) + + repo_root = Path(__file__).resolve().parent.parent + + # Resolve all templates + all_templates = resolve_all(templates_dir) + print(f"Resolved {len(all_templates)} templates") + + # Serialize templates + templates_json: dict[str, dict] = {} + for name, tpl in all_templates.items(): + templates_json[name] = { + "description": tpl.get("description", ""), + "layer": tpl.get("layer"), + "usable_alone": tpl.get("usable_alone", False), + "extends": tpl.get("extends"), + "inheritance_chain": tpl.get("inheritance_chain", []), + "columns": [_serialize_column(c) for c in tpl["all_columns"]], + "own_columns": [_serialize_column(c) for c in tpl["own_columns"]], + } + + # Extract combination rules + combination_rules = _extract_combination_rules(all_templates) + + # Load terms + terms = _load_terms(repo_root) + + # Write output + output = { + "templates": templates_json, + "combination_rules": combination_rules, + "terms": terms, + } + with open(output_path, "w") as f: + json.dump(output, f, indent=2) + + print(f"Wrote builder data to {output_path}") + + +if __name__ == "__main__": + main() diff --git a/scripts/build_template_pages.py b/scripts/build_template_pages.py new file mode 100644 index 000000000..e0f4b35a9 --- /dev/null +++ b/scripts/build_template_pages.py @@ -0,0 +1,118 @@ +#!/usr/bin/env python3 +"""Generate per-template HTML pages from YAML definitions.""" + +import re +import sys +from pathlib import Path + +from jinja2 import Environment, FileSystemLoader + +sys.path.insert(0, str(Path(__file__).parent)) +from resolve_templates import resolve_all + +REQUIREMENT_ORDER = {"required": 0, "recommended": 1, "optional": 2} + + +def process_documentation(doc_text: str) -> str: + """Convert documentation text to HTML. + + Handles mixed blocks where paragraphs and list items can coexist: + - Backtick-wrapped text (`text`) becomes text + - Lines starting with '- ' become HTML list items + - Consecutive list lines are grouped into a single
    + - Other lines become paragraphs + - Double newlines separate blocks + """ + if not doc_text: + return "" + # Convert backtick-wrapped text to + html = re.sub(r"`([^`]+)`", r"\1", doc_text.strip()) + + blocks = html.split("\n\n") + result = [] + for block in blocks: + lines = [line for line in block.strip().split("\n") if line.strip()] + if not lines: + continue + + # Process line by line, grouping consecutive list items + current_list: list[str] = [] + for line in lines: + stripped = line.strip() + if stripped.startswith("- "): + current_list.append(stripped[2:]) + else: + # Flush any pending list + if current_list: + items = "".join(f"
  • {item}
    • " for item in current_list) + result.append(f"
      {items}
    ") + current_list = [] + result.append(f"

    {stripped}

    ") + + # Flush trailing list + if current_list: + items = "".join(f"
  • {item}
    • " for item in current_list) + result.append(f"
      {items}
    ") + + return "\n".join(result) + + +def sort_columns(columns: list[dict]) -> list[dict]: + """Sort columns by requirement level: required, recommended, optional.""" + return sorted( + columns, + key=lambda c: REQUIREMENT_ORDER.get(c.get("requirement", "optional"), 2), + ) + + +def fix_jinja_reserved_keys(columns: list[dict]) -> list[dict]: + """Rename 'values' key in validator params to avoid Jinja2 dict.values() conflict.""" + for col in columns: + if col.get("validators"): + for v in col["validators"]: + if v.get("params") and "values" in v["params"]: + v["params"]["allowed_values"] = v["params"].pop("values") + return columns + + +def main(): + if len(sys.argv) < 3: + print( + "Usage: python3 build_template_pages.py " + ) + sys.exit(1) + + templates_dir = Path(sys.argv[1]) + output_dir = Path(sys.argv[2]) + output_dir.mkdir(parents=True, exist_ok=True) + + repo_root = Path(__file__).parent.parent + jinja_dir = repo_root / "site" / "templates" + + env = Environment(loader=FileSystemLoader(str(jinja_dir))) + page_template = env.get_template("template-page.html.j2") + + all_templates = resolve_all(templates_dir) + + for name, resolved in all_templates.items(): + resolved["documentation_html"] = process_documentation( + resolved.get("documentation", "") + ) + # Sort columns by requirement level + resolved["all_columns"] = sort_columns(resolved["all_columns"]) + resolved["own_columns"] = sort_columns(resolved["own_columns"]) + resolved["inherited_columns"] = sort_columns(resolved["inherited_columns"]) + # Fix Jinja2 reserved key conflicts + fix_jinja_reserved_keys(resolved["all_columns"]) + + html = page_template.render(template=resolved) + out_path = output_dir / f"{name}.html" + with open(out_path, "w") as f: + f.write(html) + print(f" Generated: {out_path}") + + print(f"Generated {len(all_templates)} template pages in {output_dir}") + + +if __name__ == "__main__": + main() diff --git a/scripts/copy-assets.sh b/scripts/copy-assets.sh deleted file mode 100755 index 6edabd576..000000000 --- a/scripts/copy-assets.sh +++ /dev/null @@ -1,38 +0,0 @@ -#!/bin/bash -# Copy static assets to the output directory -# Usage: ./copy-assets.sh - -set -e - -OUTPUT_DIR="${1:-docs}" - -echo "Copying assets to: $OUTPUT_DIR" - -# Copy images -mkdir -p "$OUTPUT_DIR/images" -cp -r sdrf-proteomics/images/* "$OUTPUT_DIR/images/" 2>/dev/null || true -cp -r images/* "$OUTPUT_DIR/images/" 2>/dev/null || true - -# Copy CSS -mkdir -p "$OUTPUT_DIR/css" -cp site/css/style.css "$OUTPUT_DIR/css/" - -# Copy JavaScript -mkdir -p "$OUTPUT_DIR/js" -cp site/js/search.js "$OUTPUT_DIR/js/" - -# Copy static HTML pages -cp site/index.html "$OUTPUT_DIR/" -cp site/sdrf-terms.html "$OUTPUT_DIR/" -cp site/quickstart.html "$OUTPUT_DIR/" - -# Copy SDRF terms data -cp sdrf-proteomics/metadata-guidelines/sdrf-terms.tsv "$OUTPUT_DIR/" - -# Copy SDRF Explorer -cp site/sdrf-explorer.html "$OUTPUT_DIR/" - -# Copy SDRF Editor page (editor JS/CSS loaded from GitHub Pages) -cp site/sdrf-editor.html "$OUTPUT_DIR/" - -echo "Assets copied successfully!" diff --git a/scripts/inject-headers.py b/scripts/inject-headers.py index f64a603ee..d84ed4cfa 100755 --- a/scripts/inject-headers.py +++ b/scripts/inject-headers.py @@ -22,7 +22,11 @@ 'guidelines': '''
    SDRF-Proteomics
    ''', - 'templates': '''
    SDRF-Proteomics
    ''' + 'templates': '''
    SDRF-Proteomics
    ''', + + 'sample_guidelines': '''
    SDRF-Proteomics
    ''', + + 'templates_guide': '''
    SDRF-Proteomics
    ''' } @@ -55,12 +59,24 @@ def main(): print(f"Injecting header into: {spec_file}") inject_header(str(spec_file), HEADERS['root']) - # Inject header into tool-support.html - tools_file = output_dir / "tool-support.html" + # Inject header into tools.html + tools_file = output_dir / "tools.html" if tools_file.exists(): print(f"Injecting header into: {tools_file}") inject_header(str(tools_file), HEADERS['tools']) + # Inject header into sample-guidelines.html + sg_file = output_dir / "sample-guidelines.html" + if sg_file.exists(): + print(f"Injecting header into: {sg_file}") + inject_header(str(sg_file), HEADERS['sample_guidelines']) + + # Inject header into templates.html (templates guide) + tpl_guide = output_dir / "templates.html" + if tpl_guide.exists(): + print(f"Injecting header into: {tpl_guide}") + inject_header(str(tpl_guide), HEADERS['templates_guide']) + # Inject headers into metadata-guidelines pages guidelines_dir = output_dir / "metadata-guidelines" if guidelines_dir.exists(): diff --git a/scripts/resolve_templates.py b/scripts/resolve_templates.py new file mode 100644 index 000000000..6473386dc --- /dev/null +++ b/scripts/resolve_templates.py @@ -0,0 +1,237 @@ +""" +Template inheritance resolver module. + +Loads YAML templates from the sdrf-templates directory, walks the extends: chain, +and produces resolved template dicts with own, inherited, and merged columns. +""" + +from __future__ import annotations + +import copy +from pathlib import Path +from typing import Any + +import yaml + + +def load_manifest(templates_dir: Path) -> dict[str, dict]: + """Load templates.yaml manifest and return the templates dict. + + Args: + templates_dir: Path to the sdrf-templates directory. + + Returns: + Dict mapping template name -> manifest entry (latest, versions, extends, etc.). + """ + manifest_path = templates_dir / "templates.yaml" + with open(manifest_path) as f: + data = yaml.safe_load(f) + return data["templates"] + + +def load_template_yaml( + templates_dir: Path, name: str, version: str +) -> dict[str, Any]: + """Load a single template YAML file. + + Args: + templates_dir: Path to the sdrf-templates directory. + name: Template name (e.g. 'base', 'human'). + version: Exact version string (e.g. '1.1.0'). + + Returns: + Parsed YAML dict for the template. + """ + yaml_path = templates_dir / name / version / f"{name}.yaml" + with open(yaml_path) as f: + return yaml.safe_load(f) + + +def _parse_extends(extends_str: str | None) -> str | None: + """Extract parent template name from an extends string like 'base@>=1.1.0'. + + Returns None if extends_str is None. + """ + if extends_str is None: + return None + # Split on '@' to get the template name + return extends_str.split("@")[0] + + +def build_inheritance_chain( + name: str, + manifest: dict[str, dict], + templates_dir: Path, +) -> list[str]: + """Build the full inheritance chain for a template, root first. + + Args: + name: Template name. + manifest: The loaded manifest dict. + templates_dir: Path to sdrf-templates directory. + + Returns: + List of template names from root ancestor to this template. + E.g. ['base', 'sample-metadata', 'human'] for human. + """ + chain: list[str] = [] + current = name + while current is not None: + chain.append(current) + entry = manifest[current] + parent_name = _parse_extends(entry.get("extends")) + current = parent_name + chain.reverse() + return chain + + +def _merge_single_column( + parent_col: dict[str, Any], child_col: dict[str, Any] +) -> dict[str, Any]: + """Merge a child column override onto a parent column. + + Child inherits ALL parent properties via copy, then overrides only + the fields explicitly specified in child_col. + """ + merged = copy.deepcopy(parent_col) + for key, value in child_col.items(): + if key == "name": + continue # name is the join key, always keep + merged[key] = copy.deepcopy(value) + return merged + + +def merge_columns( + chain: list[str], + manifest: dict[str, dict], + templates_dir: Path, +) -> tuple[list[dict], list[dict], list[dict]]: + """Walk the inheritance chain and merge columns. + + Returns: + Tuple of (own_columns, inherited_columns, all_columns). + Each column dict includes a 'source_template' annotation. + """ + if not chain: + return [], [], [] + + # Load all templates in the chain + loaded: dict[str, dict] = {} + for tname in chain: + entry = manifest[tname] + version = entry["latest"] + loaded[tname] = load_template_yaml(templates_dir, tname, version) + + # Build merged column list by walking chain from root to leaf + # merged_columns: ordered dict of name -> column dict + merged_columns: dict[str, dict[str, Any]] = {} + + # Track which template originally defined or last overrode each column + for tname in chain: + tpl = loaded[tname] + tpl_columns = tpl.get("columns", []) + for col in tpl_columns: + col_name = col["name"] + if col_name in merged_columns: + # Merge: child overrides parent + merged_columns[col_name] = _merge_single_column( + merged_columns[col_name], col + ) + else: + # New column + merged_columns[col_name] = copy.deepcopy(col) + # Update source_template to this template (last one to define/override) + merged_columns[col_name]["source_template"] = tname + + # The leaf template is the last in the chain + leaf_name = chain[-1] + leaf_col_names = { + col["name"] for col in loaded[leaf_name].get("columns", []) + } + + # Separate own vs inherited + own_columns: list[dict] = [] + inherited_columns: list[dict] = [] + for col_name, col in merged_columns.items(): + if col_name in leaf_col_names: + own_columns.append(col) + else: + inherited_columns.append(col) + + # all_columns: inherited order first, then own additions + # "own" columns that override a parent column keep their inherited position + all_columns: list[dict] = [] + own_addition_names = leaf_col_names - { + col["name"] + for tname in chain[:-1] + for col in loaded[tname].get("columns", []) + } + for col_name, col in merged_columns.items(): + if col_name not in own_addition_names: + all_columns.append(col) + # Then append own additions (new columns not in any parent) + for col_name, col in merged_columns.items(): + if col_name in own_addition_names: + all_columns.append(col) + + return own_columns, inherited_columns, all_columns + + +def resolve_template( + name: str, + templates_dir: Path, + manifest: dict[str, dict] | None = None, +) -> dict[str, Any]: + """Resolve a single template with full inheritance. + + Args: + name: Template name. + templates_dir: Path to sdrf-templates directory. + manifest: Optional pre-loaded manifest (loaded if None). + + Returns: + Resolved template dict with all metadata and merged columns. + """ + if manifest is None: + manifest = load_manifest(templates_dir) + + entry = manifest[name] + version = entry["latest"] + tpl = load_template_yaml(templates_dir, name, version) + chain = build_inheritance_chain(name, manifest, templates_dir) + own_columns, inherited_columns, all_columns = merge_columns( + chain, manifest, templates_dir + ) + + return { + "name": tpl["name"], + "description": tpl.get("description", ""), + "documentation": tpl.get("documentation", ""), + "contributors": tpl.get("contributors", []), + "version": tpl.get("version", version), + "layer": tpl.get("layer", entry.get("layer")), + "extends": tpl.get("extends", entry.get("extends")), + "usable_alone": tpl.get("usable_alone", entry.get("usable_alone", False)), + "mutually_exclusive_with": tpl.get("mutually_exclusive_with", []), + "requires": entry.get("requires"), + "excludes": entry.get("excludes"), + "inheritance_chain": chain, + "own_columns": own_columns, + "inherited_columns": inherited_columns, + "all_columns": all_columns, + } + + +def resolve_all( + templates_dir: Path, +) -> dict[str, dict[str, Any]]: + """Resolve all templates from the manifest. + + Returns: + Dict mapping template name -> resolved template dict. + """ + manifest = load_manifest(templates_dir) + result: dict[str, dict[str, Any]] = {} + for name in manifest: + result[name] = resolve_template(name, templates_dir, manifest=manifest) + return result diff --git a/scripts/test_resolve_templates.py b/scripts/test_resolve_templates.py new file mode 100644 index 000000000..bfab7989a --- /dev/null +++ b/scripts/test_resolve_templates.py @@ -0,0 +1,276 @@ +"""Tests for the template inheritance resolver module.""" + +import os +import subprocess +import tempfile + +import pytest +from pathlib import Path + +# Resolve paths +REPO_ROOT = Path(__file__).resolve().parent.parent +TEMPLATES_DIR = REPO_ROOT / "sdrf-proteomics" / "sdrf-templates" + +from resolve_templates import ( + load_manifest, + load_template_yaml, + build_inheritance_chain, + merge_columns, + resolve_template, + resolve_all, +) + +METADATA_FIELDS = [ + "name", + "description", + "documentation", + "contributors", + "version", + "layer", + "extends", + "usable_alone", + "mutually_exclusive_with", + "requires", + "excludes", + "inheritance_chain", + "own_columns", + "inherited_columns", + "all_columns", +] + + +# --- Manifest tests --- + + +class TestManifestLoading: + def test_manifest_loads_all_templates(self): + manifest = load_manifest(TEMPLATES_DIR) + assert isinstance(manifest, dict) + assert "base" in manifest + assert "sample-metadata" in manifest + assert "human" in manifest + assert "ms-proteomics" in manifest + assert "dia-acquisition" in manifest + assert "metaproteomics" in manifest + assert len(manifest) >= 10 # sanity: we know there are many templates + + +# --- Single template loading --- + + +class TestTemplateYamlLoading: + def test_load_base_template(self): + tpl = load_template_yaml(TEMPLATES_DIR, "base", "1.1.0") + assert tpl["name"] == "base" + assert "columns" in tpl + assert len(tpl["columns"]) > 0 + + def test_load_human_template(self): + tpl = load_template_yaml(TEMPLATES_DIR, "human", "1.1.0") + assert tpl["name"] == "human" + assert tpl["extends"] == "sample-metadata@>=1.0.0" + + +# --- Inheritance chain --- + + +class TestInheritanceChain: + def test_base_chain_length_1(self): + manifest = load_manifest(TEMPLATES_DIR) + chain = build_inheritance_chain("base", manifest, TEMPLATES_DIR) + assert chain == ["base"] + + def test_sample_metadata_chain(self): + manifest = load_manifest(TEMPLATES_DIR) + chain = build_inheritance_chain("sample-metadata", manifest, TEMPLATES_DIR) + assert chain == ["base", "sample-metadata"] + + def test_human_chain_3_levels(self): + manifest = load_manifest(TEMPLATES_DIR) + chain = build_inheritance_chain("human", manifest, TEMPLATES_DIR) + assert chain == ["base", "sample-metadata", "human"] + + def test_dia_acquisition_chain_4_levels(self): + manifest = load_manifest(TEMPLATES_DIR) + chain = build_inheritance_chain("dia-acquisition", manifest, TEMPLATES_DIR) + assert chain == ["base", "sample-metadata", "ms-proteomics", "dia-acquisition"] + + def test_metaproteomics_chain_not_through_sample_metadata(self): + manifest = load_manifest(TEMPLATES_DIR) + chain = build_inheritance_chain("metaproteomics", manifest, TEMPLATES_DIR) + assert chain == ["base", "metaproteomics"] + assert "sample-metadata" not in chain + + +# --- Column merging --- + + +class TestColumnMerging: + def test_own_vs_inherited_separation(self): + resolved = resolve_template("human", TEMPLATES_DIR) + own_names = {c["name"] for c in resolved["own_columns"]} + inherited_names = {c["name"] for c in resolved["inherited_columns"]} + # human defines disease override + new columns like age, sex + assert "characteristics[age]" in own_names + assert "characteristics[sex]" in own_names + # disease is overridden by human, so it's own + assert "characteristics[disease]" in own_names + # source name comes from base, not overridden by human + assert "source name" in inherited_names + + def test_child_override_of_parent_column(self): + """Human overrides disease to required (parent has recommended).""" + resolved = resolve_template("human", TEMPLATES_DIR) + disease_col = next( + c for c in resolved["all_columns"] if c["name"] == "characteristics[disease]" + ) + assert disease_col["requirement"] == "required" + # Should still have inherited validators from sample-metadata + assert "validators" in disease_col + assert len(disease_col["validators"]) > 0 + + def test_all_columns_no_duplicates(self): + resolved = resolve_template("human", TEMPLATES_DIR) + names = [c["name"] for c in resolved["all_columns"]] + assert len(names) == len(set(names)), f"Duplicate columns found: {[n for n in names if names.count(n) > 1]}" + + def test_all_columns_ordering_inherited_before_own(self): + """Inherited columns appear before own additions in all_columns.""" + resolved = resolve_template("human", TEMPLATES_DIR) + all_names = [c["name"] for c in resolved["all_columns"]] + # "source name" is inherited from base, should appear before human-only columns + source_idx = all_names.index("source name") + # "characteristics[age]" is new in human + age_idx = all_names.index("characteristics[age]") + assert source_idx < age_idx + + def test_source_template_annotation_on_every_column(self): + resolved = resolve_template("human", TEMPLATES_DIR) + for col in resolved["all_columns"]: + assert "source_template" in col, f"Column {col['name']} missing source_template" + assert isinstance(col["source_template"], str) + assert col["source_template"] in resolved["inheritance_chain"] + + +# --- Resolved template metadata --- + + +class TestResolvedMetadata: + def test_all_metadata_fields_present(self): + resolved = resolve_template("human", TEMPLATES_DIR) + for field in METADATA_FIELDS: + assert field in resolved, f"Missing field: {field}" + + def test_base_metadata(self): + resolved = resolve_template("base", TEMPLATES_DIR) + assert resolved["name"] == "base" + assert resolved["extends"] is None + assert resolved["inheritance_chain"] == ["base"] + assert resolved["usable_alone"] is False + + def test_human_metadata(self): + resolved = resolve_template("human", TEMPLATES_DIR) + assert resolved["name"] == "human" + assert resolved["extends"] == "sample-metadata@>=1.0.0" + assert resolved["layer"] == "sample" + assert isinstance(resolved["contributors"], list) + assert len(resolved["contributors"]) > 0 + + def test_mutually_exclusive_with(self): + resolved = resolve_template("human", TEMPLATES_DIR) + assert isinstance(resolved["mutually_exclusive_with"], list) + assert "vertebrates" in resolved["mutually_exclusive_with"] + + +# --- resolve_all --- + + +class TestResolveAll: + def test_resolve_all_succeeds(self): + all_resolved = resolve_all(TEMPLATES_DIR) + manifest = load_manifest(TEMPLATES_DIR) + assert len(all_resolved) == len(manifest) + for name, resolved in all_resolved.items(): + assert resolved["name"] == name + assert len(resolved["all_columns"]) > 0 + assert len(resolved["inheritance_chain"]) >= 1 + + def test_resolve_all_every_template_has_all_fields(self): + all_resolved = resolve_all(TEMPLATES_DIR) + for name, resolved in all_resolved.items(): + for field in METADATA_FIELDS: + assert field in resolved, f"Template {name} missing field: {field}" + + def test_resolve_all_no_duplicate_columns_in_any_template(self): + all_resolved = resolve_all(TEMPLATES_DIR) + for name, resolved in all_resolved.items(): + names = [c["name"] for c in resolved["all_columns"]] + assert len(names) == len(set(names)), ( + f"Template {name} has duplicate columns: " + f"{[n for n in names if names.count(n) > 1]}" + ) + + +# --- build_template_pages script --- + + +class TestBuildTemplatePages: + def test_build_template_pages_generates_html(self): + """build_template_pages.py generates HTML files for all templates.""" + repo_root = os.path.join(os.path.dirname(__file__), "..") + with tempfile.TemporaryDirectory() as tmpdir: + result = subprocess.run( + [ + "python3", + "scripts/build_template_pages.py", + "sdrf-proteomics/sdrf-templates", + tmpdir, + ], + capture_output=True, + text=True, + cwd=repo_root, + ) + assert result.returncode == 0, f"Script failed: {result.stderr}" + assert os.path.exists(os.path.join(tmpdir, "human.html")) + assert os.path.exists(os.path.join(tmpdir, "dia-acquisition.html")) + assert os.path.exists(os.path.join(tmpdir, "base.html")) + with open(os.path.join(tmpdir, "human.html")) as f: + html = f.read() + assert "characteristics[ancestry category]" in html + assert "characteristics[organism]" in html # inherited + assert "source name" in html # from base + assert "Contributors" in html + + +# --- build_index_templates script --- + + +class TestBuildIndexTemplates: + def test_build_index_templates_updates_html(self): + """build_index_templates.py replaces template section in index.html.""" + import shutil + + repo_root = os.path.join(os.path.dirname(__file__), "..") + with tempfile.TemporaryDirectory() as tmpdir: + src = os.path.join(repo_root, "site", "index.html") + dst = os.path.join(tmpdir, "index.html") + shutil.copy(src, dst) + result = subprocess.run( + [ + "python3", + "scripts/build_index_templates.py", + "sdrf-proteomics/sdrf-templates", + dst, + ], + capture_output=True, + text=True, + cwd=repo_root, + ) + assert result.returncode == 0, f"Script failed: {result.stderr}" + with open(dst) as f: + html = f.read() + # New templates present + assert "olink" in html.lower() or "Olink" in html + assert "clinical-metadata" in html.lower() or "Clinical" in html + # Still has the section + assert html.count('
    tuple[str, int]: content, c = re.subn(pattern6, replacement6, content) count += c - # Pattern 7: tool-support.adoc -> tool-support.html - pattern7 = r'href="(\.\.\/)?tool-support\.adoc([^"]*)"' - replacement7 = r'href="\1tool-support.html\2"' + # Pattern 7: TOOLS.adoc / tool-support.adoc -> tools.html + pattern7 = r'href="(\.\.\/)?(tool-support|TOOLS)\.adoc([^"]*)"' + replacement7 = r'href="\1tools.html\3"' content, c = re.subn(pattern7, replacement7, content) count += c + # Pattern 7a: TEMPLATES.adoc -> templates.html + pattern7a = r'href="(\.\.\/)?(TEMPLATES)\.adoc([^"]*)"' + replacement7a = r'href="\1templates.html\3"' + content, c = re.subn(pattern7a, replacement7a, content) + count += c + + # Pattern 7b: SAMPLE-GUIDELINES.adoc -> sample-guidelines.html + pattern7b = r'href="(\.\.\/)?(SAMPLE-GUIDELINES|sample-guidelines)\.adoc([^"]*)"' + replacement7b = r'href="\1sample-guidelines.html\3"' + content, c = re.subn(pattern7b, replacement7b, content) + count += c + # Pattern 8: Any remaining .adoc links - generic transformation pattern8 = r'href="([^"]*?)\.adoc([^"]*)"' replacement8 = r'href="\1.html\2"' diff --git a/scripts/transform-sdrf-tables.py b/scripts/transform-sdrf-tables.py index 8a609036e..79fa67e9f 100644 --- a/scripts/transform-sdrf-tables.py +++ b/scripts/transform-sdrf-tables.py @@ -12,7 +12,6 @@ import sys import re from pathlib import Path -from html.parser import HTMLParser def classify_column(header_text: str) -> str: diff --git a/sdrf-proteomics/metadata-guidelines/data-analysis-metadata.adoc b/sdrf-proteomics/DATA-ANALYSIS.adoc similarity index 100% rename from sdrf-proteomics/metadata-guidelines/data-analysis-metadata.adoc rename to sdrf-proteomics/DATA-ANALYSIS.adoc diff --git a/sdrf-proteomics/README.adoc b/sdrf-proteomics/README.adoc index eac4f27b6..2588e6998 100644 --- a/sdrf-proteomics/README.adoc +++ b/sdrf-proteomics/README.adoc @@ -80,9 +80,9 @@ Here's a minimal example: |=== |source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[biological replicate] |assay name |technology type |comment[proteomics data acquisition method] |comment[label] |comment[instrument] |comment[cleavage agent details] |comment[fraction identifier] |comment[technical replicate] |comment[data file] |factor value[disease] -|sample_1 |homo sapiens |liver |normal |1 |run_1 |proteomic profiling by mass spectrometry |Data-dependent acquisition |label free sample |Q Exactive HF |NT=Trypsin;AC=MS:1001251 |1 |1 |sample_1.raw |normal -|sample_2 |homo sapiens |liver |hepatocellular carcinoma |1 |run_2 |proteomic profiling by mass spectrometry |Data-dependent acquisition |label free sample |Q Exactive HF |NT=Trypsin;AC=MS:1001251 |1 |1 |sample_2.raw |hepatocellular carcinoma -|sample_3 |homo sapiens |not available |not available |1 |run_3 |proteomic profiling by mass spectrometry |Data-dependent acquisition |label free sample |Q Exactive HF |NT=Trypsin;AC=MS:1001251 |1 |1 |sample_3.raw |not available +|sample_1 |homo sapiens |liver |normal |1 |run_1 |proteomic profiling by mass spectrometry |data-dependent acquisition |label free sample |Q Exactive HF |NT=Trypsin;AC=MS:1001251 |1 |1 |sample_1.raw |normal +|sample_2 |homo sapiens |liver |hepatocellular carcinoma |1 |run_2 |proteomic profiling by mass spectrometry |data-dependent acquisition |label free sample |Q Exactive HF |NT=Trypsin;AC=MS:1001251 |1 |1 |sample_2.raw |hepatocellular carcinoma +|sample_3 |homo sapiens |not available |not available |1 |run_3 |proteomic profiling by mass spectrometry |data-dependent acquisition |label free sample |Q Exactive HF |NT=Trypsin;AC=MS:1001251 |1 |1 |sample_3.raw |not available |=== The file is organized into three column sections: @@ -93,8 +93,8 @@ The file is organized into three column sections: [NOTE] ==== -* This example shows **mass spectrometry** proteomics - see link:templates/ms-proteomics/README.adoc[MS-Proteomics template] for full requirements. -* For **affinity proteomics** (Olink, SomaScan), see link:templates/affinity-proteomics/README.adoc[Affinity-Proteomics template]. +* This example shows **mass spectrometry** proteomics - see https://github.com/bigbio/sdrf-templates/tree/main/ms-proteomics[MS-Proteomics template] for full requirements. +* For **affinity proteomics** (Olink, SomaScan), see https://github.com/bigbio/sdrf-templates/tree/main/affinity-proteomics[Affinity-Proteomics template]. * Unknown values use <>: `not available`, `not applicable`, or `pooled`. * For a step-by-step tutorial, see the link:quickstart.adoc[Quick Start Guide]. ==== @@ -117,7 +117,7 @@ For the complete versioning strategy — including template versioning, ontology [[reserved-words]] === Reserved words -There are general scenarios where cell values cannot be provided with actual data. The following reserved words MUST be used in these cases: +There are general scenarios where cell values cannot be provided with actual data. The following reserved words MUST be used in these cases. Reserved words MUST be all lowercase (e.g., `not available`, NOT `Not Available` or `Not available`): - **not available**: In some cases, the column is mandatory in the format, but for some samples the corresponding value is unknown or could not be determined. In those cases, users SHOULD use *not available*. - **not applicable**: In some cases, the column is mandatory, but for some samples the corresponding value or concept does not apply. In those cases, users SHOULD use *not applicable*. @@ -258,9 +258,11 @@ The value for each property, (e.g. characteristics, comment, factor value) corre - **Ontology url (Computer readable)**: Users can provide the corresponding URI (Uniform Resource Identifier) of the ontology/CV term as a value. This is recommended for enriched files where the user does not want to use intermediate tools to map from free text to ontology/CV terms. -- **Key=value representation (Human and Computer readable)**: The current representation aims to provide a mechanism to represent the complete information of the ontology/CV term including Accession, Name and other additional properties. In the key=value pair representation, the Value of the property is represented as an Object with multiple properties, where the key is one of the properties of the object and the value is the corresponding value for the particular key. An example of key value pairs is post-translational modification (see link:templates/ms-proteomics.html#_protein_modifications[Protein Modifications]): +- **Key=value representation (Human and Computer readable)**: The current representation aims to provide a mechanism to represent the complete information of the ontology/CV term including Accession, Name and other additional properties. In the key=value pair representation, the Value of the property is represented as an Object with multiple properties, where the key is one of the properties of the object and the value is the corresponding value for the particular key. The key order MUST be `NT` (name) first, followed by `AC` (accession), then any additional keys. An example of key value pairs is post-translational modification (see link:TEMPLATES.adoc[Protein Modifications]): - NT=Glu->pyro-Glu;MT=fixed;PP=Anywhere;AC=Unimod:27;TA=E + NT=Glu->pyro-Glu;AC=Unimod:27;MT=fixed;PP=Anywhere;TA=E + +NOTE: Beyond these three representations, SDRF columns may accept additional structured value types such as numbers with units (`10 ppm`), accession identifiers (`SAMN12345678`), ISO 8601 dates, semantic versions, and more. Each column's YAML template definition declares exactly which value types and formats are accepted. For the complete reference of all value types, parsing rules, and their formal patterns, see link:TEMPLATES.adoc#value-types-reference[Value Types Reference in the Templates Guide]. [[validation]] == Validating SDRF Files @@ -295,8 +297,8 @@ The Sample metadata section provides information about the samples of origin and - *source name*: Unique sample name (it can be present multiple times if the same sample is used several times in the same dataset) - *characteristics[organism]*: The organism of the Sample of origin. Values MUST come from https://www.ebi.ac.uk/ols4/ontologies/ncbitaxon[NCBI Taxonomy]. - *characteristics[organism part]*: The part of organism's anatomy or substance arising from an organism from which the biomaterial was derived (e.g., liver). Values SHOULD come from https://www.ebi.ac.uk/ols4/ontologies/uberon[UBERON] or https://www.ebi.ac.uk/ols4/ontologies/bto[BTO]. -- *characteristics[disease]*: The disease under study in the Sample. Values SHOULD come from https://www.ebi.ac.uk/ols4/ontologies/mondo[MONDO], https://www.ebi.ac.uk/ols4/ontologies/efo[EFO], or https://www.ebi.ac.uk/ols4/ontologies/doid[DOID]. For healthy/control samples, use `normal` (https://www.ebi.ac.uk/ols4/ontologies/pato/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPATO_0000461[PATO:0000461]) - see link:metadata-guidelines/sample-metadata.html#disease-annotation[Disease Annotation Guidelines]. -- *characteristics[cell type]*: A cell type is a distinct morphological or functional form of cell (e.g., epithelial, glial). Values SHOULD come from https://www.ebi.ac.uk/ols4/ontologies/cl[Cell Ontology (CL)] or https://www.ebi.ac.uk/ols4/ontologies/bto[BTO]. +- *characteristics[disease]*: The disease under study in the Sample. Values SHOULD come from https://www.ebi.ac.uk/ols4/ontologies/mondo[MONDO], https://www.ebi.ac.uk/ols4/ontologies/efo[EFO], or https://www.ebi.ac.uk/ols4/ontologies/doid[DOID]. For healthy/control samples, use `normal` (https://www.ebi.ac.uk/ols4/ontologies/pato/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPATO_0000461[PATO:0000461]) - see link:SAMPLE-GUIDELINES.adoc#disease-annotation[Disease Annotation Guidelines]. +- *characteristics[cell type]*: A cell type is a distinct morphological or functional form of cell (e.g., epithelial, glial). Values SHOULD come from https://www.ebi.ac.uk/ols4/ontologies/cl[Cell Ontology (CL)], https://www.ebi.ac.uk/ols4/ontologies/bto[BTO], or https://www.ebi.ac.uk/ols4/ontologies/clo[Cell Line Ontology (CLO)]. Example: @@ -311,7 +313,7 @@ Example: [NOTE] ==== * Additional characteristics can be added per experiment type - see https://github.com/bigbio/proteomics-metadata-standard/tree/master/sdrf-proteomics/templates[SDRF-Proteomics templates] for required properties. -* Column headers SHOULD use EFO ontology terms (e.g., `characteristics[organism]`) - see link:metadata-guidelines/sample-metadata.html#disease-annotation[Disease Annotation Guidelines]. +* Column headers SHOULD use EFO ontology terms (e.g., `characteristics[organism]`) - see link:SAMPLE-GUIDELINES.adoc#disease-annotation[Disease Annotation Guidelines]. * Multiple columns with the same `characteristics` term are allowed (see <>), but RECOMMENDED to use more specific terms (e.g., "immunophenotype" instead of duplicate "phenotype"). ==== @@ -366,8 +368,8 @@ TIP: For pooled samples, use `pooled` for individual-specific fields (biological For detailed guidance on annotating sample metadata, refer to the following conventions documents: -* link:metadata-guidelines/sample-metadata.adoc[Sample Metadata Guidelines] - Detailed guidelines for age, sex, disease, organism part, cell type, developmental stage, spiked-in samples, and other sample characteristics -* link:templates/human/README.adoc[Human Sample Metadata Guidelines] - Human-specific metadata including disease staging, treatment history, demographics, and lifestyle factors +* link:SAMPLE-GUIDELINES.adoc[Sample Metadata Guidelines] - Detailed guidelines for age, sex, disease, organism part, cell type, developmental stage, spiked-in samples, and other sample characteristics +* https://github.com/bigbio/sdrf-templates/tree/main/human[Human Sample Metadata Guidelines] - Human-specific metadata including disease staging, treatment history, demographics, and lifestyle factors [[from-sample-data]] == SDRF-Proteomics: data files metadata @@ -383,7 +385,7 @@ Examples: `NT=HCD;AC=PRIDE:0000590`, `NT=Orbitrap;AC=MS:1000484` This format enables automated validation and software extraction from raw files. Sample metadata (characteristics) can use simple term names since they are typically human-annotated. -The following properties MUST be provided for each data file in **mass spectrometry-based proteomics** experiments. For **affinity-based proteomics** (Olink, SomaScan), see the link:templates/affinity-proteomics/README.adoc[Affinity-Proteomics template] for different required columns. +The following properties MUST be provided for each data file in **mass spectrometry-based proteomics** experiments. For **affinity-based proteomics** (Olink, SomaScan), see the https://github.com/bigbio/sdrf-templates/tree/main/affinity-proteomics[Affinity-Proteomics template] for different required columns. [cols="3,1,4,2", options="header"] |=== @@ -396,7 +398,7 @@ The following properties MUST be provided for each data file in **mass spectrome |`comment[instrument]` |REQUIRED |Mass spectrometer model |PSI-MS - Instruments |`comment[cleavage agent details]` |REQUIRED |Enzyme information (use "not applicable" for top-down/undigested samples) |PSI-MS - Cleavage agents |`comment[fraction identifier]` |REQUIRED |Fraction number (1 if not fractionated) |Integer -|`comment[technical replicate]` |RECOMMENDED |Technical replicate number (1 if none) |Integer +|`comment[technical replicate]` |REQUIRED |Technical replicate number (1 if none) |Integer |`comment[data file]` |REQUIRED |Name of the raw file |Free text |=== @@ -414,12 +416,14 @@ Example: NOTE: This section applies to **mass spectrometry-based proteomics** experiments only. For affinity-based proteomics, these properties do not apply. -For detailed documentation of sample preparation and MS/MS fragmentation properties, see the link:templates/ms-proteomics/README.adoc[MS-Proteomics Template]: +For detailed documentation of sample preparation and MS/MS fragmentation properties, see the https://github.com/bigbio/sdrf-templates/tree/main/ms-proteomics[MS-Proteomics Template]: - **Sample preparation**: depletion, reduction reagent, alkylation reagent - **Fractionation**: fractionation method (used with `comment[fraction identifier]`) - **Fragmentation**: collision energy, dissociation method +NOTE: For HCD (Higher-energy C-trap Dissociation), the canonical accession is https://www.ebi.ac.uk/ols4/ontologies/ms/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMS_1000422[MS:1000422 - beam-type collision-induced dissociation]. Use `NT=beam-type collision-induced dissociation;AC=MS:1000422` or the short label `HCD`. Do not use PRIDE:0000590 or MS:1002481. + [[data-acquisition-method]] === Proteomics data acquisition method @@ -436,13 +440,13 @@ IMPORTANT: The _comment[proteomics data acquisition method]_ column is REQUIRED You can find an example of a DIA experiment in the following link: https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018830/PXD018830-DIA.sdrf.tsv[DIA example] -TIP: For DIA experiments, additional properties like MS1 scan range can be captured. See link:templates/ms-proteomics.html#_dia_scan_window[DIA Scan Window Limits] in the MS-Proteomics Template. +TIP: For DIA experiments, additional properties like MS1 scan range can be captured. See https://github.com/bigbio/sdrf-templates/tree/main/dia-acquisition[DIA Scan Window Limits] in the DIA-Acquisition Template. === MS-Proteomics Template For detailed guidance on data file metadata, refer to the conventions document: -* link:templates/ms-proteomics/README.adoc[MS-Proteomics Template] - Detailed guidelines for labels, instruments, modifications, cleavage agents, mass tolerances, RAW file URIs, and other data file properties +* https://github.com/bigbio/sdrf-templates/tree/main/ms-proteomics[MS-Proteomics Template] - Detailed guidelines for labels, instruments, modifications, cleavage agents, mass tolerances, RAW file URIs, and other data file properties [[additional-sdrf-rules]] == Additional SDRF Rules @@ -487,20 +491,57 @@ Templates follow a layered hierarchy: |Layer |Templates |Description |**TECHNOLOGY** (required) -|link:templates/ms-proteomics/README.adoc[ms-proteomics], link:templates/affinity-proteomics/README.adoc[affinity-proteomics] +|https://github.com/bigbio/sdrf-templates/tree/main/ms-proteomics[ms-proteomics], https://github.com/bigbio/sdrf-templates/tree/main/affinity-proteomics[affinity-proteomics] |Minimum valid SDRF - choose one |**SAMPLE** (recommended) -|link:templates/human/README.adoc[human], link:templates/vertebrates/README.adoc[vertebrates], link:templates/invertebrates/README.adoc[invertebrates], link:templates/plants/README.adoc[plants] -|Organism-specific metadata +|https://github.com/bigbio/sdrf-templates/tree/main/human[human], https://github.com/bigbio/sdrf-templates/tree/main/vertebrates[vertebrates], https://github.com/bigbio/sdrf-templates/tree/main/invertebrates[invertebrates], https://github.com/bigbio/sdrf-templates/tree/main/plants[plants], https://github.com/bigbio/sdrf-templates/tree/main/clinical-metadata[clinical-metadata], https://github.com/bigbio/sdrf-templates/tree/main/oncology-metadata[oncology-metadata] +|Organism-specific and clinical metadata |**EXPERIMENT** (optional) -|link:templates/cell-lines/README.adoc[cell-lines], link:templates/crosslinking/README.adoc[crosslinking], link:templates/dda-acquisition/README.adoc[dda-acquisition], link:templates/dia-acquisition/README.adoc[dia-acquisition], link:templates/single-cell/README.adoc[single-cell], link:templates/immunopeptidomics/README.adoc[immunopeptidomics] +|https://github.com/bigbio/sdrf-templates/tree/main/cell-lines[cell-lines], https://github.com/bigbio/sdrf-templates/tree/main/crosslinking[crosslinking], https://github.com/bigbio/sdrf-templates/tree/main/dia-acquisition[dia-acquisition], https://github.com/bigbio/sdrf-templates/tree/main/single-cell[single-cell], https://github.com/bigbio/sdrf-templates/tree/main/immunopeptidomics[immunopeptidomics], https://github.com/bigbio/sdrf-templates/tree/main/metaproteomics[metaproteomics], https://github.com/bigbio/sdrf-templates/tree/main/olink[olink], https://github.com/bigbio/sdrf-templates/tree/main/somascan[somascan] |Methodology-specific columns |=== Child templates inherit all columns from parents and may add new columns or strengthen requirements (e.g., `optional` → `required`). +=== Template Combination Rules + +Some layers enforce **mutually exclusive** choices, while others allow combining multiple templates: + +|=== +|Layer |Templates |Rule + +|TECHNOLOGY +|`ms-proteomics` vs `affinity-proteomics` +|Mutually exclusive — choose one (REQUIRED) + +|SAMPLE +|`human` vs `vertebrates` vs `invertebrates` vs `plants` +|Mutually exclusive — choose one based on organism (RECOMMENDED) + +|EXPERIMENT (MS) +|`dia-acquisition`, `single-cell`, `crosslinking`, `immunopeptidomics`, `metaproteomics` +|Can be combined (e.g., `dia-acquisition` + `single-cell`) + +|EXPERIMENT (affinity platform) +|`olink` vs `somascan` +|Mutually exclusive — choose one if using affinity-proteomics (OPTIONAL) +|=== + +Templates from different layers can be freely combined. Common valid combinations: + +- `ms-proteomics` + `human` (human DDA proteomics) +- `ms-proteomics` + `human` + `dia-acquisition` (human DIA proteomics) +- `ms-proteomics` + `human` + `immunopeptidomics` (human immunopeptidomics) +- `ms-proteomics` + `vertebrates` + `cell-lines` (mouse cell line proteomics) +- `ms-proteomics` + `human` + `crosslinking` (human crosslinking MS) +- `affinity-proteomics` + `human` + `olink` (human Olink) +- `affinity-proteomics` + `human` + `somascan` (human SomaScan) +- `ms-proteomics` + `metaproteomics` (environmental metaproteomics) +- `ms-proteomics` + `human` + `metaproteomics` (human gut microbiome metaproteomics) +- `ms-proteomics` + `human` + `single-cell` (human single-cell proteomics) + === Specifying Templates in SDRF Files Declare templates using `comment[sdrf template]` columns. Only list leaf templates (parents are implied). When using multiple templates, add multiple columns with the same name. Two formats are supported: @@ -532,21 +573,20 @@ sample_1 ... human v1.1.0 crosslinking v1.0.0 |=== | Template | Use For | Key Columns -| link:templates/human/README.adoc[Human] | Human clinical samples | disease, age, sex, ancestry -| link:templates/vertebrates/README.adoc[Vertebrates] | Mouse, rat, zebrafish | disease, developmental stage, strain -| link:templates/invertebrates/README.adoc[Invertebrates] | Drosophila, C. elegans | disease, developmental stage, genotype -| link:templates/plants/README.adoc[Plants] | Arabidopsis, crops | disease, developmental stage, growth conditions +| https://github.com/bigbio/sdrf-templates/tree/main/human[Human] | Human clinical samples | disease, age, sex, ancestry +| https://github.com/bigbio/sdrf-templates/tree/main/vertebrates[Vertebrates] | Mouse, rat, zebrafish | disease, developmental stage, strain +| https://github.com/bigbio/sdrf-templates/tree/main/invertebrates[Invertebrates] | Drosophila, C. elegans | disease, developmental stage, genotype +| https://github.com/bigbio/sdrf-templates/tree/main/plants[Plants] | Arabidopsis, crops | disease, developmental stage, growth conditions |=== **Experiment-type templates**: -- link:templates/dda-acquisition/README.adoc[DDA Acquisition] - dissociation method, collision energy, modifications -- link:templates/dia-acquisition/README.adoc[DIA Acquisition] - scan windows, isolation width, spectral library -- link:templates/cell-lines/README.adoc[Cell Lines] - Cellosaurus integration -- link:templates/single-cell/README.adoc[Single-Cell] - cell isolation, carrier proteome -- link:templates/immunopeptidomics/README.adoc[Immunopeptidomics] - MHC class, HLA typing -- link:templates/crosslinking/README.adoc[Crosslinking MS] - crosslinker reagents -- link:templates/metaproteomics/README.adoc[Metaproteomics] - environmental sample type +- https://github.com/bigbio/sdrf-templates/tree/main/dia-acquisition[DIA Acquisition] - scan windows, isolation width +- https://github.com/bigbio/sdrf-templates/tree/main/cell-lines[Cell Lines] - Cellosaurus integration +- https://github.com/bigbio/sdrf-templates/tree/main/single-cell[Single-Cell] - cell isolation, carrier proteome +- https://github.com/bigbio/sdrf-templates/tree/main/immunopeptidomics[Immunopeptidomics] - MHC protein complex, MHC typing +- https://github.com/bigbio/sdrf-templates/tree/main/crosslinking[Crosslinking MS] - crosslinker reagents +- https://github.com/bigbio/sdrf-templates/tree/main/metaproteomics[Metaproteomics] - environmental sample type Download templates from the https://github.com/bigbio/proteomics-metadata-standard/tree/master/sdrf-proteomics/templates[templates folder]. @@ -558,7 +598,7 @@ You can add custom columns beyond template requirements for study-specific metad - Column names MUST be valid ontology terms (search https://www.ebi.ac.uk/ols4/[OLS]) - Use controlled vocabularies for values when available -See link:metadata-guidelines/sample-metadata.html#common-additional-columns[Common Additional Columns] and link:sdrf-terms.html[SDRF Terms Reference] for commonly used columns. +See link:SAMPLE-GUIDELINES.adoc#_additional_sample_related_columns[Additional Sample-Related Columns] and link:TERMS.tsv[SDRF Terms Reference] for commonly used columns. === Contributing New Templates @@ -580,7 +620,7 @@ Use factor values to indicate: - Conditions being compared (e.g., disease vs. normal, treated vs. untreated) - Variables that define experimental groups -NOTE: Use `normal` (not "control") in the disease field for healthy samples. "Control" is an experimental design concept, not a disease state. See link:metadata-guidelines/sample-metadata.html#disease-annotation[Disease Annotation Guidelines] for details. +NOTE: Use `normal` (not "control") in the disease field for healthy samples. "Control" is an experimental design concept, not a disease state. See link:SAMPLE-GUIDELINES.adoc#disease-annotation[Disease Annotation Guidelines] for details. === Rules @@ -677,7 +717,7 @@ SDRF-Proteomics uses ontologies and controlled vocabularies (CVs) to standardize |Zebrafish anatomy and development |For zebrafish samples -4+^s|*Disease* (see link:metadata-guidelines/sample-metadata.html#disease-annotation[Disease Annotation Guidelines]) +4+^s|*Disease* (see link:SAMPLE-GUIDELINES.adoc#disease-annotation[Disease Annotation Guidelines]) |Disease |https://www.ebi.ac.uk/ols4/ontologies/mondo[Mondo Disease Ontology (MONDO)] @@ -769,7 +809,7 @@ The following table provides links to example SDRF files for different experimen |DIA |PXD018830 -|Data-independent acquisition +|data-independent acquisition |link:sdrf-explorer.html?view=PXD018830[View in Explorer] |https://github.com/bigbio/proteomics-metadata-standard/tree/master/annotated-projects/PXD018830[GitHub] diff --git a/sdrf-proteomics/metadata-guidelines/sample-metadata.adoc b/sdrf-proteomics/SAMPLE-GUIDELINES.adoc similarity index 78% rename from sdrf-proteomics/metadata-guidelines/sample-metadata.adoc rename to sdrf-proteomics/SAMPLE-GUIDELINES.adoc index 6dd43108b..30ef2c75e 100644 --- a/sdrf-proteomics/metadata-guidelines/sample-metadata.adoc +++ b/sdrf-proteomics/SAMPLE-GUIDELINES.adoc @@ -19,14 +19,18 @@ endif::[] This document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant, microorganism). -For human-specific metadata (disease staging, comorbidities, treatment history), see link:../templates/human/README.adoc[Human Template]. +For human-specific metadata (disease staging, comorbidities, treatment history), see https://github.com/bigbio/sdrf-templates/tree/main/human[Human Template]. **Version 1.1.0** - 2026-01 +== Columns Beyond the YAML Templates + +The YAML templates define the most common columns with validators and requirement levels. However, not every recognised SDRF column needs a YAML definition. The file `TERMS.tsv` serves as a broader registry of column names, ontology mappings, and allowed values. Submitters may add any term listed in `TERMS.tsv` (e.g., `characteristics[xenograft]`, `characteristics[mass]`) to their SDRF file even if no YAML template includes it. Such columns will not be subject to template-level validation but remain part of the specification. + == Best Practices 1. **Use lowercase** for all controlled vocabulary values (except proper nouns in disease names). -2. **Use ontology terms** mapped to MONDO (diseases), CL (cell types), UBERON (anatomy), PATO (phenotypes). +2. **Use ontology terms** mapped to MONDO (diseases), CL/BTO/CLO (cell types), UBERON (anatomy), PATO (phenotypes). 3. **Be consistent** with format across all samples in a dataset. 4. **Document unknowns** using `not available` (unknown) or `not applicable` (not relevant) - never leave cells empty. 5. **Validate before submission** using sdrf-pipelines to check ontology mappings. @@ -67,7 +71,7 @@ Use the scientific name in lowercase. The validator will map to the correct onto **Column:** `characteristics[organism part]` -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/uberon[UBERON] for mammals/vertebrates, https://www.ebi.ac.uk/ols4/ontologies/po[Plant Ontology (PO)] for plants, https://www.ebi.ac.uk/ols4/ontologies/fbbt[FlyBase Anatomy (FBbt)] for Drosophila. +**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/uberon[UBERON] or https://www.ebi.ac.uk/ols4/ontologies/bto[BTO]. Use lowercase for all values. For cell line samples, use `not applicable` or specify the tissue of origin (e.g., `cervix` for HeLa). @@ -75,7 +79,7 @@ Use lowercase for all values. For cell line samples, use `not applicable` or spe ==== **Do NOT use `characteristics[tissue]`** - Use `characteristics[organism part]` instead. -The `characteristics[tissue]` column should not be used as a replacement for `characteristics[organism part]`. When tissue-related columns are needed, they should be used alongside `characteristics[organism part]` for additional categorization (e.g., `characteristics[tissue supergroup]` for higher-level grouping). +The `characteristics[tissue]` column should not be used as a replacement for `characteristics[organism part]`. ==== |=== @@ -101,6 +105,8 @@ The `characteristics[tissue]` column should not be used as a replacement for `ch |Exact age |`{Number}{Unit}` |`40Y` |40 years old |Exact age |`{Number}{Unit}` |`8W` |8 weeks old +|Compound age |`{Y}{M}{W}{D}` |`30Y6M` |30 years and 6 months (strict order Y>M>W>D) +|Compound age |`{Y}{M}{W}{D}` |`2Y3M1W` |2 years, 3 months, 1 week |Age range |`{Lower}{Unit}-{Upper}{Unit}` |`40Y-50Y` |Between 40 and 50 years |Greater than |`>{Number}{Unit}` |`>18Y` |Older than 18 years |Less than |`<{Number}{Unit}` |`<65Y` |Younger than 65 years @@ -123,7 +129,7 @@ Developmental stage is useful for animal studies, pooled samples, or historical **Column:** `characteristics[sex]` -**Requirement:** REQUIRED for human samples, OPTIONAL for other organisms. Values allowed are under PATO ontology: https://www.ebi.ac.uk/ols4/ontologies/pato/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPATO_0000047[PATO:0000047 - Biological Sex] +**Requirement:** REQUIRED for human samples, RECOMMENDED for vertebrates, OPTIONAL for other organisms. Values allowed are under PATO ontology: https://www.ebi.ac.uk/ols4/ontologies/pato/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPATO_0000047[PATO:0000047 - Biological Sex] **Allowed values:** @@ -132,6 +138,8 @@ Developmental stage is useful for animal studies, pooled samples, or historical |male |Male biological sex |female |Female biological sex +|intersex |Intersex biological sex +|hermaphrodite |Hermaphrodite (for non-human organisms) |=== NOTE: For cell lines, use the sex of the original donor if known (e.g., `female` for HeLa cells), otherwise use `not available`. Use `anonymized` when the information exists but has been redacted for privacy reasons (e.g., clinical studies with de-identified data). @@ -141,7 +149,7 @@ NOTE: For cell lines, use the sex of the original donor if known (e.g., `female` **Column:** `characteristics[developmental stage]` -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/uberon[UBERON], https://www.ebi.ac.uk/ols4/ontologies/efo[EFO] +**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/efo[EFO] |=== |Value |Description @@ -157,23 +165,18 @@ For model organisms, use specific stages when applicable: `embryonic day 14` (mo **Column:** `characteristics[disease]` -**Ontology:** https://mondo.monarchinitiative.org/[MONDO Disease Ontology] (preferred), https://www.ebi.ac.uk/efo/[EFO], https://disease-ontology.org/[Human Disease Ontology (DOID)] +**Ontology:** https://mondo.monarchinitiative.org/[MONDO Disease Ontology] (preferred), https://www.ebi.ac.uk/efo/[EFO], https://disease-ontology.org/[Human Disease Ontology (DOID)], https://obofoundry.org/ontology/pato.html[PATO] (for `normal` — healthy samples) === Healthy Samples: normal vs healthy vs control For samples without disease, the terminology matters for standardization: -**`normal`** (PATO:0000461) - **Recommended** +**`normal`** (PATO:0000461) - **REQUIRED term for healthy samples** - Standard term in pathology ("normal tissue" vs "tumor tissue") -- Well-defined ontology mapping to PATO:0000461 +- Well-defined ontology mapping to https://www.ebi.ac.uk/ols4/ontologies/pato/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPATO_0000461[PATO:0000461] - Widely used in existing proteomics datasets - -**`healthy`** (SIO:001012) - **Accepted alternative** - -- More intuitive for clinical/human samples -- Has valid ontology support (Semanticscience Integrated Ontology) -- Validators should accept both `normal` and `healthy` +- This is the single canonical term for healthy/control samples [[WARNING]] ==== @@ -183,52 +186,6 @@ For samples without disease, the terminology matters for standardization: The `characteristics[disease]` column captures the **actual disease state** of the sample, while `factor value[disease]` indicates the **experimental comparison groups**: -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source name...characteristics[disease]...factor value[disease]
    healthy_1...normal...normal
    tumor_1...breast carcinoma...breast carcinoma
    adjacent_1...normal...normal
    -
    - Sample metadata - Factor value -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] |=== |source name |... |characteristics[disease] |... |factor value[disease] @@ -236,7 +193,6 @@ ifndef::backend-html5[] |tumor_1 |... |breast carcinoma |... |breast carcinoma |adjacent_1 |... |normal |... |normal |=== -endif::[] In this example: @@ -252,7 +208,6 @@ Both `healthy_1` and `adjacent_1` have `normal` as their disease state (no tumor |Disease |SDRF Value |Ontology Link |Healthy/no disease |normal |https://www.ebi.ac.uk/ols4/ontologies/pato/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPATO_0000461[PATO:0000461] -|Healthy (alternative) |healthy |https://www.ebi.ac.uk/ols4/ontologies/sio/classes/http%253A%252F%252Fsemanticscience.org%252Fresource%252FSIO_001012[SIO:001012] |Breast cancer |breast carcinoma |https://www.ebi.ac.uk/ols4/ontologies/mondo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMONDO_0004989[MONDO:0004989] |=== @@ -292,7 +247,7 @@ Describes observable characteristics or traits of a sample that result from geno **Column:** `characteristics[cell type]` -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/cl[Cell Ontology (CL)] +**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/cl[Cell Ontology (CL)], https://www.ebi.ac.uk/ols4/ontologies/bto[BRENDA Tissue Ontology (BTO)], https://www.ebi.ac.uk/ols4/ontologies/clo[Cell Line Ontology (CLO)] For cell lines, optionally include the cell type of origin. @@ -346,6 +301,7 @@ Material type describes the nature of the biological material being analyzed. |Sorted T cells |cell |blood |not applicable |Mouse whole brain |tissue |brain |not applicable |E. coli culture |whole organism |not applicable |not applicable +|Plasma sample |organism part |blood |not applicable |Synthetic peptides |synthetic |not applicable |not applicable |=== @@ -363,43 +319,43 @@ NOTE: For cell line samples, use `cell line` as the material type. The specific |Drug treatment studies |link:../sdrf-explorer.html?view=PXD017291[PXD017291] -|`characteristics[time point]` +|`characteristics[sampling time]` |Time of sample collection -|0h, 24h, 7d, baseline +|0 hour, 24 hour, 7 day |Time-course experiments |link:../sdrf-explorer.html?view=PXD007555[PXD007555] |`characteristics[dose]` -|Dose of treatment if applicable -|10 mg/kg, 100 nM, high dose +|Dose of treatment if applicable. Prefer quantitative values (number + unit). Defined in https://github.com/bigbio/sdrf-templates/tree/main/clinical-metadata[clinical-metadata] template. +|10 mg/kg, 100 nM, 50 uM |Dose-response studies |— -|`characteristics[patient bmi]` -|Body mass index (for human studies) -|25.3 kg/m2, 30.1 kg/m2 +|`characteristics[body mass index]` +|Body mass index (EFO:0004340). Defined in https://github.com/bigbio/sdrf-templates/tree/main/clinical-metadata[clinical-metadata] template. +|24.5, 31.2, 18.7 |Metabolic or obesity-related studies |link:../sdrf-explorer.html?view=PXD005780[PXD005780] |`characteristics[smoking status]` -|Smoking history of the patient -|never smoked, current smoker, former smoker +|Smoking history of the patient (NCIT:C19796). Use child terms of NCIT:C19796. Defined in https://github.com/bigbio/sdrf-templates/tree/main/clinical-metadata[clinical-metadata] template. +|never smoker, current smoker, former smoker |Lung or cardiovascular studies |— |=== -For additional columns, see the link:sdrf-terms.tsv[SDRF Terms Reference] and the link:../templates/human/README.adoc[Human Template]. +For additional columns, see the link:TERMS.tsv[SDRF Terms Reference] and the https://github.com/bigbio/sdrf-templates/tree/main/human[Human Template]. == PTM Enrichment **Column:** `characteristics[enrichment process]` -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/efo[EFO] +**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/efo[EFO] and https://www.ebi.ac.uk/ols4/ontologies/pride[PRIDE] (children of https://www.ebi.ac.uk/ols4/ontologies/efo/classes/http%253A%252F%252Fwww.ebi.ac.uk%252Fefo%252FEFO_0009090[EFO:0009090]) |=== |Value |Description -|enrichment of phosphorylated Protein |Phosphoproteomics enrichment +|enrichment of phosphorylated protein |Phosphoproteomics enrichment |not applicable |No PTM enrichment performed |=== @@ -407,6 +363,8 @@ For additional columns, see the link:sdrf-terms.tsv[SDRF Terms Reference] and th **Column:** `characteristics[depletion]` +**Template:** Defined in https://github.com/bigbio/sdrf-templates/tree/main/ms-proteomics[ms-proteomics] template. + For blood/plasma samples indicating abundant protein depletion. Values: `no depletion`, `depletion`, `not applicable`. @@ -417,39 +375,12 @@ Values: `no depletion`, `depletion`, `not applicable`. When annotating PDX samples, metadata (age, sex) MUST refer to the original patient, not the host organism. -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[xenograft]characteristics[age]
    tumor_001homo sapiensnot applicable65Y
    pdx_001homo sapienspancreatic adenocarcinoma grown in nude mice65Y
    -
    - Sample metadata -
    -
    -++++ -endif::[] +|=== +|source name |characteristics[organism] |characteristics[xenograft] |characteristics[age] + +|tumor_001 |homo sapiens |not applicable |65Y +|pdx_001 |homo sapiens |pancreatic adenocarcinoma grown in nude mice |65Y +|=== == Synthetic Peptide Libraries @@ -485,6 +416,8 @@ The injected mass of the main sample SHOULD be specified in `characteristics[mas - MONDO Disease Ontology: https://mondo.monarchinitiative.org/ - Cell Ontology (CL): https://obofoundry.org/ontology/cl.html +- BRENDA Tissue Ontology (BTO): https://www.ebi.ac.uk/ols4/ontologies/bto +- Cell Line Ontology (CLO): https://www.ebi.ac.uk/ols4/ontologies/clo - UBERON Anatomy Ontology: https://obofoundry.org/ontology/uberon.html - PATO Phenotype Ontology: https://obofoundry.org/ontology/pato.html - NCBI Taxonomy: https://www.ncbi.nlm.nih.gov/taxonomy diff --git a/sdrf-proteomics/TEMPLATES.adoc b/sdrf-proteomics/TEMPLATES.adoc new file mode 100644 index 000000000..6141b741e --- /dev/null +++ b/sdrf-proteomics/TEMPLATES.adoc @@ -0,0 +1,1339 @@ += SDRF Templates Guide +:toc: left +:toc-title: Contents +:toclevels: 3 +:icons: font +:source-highlighter: highlight.js +:sectnums: + +A comprehensive guide for template selection, combination rules, key column guidance, format conventions, and YAML schema definitions. It complements the per-template YAML definitions and auto-generated documentation. + +NOTE: **Source of truth**: The YAML file for each template (located in link:sdrf-templates/[sdrf-templates/]) is the authoritative definition of its columns, validators, and metadata. To add, remove, or modify a column, edit the corresponding YAML file. All other documentation — including this guide — is derived from or supplements those YAMLs. + +IMPORTANT: **YAML templates do not define every possible column.** Templates define the most common columns with their validators and requirement levels. Additional terms listed in `TERMS.tsv` (e.g., `characteristics[xenograft]`, `characteristics[mass]`) can be added to any SDRF file without needing a corresponding YAML definition. The YAML templates capture what is most frequently needed; `TERMS.tsv` serves as a broader registry of recognised column names and ontology mappings. + +**Template files location:** https://github.com/bigbio/sdrf-templates[sdrf-templates/] + +== Template Architecture + +=== Layers + +Templates are organized in a hierarchy with two internal construction layers (`base`, `sample-metadata`) and three user-facing layers (`technology`, `sample`, `experiment`): + +[source] +---- +base Infrastructure (identifiers, data files, versioning) [internal] + sample-metadata Shared sample biology (organism, tissue, disease) [internal] + technology templates MS or affinity proteomics columns [layer: technology] + organism templates Species-specific metadata (human, vertebrates, etc.) [layer: sample] + clinical templates Clinical/oncology metadata [layer: sample] + experiment templates Technique-specific columns (DIA, crosslinking, etc.) [layer: experiment] +---- + +=== Inheritance + +Every template inherits all columns from its parent chain. Child templates can override parent column properties (e.g., changing a column from `optional` to `required`). + +[source] +---- +base (construction artifact - not user-facing) + ├── sample-metadata (intermediate - sample columns shared by most templates) + │ ├── ms-proteomics (technology) + │ │ ├── dia-acquisition (experiment) + │ │ ├── crosslinking (experiment) + │ │ ├── immunopeptidomics (experiment) + │ │ └── single-cell (experiment) + │ ├── affinity-proteomics (technology) + │ │ ├── olink (experiment) + │ │ └── somascan (experiment) + │ ├── human (sample) + │ ├── vertebrates (sample) + │ ├── invertebrates (sample) + │ ├── plants (sample) + │ ├── cell-lines (experiment) + │ ├── clinical-metadata (sample) + │ │ └── oncology-metadata (sample) + │ └── (columns: organism, organism part, cell type, disease, biological replicate...) + └── metaproteomics (sample - MIxS-aligned, excludes sample-metadata when combined) + ├── human-gut (sample) + ├── soil (sample) + └── water (sample) +---- + +[[version-pinning-in-extends]] +=== Version Pinning in `extends` + +The `extends` field supports an optional version constraint using the `@` separator. This controls which version of the parent template a child inherits from, preventing unintended breaking changes when parent templates are updated. + +**Formats:** + +[cols="2,3,3", options="header"] +|=== +| Format | Example | Meaning + +| Name only (latest) +| `extends: ms-proteomics` +| Always inherits from the latest available version. Backwards compatible with existing templates. + +| Lower bound +| `extends: ms-proteomics@>=1.1.0` +| Inherits from the latest version >= 1.1.0. Follows Python/PEP 440 version specifier syntax. + +| Explicit range +| `extends: ms-proteomics@>=1.1.0,<2.0.0` +| Inherits from the latest version within [1.1.0, 2.0.0). Use when an upper bound is needed. + +| Exact version +| `extends: ms-proteomics@1.1.0` +| Inherits from exactly that version. Use sparingly — prevents receiving patch fixes. +|=== + +**Recommended convention:** Use lower-bound constraints (`>=major.minor.0`) for all templates. Add an upper bound (`=1.1.0 +extends: ms-proteomics@>=1.1.0 + +# If ms-proteomics is bumped to 1.2.0: single-cell automatically inherits 1.2.0 ✓ +# If ms-proteomics is bumped to 2.0.0: single-cell inherits 2.0.0 (review needed) +# → If incompatible, add upper bound: extends: ms-proteomics@>=1.1.0,<2.0.0 +---- + +**Resolution order:** When loading templates, the registry resolves version constraints by: + +1. Scanning all available versions on disk for the parent template +2. Filtering to versions matching the constraint +3. Selecting the latest matching version +4. Falling back to the manifest `latest` if no match (with a warning) + +=== Layer Definitions + +[cols="1,3,2", options="header"] +|=== +| Layer | Purpose | Examples + +| `base` +| Internal construction artifact with infrastructure columns (source name, assay name, technology type, etc.). Never used directly by users. +| base + +| `sample-metadata` +| Intermediate template with sample-level columns shared by all templates (organism, organism part, cell type, biological replicate, pooled sample, disease, biosample accession). Extends `base`. Never used directly by users. +| sample-metadata + +| `technology` +| Defines the proteomics technology. Exactly one required per SDRF. +| ms-proteomics, affinity-proteomics + +| `sample` +| Defines organism-specific sample metadata. One recommended per SDRF. +| human, vertebrates, invertebrates, plants + +| `experiment` +| Defines methodology-specific columns. Multiple can be combined if not mutually exclusive. +| dia-acquisition, single-cell, olink, cell-lines +|=== + +=== Combination Rule + +An SDRF file is built by **combining** templates: + +1. **ONE technology template** (required): `ms-proteomics` or `affinity-proteomics` +2. **ONE sample template** (recommended): either an organism template (`human`, `vertebrates`, `invertebrates`, `plants`) OR a metaproteomics template (`human-gut`, `soil`, `water`). These two groups are mutually exclusive. +3. **ZERO or more experiment templates**: `dia-acquisition`, `single-cell`, `crosslinking`, `immunopeptidomics` (extend `ms-proteomics`), `olink`, `somascan` (extend `affinity-proteomics`) +4. **ZERO or more clinical templates**: `clinical-metadata`, `oncology-metadata` +5. **ZERO or one cell-lines template**: when samples are cultured cell lines + +When templates are combined, columns from all selected templates are merged. If the same column appears in multiple templates, the most specific definition wins (experiment > technology > sample-metadata). Templates may declare `excludes` to remove columns from other templates in the combination (see <>). + +=== Mutual Exclusivity + +* **Technology**: `ms-proteomics` and `affinity-proteomics` cannot be combined +* **Organism**: only one of `human`, `vertebrates`, `invertebrates`, `plants` per study (multi-species studies use the most specific applicable template) +* **Metaproteomics**: `metaproteomics` (and its children `human-gut`, `soil`, `water`) are mutually exclusive with organism templates (`human`, `vertebrates`, `invertebrates`, `plants`). Only one metaproteomics child template per study. +* **Platform**: `olink` and `somascan` cannot be combined +* **Affinity experiments**: `olink`/`somascan` require `affinity-proteomics` (not `ms-proteomics`) + +== How to Choose Templates + +=== By Study Type + +[cols="2,3", options="header"] +|=== +| Study type | Templates to combine + +| Human clinical DDA proteomics | `human` + `ms-proteomics` + `clinical-metadata` +| Human cancer proteomics | `human` + `ms-proteomics` + `oncology-metadata` +| Mouse DDA proteomics | `vertebrates` + `ms-proteomics` +| Plant stress proteomics | `plants` + `ms-proteomics` +| Human cell line drug screen | `cell-lines` + `human` + `ms-proteomics` + `clinical-metadata` +| Human XL-MS structural study | `crosslinking` + `human` +| In-vitro XL-MS (purified proteins) | `crosslinking` +| Human immunopeptidomics / HLA ligandomics | `immunopeptidomics` + `human` +| Mouse immunopeptidomics / H-2 ligandomics | `immunopeptidomics` + `vertebrates` +| Human DIA proteomics | `dia-acquisition` + `human` +| Mouse DIA proteomics | `dia-acquisition` + `vertebrates` +| Human single-cell proteomics | `single-cell` + `human` +| Human gut metaproteomics | `human-gut` + `ms-proteomics` +| Soil metaproteomics | `soil` + `ms-proteomics` +| Aquatic metaproteomics (ocean, lake, river) | `water` + `ms-proteomics` +| Human Olink plasma study | `olink` + `human` +| Human SomaScan serum study | `somascan` + `human` +| Drosophila phosphoproteomics | `invertebrates` + `ms-proteomics` +| Zebrafish developmental proteomics | `vertebrates` + `ms-proteomics` +| Arabidopsis drought response proteomics | `plants` + `ms-proteomics` +| Mouse cancer model proteomics | `vertebrates` + `ms-proteomics` + `oncology-metadata` +|=== + +=== By Organism + +[cols="2,2", options="header"] +|=== +| Organism | Template + +| Homo sapiens | `human` +| Mouse, rat, zebrafish, other vertebrates | `vertebrates` +| Drosophila, C. elegans, insects | `invertebrates` +| Arabidopsis, rice, maize, crops | `plants` +| Cultured cell lines (any origin) | `cell-lines` + organism template matching cell origin +|=== + +=== By Technology + +[cols="2,2", options="header"] +|=== +| Technology | Template + +| Any mass spectrometry proteomics | `ms-proteomics` +| DDA (data-dependent acquisition) | `ms-proteomics` (default) +| DIA / SWATH / diaPASEF | `dia-acquisition` +| TMT / iTRAQ / SILAC | `ms-proteomics` (labeling defined by `comment[label]`) +| Label-free quantification | `ms-proteomics` (label = "label free sample") +| Olink PEA | `olink` (inherits `affinity-proteomics`) +| SomaScan aptamer | `somascan` (inherits `affinity-proteomics`) +|=== + +== Format Conventions + +=== Column Naming + +* All column names inside brackets **must be lowercase**: `characteristics[disease]`, `comment[dia method]`, not `characteristics[Disease]` or `comment[DIA method]`. +* Prefix: `characteristics[...]` for sample properties, `comment[...]` for technical/analytical metadata. + +=== Ontology Terms + +* Use **lowercase** for organism names: `homo sapiens`, not `Homo sapiens` +* Use ontology-controlled vocabulary wherever validators specify ontology validation + +=== CV Term Format (Controlled Vocabulary) + +Used for enzymes, modifications, instruments, and other ontology-mapped values: + +[source] +---- +NT={name};AC={accession} +---- + +Examples: + +* `NT=Trypsin;AC=MS:1001251` +* `NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35` +* `NT=DSS;AC=XLMOD:02001` + +=== Numbers with Units + +Format: `{value} {unit}` (space-separated) + +* Mass tolerance: `10 ppm`, `0.02 Da` +* Collision energy: `30 NCE`, `27 eV` +* Tissue mass: `50 mg`, `1 g` +* Cell diameter: `15 um` +* Temperature: `25 °C`, `-80 °C` +* Time: `24 hour`, `5 day`, `30 minute` + +=== Age Format (Human) + +See link:SAMPLE-GUIDELINES.adoc#age-annotation[Age in SAMPLE-GUIDELINES] for the complete format reference, including compound ages (`30Y6M`), ranges (`40Y-50Y`), and comparison operators (`>=21Y`). + +=== Special Values + +* `not available` — value exists but is unknown +* `not applicable` — column does not apply to this sample +* `normal` — healthy/control for disease columns (PATO:0000461) +* `untreated` — no treatment applied (for treatment columns) +* `pooled` — pooled sample (for biological replicate) + +=== Multiple Values + +Some columns allow multiple values (cardinality: multiple): + +* Use multiple columns with the same header name +* Example: `characteristics[organism part]` can appear twice for mixed-tissue samples + +=== Accession Formats + +* BioSample: `SAMN12345678`, `SAMEA12345678`, `SAMD1234567` +* Cellosaurus: `CVCL_0030`, `CVCL_0004` +* Metagenome: `MGYA00001234` (ENA), `SRP123456` (SRA) + +[[value-types-reference]] +== Value Types Reference + +SDRF cell values are **not parsed by inspecting the value itself**. Instead, each column's YAML template definition declares which value types are accepted through a list of `validators`. The validator determines how the value is interpreted and validated. + +This section provides a formal reference of all supported value types, their patterns, and examples. + +=== How Value Types Are Determined + +The parsing process for any SDRF cell value follows this logic: + +[source] +---- +1. Look up the column name in the active YAML template(s) +2. Retrieve the declared list of validators for that column +3. Validate the cell value against each declared validator +4. If no validators are declared, the value is accepted as free text +---- + +NOTE: The value type is a property of the **column definition**, not of the value itself. The same string `10` could be valid as an identifier, a free-text value, or invalid (if the column requires a unit), depending on the column's declared validators. + +=== Value Type Catalog + +The following table lists all supported value types. The **Type Name** corresponds to the `validator_name` used in YAML template definitions. The **Pattern** column shows the formal regular expression or grammar that values must match. For complete validator configuration options, see <>. + +[cols="2,2,3,3", options="header"] +|=== +| Type Name | Description | Pattern / Grammar | Examples + +| `ontology` +| Ontology-controlled term. Accepts free text (exact ontology term name), ontology URI, or key=value representation. +| Free text matching an ontology term, or `NT=_name_;AC=_prefix_:_accession_` with optional additional keys (`MT`, `PP`, `TA`, `CS`) +| `homo sapiens`, `NT=Trypsin;AC=MS:1001251`, `NT=Oxidation;MT=Variable;TA=M;AC=Unimod:35` + +| `values` +| Enumerated list. Value must exactly match one of the allowed entries (case-insensitive). +| Exact match from a declared list +| `male`, `female`, `label free sample` + +| `number_with_unit` +| Numeric value followed by a unit string, separated by optional whitespace. +| `^-?\d+(\.\d+)?\s*(_unit1_\|_unit2_\|...)$` +| `10 ppm`, `0.5 Da`, `-80 °C`, `30 NCE` + +| `pattern` +| Custom regular expression. Used for domain-specific formats not covered by other validators (e.g., age format, collision energy steps). +| Any valid regular expression declared in `params.pattern` +| `45Y`, `30Y6M`, `40Y-50Y`, `>=21Y`, `25 NCE;27 NCE;30 NCE` + +| `accession` +| Database accession identifier with a known prefix and suffix pattern. +| `^_prefix__suffix_$` (e.g., `^SAM(N\|EA\|D)\d+$` for BioSample) +| `SAMN12345678`, `CVCL_0030`, `PXD000001` + +| `identifier` +| Alphanumeric identifier with configurable character set. +| `^[A-Za-z0-9_-]+$` (default charset, configurable) +| `patient_001`, `cell.line.A`, `sample_23` + +| `date` +| ISO 8601 date at configurable precision. +| `^\d{4}$` (year), `^\d{4}-\d{2}$` (month), `^\d{4}-\d{2}-\d{2}$` (day) +| `2024`, `2024-01`, `2024-01-15` + +| `structured_kv` +| Semicolon-separated key=value pairs with declared keys and value patterns. +| `_KEY1_=_value1_;_KEY2_=_value2_` where each key and value regex is declared in `params.fields` +| `NT=DSS;AC=XLMOD:02001`, `NT=lesSDRF;VV=v0.1.0` + +| `semver` +| Semantic version string with optional prefix and prerelease suffix. +| `^v?\d+\.\d+\.\d+(-[a-zA-Z0-9.]+)?$` +| `v1.1.0`, `v2.0.0-dev`, `1.0.0` + +| `single_cardinality_validator` +| Ensures a cell contains a single value (no semicolon-separated lists). Used in combination with other validators. +| No semicolons allowed in value +| (any single value) +|=== + +=== Sentinel Values + +Regardless of value type, most columns accept the following reserved words. These are controlled at the column level via the `allow_not_available` and `allow_not_applicable` flags in the YAML definition: + +* `not available` — the value exists but is unknown +* `not applicable` — the column does not apply to this sample + +Additional sentinel values may be accepted per column via the `special_values` parameter (e.g., `pooled`, `untreated`, `room temperature`). + +=== Range and Compound Formats + +Some columns accept range expressions or compound values. These are **not a generic SDRF feature** — they are defined per column using `pattern` validators with specific regular expressions: + +* **Age ranges**: `40Y-50Y` — defined by the age pattern validator in the human/vertebrate templates +* **m/z ranges**: `400 m/z-1200 m/z` — defined by a pattern validator in the ms-proteomics template +* **Stepped collision energy**: `25 NCE;27 NCE;30 NCE` — semicolon-separated repeated `number_with_unit` values, defined by a pattern validator + +To determine if a column supports ranges or compound values, consult its YAML template definition and check the declared `pattern` validator's regex. + +== YAML Template Schema + +This section describes the technical implementation of SDRF-Proteomics templates for **developers and maintainers**. These YAML definitions are used by the https://github.com/bigbio/sdrf-pipelines[sdrf-pipelines] validator to check SDRF files for compliance. + +=== Complete Template Structure + +[source,yaml] +---- +# ============================================================================= +# TEMPLATE METADATA (required) +# ============================================================================= +name: human # Unique template identifier (used in --template flag) +description: Human SDRF template # Human-readable description +version: 1.1.0 # Semantic version (major.minor.patch) + +# ============================================================================= +# INHERITANCE AND RELATIONSHIPS (optional) +# ============================================================================= +extends: sample-metadata@>=1.0.0 # Parent template with version constraint +usable_alone: false # Can this template be used without others? +layer: sample # Layer: base, sample-metadata, technology, sample, experiment + +# Mutual exclusivity - templates that cannot be combined with this one +mutually_exclusive_with: + - vertebrates + - invertebrates + - plants + +# Required layers - for templates that need specific layer types +requires: + - layer: technology # Requires a technology template + - layer: sample # Requires a sample template + +# ============================================================================= +# TEMPLATE-LEVEL VALIDATORS (optional) +# ============================================================================= +validators: + - validator_name: min_columns + params: + min_columns: 12 + - validator_name: trailing_whitespace_validator + params: {} + +# ============================================================================= +# COLUMN DEFINITIONS (required) +# ============================================================================= +columns: + - name: characteristics[disease] + description: Disease state of the sample + requirement: required # required | recommended | optional + type: string # string | integer (default: string) + cardinality: single # single | multiple (default: single) + allow_not_applicable: true # Allow "not applicable" value + allow_not_available: true # Allow "not available" value + allow_pooled: false # Allow "pooled" value (for replicates) + validators: + - validator_name: ontology + params: + ontologies: + - mondo + - efo + - doid + - pato + error_level: warning # error | warning + description: The disease should be a valid ontology term + examples: + - normal + - breast cancer + - diabetes mellitus +---- + +=== Template Properties Reference + +[cols="2,1,1,4", options="header"] +|=== +| Property | Required | Type | Description + +| `name` +| Yes +| string +| Unique template identifier. Used in validation commands (`--template human`). + +| `description` +| Yes +| string +| Human-readable description of the template's purpose. + +| `version` +| Yes +| string +| Semantic version (e.g., `1.1.0`). Should match the specification version. + +| `extends` +| No +| string +| Parent template name with optional version constraint. Supports: `name` (latest version), `name@1.1.0` (exact version), `name@>=1.1.0` (lower bound), or `name@>=1.1.0,<2.0.0` (range). See <>. + +| `usable_alone` +| No +| boolean +| If `false`, must be combined with other templates. Default: `true`. + +| `layer` +| No +| string +| Template layer: `base`, `technology`, `sample`, or `experiment`. + +| `mutually_exclusive_with` +| No +| list +| Templates that cannot be combined with this one. + +| `requires` +| No +| list +| Layer requirements (e.g., `- layer: technology`). + +| `validators` +| No +| list +| Template-level validators applied to the entire SDRF file. + +| `columns` +| Yes +| list +| Column definitions with validation rules. + +| `excludes` +| No +| object +| Column exclusion rules applied when this template is combined with others. See <>. +|=== + +=== Column Exclusion + +When templates are combined, a template may need to **exclude** columns that another template brings through inheritance. For example, `metaproteomics` extends `base` (not `sample-metadata`) and defines its own sample-level metadata aligned with GSC MIxS standards. When combined with `ms-proteomics`, the `sample-metadata` columns inherited by `ms-proteomics` (organism, disease, cell type, etc.) are not appropriate — metaproteomics replaces them with environment-specific fields. + +The `excludes` property supports three complementary exclusion strategies, applied in order: + +[source,yaml] +---- +excludes: + # Strategy 1: Exclude all columns inherited from a named template + templates: + - sample-metadata # Remove all columns that originated from sample-metadata + + # Strategy 2: Exclude columns by prefix category + categories: + - characteristics # Remove all characteristics[...] columns from other templates + - comment # Remove all comment[...] columns from other templates + + # Strategy 3: Exclude specific columns by name + columns: + - characteristics[organism] + - characteristics[disease] + - characteristics[cell type] +---- + +==== Strategy 1: Template-level exclusion (`excludes.templates`) + +Removes **all columns** that originated from the named parent template when combining with another template that inherits from it. + +[source,yaml] +---- +# metaproteomics.yaml +name: metaproteomics +extends: base +excludes: + templates: + - sample-metadata +---- + +When `metaproteomics` is combined with `ms-proteomics`, the merge logic tracks column provenance. Columns that `ms-proteomics` inherited from `sample-metadata` (organism, organism part, cell type, disease, biological replicate, etc.) are removed from the combined result. Columns defined directly in `ms-proteomics` itself (instrument, label, cleavage agent, etc.) are preserved. + +**Provenance tracking**: During inheritance resolution, each column is tagged with its originating template. When `excludes.templates` is evaluated, columns whose origin matches a listed template are removed. + +**Use case**: A template that provides its own complete set of sample-level metadata and needs to replace (not supplement) the standard `sample-metadata` columns. + +==== Strategy 2: Category-level exclusion (`excludes.categories`) + +Removes columns from other templates that match a given **prefix category** (`characteristics` or `comment`). + +[source,yaml] +---- +excludes: + categories: + - characteristics # Exclude all characteristics[...] from other templates +---- + +This removes all `characteristics[...]` columns contributed by **other** templates in the combination. Columns defined by the excluding template itself (and its own inheritance chain) are preserved. + +**Scope**: Only affects columns from _other_ templates in the combination, not from the excluding template's own hierarchy. For example, if `metaproteomics` excludes category `characteristics`, its own `characteristics[environmental sample type]` is kept, but `characteristics[organism]` from `ms-proteomics` (via `sample-metadata`) is removed. + +**Use case**: Broad exclusion when a template replaces an entire category of metadata. For instance, metaproteomics defines its own `characteristics[...]` columns for environmental/host metadata and does not want the generic sample-metadata `characteristics[...]` columns. + +==== Strategy 3: Column-level exclusion (`excludes.columns`) + +Removes **specific named columns** from other templates. + +[source,yaml] +---- +excludes: + columns: + - characteristics[organism] + - characteristics[disease] + - characteristics[cell type] +---- + +This is the most precise strategy, removing only the listed columns from the combination result. + +**Use case**: When only a small number of specific columns conflict and the rest should be preserved. + +==== Combining Strategies + +All three strategies can be used together. They are applied in order: templates first, then categories, then individual columns. The union of all excluded columns is removed. + +[source,yaml] +---- +# Example: metaproteomics excludes sample-metadata entirely +excludes: + templates: + - sample-metadata +---- + +[source,yaml] +---- +# Example: exclude only specific columns +excludes: + columns: + - characteristics[organism] + - characteristics[disease] + - characteristics[cell type] +---- + +==== Version Independence + +Exclusion operates on **template names only**, independent of version. When `excludes.templates` lists `sample-metadata`, it matches all columns originating from `sample-metadata` regardless of which version (`1.0.0`, `1.1.0`, etc.) was resolved during inheritance. This ensures that exclusion rules remain stable across version upgrades — a template does not need to update its `excludes` list when a dependency bumps versions. + +==== Precedence Rules + +1. **Self-preservation**: A template's `excludes` never removes its own columns or columns from its own parent chain. Exclusion only applies to columns from _other_ templates in the combination. +2. **Order of application**: `templates` -> `categories` -> `columns`. +3. **Union semantics**: All three strategies contribute to a single exclusion set. A column excluded by any strategy is removed. +4. **Strictest wins**: If two templates both define the same column and one excludes it, the _excluding_ template's version (if any) is kept. If the excluding template does not define it, the column is removed entirely. + +=== Column Properties Reference + +[cols="2,1,1,4", options="header"] +|=== +| Property | Required | Type | Description + +| `name` +| Yes +| string +| Column header exactly as in SDRF (e.g., `characteristics[disease]`). + +| `description` +| Yes +| string +| What the column contains and how to fill it. + +| `requirement` +| Yes +| string +| `required` (must be present), `recommended` (should be present), `optional` (may be present). + +| `type` +| No +| string +| Data type: `string` (default) or `integer`. + +| `cardinality` +| No +| string +| `single` (default) or `multiple` (use multiple columns with the same header name). + +| `allow_not_applicable` +| No +| boolean +| Allow `not applicable` when column doesn't apply. Default: `false`. + +| `allow_not_available` +| No +| boolean +| Allow `not available` when data is unknown. Default: `false`. + +| `allow_pooled` +| No +| boolean +| Allow `pooled` value (for biological replicate). Default: `false`. + +| `validators` +| No +| list +| Column-level validators for value checking. +|=== + +== Validator Reference + +=== Template-Level Validators + +These validators apply to the entire SDRF file structure. + +==== min_columns + +Ensures minimum column count. + +[source,yaml] +---- +- validator_name: min_columns + params: + min_columns: 12 +---- + +==== trailing_whitespace_validator + +Checks for trailing whitespace in cell values. + +[source,yaml] +---- +- validator_name: trailing_whitespace_validator + params: {} +---- + +==== column_order + +Validates expected column order (source name first, data file last). + +[source,yaml] +---- +- validator_name: column_order + params: {} +---- + +==== empty_cells + +Checks for empty cells that should have values. + +[source,yaml] +---- +- validator_name: empty_cells + params: {} +---- + +==== combination_of_columns_no_duplicate_validator + +Ensures column combinations are unique (no duplicate rows). + +[source,yaml] +---- +- validator_name: combination_of_columns_no_duplicate_validator + params: + column_name: # Must be unique (error if duplicates) + - source name + - assay name + - comment[label] + column_name_warning: # Should be unique (warning if duplicates) + - source name + - assay name +---- + +=== Column-Level Validators + +These validators apply to individual column values. + +==== ontology + +Validates values against ontology terms. + +[source,yaml] +---- +- validator_name: ontology + params: + ontologies: # List of ontology prefixes + - mondo + - efo + - doid + parent_term: MS:1000044 # Optional: restrict to children of this term + error_level: warning # error or warning + description: Human-readable validation message + examples: + - normal + - breast cancer +---- + +==== pattern + +Validates values against a regular expression. + +[source,yaml] +---- +- validator_name: pattern + params: + # Age format: optional comparison operator + number + unit in strict Y>M>W>D order, with optional range + # Examples: 45Y, 6M, 3W, 14D, 30Y6M, 6M2W, 40Y-50Y, 6M-12M, >18Y, >=21Y, <65Y + pattern: ^(>=?|<=?)?(\d+[Yy](\d+[Mm](\d+[Ww](\d+[Dd])?)?)?|\d+[Mm](\d+[Ww](\d+[Dd])?)?|\d+[Ww](\d+[Dd])?|\d+[Dd])(-((\d+[Yy](\d+[Mm](\d+[Ww](\d+[Dd])?)?)?|\d+[Mm](\d+[Ww](\d+[Dd])?)?|\d+[Ww](\d+[Dd])?|\d+[Dd])))?$ + case_sensitive: false # Optional, default: true + description: "Age format: 45Y, 6M, 30Y6M (Y>M>W>D order), ranges like 40Y-50Y, or comparison operators like >18Y, >=21Y, <65Y" + examples: + - 45Y + - 6M + - 3W + - 30Y6M + - 40Y-50Y + - ">18Y" + - ">=21Y" +---- + +==== values + +Validates against a fixed list of allowed values. + +[source,yaml] +---- +- validator_name: values + params: + values: + - male + - female + - intersex + error_level: error + description: Sex must be one of the allowed values +---- + +==== single_cardinality_validator + +Ensures single value per cell (no semicolon-separated values). + +[source,yaml] +---- +- validator_name: single_cardinality_validator + params: {} +---- + +==== number_with_unit + +Validates values in ` ` format. Replaces complex regex patterns for fields like mass tolerance, temperature, concentration, and depth. + +[source,yaml] +---- +- validator_name: number_with_unit + params: + units: [ppm, Da] # Required: allowed unit strings + allow_negative: false # Optional: allow negative numbers (default: false) + allow_decimal: true # Optional: allow decimal numbers (default: true) + special_values: [] # Optional: extra allowed literals (e.g., "room temperature") + error_level: error # error or warning + description: Mass tolerance with unit + examples: + - 10 ppm + - 0.5 Da +---- + +Parameters: + +[cols="2,1,1,4", options="header"] +|=== +| Parameter | Required | Default | Description + +| `units` +| Yes +| - +| List of allowed unit strings (e.g., `[ppm, Da]`, `[mg, g]`, `[°C]`) + +| `allow_negative` +| No +| `false` +| Allow negative numbers (useful for temperature) + +| `allow_decimal` +| No +| `true` +| Allow decimal numbers (e.g., `0.5`) + +| `special_values` +| No +| `[]` +| Additional literal values accepted verbatim (e.g., `[room temperature]`) +|=== + +NOTE: `not available` and `not applicable` are handled automatically by the column-level `allow_not_available` and `allow_not_applicable` flags — do not add them to `special_values`. + +==== accession + +Validates accession identifiers with prefix + suffix format. Supports predefined formats or custom prefix/suffix patterns. + +[source,yaml] +---- +# Predefined format (recommended for known databases) +- validator_name: accession + params: + format: biosample # Predefined format name + error_level: error + description: BioSample accession + examples: + - SAMN12345678 + - SAMEA12345678 + - SAMD1234567 + +# Custom prefix + suffix +- validator_name: accession + params: + prefix: "CVCL_" # Literal or simple regex + suffix: "[A-Z0-9]+" # Simple regex (default: \d+) + error_level: error +---- + +Predefined formats: + +[cols="1,2,2,2", options="header"] +|=== +| Format | Prefix | Suffix | Example + +| `biosample` +| `SAM(N\|EA\|D)` +| `\d+` +| SAMN12345678 + +| `cellosaurus` +| `CVCL_` +| `[A-Z0-9]+` +| CVCL_0030 + +| `proteomexchange` +| `PXD` +| `\d+` +| PXD000001 +|=== + +==== identifier + +Validates alphanumeric identifiers with optional special values. Useful for individual/patient IDs and cell identifiers. + +[source,yaml] +---- +- validator_name: identifier + params: + charset: "[A-Za-z0-9_-]" # Character class (default: [A-Za-z0-9_-]) + special_values: [anonymized, pooled] # Extra allowed literals + error_level: error + description: Patient or individual identifier +---- + +The `charset` parameter accepts a regex character class. Common values: + +* `[A-Za-z0-9_-]` (default) — alphanumeric with underscores and hyphens +* `[A-Za-z0-9_.-]` — also allows dots (for cell identifiers) + +==== date + +Validates ISO 8601 dates at variable precision levels. + +[source,yaml] +---- +- validator_name: date + params: + format: iso8601 # Currently the only supported format + precision: [year, month, day] # Allowed precision levels + error_level: warning + description: Sample collection date + examples: + - "2024" + - "2024-01" + - "2024-01-15" +---- + +The `precision` list controls which granularity levels are accepted. For example, `[day]` would only accept full `YYYY-MM-DD` dates, while `[year, month, day]` accepts any level. + +==== structured_kv + +Validates semicolon-separated key=value pair formats. Useful for ontology-annotated values with `NT=name;AC=accession` structure. + +[source,yaml] +---- +- validator_name: structured_kv + params: + separator: ";" # Separator between pairs (default: ";") + fields: # Required key=value definitions + - key: NT + value: ".+" # Simple regex for the value + - key: AC + value: "(XLMOD|CHEBI|UNIMOD):\\d+" + error_level: error + description: "Cross-linker: NT=name;AC=ontology:accession" + examples: + - "NT=DSS;AC=XLMOD:02001" + - "NT=BS3;AC=XLMOD:02000" +---- + +Each entry in `fields` defines a required key and a regex pattern for its value. + +==== semver + +Validates semantic version strings. + +[source,yaml] +---- +- validator_name: semver + params: + prefix: "v" # Optional prefix character + allow_prerelease: true # Allow -alpha, -beta, -rc.1 suffixes (default: true) + error_level: error + description: SDRF specification version + examples: + - v1.1.0 + - v1.0.0 +---- + +== Supported Ontologies + +[cols="1,3,3", options="header"] +|=== +| Prefix | Ontology | Common Use + +| `ncbitaxon` | NCBI Taxonomy | organism +| `uberon` | Uberon Anatomy Ontology | organism part +| `cl` | Cell Ontology | cell type +| `clo` | Cell Line Ontology | cell line +| `bto` | BRENDA Tissue Ontology | tissue, cell type, cell line +| `mondo` | MONDO Disease Ontology | disease +| `efo` | Experimental Factor Ontology | disease, experimental factors +| `doid` | Disease Ontology | disease +| `pato` | Phenotype and Trait Ontology | phenotypes (including "normal") +| `ms` | PSI-MS Ontology | instrument, cleavage agent, mass analyzer +| `pride` | PRIDE Ontology | acquisition method, labels, affinity instruments +| `unimod` | UNIMOD | post-translational modifications +| `xlmod` | XLMOD | crosslinking reagents +| `hancestro` | Human Ancestry Ontology | ancestry category (human) +| `envo` | Environment Ontology | environmental samples (metaproteomics) +| `gaz` | Gazetteer | geographic locations +| `chebi` | ChEBI | chemical entities, treatments +|=== + +== Template Inheritance Rules + +When templates are combined, the following rules apply: + +=== Inheritance Behavior + +1. **Column inheritance**: Child templates inherit all columns from parent templates +2. **Validator inheritance**: Child templates inherit all validators from parent templates +3. **Column override**: Child templates can redefine inherited columns with stricter requirements + +=== Requirement Strengthening + +Child templates may **strengthen** but not weaken requirements: + +[cols="2,2,2", options="header"] +|=== +| Parent Requirement | Allowed in Child | Not Allowed + +| `optional` +| `optional`, `recommended`, `required` +| - + +| `recommended` +| `recommended`, `required` +| `optional` + +| `required` +| `required` +| `optional`, `recommended` +|=== + +=== Multi-Template Combination + +When multiple templates are combined: + +1. All columns from all templates are included +2. If the same column appears in multiple templates, the **strictest requirement** wins +3. Validators are merged (all validators apply) +4. Mutual exclusivity is checked first + +**Example valid combination:** +[source] +---- +ms-proteomics + human + dia-acquisition + cell-lines + ↓ ↓ ↓ ↓ + technology sample experiment experiment +---- + +== Creating a New Template: Step-by-Step Guide + +This section walks through creating a new YAML template from scratch. The example creates a hypothetical `top-down` template for top-down proteomics experiments. + +=== Step 1: Choose the Parent Template + +Every template (except `base`) must extend a parent. Choose based on where your template fits in the hierarchy: + +[cols="2,3,2", options="header"] +|=== +| You are defining... | Extend | Layer + +| A new proteomics technology (rare) +| `sample-metadata` +| `technology` + +| A new organism type +| `sample-metadata` +| `sample` + +| A new MS experiment type +| `ms-proteomics` +| `experiment` + +| A new affinity experiment type +| `affinity-proteomics` +| `experiment` + +| A template with its own sample metadata (e.g., metaproteomics) +| `base` +| `sample` +|=== + +For our example, top-down proteomics is a mass spectrometry technique, so we extend `ms-proteomics` and use the `experiment` layer. + +=== Step 2: Create the Directory Structure + +Templates live in the https://github.com/bigbio/sdrf-templates[sdrf-templates] repository. Each template has a versioned directory: + +[source] +---- +sdrf-templates/ +└── top-down/ + └── 1.0.0-dev/ + ├── top-down.yaml # Template schema (required) + └── top-down.sdrf.tsv # Example SDRF file (required) +---- + +Use the `-dev` suffix for the initial version until the template is reviewed and accepted by the community. + +=== Step 3: Write the YAML Schema + +Start with the template metadata, then define the columns your experiment type needs. Only define columns that are **new or different** from the parent — inherited columns from `ms-proteomics` do not need to be repeated. + +.top-down/1.0.0-dev/top-down.yaml +[source,yaml] +---- +# =========================================================================== +# TEMPLATE METADATA +# =========================================================================== +name: top-down +description: > + SDRF template for top-down proteomics experiments where intact proteins + are analyzed without prior enzymatic digestion. Extends ms-proteomics + with top-down-specific columns for intact mass analysis. +version: 1.0.0-dev +extends: ms-proteomics@>=1.1.0 +usable_alone: false +layer: experiment + +# =========================================================================== +# COLUMN DEFINITIONS — only columns new or changed from parent +# =========================================================================== +columns: + + # --- New column: protein separation method --- + - name: comment[protein separation method] + description: > + Method used to separate intact proteins before MS analysis + (e.g., GELFrEE, SEC, RPLC, CZE). Use "not applicable" if no + separation was performed (direct infusion). + requirement: recommended + allow_not_applicable: true + allow_not_available: true + validators: + - validator_name: ontology + params: + ontologies: + - ms + - pride + error_level: warning + description: > + Protein separation method should be a valid PSI-MS or PRIDE + ontology term. + examples: + - size exclusion chromatography + - gel electrophoresis + - capillary zone electrophoresis + - reversed-phase liquid chromatography + - not applicable + + # --- New column: intact mass range --- + - name: comment[precursor mass range] + description: > + The mass range of intact protein precursors analyzed, in Daltons. + Format: "min-max Da" (e.g., "5000-50000 Da"). + requirement: optional + allow_not_available: true + validators: + - validator_name: pattern + params: + pattern: ^(\d+-\d+\s*Da|not available)$ + case_sensitive: false + description: > + Precursor mass range in format "min-max Da". + examples: + - 5000-50000 Da + - 10000-100000 Da + - not available + + # --- Override inherited column: make cleavage agent "not applicable" --- + # In top-down experiments, proteins are not digested, so the cleavage + # agent column should always be "not applicable". We override the + # inherited column to make this explicit. + - name: comment[cleavage agent details] + description: > + Cleavage agent is not applicable for top-down experiments where + intact proteins are analyzed. Use "not applicable". + requirement: required + allow_not_applicable: true + allow_not_available: false + validators: + - validator_name: values + params: + values: + - not applicable + error_level: warning + description: > + Top-down experiments analyze intact proteins. Cleavage agent + should be "not applicable". +---- + +Key points demonstrated in this example: + +* **New columns** (`comment[protein separation method]`, `comment[precursor mass range]`) are defined with their own validators. +* **Overriding an inherited column** (`comment[cleavage agent details]`) restricts the parent's definition — in this case, forcing the value to "not applicable" since top-down experiments don't use enzymatic digestion. +* **Descriptions explain the "why"** — not just what the field is, but when to use `not applicable` and what format to follow. +* **Examples are always provided** in validators — they serve as documentation and can be used by tools to generate autocomplete suggestions. + +=== Step 4: Create an Example SDRF File + +Every template must include an example `.sdrf.tsv` file that passes validation. This file demonstrates correct usage and serves as a starting point for users. + +=== Step 5: Test Locally + +Before submitting, validate your example file against your template: + +[source,bash] +---- +# Install or upgrade the validator +pip install sdrf-pipelines + +# Validate the example SDRF file with the new template +parse_sdrf validate-sdrf \ + --sdrf_file top-down/1.0.0-dev/top-down.sdrf.tsv \ + --template ms-proteomics \ + --custom_template top-down/1.0.0-dev/top-down.yaml +---- + +Check that: + +* [ ] The example file passes validation with no errors. +* [ ] All required columns from the parent template are present. +* [ ] New columns validate correctly (ontology terms resolve, patterns match). +* [ ] The `not applicable` and `not available` values work where expected. + +=== Step 6: Submit a Pull Request + +Submit the template to the https://github.com/bigbio/sdrf-templates[sdrf-templates] repository via pull request. The PR must include: + +1. The YAML schema file (`top-down/1.0.0-dev/top-down.yaml`). +2. The example SDRF file (`top-down/1.0.0-dev/top-down.sdrf.tsv`). +3. A PR description explaining: what experiment type the template covers, why it is needed, and which parent it extends. + +Once reviewed and merged, the template appears in the `templates.yaml` manifest and becomes available to all users of sdrf-pipelines. A documentation page is auto-generated from the YAML definition. The `-dev` suffix is removed when the template is promoted to a stable release (e.g., `1.0.0`). + +=== Quick Reference: Template YAML Checklist + +[cols="1,3", options="header"] +|=== +| Field | Checklist + +| `name` +| Lowercase with hyphens. Unique across all templates. + +| `description` +| One or two sentences. Mention what it extends and what experiment type it covers. + +| `version` +| Use `X.Y.Z-dev` for new templates. Remove `-dev` after community review. + +| `extends` +| Must be an existing template name with a version constraint (e.g., `ms-proteomics@>=1.1.0`). Use `>=major.minor.patch` format to pin to a minimum version. See <>. + +| `layer` +| One of: `technology`, `sample`, `experiment`. + +| `usable_alone` +| Almost always `false` for experiment and sample layer templates. + +| `columns` +| Only define columns that are **new** or that **override** a parent column. Do not repeat inherited columns unchanged. + +| Validators +| Use `ontology` for controlled vocabularies, `values` for fixed lists, and typed validators for common formats: `number_with_unit` for numeric values with units, `accession` for database identifiers, `identifier` for alphanumeric IDs, `date` for ISO dates, `structured_kv` for key=value formats, `semver` for version strings. Use `pattern` only for unique formats not covered by typed validators. Always include `examples`. + +| Reserved words +| Set `allow_not_applicable`, `allow_not_available`, `allow_pooled`, `allow_anonymized` as appropriate for each column. +|=== + +=== Best Practices + +* **Only define what is new.** Inherited columns from the parent template do not need to be repeated. Only add a column to your template if it is new or if you need to override the parent's definition (e.g., change `requirement` from `optional` to `required`, or restrict allowed values). +* **Use ontologies over patterns.** Prefer `ontology` validators for fields where controlled vocabulary terms exist. Use typed validators (`number_with_unit`, `accession`, `identifier`, `date`, `structured_kv`, `semver`) for common structured formats. Use `pattern` validators only for unique formats not covered by typed validators. +* **Provide clear descriptions.** Explain not just what the field is, but when to use `not applicable` vs `not available`, and give format guidance. +* **Always include examples.** Examples in validators serve as documentation and help tools generate suggestions. +* **Test with real data.** Your example SDRF should represent a realistic experiment, not a toy file. If possible, base it on a real public dataset. + +== Validation Commands + +Validate SDRF files using sdrf-pipelines: + +[source,bash] +---- +# Install +pip install sdrf-pipelines + +# Validate with single template +parse_sdrf validate-sdrf --sdrf_file file.sdrf.tsv --template ms-proteomics + +# Validate with multiple templates +parse_sdrf validate-sdrf --sdrf_file file.sdrf.tsv \ + --template ms-proteomics \ + --template human \ + --template dia-acquisition + +# Check template compatibility +parse_sdrf check-templates --templates ms-proteomics,human,dia-acquisition +---- + +== Versioning + +=== Template Versions + +Templates follow semantic versioning (`MAJOR.MINOR.PATCH`): + +* **MAJOR**: Breaking changes (column removals, requirement escalations) +* **MINOR**: Additions (new optional/recommended columns) +* **PATCH**: Fixes (description updates, validator corrections) + +=== Recording Templates in SDRF + +Use `comment[sdrf template]` to record which templates were used: + +[source] +---- +NT=ms-proteomics;VV=v1.1.0 NT=human;VV=v1.1.0 +---- + +Multiple template columns supported for combined templates. + +== References + +* https://github.com/bigbio/sdrf-pipelines[sdrf-pipelines] - SDRF validation tool +* https://github.com/bigbio/proteomics-metadata-standard/tree/master/sdrf-proteomics/templates[Template files on GitHub] +* link:README.adoc[SDRF-Proteomics Specification] diff --git a/sdrf-proteomics/TERMS.tsv b/sdrf-proteomics/TERMS.tsv new file mode 100644 index 000000000..9279361d8 --- /dev/null +++ b/sdrf-proteomics/TERMS.tsv @@ -0,0 +1,222 @@ +term type ontology_term_accession usage values description allow_not_available allow_not_applicable allow_pooled +source name anchor column PRIDE:0000623 base, ms-proteomics, affinity-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition free text Unique identifier for the biological sample false false false +assay name anchor column NCIT:C178857 base, ms-proteomics, affinity-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition free text Unique identifier for the assay or sample within a study (e.g. MS run name for mass spectrometry, sample ID from platform data file for affinity proteomics) false false false +technology type anchor column PRIDE:0000663 base, ms-proteomics, affinity-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition fixed: proteomic profiling by mass spectrometry, protein expression profiling by antibody array, protein expression profiling by aptamer array Type of technology used false false false +organism characteristics COB:0000022 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition NCBITaxon Species of the sample false true false +organism part characteristics EFO:0000635 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition UBERON, BTO Anatomical part of the organism true true false +disease characteristics EFO:0000408 sample-metadata, ms-proteomics, human, vertebrates, invertebrates, plants, clinical-metadata, oncology-metadata, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition MONDO, EFO, DOID, PATO Disease state of the sample (use 'normal' from PATO for healthy samples) true true false +cell type characteristics EFO:0000324 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition CL, BTO, CLO Cell type of the sample true true false +material type characteristics PRIDE:0000837 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition, clinical-metadata fixed: tissue, cell, cell line, organism part, whole organism, synthetic Type of biological material being analyzed (derived from MAGE-TAB specification) true true false +biological replicate characteristics MS:1001809 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition integer or pooled Identifier for the biological replicate false false true +ancestry category characteristics HANCESTRO:0004 human, cell-lines HANCESTRO Ancestry or ethnic background of the donor true true false +age characteristics EFO:0000246 human pattern: {Number}{Unit} (Y/M/W/D), anonymized, or pooled Age of the donor at sample collection true false true +sex characteristics PATO:0000047 human, vertebrates fixed: male, female, intersex, hermaphrodite, anonymized, not available, not applicable, pooled Biological sex of the donor true true true +developmental stage characteristics EFO:0000399 human, vertebrates, invertebrates, plants, cell-lines EFO Developmental stage of the organism or donor true true false +individual characteristics EFO:0000542 human free text pattern or pooled Unique identifier for the donor individual true true true +cell line characteristics CLO:0000031 cell-lines CLO, BTO, EFO Name of the cell line false false false +cellosaurus accession characteristics PRIDE:0000835 cell-lines Cellosaurus (CVCL_XXXX) Cellosaurus accession number for the cell line true false false +cellosaurus name characteristics PRIDE:0000836 cell-lines Cellosaurus Official Cellosaurus name for the cell line true false false +sampling site characteristics EFO:0000688 clinical-metadata, cell-lines UBERON, BTO Specific sampling location within organism part (e.g., tumor, normal tissue adjacent to tumor, left ventricle). Use to distinguish tissue contexts. true true false +disease staging characteristics EFO:0000410 oncology-metadata NCIT, EFO Disease progression stage (stage I-IV, chronic phase, end stage). Distinct from tumor-specific staging. true true false +tumor grading characteristics OBI:0600002 oncology-metadata NCIT Histological tumor grade (grade 1-4). Describes how abnormal cells look. true true false +tumor stage characteristics EFO:0004925 oncology-metadata NCIT TNM staging notation (T0-4, N0-3, M0-1). Describes extent of cancer spread. true true false +clinical data characteristics EFO:0030083 oncology-metadata free text Free-text clinical details (receptor status, treatment history, surgical details). Use for context not captured in structured fields. true true false +clinical history characteristics EFO:0000352 oncology-metadata free text Relevant medical history information for the patient. true true false +phenotype characteristics EFO:0000651 clinical-metadata PATO, EFO, free text Observable characteristics or traits (drug sensitivity, molecular markers, expression phenotypes, environmental responses). Captures how sample behaves/appears. true true false +metastasis site characteristics NCIT:C172233 oncology-metadata UBERON, BTO Location where cancer has spread from primary site. true true false +survival time characteristics EFO:0000714 oncology-metadata pattern: number + unit Patient survival time for survival analysis studies. true true false +tumor size characteristics EFO:0004134 oncology-metadata pattern: number + unit Tumor size measurement (e.g., 2.5 cm). true true false +tumor mass characteristics EFO:0007062 oncology-metadata pattern: number + unit Tumor mass/weight measurement. true true false +biopsy site characteristics EFO:0000288 oncology-metadata UBERON, BTO Specific anatomical location of biopsy. true true false +last follow up characteristics EFO:0007058 oncology-metadata pattern: number + unit Time of last clinical follow-up for longitudinal studies. true true false +exposure duration characteristics NCIT:C83280 clinical-metadata pattern: number + time unit Duration of treatment exposure (e.g., 24 hour, 5 day) true true false +genetic modification characteristics EFO:0000510 clinical-metadata EFO Method of genetic modification (knockout, knockdown, overexpression, transduction). Describes HOW modification was done. true true false +compound characteristics CHEBI:24431 clinical-metadata CHEBI, NCIT, EFO Chemical compound or drug applied to sample. Use ChEBI ontology for standardization. true true false +dose characteristics NCIT:C25488 clinical-metadata number + unit (e.g., 10 mg/kg, 50 uM, 100 nM). Units: mg/kg, uM, nM, mg, ug, mg/mL, ug/mL, mM Dose or concentration of compound treatment. Quantitative values preferred. true true false +pre-existing condition characteristics NCIT:C54056 clinical-metadata MONDO, EFO, DOID Pre-existing medical conditions or comorbidities. true true true +treatment status characteristics NCIT:C45501 clinical-metadata fixed: pre-treatment, on treatment, post-treatment, treatment naive Treatment status at time of sampling. true true false +treatment response characteristics NCIT:C50995 clinical-metadata NCIT Response to treatment (complete response, partial response, progressive disease). true true false +body mass index characteristics EFO:0004340 clinical-metadata numeric Body mass index (BMI) in kg/m^2. true true false +smoking status characteristics NCIT:C19796 clinical-metadata NCIT (children of NCIT:C19796) Patient smoking status. true true false +menopausal status characteristics NCIT:C16151 clinical-metadata fixed: pre-menopausal, peri-menopausal, post-menopausal Menopausal status for female patients. true true false +histologic subtype characteristics NCIT:C19790 oncology-metadata NCIT Breast cancer molecular subtype (luminal A, luminal B, HER2-enriched, triple-negative). true true false +single cell isolation protocol characteristics EFO:0010214 single-cell fixed: FACS, cellenONE, microfluidics, laser capture microdissection, manual picking, nanoPOTS, droplet microfluidics, acoustic droplet ejection Method used to isolate single cells true true false +cell identifier characteristics EFO:0010197 single-cell free text pattern Unique identifier for the single cell false true false +cell viability characteristics CMPO:0000013 single-cell fixed: live, viable, dead, unknown Viability status of the cell at isolation true true false +cell cycle phase characteristics GO:0022403 single-cell fixed: G1, S, G2, G2/M, M, G0, not determined Cell cycle phase of the isolated cell true true false +enrichment marker characteristics PRIDE:0000940 single-cell free text Markers used for cell sorting/enrichment true true false +genotype characteristics EFO:0000513 single-cell, invertebrates, clinical-metadata free text Known genetic variant, mutation, or genotype of the subject true true false +strain or breed characteristics GENO:0000112 vertebrates, invertebrates, plants free text Strain, breed, cultivar, or ecotype of the organism true true false +mhc protein complex characteristics GO:0042611 immunopeptidomics fixed: MHC class I protein complex, MHC class II protein complex, non-classical MHC protein complex, mutant MHC protein complex, MHC protein complex with serotype MHC protein complex targeted for immunopeptidome enrichment (MRO terms under GO:0042611) false false false +immunopeptidome enrichment method characteristics PRIDE:0000586 immunopeptidomics fixed: immunoaffinity purification, immunoaffinity purification (iodoacetamide), mild acid elution, detergent lysis Method used to enrich MHC-bound peptides false false false +mhc typing characteristics PRIDE:0000893 immunopeptidomics IPD-MHC nomenclature (https://www.ebi.ac.uk/ipd/mhc/); IPD-IMGT/HLA for human MHC allelic composition of the sample following IPD-MHC nomenclature true true false +mhc typing method characteristics PRIDE:0000894 immunopeptidomics fixed: NGS-based typing (NCIT:C101293), sequence-based typing (NCIT:C130180), PCR-SSO (NCIT:C130181), PCR-SSP (NCIT:C130179), PCR-based genotyping (NCIT:C17003), predicted from RNA-seq, inferred from mass spectrometry, inbred strain (known genotype) Method used to determine MHC alleles true true false +enrichment process characteristics EFO:0009090 sample-metadata, crosslinking PRIDE, EFO (children of EFO:0009090) Enrichment strategy applied to the sample (phosphopeptide, crosslinked peptide, glycopeptide enrichment, etc.) true true false +crosslink distance characteristics PRIDE:0000948 crosslinking pattern: number + Å Maximum distance constraint provided by the crosslinker true true false +crosslinking reaction time characteristics PRIDE:0000949 crosslinking pattern: number + time unit Duration of the crosslinking reaction true true false +crosslinking temperature characteristics PRIDE:0000950 crosslinking pattern: number + °C Temperature at which crosslinking was performed true true false +environmental sample type characteristics PRIDE:0000993 metaproteomics, human-gut, soil, water ENVO, EFO Type of environmental sample analyzed false false false +environmental medium characteristics PRIDE:0000994 metaproteomics, human-gut, soil, water ENVO Environmental material from which the sample was obtained true true false +sample collection method characteristics PRIDE:0000997 metaproteomics, human-gut, soil, water free text Method used to collect the environmental sample true true false +geographic location characteristics PRIDE:0000995 metaproteomics, human-gut, soil, water GAZ Geographic location where sample was collected true true false +collection date characteristics PRIDE:0000996 metaproteomics, human-gut, soil, water ISO 8601 date Date when sample was collected true true false +depth characteristics PRIDE:0000711 metaproteomics, human-gut, soil, water pattern: number + m/cm/mm Depth at which sample was collected true true false +altitude characteristics PRIDE:0000712 metaproteomics, human-gut, soil, water pattern: number + m Altitude or elevation of sampling site true true false +temperature characteristics PRIDE:0000703 metaproteomics, human-gut, soil, water pattern: number + °C Temperature at sampling location true true false +ph characteristics PRIDE:0000746 metaproteomics, human-gut, soil, water numeric pH at sampling location true true false +microbiome source characteristics PRIDE:0000986 metaproteomics, human-gut, soil, water free text Source of the microbiome being studied true true false +mock community characteristics PRIDE:0000987 metaproteomics, human-gut, soil, water free text Identifier or name of mock community standard used true true false +mock community composition characteristics PRIDE:0000988 metaproteomics, human-gut, soil, water free text Description of mock community composition true true false +host organism characteristics PRIDE:0000998 human-gut NCBITaxon Host organism for host-associated microbiome samples false true false +host subject id characteristics PRIDE:0000680 human-gut free text pattern De-identified unique identifier for the host subject true true false +host disease status characteristics PRIDE:0000682 human-gut MONDO, DOID Host disease diagnoses true true false +host body site characteristics PRIDE:0000685 human-gut UBERON, BTO Body site where sample was obtained true true false +host age characteristics PRIDE:0000681 human-gut pattern: {Number}{Unit} (Y/M/W/D) Age of host at the time of sampling true true false +host sex characteristics PRIDE:0000999 human-gut fixed: male, female, intersex Sex of the host organism true true false +host body-mass index characteristics PRIDE:0000695 human-gut numeric Body mass index (weight/height^2) true true false +host height characteristics PRIDE:0000688 human-gut pattern: number + cm/m Height of the host true true false +host total mass characteristics PRIDE:0000687 human-gut pattern: number + kg/g Total mass of the host true true false +ethnicity characteristics PRIDE:0000696 human-gut free text Ethnicity of the host true true false +host diet characteristics PRIDE:0000689 human-gut free text Diet type of the host true true false +special diet characteristics PRIDE:0000679 human-gut free text Special dietary restrictions true true false +host last meal characteristics PRIDE:0000690 human-gut free text Content of last meal and time since feeding true true false +gastrointestinal tract disorder characteristics PRIDE:0000677 human-gut free text History of GI tract disorders true true false +liver disorder characteristics PRIDE:0000678 human-gut free text History of liver disorders true true false +antibiotic treatment characteristics PRIDE:0001000 human-gut free text Recent antibiotic exposure of the host true true false +ihmc medication code characteristics PRIDE:0000683 human-gut free text Medication codes (IHMC) true true false +host body product characteristics PRIDE:0000686 human-gut free text Substance produced by the body where sample was obtained true true false +host body temperature characteristics PRIDE:0000694 human-gut pattern: number + °C Core body temperature at sample collection true true false +soil type characteristics PRIDE:0001001 soil ENVO Soil classification type true true false +soil horizon characteristics PRIDE:0001002 soil fixed: O horizon, A horizon, B horizon, C horizon, E horizon, R horizon Soil horizon from which sample was collected true true false +land use characteristics PRIDE:0000713 soil free text Land use type at sampling site true true false +vegetation characteristics PRIDE:0001003 soil free text Dominant vegetation at sampling site true true false +total organic carbon characteristics PRIDE:0000749 soil pattern: number + mg/kg/g/kg/% Total organic carbon content true true false +total nitrogen characteristics PRIDE:0000751 soil pattern: number + mg/kg/g/kg/% Total nitrogen content true true false +water content characteristics PRIDE:0000727 soil pattern: number + g/g/% Water content of soil sample true true false +soil texture measurement characteristics PRIDE:0000744 soil free text Soil texture measurement (sand/silt/clay percentages) true true false +current vegetation characteristics PRIDE:0000714 soil ENVO Current vegetation type at sampling site true true false +crop rotation characteristics PRIDE:0000718 soil free text Crop rotation history true true false +water body type characteristics PRIDE:0001004 water ENVO Type of water body from which sample was collected true true false +salinity characteristics PRIDE:0000701 water pattern: number + PSU/ppt/g/L or descriptive term Salinity measurement true true false +dissolved oxygen characteristics PRIDE:0000788 water pattern: number + mg/L or descriptive term Dissolved oxygen concentration true true false +chlorophyll characteristics PRIDE:0000775 water pattern: number + ug/L/mg/L Chlorophyll concentration if measured true true false +sampling depth zone characteristics PRIDE:0001005 water fixed: epipelagic, mesopelagic, bathypelagic, abyssopelagic, hadopelagic, benthic, surface Ecological depth zone of the sampling site true true false +turbidity characteristics PRIDE:0000827 water pattern: number + NTU/FNU Turbidity measurement true true false +alkalinity characteristics PRIDE:0000760 water pattern: number + mg/L/meq/L Alkalinity measurement true true false +nitrate characteristics PRIDE:0000796 water pattern: number + mg/L/umol/L Nitrate concentration true true false +phosphate characteristics PRIDE:0000805 water pattern: number + mg/L/umol/L Phosphate concentration true true false +conductivity characteristics PRIDE:0000776 water pattern: number + uS/cm/mS/cm/S/m Electrical conductivity of water sample true true false +total dissolved solids characteristics PRIDE:0001007 water pattern: number + mg/L/g/L Total dissolved solids true true false +light intensity characteristics PRIDE:0000792 water pattern: number + lux/umol/m2/s Light intensity at sampling depth true true false +current characteristics PRIDE:0001006 water pattern: number + m/s/cm/s/knots Water current velocity true true false +perturbation characteristics PRIDE:0000700 human-gut, soil free text Type of perturbation applied true true false +chemical administration characteristics PRIDE:0000684 human-gut, soil free text Chemical compounds administered true true false +proteomics data acquisition method comment PRIDE:0000659 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition PRIDE Mass spectrometry acquisition method false false false +label comment PRIDE:0000514 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition PRIDE Labeling strategy used for quantification false false false +instrument comment MS:1000031 ms-proteomics, affinity-proteomics MS, PRIDE Mass spectrometer instrument used false false false +cleavage agent details comment MS:1001044 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition MS (PSI-MS) Enzyme or chemical used for protein digestion false true false +fraction identifier comment MS:1000858 base, ms-proteomics, affinity-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition integer Fraction number for fractionated samples false false false +technical replicate comment MS:1001808 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition integer Identifier for the technical replicate false false false +data file comment MS:1003083 base, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition file name Name of the raw data file false false false +modification parameters comment MS:1001055 ms-proteomics, dia-acquisition Unimod, PSI-MOD Post-translational modifications searched true true false +precursor mass tolerance comment PRIDE:0000575 ms-proteomics, dia-acquisition pattern: number + ppm/Da Precursor mass tolerance for database search true true false +fragment mass tolerance comment PRIDE:0000576 ms-proteomics, dia-acquisition pattern: number + ppm/Da Fragment mass tolerance for database search true true false +ms min mz comment PRIDE:0000476 ms-proteomics, dia-acquisition numeric (m/z) MS method-defined minimum precursor m/z setting used to acquire the data true true false +ms max mz comment PRIDE:0000477 ms-proteomics, dia-acquisition numeric (m/z) MS method-defined maximum precursor m/z setting used to acquire the data true true false +ms min charge comment PRIDE:0000472 ms-proteomics, dia-acquisition integer MS method-defined minimum precursor charge state setting used to acquire the data true true false +ms max charge comment PRIDE:0000473 ms-proteomics, dia-acquisition integer MS method-defined maximum precursor charge state setting used to acquire the data true true false +ms min rt comment PRIDE:0000474 ms-proteomics, dia-acquisition numeric (minutes) LC method-defined minimum retention time setting used to acquire the data true true false +ms max rt comment PRIDE:0000475 ms-proteomics, dia-acquisition numeric (minutes) LC method-defined maximum retention time setting used to acquire the data true true false +ms min im comment PRIDE:0000841 ms-proteomics, dia-acquisition numeric (1/K0 or Vs/cm2) MS method-defined minimum ion mobility setting used to acquire the data true true false +ms max im comment PRIDE:0000842 ms-proteomics, dia-acquisition numeric (1/K0 or Vs/cm2) MS method-defined maximum ion mobility setting used to acquire the data true true false +ms2 min mz comment PRIDE:0001011 ms-proteomics {number}m/z MS method-defined minimum product ion (MS2) m/z setting true true false +ms2 max mz comment PRIDE:0001012 ms-proteomics {number}m/z MS method-defined maximum product ion (MS2) m/z setting true true false +ms3 min mz comment PRIDE:0001013 ms-proteomics {number}m/z MS method-defined minimum product ion (MS3) m/z setting true true false +ms3 max mz comment PRIDE:0001014 ms-proteomics {number}m/z MS method-defined maximum product ion (MS3) m/z setting true true false +ms1 scan range comment PRIDE:0001008 ms-proteomics {number}m/z-{number}m/z m/z scan range for MS1 spectra as an interval true true false +ms2 scan range comment PRIDE:0001009 ms-proteomics {number}m/z-{number}m/z m/z scan range for MS2 spectra as an interval true true false +ms3 scan range comment PRIDE:0001010 ms-proteomics {number}m/z-{number}m/z m/z scan range for MS3 spectra as an interval true true false +sample type characteristics PRIDE:0000895 sample-metadata, single-cell PRIDE (children of PRIDE:0000895): single cell, standard, reference, bridge, carrier, pooled, empty, quality control sample, negative control, positive control, bulk control, calibrator, plate control, buffer control Classification of the sample role in the experiment. Distinguishes experimental samples from controls, references, and other roles in multiplexed or plate-based experiments. true true false +passage number characteristics EFO:0007061 cell-lines integer or range Passage number of the cell line true true false +biorepository characteristics NCIT:C48800 cell-lines free text Repository or source from which the cell line was obtained true true false +cell line authentication characteristics PRIDE:0000955 cell-lines free text Method used to authenticate the cell line identity true true false +cells per well characteristics UO:0000317 single-cell integer Number of cells per well/reaction (single-cell proteomics; use 1 for true single cells) true true false + +tissue mass characteristics OBA:2045411 sample-metadata pattern: number + mg/g Mass of tissue used for extraction true true false +antibody enrichment characteristics PRIDE:0000954 immunopeptidomics free text Antibody clone used for MHC immunoprecipitation true true false +elution conditions comment OBI:0302905 ms-proteomics free text Conditions used for peptide elution from MHC complexes true true false +chemical cross-linking coupled with ms comment PRIDE:0000430 crosslinking fixed: cross-linking mass spectrometry MS-based cross-linking methodology used false false false +cross-linker comment XLMOD:00004 crosslinking XLMOD key-value format Cross-linker compound with structured properties false false false +crosslinker concentration comment PRIDE:0000951 crosslinking pattern: number + mM/uM Concentration of crosslinking reagent used true true false +crosslinker to protein ratio comment PRIDE:0000952 crosslinking ratio pattern Molar ratio of crosslinker to protein true true false +quenching reagent comment PRIDE:0000953 crosslinking free text Reagent used to quench the crosslinking reaction true true false +crosslink enrichment method comment PRIDE:0000838 crosslinking PRIDE, MS (ontology validator, examples: size exclusion chromatography, strong cation exchange chromatography, high-pH reversed-phase chromatography, FAIMS) Method used to enrich crosslinked peptides true true false +metagenome accession comment PRIDE:0000956 metaproteomics, human-gut, soil, water accession pattern Accession number for matched metagenome data true true false +sample storage characteristics PRIDE:0000730 metaproteomics, human-gut, soil, water free text Storage conditions for the sample before analysis true true false +biomass estimation characteristics PRIDE:0000990 metaproteomics, human-gut, soil, water free text Estimated microbial biomass in the sample true true false +host contamination characteristics PRIDE:0000991 metaproteomics, human-gut, soil, water free text Level of host protein contamination if known true true false +contaminant database comment PRIDE:0000992 metaproteomics, human-gut, soil, water free text Contaminant database(s) used in database search true true false +expected organism list comment PRIDE:0000989 metaproteomics, human-gut, soil, water free text Semicolon-separated list of organisms expected in mock community true true false +scan window lower limit comment MS:1000501 dia-acquisition numeric m/z Lower m/z limit of the DIA scan window true true false +scan window upper limit comment MS:1000500 dia-acquisition numeric m/z Upper m/z limit of the DIA scan window true true false +isolation window width comment MS:1000792 dia-acquisition numeric m/z Width of the isolation window in m/z units true true false +collision energy comment MS:1000045 ms-proteomics, crosslinking, dia-acquisition pattern: {value} {unit} where value is number with optional %, unit is NCE or eV. Stepped: {value} {unit};{value} {unit} Collision energy used for fragmentation. Examples: 30 NCE, 30% NCE, 27 eV, 25 NCE;27 NCE;30 NCE true true false +dissociation method comment MS:1000044 ms-proteomics, crosslinking, dia-acquisition MS, PRIDE (children of MS:1000044) Fragmentation method used true true false +ms2 mass analyzer comment MS:1000443 ms-proteomics, dia-acquisition MS (PSI-MS) Mass analyzer used for MS2 acquisition true true false +dia method comment PRIDE:0000450 dia-acquisition PRIDE Specific DIA method variant used true true false +fractionation method comment PRIDE:0000550 ms-proteomics PRIDE (children of PRIDE:0000550) Peptide fractionation method used before MS analysis true true false +sdrf version comment PRIDE:0000839 base semver (vX.Y.Z) Version of the SDRF-Proteomics specification used to annotate this file false false false +sdrf template comment PRIDE:0000832 base pattern (NT=name;VV=vX.Y.Z or name vX.Y.Z) Template name and version used for annotation. Multiple templates can be specified using multiple columns. false false false +sdrf annotation tool comment PRIDE:0000840 base pattern (NT=name;VV=vX.Y.Z or name vX.Y.Z or manual curation) Software tool or method used to generate or annotate the SDRF file false false false +sdrf validation hash comment base free text Hash value for SDRF validation integrity checking true true false +pooled sample characteristics NCIT:C165587 sample-metadata fixed: not pooled, pooled; or pattern: SN=sample1;SN=sample2 Whether the sample is a pooled sample combining material from multiple biological sources true true false +biosample accession number characteristics NCIT:C175889 sample-metadata accession (SAMN/SAMEA/SAMD) BioSample accession number for the sample true true false +reduction reagent comment PRIDE:0000607 ms-proteomics PRIDE, MS Chemical reagent used for disulfide bond reduction true true false +alkylation reagent comment PRIDE:0000598 ms-proteomics PRIDE, MS Chemical reagent used for cysteine alkylation true true false +depletion characteristics PRIDE:0000020 ms-proteomics fixed: no depletion, depletion, not applicable Whether abundant protein depletion was performed true true false +sample preparation batch comment ms-proteomics, single-cell free text Batch identifier for sample preparation (plate, chip, processing batch) true true false +lc batch comment ms-proteomics free text Liquid chromatography batch identifier for batch effect tracking true true false +acquisition date comment ms-proteomics ISO 8601 date Date of MS data acquisition true true false +culture medium characteristics OBI:0000079 cell-lines NCIT Culture medium used to grow the cell line true true false +sample storage temperature characteristics PRIDE:0000705 cell-lines pattern: number + °C Storage temperature of the cell line true true false +cell diameter characteristics OBA:0000048 single-cell pattern: number + um/μm Physical diameter of the isolated cell true true false +forward scatter characteristics PRIDE:0000937 single-cell numeric Forward scatter (FSC) value from flow cytometry - proxy for cell size true true false +side scatter characteristics PRIDE:0000938 single-cell numeric Side scatter (SSC) value from flow cytometry - proxy for cell granularity true true false +carrier channel comment PRIDE:0000941 single-cell TMT/TMTpro channel label TMT channel used for the carrier proteome in multiplexed SCP true true false +reference channel comment PRIDE:0000942 single-cell TMT/TMTpro channel label TMT channel used for the reference sample for normalization true true false +spatial coordinates characteristics PRIDE:0000939 single-cell pattern: X=number;Y=number X,Y coordinates for spatially resolved single-cell proteomics true true false +tissue section comment NCIT:C158415 single-cell free text Tissue section identifier for spatially resolved single-cell proteomics true true false +facs nozzle size comment PRIDE:0000981 single-cell pattern: number + um/μm Nozzle diameter used for FACS-based single cell isolation true true false +facs sorting mode comment PRIDE:0000982 single-cell fixed: single cell, purity, yield, 4-way purity Sorting mode used during FACS isolation true true false +microfluidics chip type comment PRIDE:0000983 single-cell free text Type and manufacturer of the microfluidics chip used for single cell isolation true true false +lcm microscope model comment PRIDE:0000984 single-cell free text Model of the laser capture microdissection microscope used for cell isolation true true false +nanopots chip version comment PRIDE:0000985 single-cell free text Version of the nanoPOTS chip used for single cell sample preparation true true false +treatment characteristics EFO:0000727 sample-metadata, plants NCIT, EFO Treatment or perturbation applied to the sample (drug, stimulus, environmental stress) true true false +synthetic peptide characteristics PRIDE:0000495 sample-metadata synthetic, not synthetic Whether the sample is a synthetic peptide library or biological material true true false +spiked compound characteristics PRIDE:0000496 sample-metadata pattern: CT=type;QY=quantity;PS=sequence;AC=accession;CN=name;CV=vendor Spiked-in compound details (peptides, proteins, mixtures for standards or RT alignment) true true false +weight characteristics EFO:0004324 clinical-metadata pattern: number + unit (kg, g, lb) Body weight of the subject true true false +height characteristics EFO:0004339 clinical-metadata pattern: number + unit (cm, m) Height of the subject true true false +sampling time characteristics EFO:0000689 sample-metadata pattern: number + time unit Time at which the sample was collected true true false +dukes stage characteristics NCIT:C16475 oncology-metadata fixed: A, B, C, D Dukes staging for colorectal cancer true true false +ann arbor stage characteristics NCIT:C16282 oncology-metadata pattern: (I-IV)(A/B)(E/S) Ann Arbor staging for lymphoma true true false +gleason score characteristics NCIT:C28091 oncology-metadata pattern: sum or components (e.g., 3+4) Gleason score for prostate cancer grading true true false +weiss grade characteristics NCIT:C160679 oncology-metadata fixed: low, high Weiss scoring system for adrenal cortical carcinoma true true false +mitotic rate characteristics NCIT:C62401 oncology-metadata pattern: count or count/HPF Number of mitoses per high-power field true true false +growth condition characteristics EFO:0000523 plants free text Growth conditions for the plant (photoperiod, temperature, growth medium) true true false +platform comment affinity-proteomics PRIDE Affinity proteomics platform used (e.g., Olink Explore HT, SomaScan Assay 7K) false false false +panel name comment affinity-proteomics free text Name of the commercial panel used true true false +panel version comment affinity-proteomics free text Version of the assay panel true true false +quantification unit comment PRIDE:0000392 affinity-proteomics fixed: NPX, RFU Unit of quantification for the assay (NPX for Olink, RFU for SomaScan) true true false +plate comment affinity-proteomics free text Plate identifier for batch effect analysis true true false +sample matrix characteristics affinity-proteomics UBERON, BTO Type of biological matrix used as input (serum, plasma, CSF, urine) true true false +normalization method comment affinity-proteomics free text Normalization method applied to quantification values true true false +olink panel comment olink free text Specific Olink panel name (Target 96 Inflammation, Explore 3072) false false false +olink platform comment olink fixed: Olink Target 96, Olink Explore 384, Olink Explore HT, Olink Reveal Olink platform version false false false +npx normalization comment olink fixed: plate control normalized, intensity normalized, bridge normalized, not normalized Normalization method applied to NPX values true true false +olink lot number comment olink free text Reagent lot number for traceability true true false +somascan menu comment somascan fixed: SomaScan 1.1K, SomaScan 1.3K, SomaScan 5K, SomaScan 7K, SomaScan 11K SomaScan assay menu (number of aptamers/proteins measured) false false false +somascan platform comment somascan fixed: SomaScan Assay, SomaScan Assay v4, SomaScan Assay v4.1 SomaScan instrument/platform version false false false +somascan lot number comment somascan free text Reagent lot number for traceability true true false +dilution comment OBI:0002483 somascan pattern: 0.005%, 0.5%, 20%, 40% Sample dilution factor used in SomaScan assay true true false +xenograft characteristics EFO:0003942 human, vertebrates free text Indicates if sample is a patient-derived xenograft (PDX). Metadata (age, sex) must refer to the original patient, not the host organism. true true false +mass characteristics PRIDE:0000505 sample-metadata pattern: number + unit (e.g., 1 ug, 500 ng, 10 fmol) Injected mass of the sample. Used for spiked-in experiments and quantitative comparisons. true true false diff --git a/sdrf-proteomics/tool-support.adoc b/sdrf-proteomics/TOOLS.adoc similarity index 100% rename from sdrf-proteomics/tool-support.adoc rename to sdrf-proteomics/TOOLS.adoc diff --git a/sdrf-proteomics/VERSIONING.adoc b/sdrf-proteomics/VERSIONING.adoc index 9d947ffdf..697180119 100644 --- a/sdrf-proteomics/VERSIONING.adoc +++ b/sdrf-proteomics/VERSIONING.adoc @@ -104,7 +104,7 @@ NOTE: If the `comment[sdrf version]` or `comment[sdrf template]` columns are abs === Template Inheritance and Updates -Templates follow a layered hierarchy where child templates inherit from parent templates (see link:metadata-guidelines/template-definitions.adoc[Template Definitions Guide]). When a parent template is updated, the following rules apply: +Templates follow a layered hierarchy where child templates inherit from parent templates (see link:TEMPLATES.adoc[Templates Guide]). When a parent template is updated, the following rules apply: [cols="2,4,2", options="header"] |=== @@ -139,7 +139,7 @@ Community-contributed templates MUST: 1. Be submitted as a pull request to the https://github.com/bigbio/sdrf-templates[sdrf-templates] repository. The PR must include the YAML schema, an example `.sdrf.tsv` file, and documentation (a `README.adoc` in the corresponding `templates/` directory). 2. Extend an official template using the `extends` field. -3. Follow the same YAML schema structure defined in the link:metadata-guidelines/template-definitions.adoc[Template Definitions Guide]. +3. Follow the same YAML schema structure defined in the link:TEMPLATES.adoc[Templates Guide]. 4. Use the `-dev` suffix for pre-release versions (e.g., `1.0.0-dev`) until the template has been reviewed and accepted by the core team. 5. Declare their `spec_compatibility` range (see <>). @@ -503,7 +503,7 @@ When a breaking change is introduced, a migration guide MUST be provided. The gu == See Also * link:README.adoc[SDRF-Proteomics Core Specification] — see <> section -* link:metadata-guidelines/template-definitions.adoc[Template Definitions Guide] — YAML schema structure +* link:TEMPLATES.adoc[Templates Guide] — YAML schema structure, template selection, and developer reference * https://github.com/bigbio/proteomics-sample-metadata/issues[Open Issues and Future Decisions] — active community discussions * https://semver.org/[Semantic Versioning 2.0.0] * https://github.com/bigbio/proteomics-sample-metadata/issues/771[Issue #771: Versioning strategy discussion] diff --git a/sdrf-proteomics/metadata-guidelines/sdrf-terms.tsv b/sdrf-proteomics/metadata-guidelines/sdrf-terms.tsv deleted file mode 100644 index 1e365e5c3..000000000 --- a/sdrf-proteomics/metadata-guidelines/sdrf-terms.tsv +++ /dev/null @@ -1,115 +0,0 @@ -term type ontology_term_accession usage values description allow_not_available allow_not_applicable allow_pooled -source name anchor column PRIDE:0000623 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition free text Unique identifier for the biological sample false false false -assay name anchor column NCIT:C178857 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition free text Unique identifier for the MS run false false false -technology type anchor column PRIDE:0000663 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition fixed: proteomic profiling by mass spectrometry, protein expression profiling by antibody array, protein expression profiling by aptamer array Type of technology used false false false -organism characteristics OBI:0100026 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition NCBITaxon Species of the sample false true false -organism part characteristics EFO:0000635 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition UBERON, BTO Anatomical part of the organism true true true -disease characteristics OGMS:0000031 default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition, dda-acquisition MONDO, EFO, DOID, PATO Disease state of the sample (use 'normal' from PATO for healthy samples) true true true -cell type characteristics EFO:0000324 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition CL, BTO, CLO Cell type of the sample true true true -material type characteristics PRIDE:0000837 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition fixed: tissue, cell, cell line, organism part, whole organism, synthetic Type of biological material being analyzed (derived from MAGE-TAB specification) true true false -biological replicate characteristics MS:1001809 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition integer or pooled Identifier for the biological replicate false false true -ancestry category characteristics HANCESTRO:0004 human, cell-lines HANCESTRO, EFO Ancestry or ethnic background of the donor true true true -age characteristics EFO:0000246 human, cell-lines pattern: {Number}{Unit} (Y/M/W/D), anonymized, or pooled Age of the donor at sample collection true true true -sex characteristics PATO:0000047 human, cell-lines fixed: male, female, intersex, anonymized, not available, not applicable, pooled Biological sex of the donor true true true -developmental stage characteristics EFO:0000399 human, cell-lines, single-cell HsapDv, EFO, MmusDv, UBERON Developmental stage of the donor true true true -individual characteristics to be filled human, cell-lines free text pattern or pooled Unique identifier for the donor individual true true true -cell line characteristics CLO:0000031 cell-lines, immunopeptidomics CLO, BTO, EFO Name of the cell line false true false -cellosaurus accession characteristics to be filled cell-lines Cellosaurus (CVCL_XXXX) Cellosaurus accession number for the cell line true true false -cellosaurus name characteristics to be filled cell-lines Cellosaurus Official Cellosaurus name for the cell line true true false -sampling site characteristics EFO:0000688 human, cell-lines UBERON, BTO Specific sampling location within organism part (e.g., tumor, normal tissue adjacent to tumor, left ventricle). Use to distinguish tissue contexts. true true false -disease staging characteristics EFO:0000410 human NCIT, EFO Disease progression stage (stage I-IV, chronic phase, end stage). Distinct from tumor-specific staging. true true false -tumor grading characteristics NCIT:C28076 human NCIT Histological tumor grade (grade 1-4). Describes how abnormal cells look. true true false -tumor stage characteristics EFO:0004925 human NCIT TNM staging notation (T0-4, N0-3, M0-1). Describes extent of cancer spread. true true false -clinical data characteristics EFO:0030083 human free text Free-text clinical details (receptor status, treatment history, surgical details). Use for context not captured in structured fields. true true false -clinical history characteristics EFO:0000352 human free text Relevant medical history information for the patient. true true false -phenotype characteristics EFO:0000651 default, human, cell-lines, vertebrates, invertebrates, plants PATO, EFO, free text Observable characteristics or traits (drug sensitivity, molecular markers, expression phenotypes, environmental responses). Captures how sample behaves/appears. true true false -metastasis site characteristics EFO:0009708 human UBERON, BTO Location where cancer has spread from primary site. true true false -survival time characteristics EFO:0000714 human pattern: number + unit Patient survival time for survival analysis studies. true true false -tumor size characteristics EFO:0004134 human pattern: number + unit Tumor size measurement (e.g., 2.5 cm). true true false -tumor mass characteristics EFO:0007062 human pattern: number + unit Tumor mass/weight measurement. true true false -biopsy site characteristics EFO:0000288 human UBERON, BTO Specific anatomical location of biopsy. true true false -last follow up characteristics EFO:0007058 human pattern: number + unit Time of last clinical follow-up for longitudinal studies. true true false -treatment time characteristics to be filled human pattern: number + time unit Duration of treatment exposure (e.g., 24 hour, 5 days). true true false -genetic modification characteristics EFO:0000510 human, cell-lines, vertebrates, invertebrates EFO Method of genetic modification (knockout, knockdown, overexpression, transduction). Describes HOW modification was done. true true false -compound characteristics CHEBI:24431 human, cell-lines CHEBI, NCIT, EFO Chemical compound or drug applied to sample. Use ChEBI ontology for standardization. true true false -dose characteristics to be filled human, cell-lines pattern: number + unit Dose or concentration of compound treatment. true true false -pre-existing condition characteristics to be filled human MONDO, EFO, DOID Pre-existing medical conditions or comorbidities. true true true -treatment status characteristics to be filled human fixed: pre-treatment, on treatment, post-treatment, treatment naive Treatment status at time of sampling. true true false -treatment response characteristics NCIT:C50995 human NCIT Response to treatment (complete response, partial response, progressive disease). true true false -body mass index characteristics EFO:0004340 human numeric Body mass index (BMI) in kg/m^2. true true false -smoking status characteristics NCIT:C19796 human fixed: never smoker, former smoker, current smoker Patient smoking status. true true false -menopausal status characteristics NCIT:C16151 human fixed: pre-menopausal, peri-menopausal, post-menopausal Menopausal status for female patients. true true false -breast cancer subtype characteristics to be filled human NCIT Breast cancer molecular subtype (luminal A, luminal B, HER2-enriched, triple-negative). true true false -single cell isolation method characteristics EFO:0010214 single-cell fixed: FACS, microfluidics, laser capture microdissection, manual picking, CellenONE, nanoPOTS Method used to isolate single cells false true false -cell identifier characteristics EFO:0010197 single-cell free text pattern Unique identifier for the single cell false false false -cell viability characteristics to be filled single-cell fixed: live, dead, unknown Viability status of the cell at isolation true true false -cell cycle phase characteristics GO:0022403 single-cell fixed: G1, S, G2, M, G0 Cell cycle phase of the isolated cell true true false -sorting marker characteristics to be filled single-cell free text Markers used for cell sorting/selection true true false -genotype characteristics EFO:0000513 single-cell free text Genotype of the organism (for model organisms) true true false -strain characteristics EFO:0005135 single-cell free text Strain or genetic background of model organisms true true false -MHC class characteristics to be filled immunopeptidomics fixed: MHC class I, MHC class II, MHC class I and II MHC class targeted for immunopeptidome enrichment false false false -immunopeptidome enrichment method characteristics to be filled immunopeptidomics fixed: immunoaffinity purification, mild acid elution, detergent lysis Method used to enrich MHC-bound peptides false false false -HLA typing characteristics NCIT:C71329 immunopeptidomics HLA nomenclature pattern HLA alleles expressed by the sample true true true -HLA typing method characteristics to be filled immunopeptidomics fixed: NGS-based typing, SSO typing, SSP typing, SBT typing, predicted from RNA-seq Method used for HLA typing true true false -crosslinking reagent characteristics to be filled crosslinking XLMOD, ChEBI Name of the cross-linking reagent used false false false -enrichment process characteristics to be filled crosslinking fixed: enrichment of cross-linked peptides, not applicable Indicates if the sample was enriched for cross-linked peptides false true false -crosslink type characteristics to be filled crosslinking fixed: homo-bifunctional, hetero-bifunctional, zero-length, photo-reactive, cleavable Type of crosslinks being studied true true false -crosslink distance characteristics to be filled crosslinking pattern: number + A Maximum distance constraint provided by the crosslinker true true false -crosslinking reaction time characteristics to be filled crosslinking pattern: number + time unit Duration of the crosslinking reaction true true false -crosslinking temperature characteristics to be filled crosslinking pattern: number + C Temperature at which crosslinking was performed true true false -environmental sample type characteristics to be filled metaproteomics ENVO, EFO Type of environmental sample analyzed false true true -sample collection method characteristics OBI:0000659 metaproteomics free text Method used to collect the environmental sample true true false -geographic location characteristics GAZ:00000448 metaproteomics GAZ Geographic location where sample was collected true true true -collection date characteristics to be filled metaproteomics ISO 8601 date Date when sample was collected true true false -depth characteristics PATO:0001595 metaproteomics pattern: number + m/cm Depth at which sample was collected true true false -temperature characteristics PATO:0000146 metaproteomics pattern: number + C Temperature at sampling location true true false -pH characteristics PATO:0001842 metaproteomics numeric pH at sampling location true true false -host organism characteristics to be filled metaproteomics NCBITaxon Host organism for host-associated microbiome samples true true false -host disease characteristics to be filled metaproteomics MONDO, DOID Disease state of the host organism true true true -proteomics data acquisition method comment PRIDE:0000659 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition PRIDE Mass spectrometry acquisition method false true false -label comment PRIDE:0000514 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition PRIDE Labeling strategy used for quantification false false false -instrument comment MS:1000031 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition MS (PSI-MS) Mass spectrometer instrument used false false false -cleavage agent details comment MS:1001045 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition MS (PSI-MS) Enzyme or chemical used for protein digestion false true false -fraction identifier comment MS:1000858 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition integer Fraction number for fractionated samples false false false -technical replicate comment MS:1001808 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition integer Identifier for the technical replicate false false false -data file comment MS:1000577 minimum, default, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition file name Name of the raw data file false false false -modification parameters comment MS:1001055 dia-acquisition, dda-acquisition Unimod, PSI-MOD Post-translational modifications searched true false false -precursor mass tolerance comment PRIDE:0000575 dia-acquisition, dda-acquisition pattern: number + ppm/Da Precursor mass tolerance for database search true true false -fragment mass tolerance comment PRIDE:0000576 dia-acquisition, dda-acquisition pattern: number + ppm/Da Fragment mass tolerance for database search true true false -precursor min mz comment PRIDE:0000476 dia-acquisition, dda-acquisition numeric (m/z) MS method-defined minimum precursor m/z setting used to acquire the data true true false -precursor max mz comment PRIDE:0000477 dia-acquisition, dda-acquisition numeric (m/z) MS method-defined maximum precursor m/z setting used to acquire the data true true false -precursor min charge comment PRIDE:0000472 dia-acquisition, dda-acquisition integer MS method-defined minimum precursor charge state setting used to acquire the data true true false -precursor max charge comment PRIDE:0000473 dia-acquisition, dda-acquisition integer MS method-defined maximum precursor charge state setting used to acquire the data true true false -min retention time comment PRIDE:0000474 dia-acquisition, dda-acquisition numeric (minutes) LC method-defined minimum retention time setting used to acquire the data true true false -max retention time comment PRIDE:0000475 dia-acquisition, dda-acquisition numeric (minutes) LC method-defined maximum retention time setting used to acquire the data true true false -min ion mobility comment PRIDE:0000841 dia-acquisition, dda-acquisition numeric (1/K0 or Vs/cm2) MS method-defined minimum ion mobility setting used to acquire the data true true false -max ion mobility comment PRIDE:0000842 dia-acquisition, dda-acquisition numeric (1/K0 or Vs/cm2) MS method-defined maximum ion mobility setting used to acquire the data true true false -passage number comment to be filled cell-lines integer or range Passage number of the cell line true true false -cell line source comment to be filled cell-lines free text Repository or source from which the cell line was obtained true true false -authentication method comment to be filled cell-lines free text Method used to authenticate the cell line identity true true false -carrier proteome comment to be filled single-cell fixed: yes, no, not applicable Carrier proteome used in carrier-assisted SCP methods false true false -carrier channel comment to be filled single-cell TMT channel pattern TMT channel used for carrier proteome true true false -reference channel comment to be filled single-cell TMT channel pattern TMT channel used for reference/booster true true false -cells per well comment to be filled single-cell integer Number of cells per well/reaction true true false -single cell quality comment to be filled single-cell fixed: OK, pass, fail, not OK Quality assessment of the single cell preparation true true false -cell number comment to be filled immunopeptidomics scientific notation Number of cells used for immunopeptidome extraction true true false -tissue mass comment to be filled immunopeptidomics pattern: number + mg/g Mass of tissue used for immunopeptidome extraction true true false -antibody used comment to be filled immunopeptidomics free text Antibody clone used for MHC immunoprecipitation true true false -elution conditions comment to be filled immunopeptidomics free text Conditions used for peptide elution from MHC complexes true true false -cross-linking method comment to be filled crosslinking fixed: cross-linking mass spectrometry, hydrogen-deuterium exchange, ion-mobility mass spectrometry MS-based cross-linking methodology used false false false -cross-linker comment to be filled crosslinking XLMOD key-value format Cross-linker compound with structured properties false false false -crosslinker concentration comment to be filled crosslinking pattern: number + mM/uM Concentration of crosslinking reagent used true true false -crosslinker to protein ratio comment to be filled crosslinking ratio pattern Molar ratio of crosslinker to protein true true false -quenching reagent comment to be filled crosslinking free text Reagent used to quench the crosslinking reaction true true false -crosslink enrichment method comment to be filled crosslinking fixed: size exclusion chromatography, strong cation exchange, affinity enrichment, peptide SEC, high-pH reversed phase, FAIMS Method used to enrich crosslinked peptides true true false -database search strategy comment to be filled metaproteomics fixed: matched metagenome, reference database, two-step search, spectral library Strategy used for protein database searching true true false -metagenome accession comment to be filled metaproteomics accession pattern Accession number for matched metagenome data true true false -sample storage comment to be filled metaproteomics free text Storage conditions for the sample before analysis true true false -scan window lower limit comment to be filled dia-acquisition numeric m/z Lower m/z limit of the DIA scan window true true false -scan window upper limit comment to be filled dia-acquisition numeric m/z Upper m/z limit of the DIA scan window true true false -isolation window width comment MS:1000792 dia-acquisition numeric m/z Width of the isolation window in m/z units true true false -collision energy comment MS:1000045 dia-acquisition, dda-acquisition pattern: {value} {unit} where value is number with optional %, unit is NCE or eV. Stepped: {value} {unit};{value} {unit} Collision energy used for fragmentation. Examples: 30 NCE, 30% NCE, 27 eV, 25 NCE;27 NCE;30 NCE true true false -dissociation method comment MS:1000044 dia-acquisition, dda-acquisition MS, PRIDE (children of MS:1000044) Fragmentation method used true true false -MS2 mass analyzer comment MS:1000443 dia-acquisition, dda-acquisition MS (PSI-MS) Mass analyzer used for MS2 acquisition true true false -DIA method comment PRIDE:0000450 dia-acquisition PRIDE Specific DIA method variant used true true false -fractionation method comment PRIDE:0000550 dda-acquisition PRIDE (children of PRIDE:0000550) Peptide fractionation method used before MS analysis true true false diff --git a/sdrf-proteomics/metadata-guidelines/template-definitions.adoc b/sdrf-proteomics/metadata-guidelines/template-definitions.adoc deleted file mode 100644 index 502d33a41..000000000 --- a/sdrf-proteomics/metadata-guidelines/template-definitions.adoc +++ /dev/null @@ -1,765 +0,0 @@ -= SDRF-Proteomics Template Definitions Guide -:toc: left -:toc-title: Contents -:toclevels: 3 -:icons: font -:source-highlighter: highlight.js -:sectnums: - -== Introduction - -This document describes the technical implementation of SDRF-Proteomics templates for **developers and maintainers**. Templates are implemented as YAML files that define validation rules, column requirements, and inheritance relationships. - -These YAML definitions are used by the https://github.com/bigbio/sdrf-pipelines[sdrf-pipelines] validator to check SDRF files for compliance. - -**Template files location:** https://github.com/bigbio/proteomics-metadata-standard/tree/master/sdrf-proteomics/templates[sdrf-proteomics/templates/] - -== Template Architecture - -=== Layered Hierarchy - -Templates are organized in a layered hierarchy where each layer serves a specific purpose: - -[source] ----- -base (construction artifact - not user-facing) -│ -├── TECHNOLOGY LAYER (mutually exclusive) -│ ├── ms-proteomics # Mass spectrometry proteomics -│ │ └── EXPERIMENT LAYER -│ │ ├── dda-acquisition # Data-dependent acquisition -│ │ ├── dia-acquisition # Data-independent acquisition -│ │ ├── single-cell # Single-cell proteomics -│ │ ├── immunopeptidomics # MHC peptide analysis -│ │ ├── crosslinking # XL-MS experiments -│ │ └── metaproteomics # Microbiome proteomics -│ │ -│ └── affinity-proteomics # Affinity-based proteomics -│ └── EXPERIMENT LAYER -│ ├── olink # Olink PEA platform -│ └── somascan # SomaScan aptamer platform -│ -└── SAMPLE LAYER (mutually exclusive) - ├── human # Human samples - ├── vertebrates # Non-human vertebrates (mouse, rat, etc.) - ├── invertebrates # Invertebrates (Drosophila, C. elegans) - └── plants # Plant samples (Arabidopsis, crops) - -cell-lines (EXPERIMENT layer - requires technology + sample) ----- - -=== Layer Definitions - -[cols="1,3,2", options="header"] -|=== -| Layer | Purpose | Examples - -| `base` -| Internal construction artifact with shared columns. Never used directly by users. -| base - -| `technology` -| Defines the proteomics technology. Exactly one required per SDRF. -| ms-proteomics, affinity-proteomics - -| `sample` -| Defines organism-specific sample metadata. One recommended per SDRF. -| human, vertebrates, invertebrates, plants - -| `experiment` -| Defines methodology-specific columns. Multiple can be combined if not mutually exclusive. -| dda-acquisition, single-cell, olink, cell-lines -|=== - -=== Mutual Exclusivity - -Some templates cannot be combined because they represent mutually exclusive concepts: - -[cols="2,2,3", options="header"] -|=== -| Template A | Template B | Reason - -| ms-proteomics | affinity-proteomics | Different technologies -| dda-acquisition | dia-acquisition | Different acquisition methods -| somascan | olink | Different affinity platforms -| human | vertebrates | Different organism types -| human | invertebrates | Different organism types -| human | plants | Different organism types -| vertebrates | invertebrates | Different organism types -| vertebrates | plants | Different organism types -| invertebrates | plants | Different organism types -|=== - -== YAML Template Schema - -=== Complete Template Structure - -[source,yaml] ----- -# ============================================================================= -# TEMPLATE METADATA (required) -# ============================================================================= -name: human # Unique template identifier (used in --template flag) -description: Human SDRF template # Human-readable description -version: 1.1.0 # Semantic version (major.minor.patch) - -# ============================================================================= -# INHERITANCE AND RELATIONSHIPS (optional) -# ============================================================================= -extends: base # Parent template to inherit from -usable_alone: false # Can this template be used without others? -layer: sample # Layer: base, technology, sample, experiment - -# Mutual exclusivity - templates that cannot be combined with this one -mutually_exclusive_with: - - vertebrates - - invertebrates - - plants - -# Required layers - for templates that need specific layer types -requires: - - layer: technology # Requires a technology template - - layer: sample # Requires a sample template - -# ============================================================================= -# TEMPLATE-LEVEL VALIDATORS (optional) -# ============================================================================= -validators: - - validator_name: min_columns - params: - min_columns: 12 - - validator_name: trailing_whitespace_validator - params: {} - -# ============================================================================= -# COLUMN DEFINITIONS (required) -# ============================================================================= -columns: - - name: characteristics[disease] - description: Disease state of the sample - requirement: required # required | recommended | optional - type: string # string | integer (default: string) - cardinality: single # single | multiple (default: single) - allow_not_applicable: true # Allow "not applicable" value - allow_not_available: true # Allow "not available" value - allow_pooled: false # Allow "pooled" value (for replicates) - validators: - - validator_name: ontology - params: - ontologies: - - mondo - - efo - - doid - - pato - error_level: warning # error | warning - description: The disease should be a valid ontology term - examples: - - normal - - breast cancer - - diabetes mellitus ----- - -=== Template Properties Reference - -[cols="2,1,1,4", options="header"] -|=== -| Property | Required | Type | Description - -| `name` -| Yes -| string -| Unique template identifier. Used in validation commands (`--template human`). - -| `description` -| Yes -| string -| Human-readable description of the template's purpose. - -| `version` -| Yes -| string -| Semantic version (e.g., `1.1.0`). Should match the specification version. - -| `extends` -| No -| string -| Parent template name. Child inherits all columns and validators. - -| `usable_alone` -| No -| boolean -| If `false`, must be combined with other templates. Default: `true`. - -| `layer` -| No -| string -| Template layer: `base`, `technology`, `sample`, or `experiment`. - -| `mutually_exclusive_with` -| No -| list -| Templates that cannot be combined with this one. - -| `requires` -| No -| list -| Layer requirements (e.g., `- layer: technology`). - -| `validators` -| No -| list -| Template-level validators applied to the entire SDRF file. - -| `columns` -| Yes -| list -| Column definitions with validation rules. -|=== - -=== Column Properties Reference - -[cols="2,1,1,4", options="header"] -|=== -| Property | Required | Type | Description - -| `name` -| Yes -| string -| Column header exactly as in SDRF (e.g., `characteristics[disease]`). - -| `description` -| Yes -| string -| What the column contains and how to fill it. - -| `requirement` -| Yes -| string -| `required` (must be present), `recommended` (should be present), `optional` (may be present). - -| `type` -| No -| string -| Data type: `string` (default) or `integer`. - -| `cardinality` -| No -| string -| `single` (default) or `multiple` (semicolon-separated values). - -| `allow_not_applicable` -| No -| boolean -| Allow `not applicable` when column doesn't apply. Default: `false`. - -| `allow_not_available` -| No -| boolean -| Allow `not available` when data is unknown. Default: `false`. - -| `allow_pooled` -| No -| boolean -| Allow `pooled` value (for biological replicate). Default: `false`. - -| `validators` -| No -| list -| Column-level validators for value checking. -|=== - -== Validator Reference - -=== Template-Level Validators - -These validators apply to the entire SDRF file structure. - -==== min_columns - -Ensures minimum column count. - -[source,yaml] ----- -- validator_name: min_columns - params: - min_columns: 12 ----- - -==== trailing_whitespace_validator - -Checks for trailing whitespace in cell values. - -[source,yaml] ----- -- validator_name: trailing_whitespace_validator - params: {} ----- - -==== column_order - -Validates expected column order (source name first, data file last). - -[source,yaml] ----- -- validator_name: column_order - params: {} ----- - -==== empty_cells - -Checks for empty cells that should have values. - -[source,yaml] ----- -- validator_name: empty_cells - params: {} ----- - -==== combination_of_columns_no_duplicate_validator - -Ensures column combinations are unique (no duplicate rows). - -[source,yaml] ----- -- validator_name: combination_of_columns_no_duplicate_validator - params: - column_name: # Must be unique (error if duplicates) - - source name - - assay name - - comment[label] - column_name_warning: # Should be unique (warning if duplicates) - - source name - - assay name ----- - -=== Column-Level Validators - -These validators apply to individual column values. - -==== ontology - -Validates values against ontology terms. - -[source,yaml] ----- -- validator_name: ontology - params: - ontologies: # List of ontology prefixes - - mondo - - efo - - doid - parent_term: MS:1000044 # Optional: restrict to children of this term - error_level: warning # error or warning - description: Human-readable validation message - examples: - - normal - - breast cancer ----- - -==== pattern - -Validates values against a regular expression. - -[source,yaml] ----- -- validator_name: pattern - params: - pattern: ^(\d+[yYmMdD])+(-(\d+[yYmMdD])+)?$ - case_sensitive: false # Optional, default: true - description: Age format like 45Y, 6M, 30Y6M - examples: - - 45Y - - 30Y6M - - 40Y-50Y ----- - -==== values - -Validates against a fixed list of allowed values. - -[source,yaml] ----- -- validator_name: values - params: - values: - - male - - female - - intersex - - not available - - not applicable - error_level: error - description: Sex must be one of the allowed values ----- - -==== single_cardinality_validator - -Ensures single value per cell (no semicolon-separated values). - -[source,yaml] ----- -- validator_name: single_cardinality_validator - params: {} ----- - -== Supported Ontologies - -[cols="1,3,3", options="header"] -|=== -| Prefix | Ontology | Common Use - -| `ncbitaxon` | NCBI Taxonomy | organism -| `uberon` | Uberon Anatomy Ontology | organism part -| `cl` | Cell Ontology | cell type -| `clo` | Cell Line Ontology | cell line -| `bto` | BRENDA Tissue Ontology | tissue, cell type, cell line -| `mondo` | MONDO Disease Ontology | disease -| `efo` | Experimental Factor Ontology | disease, experimental factors -| `doid` | Disease Ontology | disease -| `pato` | Phenotype and Trait Ontology | phenotypes (including "normal") -| `ms` | PSI-MS Ontology | instrument, cleavage agent, mass analyzer -| `pride` | PRIDE Ontology | acquisition method, labels, affinity instruments -| `unimod` | UNIMOD | post-translational modifications -| `xlmod` | XLMOD | crosslinking reagents -| `hancestro` | Human Ancestry Ontology | ancestry category (human) -| `hsapdv` | Human Developmental Stages | developmental stage (human) -| `mmusdv` | Mouse Developmental Stages | developmental stage (mouse) -| `fbdv` | FlyBase Developmental | developmental stage (Drosophila) -| `wbls` | WormBase Life Stage | developmental stage (C. elegans) -| `po` | Plant Ontology | plant tissues, developmental stages -| `envo` | Environment Ontology | environmental samples (metaproteomics) -| `gaz` | Gazetteer | geographic locations -| `chebi` | ChEBI | chemical entities, treatments -|=== - -== Template Inheritance Rules - -When templates are combined, the following rules apply: - -=== Inheritance Behavior - -1. **Column inheritance**: Child templates inherit all columns from parent templates -2. **Validator inheritance**: Child templates inherit all validators from parent templates -3. **Column override**: Child templates can redefine inherited columns with stricter requirements - -=== Requirement Strengthening - -Child templates may **strengthen** but not weaken requirements: - -[cols="2,2,2", options="header"] -|=== -| Parent Requirement | Allowed in Child | Not Allowed - -| `optional` -| `optional`, `recommended`, `required` -| - - -| `recommended` -| `recommended`, `required` -| `optional` - -| `required` -| `required` -| `optional`, `recommended` -|=== - -=== Multi-Template Combination - -When multiple templates are combined: - -1. All columns from all templates are included -2. If the same column appears in multiple templates, the **strictest requirement** wins -3. Validators are merged (all validators apply) -4. Mutual exclusivity is checked first - -**Example valid combination:** -[source] ----- -ms-proteomics + human + dda-acquisition + cell-lines - ↓ ↓ ↓ ↓ - technology sample experiment experiment ----- - -== Creating a New Template: Step-by-Step Guide - -This section walks through creating a new YAML template from scratch. The example creates a hypothetical `top-down` template for top-down proteomics experiments. - -=== Step 1: Choose the Parent Template - -Every template (except `base`) must extend a parent. Choose based on where your template fits in the hierarchy: - -[cols="2,3,2", options="header"] -|=== -| You are defining... | Extend | Layer - -| A new proteomics technology (rare) -| `base` -| `technology` - -| A new organism type -| `base` -| `sample` - -| A new MS experiment type -| `ms-proteomics` -| `experiment` - -| A new affinity experiment type -| `affinity-proteomics` -| `experiment` -|=== - -For our example, top-down proteomics is a mass spectrometry technique, so we extend `ms-proteomics` and use the `experiment` layer. - -=== Step 2: Create the Directory Structure - -Templates live in the https://github.com/bigbio/sdrf-templates[sdrf-templates] repository. Each template has a versioned directory: - -[source] ----- -sdrf-templates/ -└── top-down/ - └── 1.0.0-dev/ - ├── top-down.yaml # Template schema (required) - └── top-down.sdrf.tsv # Example SDRF file (required) ----- - -Use the `-dev` suffix for the initial version until the template is reviewed and accepted by the community. - -=== Step 3: Write the YAML Schema - -Start with the template metadata, then define the columns your experiment type needs. Only define columns that are **new or different** from the parent — inherited columns from `ms-proteomics` do not need to be repeated. - -.top-down/1.0.0-dev/top-down.yaml -[source,yaml] ----- -# =========================================================================== -# TEMPLATE METADATA -# =========================================================================== -name: top-down -description: > - SDRF template for top-down proteomics experiments where intact proteins - are analyzed without prior enzymatic digestion. Extends ms-proteomics - with top-down-specific columns for intact mass analysis. -version: 1.0.0-dev -extends: ms-proteomics -usable_alone: false -layer: experiment - -# =========================================================================== -# COLUMN DEFINITIONS — only columns new or changed from parent -# =========================================================================== -columns: - - # --- New column: protein separation method --- - - name: comment[protein separation method] - description: > - Method used to separate intact proteins before MS analysis - (e.g., GELFrEE, SEC, RPLC, CZE). Use "not applicable" if no - separation was performed (direct infusion). - requirement: recommended - allow_not_applicable: true - allow_not_available: true - validators: - - validator_name: ontology - params: - ontologies: - - ms - - pride - error_level: warning - description: > - Protein separation method should be a valid PSI-MS or PRIDE - ontology term. - examples: - - size exclusion chromatography - - gel electrophoresis - - capillary zone electrophoresis - - reversed-phase liquid chromatography - - not applicable - - # --- New column: intact mass range --- - - name: comment[precursor mass range] - description: > - The mass range of intact protein precursors analyzed, in Daltons. - Format: "min-max Da" (e.g., "5000-50000 Da"). - requirement: optional - allow_not_available: true - validators: - - validator_name: pattern - params: - pattern: ^(\d+-\d+\s*Da|not available)$ - case_sensitive: false - description: > - Precursor mass range in format "min-max Da". - examples: - - 5000-50000 Da - - 10000-100000 Da - - not available - - # --- Override inherited column: make cleavage agent "not applicable" --- - # In top-down experiments, proteins are not digested, so the cleavage - # agent column should always be "not applicable". We override the - # inherited column to make this explicit. - - name: comment[cleavage agent details] - description: > - Cleavage agent is not applicable for top-down experiments where - intact proteins are analyzed. Use "not applicable". - requirement: required - allow_not_applicable: true - allow_not_available: false - validators: - - validator_name: values - params: - values: - - not applicable - error_level: warning - description: > - Top-down experiments analyze intact proteins. Cleavage agent - should be "not applicable". ----- - -Key points demonstrated in this example: - -* **New columns** (`comment[protein separation method]`, `comment[precursor mass range]`) are defined with their own validators. -* **Overriding an inherited column** (`comment[cleavage agent details]`) restricts the parent's definition — in this case, forcing the value to "not applicable" since top-down experiments don't use enzymatic digestion. -* **Descriptions explain the "why"** — not just what the field is, but when to use `not applicable` and what format to follow. -* **Examples are always provided** in validators — they serve as documentation and can be used by tools to generate autocomplete suggestions. - -=== Step 4: Create an Example SDRF File - -Every template must include an example `.sdrf.tsv` file that passes validation. This file demonstrates correct usage and serves as a starting point for users. - -.top-down/1.0.0-dev/top-down.sdrf.tsv (tab-separated) -[source,tsv] ----- -source name characteristics[organism] characteristics[organism part] characteristics[disease] characteristics[biological replicate] assay name technology type comment[proteomics data acquisition method] comment[label] comment[instrument] comment[cleavage agent details] comment[fraction identifier] comment[technical replicate] comment[data file] comment[protein separation method] comment[precursor mass range] factor value[disease] -sample_1 homo sapiens heart normal 1 run_1 proteomic profiling by mass spectrometry data-dependent acquisition label free sample LTQ Orbitrap Elite not applicable 1 1 sample_1.raw gel electrophoresis 10000-100000 Da normal -sample_2 homo sapiens heart dilated cardiomyopathy 1 run_2 proteomic profiling by mass spectrometry data-dependent acquisition label free sample LTQ Orbitrap Elite not applicable 1 1 sample_2.raw gel electrophoresis 10000-100000 Da dilated cardiomyopathy ----- - -=== Step 5: Create the Documentation - -Add a `README.adoc` file in the specification repository under `sdrf-proteomics/templates/top-down/`: - -.sdrf-proteomics/templates/top-down/README.adoc (outline) -[source,asciidoc] ----- -= Top-Down Proteomics Template - -== Overview -[describe when to use this template] - -== Columns -[table of columns with requirement levels, descriptions, and examples] - -== Examples -[link to the example SDRF file] - -== See Also -* link:../../README.adoc[SDRF-Proteomics Specification] -* link:../ms-proteomics/README.adoc[MS-Proteomics Template] (parent) ----- - -=== Step 6: Test Locally - -Before submitting, validate your example file against your template: - -[source,bash] ----- -# Install or upgrade the validator -pip install sdrf-pipelines - -# Validate the example SDRF file with the new template -parse_sdrf validate-sdrf \ - --sdrf_file top-down/1.0.0-dev/top-down.sdrf.tsv \ - --template ms-proteomics \ - --custom_template top-down/1.0.0-dev/top-down.yaml ----- - -Check that: - -* [ ] The example file passes validation with no errors. -* [ ] All required columns from the parent template are present. -* [ ] New columns validate correctly (ontology terms resolve, patterns match). -* [ ] The `not applicable` and `not available` values work where expected. - -=== Step 7: Submit a Pull Request - -Submit the template to the https://github.com/bigbio/sdrf-templates[sdrf-templates] repository via pull request. The PR must include: - -1. The YAML schema file (`top-down/1.0.0-dev/top-down.yaml`). -2. The example SDRF file (`top-down/1.0.0-dev/top-down.sdrf.tsv`). -3. A PR description explaining: what experiment type the template covers, why it is needed, and which parent it extends. - -The corresponding `README.adoc` documentation goes into a separate PR to the https://github.com/bigbio/proteomics-metadata-standard[specification repository] under `sdrf-proteomics/templates/top-down/`. - -Once reviewed and merged, the template appears in the `templates.yaml` manifest and becomes available to all users of sdrf-pipelines. The `-dev` suffix is removed when the template is promoted to a stable release (e.g., `1.0.0`). - -=== Quick Reference: Template YAML Checklist - -[cols="1,3", options="header"] -|=== -| Field | Checklist - -| `name` -| Lowercase with hyphens. Unique across all templates. - -| `description` -| One or two sentences. Mention what it extends and what experiment type it covers. - -| `version` -| Use `X.Y.Z-dev` for new templates. Remove `-dev` after community review. - -| `extends` -| Must be an existing template name (`ms-proteomics`, `affinity-proteomics`, or `base`). - -| `layer` -| One of: `technology`, `sample`, `experiment`. - -| `usable_alone` -| Almost always `false` for experiment and sample layer templates. - -| `columns` -| Only define columns that are **new** or that **override** a parent column. Do not repeat inherited columns unchanged. - -| Validators -| Use `ontology` for controlled vocabularies, `pattern` for structured text, `values` for fixed lists. Always include `examples`. - -| Reserved words -| Set `allow_not_applicable`, `allow_not_available`, `allow_pooled`, `allow_anonymized` as appropriate for each column. -|=== - -=== Best Practices - -- **Only define what is new.** Inherited columns from the parent template do not need to be repeated. Only add a column to your template if it is new or if you need to override the parent's definition (e.g., change `requirement` from `optional` to `required`, or restrict allowed values). -- **Use ontologies over patterns.** Prefer `ontology` validators for fields where controlled vocabulary terms exist. Use `pattern` validators only for structured free text (ages, mass ranges, file names). -- **Provide clear descriptions.** Explain not just what the field is, but when to use `not applicable` vs `not available`, and give format guidance. -- **Always include examples.** Examples in validators serve as documentation and help tools generate suggestions. -- **Test with real data.** Your example SDRF should represent a realistic experiment, not a toy file. If possible, base it on a real public dataset. - -== Validation Commands - -Validate SDRF files using sdrf-pipelines: - -[source,bash] ----- -# Install -pip install sdrf-pipelines - -# Validate with single template -parse_sdrf validate-sdrf --sdrf_file file.sdrf.tsv --template ms-proteomics - -# Validate with multiple templates -parse_sdrf validate-sdrf --sdrf_file file.sdrf.tsv \ - --template ms-proteomics \ - --template human \ - --template dda-acquisition - -# Check template compatibility -parse_sdrf check-templates --templates ms-proteomics,human,dda-acquisition ----- - -== References - -- https://github.com/bigbio/sdrf-pipelines[sdrf-pipelines] - SDRF validation tool -- https://github.com/bigbio/proteomics-metadata-standard/tree/master/sdrf-proteomics/templates[Template files on GitHub] -- link:../README.adoc[SDRF-Proteomics Specification] diff --git a/sdrf-proteomics/quickstart.adoc b/sdrf-proteomics/quickstart.adoc index a2a9bf4a9..058bd7f2b 100644 --- a/sdrf-proteomics/quickstart.adoc +++ b/sdrf-proteomics/quickstart.adoc @@ -77,7 +77,7 @@ Add extra columns for specific experimental workflows: |DIA-specific parameters. link:templates/dia-acquisition/README.adoc[View template] |**immunopeptidomics** -|HLA typing and related metadata. link:templates/immunopeptidomics/README.adoc[View template] +|MHC typing and related metadata. link:templates/immunopeptidomics/README.adoc[View template] |**crosslinking** |XL-MS specific columns. link:templates/crosslinking/README.adoc[View template] diff --git a/sdrf-proteomics/sdrf-templates b/sdrf-proteomics/sdrf-templates index e65e4033a..149a9de53 160000 --- a/sdrf-proteomics/sdrf-templates +++ b/sdrf-proteomics/sdrf-templates @@ -1 +1 @@ -Subproject commit e65e4033aaf02e8d6bffa097480a922e3c1d254d +Subproject commit 149a9de53cba4ffa13bb2082ae63da8e596521b8 diff --git a/sdrf-proteomics/templates/affinity-proteomics/README.adoc b/sdrf-proteomics/templates/affinity-proteomics/README.adoc deleted file mode 100644 index 3427f4769..000000000 --- a/sdrf-proteomics/templates/affinity-proteomics/README.adoc +++ /dev/null @@ -1,599 +0,0 @@ -= SDRF-Proteomics: Affinity Proteomics Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides guidelines for annotating affinity-based proteomics experiments in SDRF-Proteomics format. - -**Type:** Technology Template - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -Affinity proteomics uses affinity-based capture methods (antibodies, aptamers, or other reagents) to detect and quantify proteins. Unlike mass spectrometry-based proteomics, these methods typically produce a single data file per study containing measurements for all samples across all targeted proteins. - -This template covers: - -* **Olink** - Proximity Extension Assay (PEA) -* **SomaScan** - Aptamer-based protein profiling - -[[key-differences]] -== Key Differences from MS-Based Proteomics - -Understanding these differences is critical for correct SDRF annotation. - -=== Data File Structure - -[cols="1,1", options="header"] -|=== -|MS-Based Proteomics |Affinity Proteomics - -|Each row = one sample-to-raw-file relationship -|Each row = one sample in a shared data file - -|Multiple raw files (one per sample or fraction) -|**One data file per study** containing all samples - -|Each sample typically has its own data file -|Same data file appears in multiple rows -|=== - -=== Technology Type - -[cols="1,1", options="header"] -|=== -|MS-Based |Affinity-Based - -|`proteomic profiling by mass spectrometry` -|`protein expression profiling by antibody array` or `protein expression profiling by aptamer array` -|=== - -=== Assay Name Purpose - -[IMPORTANT] -==== -In affinity proteomics, `assay name` serves a different purpose than in MS-based proteomics: - -* **MS-based**: Unique identifier for each MS run/data file -* **Affinity-based**: **Sample ID from the platform data file** - this is the critical linking column that connects SDRF rows to samples in the shared data file -==== - -=== Columns NOT Applicable - -The following MS-specific columns should **NOT** be included in affinity proteomics SDRF files: - -* `comment[proteomics data acquisition method]` - No MS acquisition -* `comment[label]` - No isotopic labeling -* `comment[cleavage agent details]` - No protein digestion -* `comment[fraction identifier]` - Typically no fractionation -* `comment[modification parameters]` - Not relevant -* `comment[precursor mass tolerance]` / `comment[fragment mass tolerance]` - No MS tolerances -* `comment[dissociation method]` / `comment[collision energy]` - No MS/MS - -[[hierarchy]] -== Template Hierarchy - -[source] ----- -base - └── affinity-proteomics (THIS TEMPLATE) - ├── olink (Olink-specific columns) - └── somascan (SomaScan-specific columns) ----- - -[[checklist]] -== Checklist - -=== Required Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionExample Values
    source nameREQUIREDUnique identifier for the biological samplepatient_001_plasma, sample_A
    characteristics[organism]REQUIREDSpecies (NCBI Taxonomy)homo sapiens
    characteristics[organism part]REQUIREDAnatomical part or sample typeblood plasma, blood serum, CSF
    characteristics[disease]RECOMMENDEDDisease state (use "normal" for healthy)rheumatoid arthritis, normal
    characteristics[biological replicate]REQUIREDBiological replicate number or "pooled"1, 2, pooled, not available
    assay nameREQUIREDSample ID from platform data file - critical linking columnXB6, Sample_ID_1, L14_NIST
    technology typeREQUIREDMust be affinity-specific technology typeprotein expression profiling by antibody array
    comment[instrument]REQUIREDAffinity platform/instrumentOlink Explore HT, SomaScan Assay 7K
    comment[data file]REQUIREDSingle data file name (same for all rows)olink_npx.csv, somascan_results.adat
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column |Requirement |Description |Example Values - -|source name |REQUIRED |Unique identifier for the biological sample |patient_001_plasma -|characteristics[organism] |REQUIRED |Species (NCBI Taxonomy) |homo sapiens -|characteristics[organism part] |REQUIRED |Anatomical part or sample type |blood plasma, blood serum -|characteristics[disease] |RECOMMENDED |Disease state (use "normal" for healthy) |rheumatoid arthritis, normal -|characteristics[biological replicate] |REQUIRED |Biological replicate number or "pooled" |1, 2, pooled -|assay name |REQUIRED |**Sample ID from platform data file** |XB6, Sample_ID_1 -|technology type |REQUIRED |Must be affinity-specific |protein expression profiling by antibody array -|comment[instrument] |REQUIRED |Affinity platform/instrument |Olink Explore HT -|comment[data file] |REQUIRED |Single data file name |olink_npx.csv -|=== -endif::[] - -=== Recommended Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionExample Values
    comment[sample type]RECOMMENDEDSample classification from platformsample, sample_control, negative_control, plate_control
    comment[plate]OPTIONALPlate identifier for batch effect analysis1, 2, plate_A
    comment[panel name]RECOMMENDEDCommercial panel nameOlink Explore 3072, SomaScan 7K
    comment[panel version]OPTIONALPanel versionv4.1, 2023-01
    comment[quantification unit]RECOMMENDEDPlatform-specific measurement unitNPX, RFU, MFI, pg/mL
    comment[technical replicate]RECOMMENDEDTechnical replicate number1
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column |Requirement |Description |Example Values - -|comment[sample type] |RECOMMENDED |Sample classification from platform |sample, negative_control, plate_control -|comment[plate] |OPTIONAL |Plate identifier for batch effects |1, 2, plate_A -|comment[panel name] |RECOMMENDED |Commercial panel name |Olink Explore 3072, SomaScan 7K -|comment[panel version] |OPTIONAL |Panel version |v4.1, 2023-01 -|comment[quantification unit] |RECOMMENDED |Measurement unit |NPX, RFU, MFI, pg/mL -|comment[technical replicate] |RECOMMENDED |Technical replicate number |1 -|=== -endif::[] - -[[technology-types]] -== Technology Type Values - -Use the appropriate technology type for your platform: - -[cols="1,2", options="header"] -|=== -|Platform |Technology Type Value - -|Olink (PEA) -|`protein expression profiling by antibody array` - -|SomaScan -|`protein expression profiling by aptamer array` -|=== - -[[data-file-structure]] -== Understanding the Data File Structure - -=== One Data File, Multiple Rows - -In affinity proteomics, **one data file contains all samples**. The SDRF reflects this: - -* Same `comment[data file]` value for all rows -* `assay name` (Sample ID) distinguishes different samples -* Multiple rows may exist for the same sample (one per protein measured, if tracking at that granularity) - -**Example:** -[source] ----- -source name | assay name | comment[data file] -sample_1 | Sample_ID_1 | olink_npx.csv -sample_2 | Sample_ID_2 | olink_npx.csv -sample_3 | Sample_ID_3 | olink_npx.csv ----- - -=== Assay Name = Sample ID - -The `assay name` column contains the **Sample ID from the platform data file**: - -* This is the key that links SDRF rows to the data file -* Each unique Sample ID in the data file = one unique `assay name` in SDRF -* Must match exactly what appears in the platform output - -[[special-cases]] -== Handling Special Cases - -=== Pooled Samples - -For samples pooled from multiple individuals: - -[cols="1,2", options="header"] -|=== -|Column |Value - -|characteristics[individual] |pooled -|characteristics[age] |pooled (or age range if known, e.g., "40Y-50Y") -|characteristics[sex] |pooled (if mixed) or specific value if all same sex -|characteristics[biological replicate] |pooled -|=== - -=== Control Samples - -For negative controls, plate controls, and other QC samples: - -[cols="1,2", options="header"] -|=== -|Column |Value - -|characteristics[disease] |not applicable -|characteristics[age] |not applicable -|characteristics[sex] |not applicable -|characteristics[individual] |not applicable -|comment[sample type] |negative_control, plate_control, sample_control -|=== - -[[example-olink]] -== Example: Olink Proteomics - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]characteristics[biological replicate]assay nametechnology typecomment[instrument]comment[panel name]comment[quantification unit]comment[data file]
    patient_001homo sapiensblood plasmarheumatoid arthritis1XB6protein expression profiling by antibody arrayOlink Explore HTOlink Explore 1536NPXolink_npx.csv
    patient_002homo sapiensblood plasmanormal2XB65protein expression profiling by antibody arrayOlink Explore HTOlink Explore 1536NPXolink_npx.csv
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -[cols="1,1,1,1,1,1,1,1,1,1,1", options="header"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[biological replicate] |assay name |technology type |comment[instrument] |comment[panel name] |comment[quantification unit] |comment[data file] - -|patient_001 |homo sapiens |blood plasma |rheumatoid arthritis |1 |XB6 |protein expression profiling by antibody array |Olink Explore HT |Olink Explore 1536 |NPX |olink_npx.csv -|patient_002 |homo sapiens |blood plasma |normal |2 |XB65 |protein expression profiling by antibody array |Olink Explore HT |Olink Explore 1536 |NPX |olink_npx.csv -|=== -endif::[] - -[[example-somascan]] -== Example: SomaScan Proteomics - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]assay nametechnology typecomment[instrument]comment[panel name]comment[quantification unit]comment[data file]
    subject_Ahomo sapiensblood serumtype 2 diabetes mellitusSample_001protein expression profiling by aptamer arraySomaScan Assay 7KSomaScan 7K v4.1RFUsomascan_results.adat
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -[cols="1,1,1,1,1,1,1,1,1,1", options="header"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |assay name |technology type |comment[instrument] |comment[panel name] |comment[quantification unit] |comment[data file] - -|subject_A |homo sapiens |blood serum |type 2 diabetes mellitus |Sample_001 |protein expression profiling by aptamer array |SomaScan Assay 7K |SomaScan 7K v4.1 |RFU |somascan_results.adat -|=== -endif::[] - -[[example-controls]] -== Example: With Controls - -For experiments that include various control types: - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[disease]assay namecomment[sample type]comment[plate]comment[data file]
    patient_001homo sapienscardiovascular diseaseL14_P001sample2olink_reveal.parquet
    pool_controlhomo sapiensnot applicableL14_NISTsample_control2olink_reveal.parquet
    neg_ctrlnot applicablenot applicableL14_NEG1negative_control2olink_reveal.parquet
    -
    -++++ -endif::[] - -ifdef::env-github[] -[cols="1,1,1,1,1,1,1", options="header"] -|=== -|source name |characteristics[organism] |characteristics[disease] |assay name |comment[sample type] |comment[plate] |comment[data file] - -|patient_001 |homo sapiens |cardiovascular disease |L14_P001 |sample |2 |olink_reveal.parquet -|pool_control |homo sapiens |not applicable |L14_NIST |sample_control |2 |olink_reveal.parquet -|neg_ctrl |not applicable |not applicable |L14_NEG1 |negative_control |2 |olink_reveal.parquet -|=== -endif::[] - -[[platforms]] -== Platform-Specific Information - -=== Quantification Units - -[cols="1,2,2", options="header"] -|=== -|Platform |Quantification Unit |Description - -|Olink |NPX |Normalized Protein eXpression (log2 scale) -|SomaScan |RFU |Relative Fluorescence Units -|=== - -=== Common Instruments - -[cols="1,2", options="header"] -|=== -|Platform |Instrument Examples - -|Olink |Olink Explore HT, Olink Signature Q100, Olink Flex -|SomaScan |SomaScan Assay 7K, SomaScan Assay 11K -|=== - -=== Data File Formats - -[cols="1,2,1", options="header"] -|=== -|Platform |Typical Format |Extension - -|Olink |Excel, CSV, or Parquet with NPX values |.xlsx, .csv, .parquet -|SomaScan |ADAT format (proprietary) or CSV |.adat, .csv -|=== - -[[best-practices]] -== Best Practices - -1. **Use platform Sample IDs as assay name**: The `assay name` must match exactly what appears in the platform data file to enable proper linking. - -2. **Specify technology type correctly**: Always use affinity-specific technology types, never MS technology types for non-MS platforms. - -3. **Document quantification units**: Different platforms use different scales - always specify (NPX, RFU, MFI, pg/mL). - -4. **Include plate information**: For multi-plate experiments, `comment[plate]` is important for batch effect analysis. - -5. **Classify samples properly**: Use `comment[sample type]` to distinguish biological samples from controls. - -6. **Handle pooled samples correctly**: Use "pooled" for individual-specific fields when samples are pooled. - -7. **Mark controls appropriately**: Use "not applicable" for sample characteristics of controls where the value doesn't apply. - -[[validation]] -== Validation - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template affinity-proteomics ----- - -NOTE: MS-specific validations (label, cleavage agent, etc.) do not apply to affinity proteomics. - -[[template-file]] -== Template File - -The affinity proteomics SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/affinity-proteomics/1.1.0/affinity-proteomics.sdrf.tsv[affinity-proteomics.sdrf.tsv] - -[[related-templates]] -== Related Templates - -* link:../olink/README.adoc[Olink Template] - Olink-specific columns (NPX normalization, QC warnings) -* link:../somascan/README.adoc[SomaScan Template] - SomaScan-specific columns (menu version, matrix) -* link:../human/README.adoc[Human Template] - Human sample metadata (can be combined) - -[[references]] -== References - -- Assarsson E, et al. (2014) Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. -- Gold L, et al. (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. -- Olink Proteomics: https://www.olink.com/ -- SomaLogic: https://somalogic.com/ diff --git a/sdrf-proteomics/templates/base/README.adoc b/sdrf-proteomics/templates/base/README.adoc deleted file mode 100644 index 7c31277c2..000000000 --- a/sdrf-proteomics/templates/base/README.adoc +++ /dev/null @@ -1,32 +0,0 @@ -= SDRF-Proteomics: Base Template -:sectnums: -:toc: left -:doctype: book - -[[status]] -== Status - -**Status:** Internal Construction Artifact - -**Version:** 1.1.0 - 2026-01 - -[IMPORTANT] -==== -**This template cannot be used directly.** It is an internal construction artifact that defines shared columns inherited by all other templates. - -For documentation of base columns, see the link:../../README.adoc[main SDRF-Proteomics specification], specifically the sample metadata and data file metadata sections. -==== - -[[usage]] -== Usage - -Use one of the following technology templates instead: - -* link:../ms-proteomics/README.adoc[MS-Proteomics Template] - For mass spectrometry-based proteomics -* link:../affinity-proteomics/README.adoc[Affinity-Proteomics Template] - For affinity-based proteomics (Olink, SomaScan) - -[[files]] -== Template Files - -- link:https://github.com/bigbio/sdrf-templates/blob/main/base/1.1.0/base.yaml[base.yaml] - YAML template definition for validation -- link:https://github.com/bigbio/sdrf-templates/blob/main/base/1.1.0/base.sdrf.tsv[base.sdrf.tsv] - Column header template diff --git a/sdrf-proteomics/templates/cell-lines/README.adoc b/sdrf-proteomics/templates/cell-lines/README.adoc deleted file mode 100644 index a1eca527b..000000000 --- a/sdrf-proteomics/templates/cell-lines/README.adoc +++ /dev/null @@ -1,613 +0,0 @@ -= SDRF-Proteomics: Cell Line Template -:sectnums: -:toc: left -:doctype: book -//only works on some backends, not HTML -:showcomments: -//use style like Section 1 when referencing within the document. -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -//GitHub specific settings -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides guidelines for annotating cell line-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with cell line-specific metadata fields and resources. - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -Cell lines are extensively used in proteomics research for biological studies and technology development. They present unique annotation challenges: metadata (sex, age, disease) refers to the original donor, multiple naming conventions exist (HeLa, HELA, He-La), and cell lines may be misidentified or have undergone genetic drift. - -This template defines standardized approaches for annotating cell line experiments, using **Cellosaurus as the PRIMARY standard** for cell line identification and metadata retrieval. - -IMPORTANT: **Cellosaurus is the REQUIRED primary standard** for cell line annotation in SDRF-Proteomics. The `characteristics[cellosaurus accession]` column (CVCL_XXXX format) is REQUIRED for all cell line experiments. Do NOT use EFO, CLO, or BTO as primary identifiers - these are accepted only for legacy compatibility and cross-reference purposes. - -[[cellosaurus]] -== Cellosaurus: The Primary Cell Line Resource - -https://www.cellosaurus.org/[Cellosaurus] is a comprehensive knowledge resource on cell lines maintained by the SIB Swiss Institute of Bioinformatics. It provides: - -- Standardized cell line names -- Unique accession numbers (CVCL_XXXX format) -- Cross-references to other databases -- Information about species, diseases, and cell types -- Documentation of cell line problems (contamination, misidentification) - -IMPORTANT: While Cellosaurus is not a formal ontology, it is the most comprehensive and actively maintained resource for cell line information. SDRF-Proteomics RECOMMENDS using Cellosaurus accession numbers for cell line identification. - -=== Cellosaurus Accession Format - -Cellosaurus accessions follow the format `CVCL_XXXX` where XXXX is a unique identifier: - -|=== -|Cell Line |Cellosaurus Name |Cellosaurus Accession - -|HeLa -|HeLa -|CVCL_0030 - -|HEK293 -|HEK293 -|CVCL_0045 -|=== - -[[cell-line-metadata-db]] -== SDRF Cell Line Metadata Database - -To facilitate consistent annotation of cell line experiments, a curated database of cell line metadata is available: - -https://github.com/bigbio/sdrf-cellline-metadata-db[SDRF Cell Line Metadata Database] - -The database file is available at: -https://raw.githubusercontent.com/bigbio/sdrf-cellline-metadata-db/main/cl-annotations-db.tsv - -[[checklist]] -== Checklist - -This section defines the metadata columns required and recommended for cell line experiments. - -=== Required Columns - -The following columns are REQUIRED for cell line experiments: - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    characteristics[cell line]REQUIREDName of the cell lineCellosaurusHeLa, HEK293, K562
    characteristics[organism]REQUIREDSpecies of the cell lineNCBITaxonhomo sapiens, mus musculus
    characteristics[organism part]REQUIREDTissue/organ of originUBERONcervix, kidney, blood
    characteristics[disease]REQUIREDDisease state of original tissueMONDOcervical adenocarcinoma, normal, chronic myelogenous leukemia
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|characteristics[cell line] |REQUIRED |Name of the cell line |Cellosaurus |HeLa, HEK293, K562 -|characteristics[organism] |REQUIRED |Species of the cell line |NCBITaxon |homo sapiens, mus musculus -|characteristics[organism part] |REQUIRED |Tissue/organ of origin |UBERON |cervix, kidney, blood -|characteristics[disease] |REQUIRED |Disease state of original tissue |MONDO |cervical adenocarcinoma, normal, chronic myelogenous leukemia -|=== -endif::[] - -=== Required Cellosaurus Columns - -The following Cellosaurus columns are REQUIRED for cell line experiments: - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    characteristics[cellosaurus accession]REQUIREDCellosaurus unique identifierCellosaurusCVCL_0030, CVCL_0045, CVCL_0004
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|characteristics[cellosaurus accession] |REQUIRED |Cellosaurus unique identifier |Cellosaurus |CVCL_0030, CVCL_0045, CVCL_0004 -|=== -endif::[] - -=== Recommended Columns - -The following columns are RECOMMENDED for cell line experiments: - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    characteristics[cellosaurus name]RECOMMENDEDOfficial Cellosaurus nameCellosaurusHeLa, HEK293, K-562
    characteristics[cell type]RECOMMENDEDCell type classificationCell Ontology (CL)epithelial cell, fibroblast, lymphoblast
    characteristics[sex]RECOMMENDEDSex of original donorPATOfemale, male, not available
    characteristics[age]RECOMMENDEDAge of donor at sample collectionFree text31Y, not available, fetal
    characteristics[sampling site]OPTIONALSpecific anatomical sampling locationUBERONcervix uteri, fetal kidney, peripheral blood
    comment[passage number]RECOMMENDEDPassage number of cells usedEFO:0007061P15, P20-25, low passage
    comment[cell line source]OPTIONALSource/provider of cell lineEFO:0004443ATCC, DSMZ, ECACC, in-house
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|characteristics[cellosaurus name] |RECOMMENDED |Official Cellosaurus name |Cellosaurus |HeLa, HEK293, K-562 -|characteristics[cell type] |RECOMMENDED |Cell type classification |Cell Ontology (CL) |epithelial cell, fibroblast, lymphoblast -|characteristics[sex] |RECOMMENDED |Sex of original donor |PATO |female, male, not available -|characteristics[age] |RECOMMENDED |Age of donor at sample collection |Free text |31Y, not available, fetal -|characteristics[sampling site] |OPTIONAL |Specific anatomical sampling location |UBERON |cervix uteri, fetal kidney, peripheral blood -|comment[passage number] |RECOMMENDED |Passage number of cells used |EFO:0007061 |P15, P20-25, low passage -|comment[cell line source] |OPTIONAL |Source/provider of cell line |EFO:0004443 |ATCC, DSMZ, ECACC, in-house -|=== -endif::[] - -=== Optional Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    characteristics[developmental stage]OPTIONALDevelopmental stage of donorUBERONadult, fetus, embryo
    characteristics[ancestry category]OPTIONALAncestry of donor if knownHANCESTROAfrican American, European, not available
    comment[cell line modifications]OPTIONALGenetic or other modificationsEFO:0000510CRISPR knockout of TP53, GFP-tagged, parental
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|characteristics[developmental stage] |OPTIONAL |Developmental stage of donor |UBERON |adult, fetus, embryo -|characteristics[ancestry category] |OPTIONAL |Ancestry of donor if known |HANCESTRO |African American, European, not available -|comment[cell line modifications] |OPTIONAL |Genetic or other modifications |EFO:0000510 |CRISPR knockout of TP53, GFP-tagged, parental -|=== -endif::[] - -[[metadata-sources]] -== Understanding Metadata Sources - -Cell line metadata comes from two sources: - -=== Database-Derived Metadata - -These fields describe the original cell line and SHOULD be obtained from Cellosaurus or the SDRF Cell Line Metadata Database: - -- `characteristics[organism]` - Species -- `characteristics[organism part]` - Tissue of origin -- `characteristics[disease]` - Disease of original tissue -- `characteristics[sex]` - Sex of donor -- `characteristics[age]` - Age of donor -- `characteristics[cell type]` - Cell type -- `characteristics[ancestry category]` - Donor ancestry -- `characteristics[developmental stage]` - Donor developmental stage -- `characteristics[cellosaurus accession]` - Identifier -- `characteristics[sampling site]` - Anatomical location - -IMPORTANT: For database-derived fields, use the values from the cell line database, NOT values specific to your experiment. For example, `characteristics[age]` should be the age of the original donor (e.g., "31Y" for HeLa), not the "age" of your cell culture. - -=== Experiment-Specific Metadata - -These fields describe your specific experiment and SHOULD be provided by the user: - -- `comment[passage number]` - Your passage number (https://www.ebi.ac.uk/ols4/ontologies/efo/classes/http%253A%252F%252Fwww.ebi.ac.uk%252Fefo%252FEFO_0007061[EFO:0007061]) -- `comment[cell line source]` - Where you obtained cells (https://www.ebi.ac.uk/ols4/ontologies/efo/classes/http%253A%252F%252Fwww.ebi.ac.uk%252Fefo%252FEFO_0004443[EFO:0004443 - Material Supplier]) -- `comment[cell line modifications]` - Any modifications made (https://www.ebi.ac.uk/ols4/ontologies/efo/classes/http%253A%252F%252Fwww.ebi.ac.uk%252Fefo%252FEFO_0000510[EFO:0000510 - Genetic modification]) -- `characteristics[treatment]` - Experimental treatments (https://www.ebi.ac.uk/ols4/ontologies/efo/classes/http%253A%252F%252Fwww.ebi.ac.uk%252Fefo%252FEFO_0000727[EFO:0000727]) -- `characteristics[compound]` - Drugs/compounds applied (https://www.ebi.ac.uk/ols4/ontologies/efo/classes/http%253A%252F%252Fwww.ebi.ac.uk%252Fefo%252FEFO_0000369[EFO:0000369 - Compound Based Treatment]) - -[[ontology-mapping]] -== Ontology Mapping - -While Cellosaurus is the RECOMMENDED primary resource, SDRF-Proteomics also accepts terms from: - -|=== -|Resource |Use Case |OLS Link |Example - -|Cellosaurus -|Primary cell line identification (RECOMMENDED) -|https://www.cellosaurus.org/[Cellosaurus] -|CVCL_0030 - -|BTO (BRENDA Tissue Ontology) -|Alternative ontology terms for cell lines -|https://www.ebi.ac.uk/ols4/ontologies/bto[OLS - BTO] -|BTO:0000567 - -|CLO (Cell Line Ontology) -|Legacy support (not actively maintained) -|https://www.ebi.ac.uk/ols4/ontologies/clo[OLS - CLO] -|CLO:0003684 - -|EFO (Experimental Factor Ontology) -|General experimental factors -|https://www.ebi.ac.uk/ols4/ontologies/efo[OLS - EFO] -|EFO:0001185 -|=== - -When multiple identifiers are available, we RECOMMEND including at minimum: -1. `characteristics[cell line]` - Common name -2. `characteristics[cellosaurus accession]` - Cellosaurus ID - -[[example-sdrf]] -== Example SDRF Files - -=== Basic Cell Line Experiment - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[cell line]characteristics[cellosaurus accession]characteristics[organism]characteristics[disease]...comment[passage number]assay namecomment[data file]
    HeLa_ctrl_rep1HeLaCVCL_0030homo sapienscervical adenocarcinoma...P18HeLa_ctrl_run1HeLa_ctrl_1.raw
    HeLa_ctrl_rep2HeLaCVCL_0030homo sapienscervical adenocarcinoma...P18HeLa_ctrl_run2HeLa_ctrl_2.raw
    HeLa_treat_rep1HeLaCVCL_0030homo sapienscervical adenocarcinoma...P18HeLa_treat_run1HeLa_treat_1.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |characteristics[cell line] |characteristics[cellosaurus accession] |characteristics[organism] |characteristics[disease] |... |comment[passage number] |assay name |comment[data file] - -|HeLa_ctrl_rep1 |HeLa |CVCL_0030 |homo sapiens |cervical adenocarcinoma |... |P18 |HeLa_ctrl_run1 |HeLa_ctrl_1.raw -|HeLa_ctrl_rep2 |HeLa |CVCL_0030 |homo sapiens |cervical adenocarcinoma |... |P18 |HeLa_ctrl_run2 |HeLa_ctrl_2.raw -|HeLa_treat_rep1 |HeLa |CVCL_0030 |homo sapiens |cervical adenocarcinoma |... |P18 |HeLa_treat_run1 |HeLa_treat_1.raw -|=== -endif::[] - -=== Multi-Cell Line Comparison - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[cell line]characteristics[cellosaurus accession]characteristics[organism]characteristics[disease]...assay namecomment[data file]factor value[cell line]
    MCF7_rep1MCF7CVCL_0031homo sapiensbreast adenocarcinoma...MCF7_run1MCF7_1.rawMCF7
    MCF7_rep2MCF7CVCL_0031homo sapiensbreast adenocarcinoma...MCF7_run2MCF7_2.rawMCF7
    MDA-MB-231_rep1MDA-MB-231CVCL_0062homo sapiensbreast adenocarcinoma...MDAMB231_run1MDAMB231_1.rawMDA-MB-231
    MDA-MB-231_rep2MDA-MB-231CVCL_0062homo sapiensbreast adenocarcinoma...MDAMB231_run2MDAMB231_2.rawMDA-MB-231
    -
    - Sample metadata - Data file metadata - Factor value -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |characteristics[cell line] |characteristics[cellosaurus accession] |characteristics[organism] |characteristics[disease] |... |assay name |comment[data file] |factor value[cell line] - -|MCF7_rep1 |MCF7 |CVCL_0031 |homo sapiens |breast adenocarcinoma |... |MCF7_run1 |MCF7_1.raw |MCF7 -|MCF7_rep2 |MCF7 |CVCL_0031 |homo sapiens |breast adenocarcinoma |... |MCF7_run2 |MCF7_2.raw |MCF7 -|MDA-MB-231_rep1 |MDA-MB-231 |CVCL_0062 |homo sapiens |breast adenocarcinoma |... |MDAMB231_run1 |MDAMB231_1.raw |MDA-MB-231 -|MDA-MB-231_rep2 |MDA-MB-231 |CVCL_0062 |homo sapiens |breast adenocarcinoma |... |MDAMB231_run2 |MDAMB231_2.raw |MDA-MB-231 -|=== -endif::[] - -[[cell-line-issues]] -== Common Cell Line Issues - -=== Misidentified Cell Lines - -Some cell lines have known issues with misidentification or contamination. Cellosaurus documents these problems. When using cell lines with known issues: - -1. Check Cellosaurus for any documented problems -2. Document your authentication method in `comment[authentication method]` -3. Consider noting issues in `comment[cell line notes]` - -=== Cell Line Variants and Sublines - -For cell line variants or sublines: - -|=== -|Parent Cell Line |Variant |How to Annotate - -|HeLa -|HeLa S3 -|Use specific Cellosaurus accession (CVCL_0058) - -|HEK293 -|HEK293T -|Use HEK293T accession (CVCL_0063) - -|Jurkat -|Jurkat E6-1 -|Use Jurkat E6-1 accession (CVCL_0367) -|=== - -Always use the most specific Cellosaurus accession for your cell line variant. - -=== Cell Lines with Unknown Donor Information - -For cell lines where donor information is unknown: - -- Use `not available` for unknown fields (age, sex, ancestry) -- Do NOT leave cells empty -- Document what is known from Cellosaurus - -[[best-practices]] -== Best Practices - -1. **Use Cellosaurus accessions**: Always include `characteristics[cellosaurus accession]` when available. - -2. **Retrieve metadata from databases**: Use the SDRF Cell Line Metadata Database for consistent annotation. - -3. **Document passage number**: Include `comment[passage number]` for reproducibility. - -4. **Use official names**: Prefer Cellosaurus names over informal abbreviations. - -5. **Separate database vs. experiment metadata**: Understand which fields come from databases vs. your experiment. - -6. **Check for known issues**: Review Cellosaurus for contamination or misidentification reports. - -7. **Include source information**: Document where cells were obtained with `comment[cell line source]`. - -[[template-file]] -== Template File - -The cell line SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/cell-lines/1.1.0/cell-lines.sdrf.tsv[cell-lines.sdrf.tsv] - -[[validation]] -== Validation - -Cell line SDRF files should be validated using the sdrf-pipelines tool: - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv ----- - -[[authors]] -== Authors and Maintainers - -This template was developed by the SDRF-Proteomics community. - -For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository]. - -[[references]] -== References - -- Cellosaurus: https://www.cellosaurus.org/ -- SDRF Cell Line Metadata Database: https://github.com/bigbio/sdrf-cellline-metadata-db -- Bairoch A. (2018) The Cellosaurus, a cell-line knowledge resource. Journal of Biomolecular Techniques. -- ICLAC (International Cell Line Authentication Committee): https://iclac.org/ diff --git a/sdrf-proteomics/templates/crosslinking/README.adoc b/sdrf-proteomics/templates/crosslinking/README.adoc deleted file mode 100644 index dfa1667dd..000000000 --- a/sdrf-proteomics/templates/crosslinking/README.adoc +++ /dev/null @@ -1,507 +0,0 @@ -= SDRF-Proteomics: Crosslinking Mass Spectrometry Template -:sectnums: -:toc: left -:doctype: book -//only works on some backends, not HTML -:showcomments: -//use style like Section 1 when referencing within the document. -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -//GitHub specific settings -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides a template for annotating crosslinking mass spectrometry (XL-MS) experiments in SDRF-Proteomics format. This template defines additional columns that can be combined with any sample template (human, vertebrates, etc.) to capture crosslinking-specific metadata. - -**Type:** Experiment Template (used in combination with sample templates) - -**Status:** Stable - -**Version:** 1.0.0 - 2026-01 - -[[abstract]] -== Abstract - -Crosslinking mass spectrometry (XL-MS) uses chemical reagents to covalently link amino acid residues in close spatial proximity, providing information for protein structure determination, protein-protein interaction mapping, complex characterization, and integrative structural biology. - -This template is designed with **data analysis in mind**. The REQUIRED columns capture the minimum metadata needed to configure XL-MS search engines like Scout, xiSEARCH, pLink2, or MeroX. Sample preparation details (reaction time, temperature, concentration) are captured as OPTIONAL columns for reproducibility documentation. -[[checklist]] -== Column Checklist - -=== REQUIRED Columns - -These columns are essential for configuring XL-MS analysis workflows: - -|=== -|Column Name |Type |Description |Example Values - -|characteristics[enrichment process] -|Sample -|Indicates the sample was enriched for crosslinked peptides (https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000838[PRIDE:0000838]). This is a sample-level property. -|enrichment of cross-linked peptides - -|comment[cross-linker] -|Data acquisition -|Cross-linker compound with structured properties for analysis tools. Uses XLMOD ontology (parent term XLMOD:00004). Format: NT=name;AC=accession;CL=cleavable;TA=targets;MH/ML=stub masses -|NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98 - -|comment[dissociation method] -|Data acquisition -|Fragmentation method used in MS2. Critical for cleavable crosslinkers (DSSO, DSBU) which generate diagnostic stub ions. -|HCD, CID, ETD, EThcD, stepped HCD -|=== - -NOTE: Columns inherited from ms-proteomics are also required: `comment[cleavage agent details]`, `comment[instrument]`, `comment[label]`, `comment[fraction identifier]`. - -=== Column Type Distinction - -- **`characteristics[...]`** = Sample properties (what IS the sample) -- **`comment[...]`** = Data acquisition properties (how was data acquired) - -For crosslinking: - -- `characteristics[enrichment process]` = the sample underwent enrichment for crosslinked peptides (PRIDE:0000838, sample property) -- `comment[cross-linker]` = which crosslinker was used and its properties (data acquisition) - -=== Template Selection: When to Apply Human Template - -The **human template** should only be applied to **biological human samples** (tissues, cell lines, body fluids). It should NOT be applied to: - -- **Recombinant protein standards** with human sequences -- **Synthetic protein mixtures** for benchmarking -- **In-vitro crosslinked purified proteins** - -For these non-biological samples: - -|=== -|Sample Type |Templates |characteristics[organism] |characteristics[material type] - -|Human tissue/cells -|ms-proteomics, crosslinking, **human** -|homo sapiens -|tissue, cell line - -|Recombinant protein standard -|ms-proteomics, crosslinking -|homo sapiens -|recombinant protein - -|Synthetic benchmark -|ms-proteomics, crosslinking -|homo sapiens (or source species) -|synthetic construct -|=== - -NOTE: The `characteristics[organism]` indicates the **proteome to search against**, not necessarily the biological origin of the sample. Use `characteristics[material type]` to clarify the sample nature. - -=== File Metadata Columns - -SDRF files SHOULD include metadata columns to specify version and template information. Only list leaf templates; parent templates are implied by inheritance (crosslinking inherits from ms-proteomics). Place these columns at the end of the file. - -**Non-biological samples** (recombinant proteins, synthetic constructs): - -|=== -|... |comment[sdrf version] |comment[sdrf template] - -|... |v1.1.0 |crosslinking v1.0.0 -|=== - -**Human biological samples** (tissues, cell lines) - use multiple template columns: - -|=== -|... |comment[sdrf version] |comment[sdrf template] |comment[sdrf template] - -|... |v1.1.0 |human v1.1.0 |crosslinking v1.0.0 -|=== - -Each template's version indicates which version of that specific template the file conforms to. - -=== RECOMMENDED Columns - -|=== -|Column Name |Description |Example Values - -|comment[collision energy] -|Collision energy used for fragmentation. Important for cleavable crosslinker analysis. -|27, 30%, stepped 27+-6% - -|comment[crosslink enrichment method] -|Method used to enrich crosslinked peptides before MS analysis. -|size exclusion chromatography, strong cation exchange chromatography, FAIMS - -|comment[modification parameters] -|Post-translational modifications (inherited from base template). -|NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed -|=== - -=== OPTIONAL Columns (Sample Preparation Details) - -These columns document sample preparation for reproducibility but are not required for analysis: - -|=== -|Column Name |Description |Example Values - -|characteristics[crosslink type] -|Type of crosslinker chemistry (derivable from reagent). -|homo-bifunctional, hetero-bifunctional, zero-length, MS-cleavable - -|characteristics[crosslink distance] -|Maximum Ca-Ca distance constraint (for structural interpretation). -|30 A, 26.4 A, 11.4 A - -|comment[crosslinker concentration] -|Concentration of crosslinking reagent used. -|2 mM, 500 uM, 1 mM - -|characteristics[crosslinking reaction time] -|Duration of the crosslinking reaction. -|30 min, 1 h, 45 min - -|characteristics[crosslinking temperature] -|Temperature at which crosslinking was performed. -|25 C, 4 C, room temperature - -|comment[crosslinker to protein ratio] -|Molar ratio of crosslinker to protein. -|50:1, 100:1 - -|comment[quenching reagent] -|Reagent used to quench the crosslinking reaction. -|Tris-HCl, ammonium bicarbonate, glycine -|=== - -[[crosslinker-annotation]] -== Crosslinker Annotation Format - -The `comment[cross-linker]` column uses a structured key-value format that enables automated analysis configuration. The accession should reference terms from the XLMOD ontology (parent term https://www.ebi.ac.uk/ols4/ontologies/xlmod/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FXLMOD_00004[XLMOD:00004 - cross-linker]): - -[source] ----- -NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98 ----- - -=== Key-Value Properties - -|=== -|Key |Property |Status |Description |Example - -|NT -|Name -|REQUIRED -|Cross-linker name -|NT=DSSO - -|AC -|Accession -|REQUIRED -|XLMOD or ChEBI accession -|AC=XLMOD:02010 - -|CL -|Cleavable -|REQUIRED -|MS-cleavable (yes/no) -|CL=yes - -|TA -|Target Amino Acids -|RECOMMENDED -|Residues targeted by crosslinker -|TA=K,S,T,Y,nterm - -|MH -|Heavy Stub Mass -|REQUIRED (if cleavable) -|Mass of heavy fragment (Da) -|MH=54.01 - -|ML -|Light Stub Mass -|REQUIRED (if cleavable) -|Mass of light fragment (Da) -|ML=85.98 - -|SM -|Spacer Mass -|REQUIRED (if non-cleavable, except zero-length) -|Full crosslinker mass (Da). For zero-length crosslinkers (e.g., EDC), SM=0 and can be omitted. -|SM=138.07 -|=== - -=== Common Crosslinker Examples - -[source] ----- -# MS-cleavable crosslinkers (Scout defaults) -NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01056468;ML=85.98263585 -NT=DSBU;AC=XLMOD:02011;CL=yes;TA=K,S,T,Y,nterm;MH=85.05276381;ML=111.03202835 -NT=DSBSO;AC=XLMOD:02012;CL=yes;TA=K,S,T,Y,nterm;MH=54.01056;ML=236.0177 -NT=DSAU;AC=XLMOD:02013;CL=yes;TA=K,S,T,Y,nterm;MH=57.02146371;ML=83.00072827 - -# Non-cleavable crosslinkers -NT=DSS;AC=XLMOD:02001;CL=no;TA=K,S,T,Y,nterm;SM=138.07 -NT=BS3;AC=XLMOD:02000;CL=no;TA=K,S,T,Y,nterm;SM=138.07 - -# Zero-length crosslinker (SM=0 is implicit for zero-length) -NT=EDC;AC=XLMOD:02009;CL=no;TA=K,D,E;SM=0 - -# Photo-reactive crosslinker -NT=SDA;AC=XLMOD:02005;CL=no;TA=K,S,T,Y,nterm ----- - -=== Crosslinker Reference Table - -|=== -|Crosslinker |Type |Target Residues |Cleavable |Spacer Arm |Max Ca-Ca - -|DSSO -|Homo-bifunctional, NHS ester -|K, S, T, Y, N-term -|Yes -|10.3 A -|~26 A - -|DSBU -|Homo-bifunctional, NHS ester -|K, S, T, Y, N-term -|Yes -|12.5 A -|~30 A - -|DSBSO -|Homo-bifunctional, NHS ester -|K, S, T, Y, N-term -|Yes -|10.3 A -|~25 A - -|DSAU -|Homo-bifunctional, NHS ester -|K, S, T, Y, N-term -|Yes -|10.0 A -|~25 A - -|DSS -|Homo-bifunctional, NHS ester -|K, S, T, Y, N-term -|No -|11.4 A -|~30 A - -|BS3 -|Homo-bifunctional, NHS ester (water-soluble) -|K, S, T, Y, N-term -|No -|11.4 A -|~30 A - -|EDC -|Zero-length -|D, E to K -|No -|0 A -|~15 A - -|SDA -|Photo-reactive -|K + any -|No -|3.9 A -|~20 A -|=== - -[[example-project]] -== Example Project - -A complete annotated crosslinking dataset is available: - -**PXD042173** - Proteome-scale recombinant standard datasets for XL-MS - -- **Crosslinker:** DSSO (MS-cleavable) -- **Instrument:** Orbitrap Fusion Lumos with FAIMS -- **Enrichment:** Strong cation exchange chromatography -- **Fragmentation:** Stepped HCD (27+-6%) -- **Material Type:** Recombinant protein standard (not a biological sample) - -link:../../sdrf-explorer.html?view=PXD042173[Open in SDRF Viewer] | link:../../../annotated-projects/PXD042173/PXD042173.sdrf.tsv[Download SDRF file] - -[[example-sdrf]] -== Example SDRF Structure - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[material type]characteristics[enrichment process]comment[cross-linker]comment[dissociation method]comment[collision energy]comment[data file]
    batch1_sample1homo sapiensrecombinant proteinenrichment of cross-linked peptidesNT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98HCDstepped 27+-6%sample1_fraction1.raw
    batch1_sample2homo sapiensrecombinant proteinenrichment of cross-linked peptidesNT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98HCDstepped 27+-6%sample1_fraction2.raw
    -
    - Sample metadata - Data acquisition metadata -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[material type] |characteristics[enrichment process] |comment[cross-linker] |comment[dissociation method] |comment[collision energy] |comment[data file] - -|batch1_sample1 -|homo sapiens -|recombinant protein -|enrichment of cross-linked peptides -|NT=DSSO;AC=XLMOD:02010;CL=yes;... -|HCD -|stepped 27+-6% -|sample1_fraction1.raw - -|batch1_sample2 -|homo sapiens -|recombinant protein -|enrichment of cross-linked peptides -|NT=DSSO;AC=XLMOD:02010;CL=yes;... -|HCD -|stepped 27+-6% -|sample1_fraction2.raw -|=== -endif::[] - -[[analysis-tool-mapping]] -== Mapping to Analysis Tools - -This section shows how SDRF columns map to parameters in common XL-MS search engines: - -=== Scout - -|=== -|SDRF Column |Scout Parameter |Notes - -|comment[cross-linker] (NT) -|CXLReagent.Name -|Crosslinker name - -|comment[cross-linker] (TA) -|CXLReagent.Targets -|Target residues (K, S, T, Y) - -|comment[cross-linker] (MH) -|CXLReagent.HeavyFragment -|Heavy stub mass for cleavable XL - -|comment[cross-linker] (ML) -|CXLReagent.LightFragment -|Light stub mass for cleavable XL - -|comment[cleavage agent details] -|Enzyme -|Trypsin, Lys-C, etc. - -|comment[modification parameters] -|StaticModifications, VariableModifications -|Carbamidomethyl, Oxidation, etc. -|=== - -=== xiSEARCH - -|=== -|SDRF Column |xiSEARCH Parameter |Notes - -|comment[cross-linker] -|crosslinker: definition -|Full crosslinker config - -|comment[dissociation method] -|Fragment ions considered -|HCD enables stub ion detection - -|comment[cleavage agent details] -|digestion: config -|Enzyme definition - -|comment[modification parameters] -|modification: config -|Fixed and variable mods -|=== - -[[validation]] -== Validation - -Crosslinking SDRF files should be validated using sdrf-pipelines: - -[source,bash] ----- -pip install sdrf-pipelines - -# Validate with crosslinking template -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv \ - --template ms-proteomics \ - --template crosslinking - -# For human samples -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv \ - --template ms-proteomics \ - --template human \ - --template crosslinking ----- - -[[template-file]] -== Template File - -The crosslinking SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/crosslinking/1.1.0/crosslinking.sdrf.tsv[crosslinking.sdrf.tsv] - -[[references]] -== References - -- Leitner A, et al. (2016) Crosslinking and Mass Spectrometry: An Integrated Technology to Understand the Structure and Function of Molecular Machines. Trends in Biochemical Sciences. -- O'Reilly FJ, Rappsilber J. (2018) Cross-linking mass spectrometry: methods and applications in structural, molecular and systems biology. Nature Structural & Molecular Biology. -- Iacobucci C, et al. (2019) A cross-linking/mass spectrometry workflow based on MS-cleavable cross-linkers and the MeroX software. Nature Protocols. -- XLMOD database: https://www.ebi.ac.uk/ols4/ontologies/xlmod -- Scout: https://github.com/diogobor/Scout -- xiSEARCH: https://www.rappsilberlab.org/software/xisearch/ diff --git a/sdrf-proteomics/templates/dda-acquisition/README.adoc b/sdrf-proteomics/templates/dda-acquisition/README.adoc deleted file mode 100644 index 395cff941..000000000 --- a/sdrf-proteomics/templates/dda-acquisition/README.adoc +++ /dev/null @@ -1,444 +0,0 @@ -= SDRF-Proteomics: Data-dependent acquisition (DDA) Template -:sectnums: -:toc: left -:doctype: book -//only works on some backends, not HTML -:showcomments: -//use style like Section 1 when referencing within the document. -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -//GitHub specific settings -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides a template for annotating Data-dependent acquisition (DDA) mass spectrometry experiments in SDRF-Proteomics format. This template defines additional columns that can be combined with any core template (human, vertebrates, etc.) to capture DDA-specific metadata. - -**Type:** Experiment-type Template (used in combination with core templates) - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -Data-dependent acquisition (DDA) is the most widely used mass spectrometry acquisition strategy for proteomics. This template captures acquisition-specific parameters that affect data quality and reproducibility: dissociation method, collision energy, fractionation, modification parameters, mass tolerances, and MS2 mass analyzer. - -[[checklist]] -== Checklist - -This section defines the metadata columns required and recommended for DDA experiments. - -=== Recommended Columns - -The following columns are RECOMMENDED for DDA experiments (in addition to the core SDRF-Proteomics requirements): - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntology/CVExample Values
    comment[dissociation method]RECOMMENDEDFragmentation method usedPRIDE (MS:1000044)NT=HCD;AC=PRIDE:0000590
    comment[modification parameters]RECOMMENDEDPost-translational modifications searchedUNIMODNT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35;PP=Anywhere
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology/CV |Example Values - -|comment[dissociation method] |RECOMMENDED |Fragmentation method used |PRIDE (MS:1000044) |NT=HCD;AC=PRIDE:0000590 -|comment[modification parameters] |RECOMMENDED |Post-translational modifications searched |UNIMOD |NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35;PP=Anywhere -|=== -endif::[] - -=== Optional Columns - -The following columns are OPTIONAL but commonly used: - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntology/CVExample Values
    comment[collision energy]OPTIONALCollision energy used for fragmentationPSI-MS (MS:1000045)27, 30, normalized 27
    comment[fractionation method]OPTIONALMethod used to fractionate the sample before MSPRIDE (PRIDE:0000550)NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564
    comment[precursor mass tolerance]OPTIONALMass tolerance for precursor ions in database searchNumeric value with unit10 ppm, 20 ppm
    comment[fragment mass tolerance]OPTIONALMass tolerance for fragment ions in database searchNumeric value with unit0.02 Da, 20 ppm
    comment[MS2 mass analyzer]OPTIONALMass analyzer used for MS2 acquisitionPSI-MS (MS:1000443)NT=orbitrap;AC=MS:1000484
    comment[precursor min mz]OPTIONALMS method-defined minimum precursor m/z setting used to acquire the dataPRIDE (PRIDE:0000476)350, 400
    comment[precursor max mz]OPTIONALMS method-defined maximum precursor m/z setting used to acquire the dataPRIDE (PRIDE:0000477)1600, 2000
    comment[precursor min charge]OPTIONALMS method-defined minimum precursor charge state setting used to acquire the dataPRIDE (PRIDE:0000472)1, 2
    comment[precursor max charge]OPTIONALMS method-defined maximum precursor charge state setting used to acquire the dataPRIDE (PRIDE:0000473)4, 6
    comment[min retention time]OPTIONALLC method-defined minimum retention time setting used to acquire the dataPRIDE (PRIDE:0000474)0, 5
    comment[max retention time]OPTIONALLC method-defined maximum retention time setting used to acquire the dataPRIDE (PRIDE:0000475)120, 90
    comment[min ion mobility]OPTIONALMS method-defined minimum ion mobility setting used to acquire the dataPRIDE (PRIDE:0000841)0.6, 0.7
    comment[max ion mobility]OPTIONALMS method-defined maximum ion mobility setting used to acquire the dataPRIDE (PRIDE:0000842)1.4, 1.6
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology/CV |Example Values - -|comment[collision energy] |OPTIONAL |Collision energy used for fragmentation |PSI-MS (MS:1000045) |27, 30, normalized 27 -|comment[fractionation method] |OPTIONAL |Method used to fractionate the sample before MS |PRIDE (PRIDE:0000550) |NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564 -|comment[precursor mass tolerance] |OPTIONAL |Mass tolerance for precursor ions in database search |Numeric value with unit |10 ppm, 20 ppm -|comment[fragment mass tolerance] |OPTIONAL |Mass tolerance for fragment ions in database search |Numeric value with unit |0.02 Da, 20 ppm -|comment[MS2 mass analyzer] |OPTIONAL |Mass analyzer used for MS2 acquisition |PSI-MS (MS:1000443) |NT=orbitrap;AC=MS:1000484 -|comment[precursor min mz] |OPTIONAL |MS method-defined minimum precursor m/z setting used to acquire the data |PRIDE (PRIDE:0000476) |350, 400 -|comment[precursor max mz] |OPTIONAL |MS method-defined maximum precursor m/z setting used to acquire the data |PRIDE (PRIDE:0000477) |1600, 2000 -|comment[precursor min charge] |OPTIONAL |MS method-defined minimum precursor charge state setting used to acquire the data |PRIDE (PRIDE:0000472) |1, 2 -|comment[precursor max charge] |OPTIONAL |MS method-defined maximum precursor charge state setting used to acquire the data |PRIDE (PRIDE:0000473) |4, 6 -|comment[min retention time] |OPTIONAL |LC method-defined minimum retention time setting used to acquire the data |PRIDE (PRIDE:0000474) |0, 5 -|comment[max retention time] |OPTIONAL |LC method-defined maximum retention time setting used to acquire the data |PRIDE (PRIDE:0000475) |120, 90 -|comment[min ion mobility] |OPTIONAL |MS method-defined minimum ion mobility setting used to acquire the data |PRIDE (PRIDE:0000841) |0.6, 0.7 -|comment[max ion mobility] |OPTIONAL |MS method-defined maximum ion mobility setting used to acquire the data |PRIDE (PRIDE:0000842) |1.4, 1.6 -|=== -endif::[] - -NOTE: For data file metadata (comment columns), use the full CV term format `NT={name};AC={accession}` when possible. This format enables automated validation and software can often determine these values from raw files. - -[[example-sdrf]] -== Example SDRF File - -A complete example for a fractionated DDA proteomics experiment: - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source name...assay namecomment[proteomics data acquisition method]comment[label]comment[fraction identifier]comment[dissociation method]comment[data file]
    liver_sample_001...DDA_liver001_F01Data-dependent acquisitionlabel free sample1HCDliver001_F01.raw
    liver_sample_001...DDA_liver001_F02Data-dependent acquisitionlabel free sample2HCDliver001_F02.raw
    liver_sample_002...DDA_liver002_F01Data-dependent acquisitionlabel free sample1HCDliver002_F01.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |... |assay name |comment[proteomics data acquisition method] |comment[label] |comment[fraction identifier] |comment[dissociation method] |comment[data file] - -|liver_sample_001 |... |DDA_liver001_F01 |Data-dependent acquisition |label free sample |1 |HCD |liver001_F01.raw -|liver_sample_001 |... |DDA_liver001_F02 |Data-dependent acquisition |label free sample |2 |HCD |liver001_F02.raw -|liver_sample_002 |... |DDA_liver002_F01 |Data-dependent acquisition |label free sample |1 |HCD |liver002_F01.raw -|=== -endif::[] - -NOTE: The `...` column indicates omitted core columns (organism, organism part, disease, biological replicate, technology type, instrument, cleavage agent, modification parameters, etc.). - -[[single-shot-example]] -== Single-Shot DDA Example - -For high-throughput or clinical samples without fractionation: - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - -
    source name...assay namecomment[proteomics data acquisition method]comment[label]comment[instrument]comment[dissociation method]comment[data file]
    plasma_001...plasma001_run1Data-dependent acquisitionlabel free sampleOrbitrap Exploris 480HCDplasma_001.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |... |assay name |comment[proteomics data acquisition method] |comment[label] |comment[instrument] |comment[dissociation method] |comment[data file] - -|plasma_001 |... |plasma001_run1 |Data-dependent acquisition |label free sample |Orbitrap Exploris 480 |HCD |plasma_001.raw -|=== -endif::[] - -NOTE: For single-shot experiments, `comment[fractionation method]` can be omitted or set to `not applicable`. - -[[tmt-dda-example]] -== TMT-Labeled DDA Example - -For isobaric labeling experiments (TMT, iTRAQ): - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source name...assay namecomment[proteomics data acquisition method]comment[label]comment[fraction identifier]comment[dissociation method]comment[data file]
    sample_A_rep1...TMT_set1_F01Data-dependent acquisitionTMT1261HCDTMT_set1_F01.raw
    sample_B_rep1...TMT_set1_F01Data-dependent acquisitionTMT127N1HCDTMT_set1_F01.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |... |assay name |comment[proteomics data acquisition method] |comment[label] |comment[fraction identifier] |comment[dissociation method] |comment[data file] - -|sample_A_rep1 |... |TMT_set1_F01 |Data-dependent acquisition |TMT126 |1 |HCD |TMT_set1_F01.raw -|sample_B_rep1 |... |TMT_set1_F01 |Data-dependent acquisition |TMT127N |1 |HCD |TMT_set1_F01.raw -|=== -endif::[] - -NOTE: For TMT experiments, multiple samples share the same raw file. Use `comment[label]` to distinguish channels. TMT quantification can use MS2 or MS3 acquisition—for MS3-based TMT, use https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000646[PRIDE:0000646 (MS3 spectra)]. - -[[best-practices]] -== Best Practices for DDA Annotation - -1. **Always specify acquisition method**: Use `comment[proteomics data acquisition method]` with `Data-dependent acquisition`. - -2. **Document fragmentation method**: Use `comment[dissociation method]` to specify HCD, CID, ETD, or EThcD—these produce different fragmentation patterns and affect peptide identification. - -3. **Include modification parameters**: Document all searched PTMs using `comment[modification parameters]` with UNIMOD accessions. - -4. **Document fractionation**: Include `comment[fractionation method]` and properly number fractions with `comment[fraction identifier]`. - -5. **Report collision energy**: Include `comment[collision energy]` when available, as it affects fragmentation quality. - -6. **Specify MS2 analyzer**: Use `comment[MS2 mass analyzer]` for hybrid instruments (e.g., Orbitrap vs ion trap MS2). - -7. **Report mass tolerances when known**: `comment[precursor mass tolerance]` and `comment[fragment mass tolerance]` aid data reanalysis. - -[[template-file]] -== Template File - -The DDA SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/dda-acquisition/1.1.0/dda-acquisition.sdrf.tsv[dda-acquisition.sdrf.tsv] - -[[validation]] -== Validation - -DDA SDRF files should be validated using the sdrf-pipelines tool: - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv ----- - -NOTE: DDA-specific validation rules are under development. - -[[authors]] -== Authors and Maintainers - -This template was developed by the SDRF-Proteomics community. - -For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository]. - diff --git a/sdrf-proteomics/templates/dia-acquisition/README.adoc b/sdrf-proteomics/templates/dia-acquisition/README.adoc deleted file mode 100644 index 449f5fdbb..000000000 --- a/sdrf-proteomics/templates/dia-acquisition/README.adoc +++ /dev/null @@ -1,527 +0,0 @@ -= SDRF-Proteomics: Data-independent acquisition (DIA) Template -:sectnums: -:toc: left -:doctype: book -//only works on some backends, not HTML -:showcomments: -//use style like Section 1 when referencing within the document. -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -//GitHub specific settings -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides a template for annotating Data-independent acquisition (DIA) mass spectrometry experiments in SDRF-Proteomics format. This template defines additional columns that can be combined with any core template (human, vertebrates, etc.) to capture DIA-specific metadata. - -**Type:** Experiment-type Template (used in combination with core templates) - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -Data-independent acquisition (DIA) is a mass spectrometry acquisition strategy where all precursor ions within a specified m/z range are fragmented systematically, regardless of their intensity. Unlike Data-dependent acquisition (DDA), DIA provides comprehensive and reproducible proteome coverage, reduced missing values across samples, and better quantitative accuracy. Popular DIA methods include SWATH-MS, MSE, All-Ion Fragmentation (AIF), and various windowed DIA approaches. - -DIA experiments have unique characteristics: predefined m/z isolation windows, scan window ranges, stepped collision energies, and spectral library requirements. This template captures the acquisition parameters essential for DIA data analysis and reproducibility. - -[[connections]] -== Connections to Analysis Pipelines - -DIA data is typically analyzed using specialized software: - -- **DIA-NN**: Deep learning-based DIA analysis -- **Spectronaut**: Commercial DIA analysis platform -- **OpenSWATH**: Open-source targeted analysis -- **MaxDIA**: MaxQuant's DIA module -- **EncyclopeDIA**: Chromatogram library search -- **Skyline**: Targeted quantification - -When documenting DIA experiments, noting the intended or used analysis software is RECOMMENDED. - -[[checklist]] -== Checklist - -This section defines the metadata columns required and recommended for DIA experiments. - -=== Recommended Columns - -The following columns are RECOMMENDED for DIA experiments (in addition to the core SDRF-Proteomics requirements): - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntology/CVExample Values
    comment[scan window lower limit]RECOMMENDEDLower m/z limit of the DIA scan rangeNumeric value (m/z)400, 350
    comment[scan window upper limit]RECOMMENDEDUpper m/z limit of the DIA scan rangeNumeric value (m/z)1200, 1650
    comment[isolation window width]RECOMMENDEDWidth of DIA isolation windowsPSI-MS (MS:1000828)25, 8, variable
    comment[DIA method]RECOMMENDEDSpecific DIA method variant (child of PRIDE:0000450)PRIDE (PRIDE:0000450)NT=SWATH-MS;AC=PRIDE:0000451, diaPASEF, scanning SWATH
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology/CV |Example Values - -|comment[scan window lower limit] |RECOMMENDED |Lower m/z limit of the DIA scan range |Numeric value (m/z) |400, 350 -|comment[scan window upper limit] |RECOMMENDED |Upper m/z limit of the DIA scan range |Numeric value (m/z) |1200, 1650 -|comment[isolation window width] |RECOMMENDED |Width of DIA isolation windows |PSI-MS (MS:1000828) |25, 8, variable -|comment[DIA method] |RECOMMENDED |Specific DIA method variant |PRIDE (PRIDE:0000450) |NT=SWATH-MS;AC=PRIDE:0000451, diaPASEF, scanning SWATH -|=== -endif::[] - -NOTE: The parent term for all DIA methods is https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000450[Data-independent acquisition (PRIDE:0000450)]. Use `comment[DIA method]` to specify the specific variant when known. Check the https://www.ebi.ac.uk/ols4/ontologies/pride[PRIDE Controlled Vocabulary] for available terms. - -=== Optional Columns - -The following columns are OPTIONAL but commonly used: - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntology/CVExample Values
    comment[collision energy]OPTIONALCollision energy used for fragmentation (can have multiple for stepped CE)PSI-MS (MS:1000045)27 NCE, 30 eV, 22 NCE;26 NCE;30 NCE
    comment[dissociation method]OPTIONALFragmentation method usedPRIDE (MS:1000044)NT=HCD;AC=PRIDE:0000590
    comment[MS2 mass analyzer]OPTIONALMass analyzer used for MS2 acquisitionPSI-MS (MS:1000443)NT=Orbitrap;AC=MS:1000484
    comment[precursor mass tolerance]OPTIONALMass tolerance for precursor ions in database searchNumeric value with unit10 ppm, 20 ppm
    comment[fragment mass tolerance]OPTIONALMass tolerance for fragment ions in database searchNumeric value with unit0.02 Da, 20 ppm
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology/CV |Example Values - -|comment[collision energy] |OPTIONAL |Collision energy used for fragmentation |PSI-MS (MS:1000045) |27 NCE, 30 eV, 22 NCE;26 NCE;30 NCE -|comment[dissociation method] |OPTIONAL |Fragmentation method used |PRIDE (MS:1000044) |NT=HCD;AC=PRIDE:0000590 -|comment[MS2 mass analyzer] |OPTIONAL |Mass analyzer used for MS2 acquisition |PSI-MS (MS:1000443) |NT=Orbitrap;AC=MS:1000484 -|comment[precursor mass tolerance] |OPTIONAL |Mass tolerance for precursor ions in database search |Numeric value with unit |10 ppm, 20 ppm -|comment[fragment mass tolerance] |OPTIONAL |Mass tolerance for fragment ions in database search |Numeric value with unit |0.02 Da, 20 ppm -|=== -endif::[] - -NOTE: The parent term for all DIA methods is https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000450[Data-independent acquisition (PRIDE:0000450)]. Use `comment[DIA method]` to specify the specific variant when known. Check the https://www.ebi.ac.uk/ols4/ontologies/pride[PRIDE Controlled Vocabulary] for available terms. - -=== Optional Columns - -The following columns are OPTIONAL but commonly used: - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntology/CVExample Values
    comment[precursor mass tolerance]OPTIONALMass tolerance for precursor ions in database searchNumeric value with unit10 ppm, 20 ppm
    comment[fragment mass tolerance]OPTIONALMass tolerance for fragment ions in database searchNumeric value with unit0.02 Da, 20 ppm
    comment[precursor min mz]OPTIONALMS method-defined minimum precursor m/z setting used to acquire the dataPRIDE (PRIDE:0000476)350, 400
    comment[precursor max mz]OPTIONALMS method-defined maximum precursor m/z setting used to acquire the dataPRIDE (PRIDE:0000477)1600, 2000
    comment[precursor min charge]OPTIONALMS method-defined minimum precursor charge state setting used to acquire the dataPRIDE (PRIDE:0000472)1, 2
    comment[precursor max charge]OPTIONALMS method-defined maximum precursor charge state setting used to acquire the dataPRIDE (PRIDE:0000473)4, 6
    comment[min retention time]OPTIONALLC method-defined minimum retention time setting used to acquire the dataPRIDE (PRIDE:0000474)0, 5
    comment[max retention time]OPTIONALLC method-defined maximum retention time setting used to acquire the dataPRIDE (PRIDE:0000475)120, 90
    comment[min ion mobility]OPTIONALMS method-defined minimum ion mobility setting used to acquire the dataPRIDE (PRIDE:0000841)0.6, 0.7
    comment[max ion mobility]OPTIONALMS method-defined maximum ion mobility setting used to acquire the dataPRIDE (PRIDE:0000842)1.4, 1.6
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology/CV |Example Values - -|comment[precursor mass tolerance] |OPTIONAL |Mass tolerance for precursor ions in database search |Numeric value with unit |10 ppm, 20 ppm -|comment[fragment mass tolerance] |OPTIONAL |Mass tolerance for fragment ions in database search |Numeric value with unit |0.02 Da, 20 ppm -|comment[precursor min mz] |OPTIONAL |MS method-defined minimum precursor m/z setting used to acquire the data |PRIDE (PRIDE:0000476) |350, 400 -|comment[precursor max mz] |OPTIONAL |MS method-defined maximum precursor m/z setting used to acquire the data |PRIDE (PRIDE:0000477) |1600, 2000 -|comment[precursor min charge] |OPTIONAL |MS method-defined minimum precursor charge state setting used to acquire the data |PRIDE (PRIDE:0000472) |1, 2 -|comment[precursor max charge] |OPTIONAL |MS method-defined maximum precursor charge state setting used to acquire the data |PRIDE (PRIDE:0000473) |4, 6 -|comment[min retention time] |OPTIONAL |LC method-defined minimum retention time setting used to acquire the data |PRIDE (PRIDE:0000474) |0, 5 -|comment[max retention time] |OPTIONAL |LC method-defined maximum retention time setting used to acquire the data |PRIDE (PRIDE:0000475) |120, 90 -|comment[min ion mobility] |OPTIONAL |MS method-defined minimum ion mobility setting used to acquire the data |PRIDE (PRIDE:0000841) |0.6, 0.7 -|comment[max ion mobility] |OPTIONAL |MS method-defined maximum ion mobility setting used to acquire the data |PRIDE (PRIDE:0000842) |1.4, 1.6 -|=== -endif::[] - -[[stepped-collision-energy]] -== Stepped Collision Energy - -Many DIA methods use stepped or ramped collision energies to improve fragmentation coverage. Document this using multiple `comment[collision energy]` columns or semicolon-separated values: - -=== Multiple Columns Approach - -|=== -|comment[collision energy] |comment[collision energy] |comment[collision energy] - -|22 NCE -|26 NCE -|30 NCE -|=== - -=== Semicolon-Separated Approach - -|=== -|comment[collision energy] - -|22 NCE;26 NCE;30 NCE -|=== - -Both approaches are valid. Use the approach that best fits your workflow. - -[[isolation-window-schemes]] -== Isolation Window Schemes - -DIA methods vary in their isolation window strategies: - -|=== -|Scheme |Description |How to Document - -|Fixed windows -|Equal-width windows across mass range -|comment[isolation window width] = 25 - -|Variable windows -|Windows optimized for ion density -|comment[isolation window width] = variable; provide method file reference - -|Overlapping windows -|Windows with m/z overlap -|Note in comment[DIA method] or separate documentation - -|Scanning/sliding windows -|Continuous scanning approach -|comment[DIA method] = scanning SWATH -|=== - -For complex schemes, reference the instrument method file in `comment[method file]` if available. - -[[dia-variants]] -== DIA Method Variants - -Common DIA acquisition methods and their characteristics: - -|=== -|Method |PRIDE CV |Vendor/Origin |Key Features |Example Annotation - -|SWATH-MS -|PRIDE:0000451 -|SCIEX -|Fixed or variable windows, typically 25-100 windows -|NT=SWATH-MS;AC=PRIDE:0000451 - -|MSE -|PRIDE:0000452 -|Waters -|All-ion fragmentation, alternating low/high energy -|NT=MSE;AC=PRIDE:0000452 - -|All ion fragmentation (AIF) -|PRIDE:0000453 -|Thermo -|All-ion fragmentation approach -|NT=All ion fragmentation;AC=PRIDE:0000453 - -|diaPASEF -|(pending) -|Bruker -|Ion mobility-enhanced DIA -|diaPASEF - -|boxcar DIA -|(pending) -|Various -|Multiplexed acquisition with notched windows -|boxcar DIA - -|Scanning SWATH -|(pending) -|SCIEX -|Continuously scanning isolation window -|scanning SWATH -|=== - -NOTE: Methods marked as "(pending)" do not yet have PRIDE CV accessions. Use the free text name until official terms are available. - -[[example-sdrf]] -== Example SDRF File - -A complete example for a DIA proteomics experiment: - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[disease]...comment[proteomics data acquisition method]comment[scan window lower limit]comment[scan window upper limit]comment[DIA method]comment[data file]
    plasma_sample_001homo sapiensnormal...Data-independent acquisition3501650SWATH-MSplasma_001.raw
    plasma_sample_002homo sapiensnormal...Data-independent acquisition3501650SWATH-MSplasma_002.raw
    plasma_sample_003homo sapienstype 2 diabetes mellitus...Data-independent acquisition3501650SWATH-MSplasma_003.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |characteristics[organism] |characteristics[disease] |... |comment[proteomics data acquisition method] |comment[scan window lower limit] |comment[scan window upper limit] |comment[DIA method] |comment[data file] - -|plasma_sample_001 |homo sapiens |normal |... |Data-independent acquisition |350 |1650 |SWATH-MS |plasma_001.raw -|plasma_sample_002 |homo sapiens |normal |... |Data-independent acquisition |350 |1650 |SWATH-MS |plasma_002.raw -|plasma_sample_003 |homo sapiens |type 2 diabetes mellitus |... |Data-independent acquisition |350 |1650 |SWATH-MS |plasma_003.raw -|=== -endif::[] - -NOTE: The `...` column indicates omitted columns (organism part, biological replicate, technology type, label, instrument, cleavage agent, fraction identifier, technical replicate, isolation window width, collision energy, mass tolerances, dissociation method). - -[[diaPASEF-example]] -== diaPASEF Example - -For ion mobility-enhanced DIA (diaPASEF), the following columns capture the ion mobility acquisition window: - -|=== -|Column Name |Description |PRIDE CV |Example Values - -|comment[min ion mobility] -|MS method-defined minimum ion mobility setting used to acquire the data -|PRIDE:0000841 -|0.6 - -|comment[max ion mobility] -|MS method-defined maximum ion mobility setting used to acquire the data -|PRIDE:0000842 -|1.6 -|=== - -[[best-practices]] -== Best Practices for DIA Annotation - -1. **Always specify acquisition method**: Use `comment[proteomics data acquisition method]` with the PRIDE CV term for DIA. - -2. **Document scan range**: Include `comment[scan window lower limit]` and `comment[scan window upper limit]` for reproducibility. - -3. **Report isolation window details**: Document window width and number of windows when known. - -4. **Include collision energy**: Document all collision energies used, especially for stepped CE methods. - -5. **Note the DIA variant**: Use `comment[DIA method]` to specify SWATH-MS, diaPASEF, MSE, etc. - -6. **Reference spectral libraries**: If using a spectral library, document it in `comment[spectral library]`. - -7. **Report mass tolerances**: These are essential for data reanalysis. - -8. **Consider instrument-specific parameters**: Different platforms may have unique parameters worth documenting. - -[[template-file]] -== Template File - -The DIA SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/dia-acquisition/1.1.0/dia-acquisition.sdrf.tsv[dia-acquisition.sdrf.tsv] - -[[validation]] -== Validation - -DIA SDRF files should be validated using the sdrf-pipelines tool: - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv ----- - -NOTE: DIA-specific validation rules are under development. - -[[authors]] -== Authors and Maintainers - -This template was developed by the SDRF-Proteomics community with contributions from DIA proteomics researchers. - -For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository]. - diff --git a/sdrf-proteomics/templates/human/README.adoc b/sdrf-proteomics/templates/human/README.adoc deleted file mode 100644 index 2f596ef8b..000000000 --- a/sdrf-proteomics/templates/human/README.adoc +++ /dev/null @@ -1,1664 +0,0 @@ -= SDRF-Proteomics: Human Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -The human template provides standardized metadata fields for human proteomics experiments. It extends the base template with clinical and demographic metadata required for human samples. - -This template is appropriate for: - -* Clinical proteomics studies -* Healthy human donor samples -* Cancer and disease biomarker studies -* Drug treatment and pharmacoproteomics studies - -[[extends]] -== Template Hierarchy - -[source] ----- -base (construction artifact) - └── human (SAMPLE layer - must combine with TECHNOLOGY template) ----- - -The human template extends the **base** template, adding disease annotation and human-specific clinical metadata fields. - -[IMPORTANT] -==== -The human template **cannot be used alone**. You must combine it with a technology template: - -* `ms-proteomics` + `human` - For MS-based proteomics of human samples -* `affinity-proteomics` + `human` - For affinity proteomics (Olink, SomaScan) of human samples -==== - -[[checklist]] -== Checklist - -=== Inherited Columns - -All columns from the base template are inherited (source name, organism, organism part, biological replicate, assay name, technology type, instrument, technical replicate, data file). Technology-specific columns (cleavage agent, label, fraction identifier, etc.) come from the technology template (`ms-proteomics` or `affinity-proteomics`). - -=== Human-Specific Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionSection
    characteristics[disease]REQUIREDDisease state of the sampleSample Metadata
    characteristics[age]RECOMMENDEDAge of the donor at sample collectionSample Metadata
    characteristics[sex]RECOMMENDEDBiological sex of the donorSample Metadata
    characteristics[individual]RECOMMENDEDUnique identifier for the donorIndividual Identifier
    characteristics[ancestry category]RECOMMENDEDAncestry or ethnic backgroundAncestry Category
    characteristics[developmental stage]OPTIONALDevelopmental stage (adult, fetal, etc.)Sample Metadata
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column Name |Requirement |Description |Section - -|characteristics[disease] |REQUIRED |Disease state of the sample |Sample Metadata -|characteristics[age] |RECOMMENDED |Age of the donor at sample collection |Sample Metadata -|characteristics[sex] |RECOMMENDED |Biological sex of the donor |Sample Metadata -|characteristics[individual] |RECOMMENDED |Unique identifier for the donor |Individual Identifier -|characteristics[ancestry category] |RECOMMENDED |Ancestry or ethnic background |Ancestry Category -|characteristics[developmental stage] |OPTIONAL |Developmental stage (adult, fetal, etc.) |Sample Metadata -|=== -endif::[] - -=== Clinical Study Columns (Optional) - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionSection
    characteristics[pre-existing condition]OPTIONALPre-existing medical conditionsPre-existing Condition
    characteristics[disease staging]OPTIONALDisease stage (I, II, III, IV)Disease Staging
    characteristics[clinical data]OPTIONALClinical measurements (e.g., glucose level)Clinical Data
    characteristics[tumor stage]OPTIONALTNM staging for cancerTumor Stage
    characteristics[tumor grade]OPTIONALTumor differentiation gradeTumor Grading
    characteristics[treatment]OPTIONALTreatment administeredTreatment
    characteristics[compound]OPTIONALDrug or compound usedCompound
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column Name |Requirement |Description |Section - -|characteristics[pre-existing condition] |OPTIONAL |Pre-existing medical conditions |Pre-existing Condition -|characteristics[disease staging] |OPTIONAL |Disease stage (I, II, III, IV) |Disease Staging -|characteristics[clinical data] |OPTIONAL |Clinical measurements (e.g., glucose level) |Clinical Data -|characteristics[tumor stage] |OPTIONAL |TNM staging for cancer |Tumor Stage -|characteristics[tumor grade] |OPTIONAL |Tumor differentiation grade |Tumor Grading -|characteristics[treatment] |OPTIONAL |Treatment administered |Treatment -|characteristics[compound] |OPTIONAL |Drug or compound used |Compound -|=== -endif::[] - -[[validation]] -== Validation - -Validate SDRF files using sdrf-pipelines: - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template human ----- - -[[examples]] -== Example - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[disease]characteristics[organism part]characteristics[age]characteristics[sex]characteristics[individual]characteristics[biological replicate]assay namecomment[data file]factor value[disease]
    patient_001homo sapienshepatocellular carcinomaliver55YmaleP0011run_001patient_001.rawhepatocellular carcinoma
    patient_002homo sapienshepatocellular carcinomaliver62YfemaleP0021run_002patient_002.rawhepatocellular carcinoma
    control_001homo sapiensnormalliver48YmaleC0011run_003control_001.rawnormal
    -
    - Sample metadata - Data file metadata - Factor values -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[disease] |characteristics[organism part] |characteristics[age] |characteristics[sex] |characteristics[individual] |characteristics[biological replicate] |assay name |comment[data file] |factor value[disease] - -|patient_001 |homo sapiens |hepatocellular carcinoma |liver |55Y |male |P001 |1 |run_001 |patient_001.raw |hepatocellular carcinoma -|patient_002 |homo sapiens |hepatocellular carcinoma |liver |62Y |female |P002 |1 |run_002 |patient_002.raw |hepatocellular carcinoma -|control_001 |homo sapiens |normal |liver |48Y |male |C001 |1 |run_003 |control_001.raw |normal -|=== -endif::[] - -== Detailed Column Guidelines - -This section provides detailed guidelines for each human-specific metadata column, organized by category: - -* <> - Basic donor/patient information -* <> - Clinical study metadata -* <> - Tumor characterization -* <> - Anatomical location specificity -* <> - Biomarker annotations -* <> - Drug treatments - -[[general-human-metadata]] -== General Human Metadata - -This section describes basic metadata columns applicable to all human samples, including healthy donors and patients. - -=== Individual Identifier - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[individual]EFO:0000542Recommended
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[individual]` |EFO:0000542 |Recommended -|=== -endif::[] - -**Format:** Alphanumeric pseudonymized identifier (e.g., `patient_001`, `P023455`, `donor_1`). - -IMPORTANT: Never use actual patient names. Use pseudonymized identifiers only. Consider GDPR, HIPAA regulations. - -Enables tracking of: - -* Biological replicates from the same individual -* Matched samples (tumor/normal pairs from same patient) -* Longitudinal samples (same patient over time) -* Family/pedigree studies - -**Examples:** -[source] ----- -characteristics[individual]: patient_001 -characteristics[individual]: individual 234 -characteristics[individual]: donor_1 ----- - -When multiple samples come from the same patient, use consistent identifier: - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[individual]characteristics[organism part]
    sample_001patient_001tumor
    sample_002patient_001adjacent normal
    -
    - Sample metadata (characteristics) -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1"] -|=== -|source name |characteristics[individual] |characteristics[organism part] - -|sample_001 |patient_001 |tumor -|sample_002 |patient_001 |adjacent normal -|=== -endif::[] - -=== Ancestry Category - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[ancestry category]HANCESTRORecommended
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[ancestry category]` |HANCESTRO |Recommended -|=== -endif::[] - -|=== -|Value |HANCESTRO ID |Description - -|African |HANCESTRO:0010 |African ancestry -|European |HANCESTRO:0005 |European ancestry -|East Asian |HANCESTRO:0009 |East Asian ancestry -|South Asian |HANCESTRO:0006 |South Asian ancestry -|American |HANCESTRO:0013 |American ancestry (Indigenous peoples of the Americas) -|=== - -NOTE: Ancestry category values retain proper noun capitalization (e.g., `African`, `European`) since they refer to geographic populations. This is an exception to the general lowercase rule for controlled vocabulary terms. Use the short form (e.g., `African`) rather than the full label (e.g., `African ancestry`). - -Use `not available` when ancestry is unknown, `not applicable` for non-human samples or cell lines where ancestry doesn't apply. - -=== Body Measurements - -|=== -|Column |Ontology |Format |Example - -|`characteristics[body mass index]` |EFO:0004340 |Numeric (kg/m²) |25.5 -|`characteristics[weight]` |EFO:0004324 |{value} kg |70 kg -|`characteristics[height]` |EFO:0004339 |{value} cm |175 cm -|=== - -=== Sampling Time Point - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[sampling time point]EFO:0000688Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[sampling time point]` |EFO:0000688 |Optional -|=== -endif::[] - -For longitudinal studies, indicates when sample was collected relative to a reference point. - -Values: `baseline`, `week 1`, `day 7`, `post-treatment`, `follow-up`. - -[[clinical-specific-terms]] -== Clinical-Specific Terms - -This section describes columns for capturing clinical metadata in human studies, applicable to patient samples regardless of disease type. - -=== Pre-existing Condition - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[pre-existing condition]MONDOOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[pre-existing condition]` |MONDO |Optional -|=== -endif::[] - -Comorbidities or pre-existing medical conditions. For multiple conditions, use multiple columns (preferred) or semicolon-separated values. - -|=== -|Condition |SDRF Value |MONDO ID - -|High blood pressure |hypertension |MONDO:0005044 -|Diabetes |type 2 diabetes mellitus |MONDO:0005148 -|Heart disease |coronary artery disease |MONDO:0005010 -|Obesity |obesity |MONDO:0011122 -|=== - -=== Disease Staging - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[disease staging]NCIT, EFO:0000410Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[disease staging]` |NCIT, EFO:0000410 |Optional -|=== -endif::[] - -Disease staging captures overall disease progression, including cancer staging, chronic disease phases, and severity classifications. - -|=== -|Value |NCIT ID |Description |Use Case - -|stage I |NCIT:C27966 |Early localized disease |Solid tumors -|stage II |? |Locally advanced disease |Solid tumors (use disease-specific staging) -|stage III |NCIT:C27970 |Regional spread |Solid tumors -|stage IV |NCIT:C27971 |Distant metastasis |Solid tumors -|chronic phase |? |Stable chronic disease |Leukemia, chronic conditions (use disease-specific terms) -|end stage |? |Terminal disease phase |End-stage organ failure (use disease-specific terms) -|=== - -NOTE: Some staging terms like "stage II", "chronic phase", and "end stage" do not have generic NCIT codes. For these, use disease-specific staging terms when available (e.g., NCIT:C3175 for Chronic Phase CML). - -**Examples:** -[source] ----- -characteristics[disease staging]: chronic phase -characteristics[disease staging]: end stage -characteristics[disease staging]: stage 1 -characteristics[disease staging]: mild inflammation ----- - -Use `not available` when staging is unknown, `not applicable` for non-disease samples. - -=== Clinical Data - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[clinical data]EFO:0030083Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[clinical data]` |EFO:0030083 |Optional -|=== -endif::[] - -Free-text or structured clinical details about samples that don't fit into other structured fields. Use this column for receptor status, treatment history, surgical details, and other clinical annotations. - -NOTE: Use the term `clinical data` (EFO:0030083) rather than `clinical information` to align with EFO ontology. - -**Examples:** -[source] ----- -characteristics[clinical data]: breast reduction mammoplasty tissue explant -characteristics[clinical data]: lesional -characteristics[clinical data]: estrogen-receptor-positive, progesterone-receptor-positive, epidermal growth-factor-2-negative -characteristics[clinical data]: no cytogenetic response to imatinib ----- - -**Best Practice:** Consider using structured columns (e.g., separate columns for ER/PR/HER2 status) when possible. Use `clinical data` for additional context that doesn't fit elsewhere. - -=== Clinical History - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[clinical history]EFO:0000352Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[clinical history]` |EFO:0000352 |Optional -|=== -endif::[] - -Captures relevant medical history information for the patient. - -[[cancer-specific-terms]] -== Cancer-Specific Terms - -This section describes columns specific to cancer proteomics studies. These terms are distinct from general clinical staging and provide detailed tumor characterization. - -=== Tumor Stage (TNM Staging) - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[tumor stage]
    Alt: characteristics[TNM staging]    		NCIT, EFO:0004925Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[tumor stage]` (alt: `characteristics[TNM staging]`) |NCIT, EFO:0004925 |Optional -|=== -endif::[] - -TNM staging describes the extent of cancer spread. Format: `T{0-4}N{0-3}M{0-1}` where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix `p` indicates pathological staging (post-surgery), `c` indicates clinical staging. - -|=== -|Value |Description |Staging Type - -|T1N0M0 |Small tumor, no lymph nodes, no metastasis |Clinical or pathological -|pT2pN1M0 |Pathological staging after surgery |Pathological -|Type IV |Stage IV disease |Roman numeral notation -|IIB |Stage IIB |Roman numeral with substage -|=== - -**Examples:** -[source] ----- -characteristics[tumor stage]: Type IV -characteristics[tumor stage]: IIB -characteristics[tumor stage]: T3N0M0 ----- - -=== Tumor Grading - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[tumor grading]
    Alt: characteristics[tumor grade]    		NCIT:C28076Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[tumor grading]` (alt: `characteristics[tumor grade]`) |NCIT:C28076 |Optional -|=== -endif::[] - -Histological tumor grade describes how abnormal cancer cells look under a microscope. Grade correlates with tumor aggressiveness. - -|=== -|Value |NCIT ID |Description - -|grade 1 |NCIT:C28077 |Well differentiated (low grade) -|grade 2 |NCIT:C28078 |Moderately differentiated (intermediate grade) -|grade 3 |NCIT:C28079 |Poorly differentiated (high grade) -|grade 4 |NCIT:C28082 |Undifferentiated (high grade) -|=== - -**Examples:** -[source] ----- -characteristics[tumor grading]: grade 2 -characteristics[tumor grading]: grade 3 ----- - -=== Metastasis Site - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[metastasis site]EFO:0009708, UBERONOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[metastasis site]` |EFO:0009708, UBERON |Optional -|=== -endif::[] - -Location where cancer has spread from the primary site. - -|=== -|Value |Description - -|lymph node |Metastasis to lymph nodes -|liver |Hepatic metastasis -|lung |Pulmonary metastasis -|bone |Bone metastasis -|brain |Brain metastasis -|pleura |Pleural metastasis -|=== - -=== Tumor Size and Mass - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[tumor size]
    Alt: characteristics[tumor mass]    		EFO:0004134, EFO:0007062Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[tumor size]` (alt: `characteristics[tumor mass]`) |EFO:0004134, EFO:0007062 |Optional -|=== -endif::[] - -**Format:** `{value} {unit}` (e.g., `2.5 cm`, `15 mm`, `50 g`) - -=== Biopsy Site - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[biopsy site]EFO:0000288, UBERONOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[biopsy site]` |EFO:0000288, UBERON |Optional -|=== -endif::[] - -Specific anatomical location where biopsy was performed. - -**Examples:** `left leg`, `right breast`, `Brodmann area 46`, `liver segment 7` - -=== Survival Time - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[survival time]EFO:0000714Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[survival time]` |EFO:0000714 |Optional -|=== -endif::[] - -**Format:** `{value} {unit}` (e.g., `24 months`, `3 years`) - -Used for survival analysis studies to track patient outcomes. - -=== Last Follow Up - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[last follow up]EFO:0007058Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[last follow up]` |EFO:0007058 |Optional -|=== -endif::[] - -**Format:** `{value} {unit}` (e.g., `12 months`, `2 years`) - -Time of last clinical follow-up for longitudinal studies. - -=== Mitotic Rate - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[mitotic rate]—Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[mitotic rate]` |— |Optional -|=== -endif::[] - -Number of mitoses per high-power field. Used for histological grading in some cancer types. - -=== Cancer Subtype Classifications - -**Breast cancer subtype** (`characteristics[breast cancer subtype]`): - -|=== -|Value |NCIT ID |Description - -|luminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67 -|luminal B |NCIT:C53555 |ER+/PR+, HER2+/- , high Ki67 -|HER2-enriched |NCIT:C53556 |ER-/PR-, HER2+ -|triple-negative |NCIT:C71732 |ER-/PR-/HER2- -|=== - -**Other cancer-specific staging systems:** - -* `characteristics[Dukes stage]` - Colorectal cancer staging (A, B, C, D) -* `characteristics[Ann Arbor stage]` - Lymphoma staging (I, II, III, IV) -* `characteristics[Gleason score]` - Prostate cancer grading -* `characteristics[Weiss grade]` - Adrenal cortical carcinoma (low, high) - -[[sampling-site]] -== Sampling Site - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[sampling site]EFO:0000688, UBERON, BTOOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[sampling site]` |EFO:0000688, UBERON, BTO |Optional -|=== -endif::[] - -Specifies the exact sampling location within an organ or tissue, providing more detail than `characteristics[organism part]`. This column is critical for cancer proteomics studies to distinguish tumor tissue from normal tissue. - -=== Relationship with `characteristics[organism part]` - -These two columns work together to provide hierarchical anatomical information: - -* **`characteristics[organism part]`** = General anatomical structure (e.g., "breast", "liver", "heart") -* **`characteristics[sampling site]`** = Specific location or context within that structure (e.g., "tumor", "normal tissue adjacent to tumor", "left ventricle") - -=== When to Use Sampling Site - -Use `characteristics[sampling site]` when you need to specify: - -* **Tumor vs. normal distinction** - Critical for matched tumor/normal studies -* **Specific anatomical sub-regions** - e.g., "left ventricle" within "heart" -* **Disease-specific locations** - e.g., "adenoma" within "colorectum" -* **Developmental zones** - e.g., "root differentiation zone" (for plant studies) - -=== Usage Patterns - -**Pattern 1: Cancer Studies (Tumor/Normal/Adjacent)** - -|=== -|characteristics[organism part] |characteristics[sampling site] |Use Case - -|breast |tumor |Primary tumor tissue -|breast |normal tissue adjacent to tumor |Adjacent normal tissue (may have field effects) -|breast |tumor-distant section |Normal tissue from same organ, distant from tumor -|colorectum |tumor |Colorectal tumor -|colorectum |normal tissue |Normal colorectal tissue -|liver |normal tissue |Unaffected liver tissue -|=== - -**Examples:** -[source] ----- -characteristics[organism part]: breast -characteristics[sampling site]: tumor-distant section - -characteristics[organism part]: colorectum -characteristics[sampling site]: normal tissue adjacent to tumor ----- - -**Pattern 2: Anatomical Sub-Regions** - -|=== -|characteristics[organism part] |characteristics[sampling site] |Use Case - -|heart |left ventricle |Specific heart chamber -|brain |frontal cortex |Specific brain region -|cerebellum |posterior inferior cerebellum |Detailed cerebellar location -|colonic mucosa |sigmoid colon |Specific colon region -|=== - -=== Annotation Preferences - -There are two valid approaches for anatomical annotation: - -**Option 1: Most specific level in organism part (preferred for simple cases)** - -When no additional context is needed, use the most specific anatomical term directly: - -[source] ----- -characteristics[organism part]: left ventricle -characteristics[organism part]: cerebral cortex -characteristics[organism part]: sigmoid colon ----- - -**Option 2: General + sampling site (preferred for complex cases)** - -When you need additional context (e.g., tumor vs. normal), use both columns: - -[source] ----- -characteristics[organism part]: heart -characteristics[sampling site]: left ventricle - -characteristics[organism part]: breast -characteristics[sampling site]: tumor ----- - -**Guidelines:** - -1. **Prefer most specific level** in `organism part` when simple anatomical annotation is sufficient -2. **Use `sampling site`** when you need to capture tumor/normal distinction, disease context, or other qualitative information -3. **Do NOT use multiple organism part columns** - This pattern is not recommended -4. Use lowercase for all values - -[[phenotype-and-biomarkers]] -== Phenotype and Biomarkers - -For general phenotype annotation guidelines applicable to all organisms, see link:../../metadata-guidelines/sample-metadata.adoc#phenotype-annotation[Sample Metadata Guidelines - Phenotype]. - -This section focuses on **human-specific biomarker applications** of the phenotype column. - -=== Clinical Biomarkers - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[phenotype]PATO, HPOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[phenotype]` |PATO, HP |Optional -|=== -endif::[] - -In clinical proteomics, phenotype is commonly used to capture biomarker status for patient stratification: - -|=== -|Biomarker Type |Example Values |Clinical Application - -|Hormone receptor status |ER positive, PR negative |Breast cancer treatment selection -|Growth factor receptors |HER2 positive, EGFR positive |Targeted therapy eligibility -|Immune markers |PD-L1 high, CD8+ infiltrating |Immunotherapy response prediction -|Stem cell markers |CD34 positive, ALDH+ |Stem cell identification -|=== - -**Examples:** -[source] ----- -characteristics[phenotype]: HER2 positive -characteristics[phenotype]: ER positive -characteristics[phenotype]: triple negative -characteristics[phenotype]: PD-L1 high expression ----- - -=== Drug Response in Human Studies - -For pharmacoproteomics and precision medicine studies: - -[source] ----- -characteristics[phenotype]: gefitinib sensitive -characteristics[phenotype]: cisplatin resistant -characteristics[phenotype]: tamoxifen resistant -characteristics[phenotype]: imatinib responder ----- - -=== Genotype for Human Variants - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[genotype]EFOOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[genotype]` |EFO |Optional -|=== -endif::[] - -For human genetic variants, use genotype to capture specific mutations: - -[source] ----- -characteristics[genotype]: BRCA1 mutation carrier -characteristics[genotype]: KRAS G12D mutant -characteristics[genotype]: wild type -characteristics[genotype]: TP53 R175H ----- - -=== Biomarker vs Genotype vs Phenotype - -|=== -|Concept |Column |Example |Use Case - -|Genetic mutation |`characteristics[genotype]` |BRCA1 mutation |Known genetic variant -|Protein expression status |`characteristics[phenotype]` |HER2 positive |Biomarker measured by IHC/proteomics -|Drug sensitivity |`characteristics[phenotype]` |cisplatin resistant |Functional drug response -|=== - -[[treatment-and-perturbation-metadata]] -== Treatment and Perturbation Metadata - -This section describes columns for capturing drug treatment, compound exposure, and perturbation information. These fields are critical for pharmacoproteomics studies and treatment comparison experiments. - -=== Treatment - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[treatment]NCITOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[treatment]` |NCIT |Optional -|=== -endif::[] - -General treatment or intervention applied to samples. Use for treatment categories when more general than specific compounds. - -|=== -|Value |NCIT ID |Description - -|chemotherapy |NCIT:C15632 |Chemical drug treatment -|immunotherapy |NCIT:C15262 |Immune-based treatment -|radiation therapy |NCIT:C15313 |Radiation-based treatment -|surgery |NCIT:C17173 |Surgical intervention -|untreated |NCIT:C48660 |No treatment applied -|=== - -**Examples:** -[source] ----- -characteristics[treatment]: untreated -characteristics[treatment]: Mycobacterium tuberculosis H37Rv whole cell lysate -characteristics[treatment]: LPS stimulation ----- - -Use `untreated` for no treatment, `not available` when unknown. - -=== Compound - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[compound]ChEBI, NCIT, EFOOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[compound]` |ChEBI, NCIT, EFO |Optional -|=== -endif::[] - -Chemical compound, drug, or biological agent applied to samples. Use ChEBI ontology for standardized compound identification. - -|=== -|Compound |ChEBI ID |Drug Class - -|doxorubicin |CHEBI:28748 |Anthracycline chemotherapy -|cisplatin |CHEBI:27899 |Platinum chemotherapy -|tamoxifen |CHEBI:41774 |Selective estrogen receptor modulator -|dexamethasone |CHEBI:41879 |Glucocorticoid -|none |EFO:0001461 |Control (no compound) -|=== - -**Examples:** -[source] ----- -characteristics[compound]: tamoxifen (CHEBI_41774) -characteristics[compound]: dexamethasone -characteristics[compound]: none (EFO:0001461) -characteristics[compound]: lipopolysaccharide -characteristics[compound]: interferon gamma ----- - -**Best Practice:** Include ChEBI accession in format `compound_name (CHEBI:XXXXX)` when available. - -=== Dose - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[dose]UOOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[dose]` |UO |Optional -|=== -endif::[] - -**Format:** `{value} {unit}` - -|=== -|Concentration Unit |Example |Use Case - -|nanomolar |100 nanomolar |Cell culture experiments -|micromolar |10 micromolar |In vitro studies -|millimolar |1 millimolar |High concentration studies -|mg/kg |5 mg/kg |Animal studies (body weight-based) -|ng/ml |50 ng/ml |Serum/media concentration -|μg/ml |10 μg/ml |Protein/antibody concentration -|=== - -**Examples:** -[source] ----- -characteristics[dose]: 100 nanomolar -characteristics[dose]: 10 micromolar -characteristics[dose]: 50 nanogram per millilitre ----- - -=== Treatment Time - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[treatment time]UOOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[treatment time]` |UO |Optional -|=== -endif::[] - -**Format:** `{value} {unit}` where unit is hour, day, week, month (or h, d, w abbreviations) - -Duration of treatment exposure. - -|=== -|Value |Description - -|24 hour |One day treatment -|4 hours |Short-term treatment -|5 days |Multi-day treatment -|2 weeks |Extended treatment -|=== - -**Examples:** -[source] ----- -characteristics[treatment time]: 24 hour -characteristics[treatment time]: 4 hours -characteristics[treatment time]: 5 days ----- - -=== Treatment Status - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[treatment status]—Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[treatment status]` |— |Optional -|=== -endif::[] - -Values: `pre-treatment`, `on treatment`, `post-treatment`, `treatment naive`. - -=== Treatment Response - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[treatment response]NCIT:C50995Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[treatment response]` |NCIT:C50995 |Optional -|=== -endif::[] - -|=== -|Value |NCIT ID |Description - -|complete response |NCIT:C4870 |No detectable disease (complete remission) -|partial response |NCIT:C18058 |Tumor size reduced (partial remission) -|stable disease |NCIT:C18213 |No significant change -|progressive disease |NCIT:C17747 |Disease progression -|=== - -=== Genetic Modification - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[genetic modification]EFOOptional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[genetic modification]` |EFO |Optional -|=== -endif::[] - -Describes the method or type of genetic modification applied to samples (particularly relevant for engineered cell lines and model organisms). - -NOTE: This is distinct from `characteristics[genotype]` which describes WHAT variant is present. `genetic modification` describes HOW the modification was done. - -|=== -|Value |EFO ID |Description - -|gene knock out |EFO:0000506 |Complete gene deletion -|gene knock down |EFO:0000513 |Gene expression reduction (siRNA, shRNA) -|gene overexpression |EFO:0000514 |Increased gene expression -|transfection |EFO:0000515 |DNA introduction (non-viral) -|transduction |EFO:0000516 |DNA introduction (viral) -|wild type genotype |EFO:0005168 |No genetic modification -|=== - -**Examples:** -[source] ----- -characteristics[genetic modification]: gene knock out (EFO:0000506) -characteristics[genetic modification]: AML1-ETO fusion gene transduction -characteristics[genetic modification]: transduction of hTERT, HPVE6 -characteristics[genotype]: DNMT3a R882 mutant -characteristics[genotype]: wild type genotype ----- - -=== Complete Treatment Annotation Example - -For comprehensive pharmacoproteomics annotation, combine compound, dose, and treatment time: - -|=== -|source name |characteristics[compound] |characteristics[dose] |characteristics[treatment time] |characteristics[phenotype] - -|sample_treated_1 |tamoxifen (CHEBI:41774) |1 micromolar |48 hour |tamoxifen sensitive -|sample_treated_2 |tamoxifen (CHEBI:41774) |1 micromolar |48 hour |tamoxifen resistant -|sample_control |none (EFO:0001461) |not applicable |not applicable |control -|=== - -== Best Practices - -=== General Guidelines - -1. **Protect privacy** - Never include identifiable patient information. Use pseudonymized identifiers only. -2. **Use ontology terms** - Prefer MONDO for diseases, NCIT for staging/treatments, ChEBI for compounds, PATO for phenotypes. -3. **Be consistent** - Use the same format for all samples in a dataset. -4. **Document unknowns** - Use `not available` rather than leaving cells empty. -5. **Include temporal context** - Specify when measurements were taken relative to treatment. -6. **Ensure regulatory compliance** - Follow GDPR, HIPAA, and other data protection regulations. - -=== Clinical Proteomics Best Practices - -1. **Separate disease from staging** - Use `characteristics[disease]` for the condition and `characteristics[disease staging]` for progression. -2. **Use sampling site for tumor/normal** - Distinguish tissue types using `characteristics[sampling site]` (e.g., "tumor", "normal tissue adjacent to tumor"). -3. **Track matched samples** - Use consistent `characteristics[individual]` identifiers for samples from the same patient. -4. **Document treatment context** - Combine `characteristics[compound]`, `characteristics[dose]`, and `characteristics[treatment time]` for complete treatment annotation. -5. **Use phenotype for biomarkers** - Capture molecular markers and drug response status in `characteristics[phenotype]`. - -=== Cancer-Specific Best Practices - -1. **Avoid embedding staging in disease** - Don't use "high grade serous ovarian cancer" in disease column; use separate staging columns. -2. **Use standard staging systems** - Prefer TNM notation for solid tumors, Ann Arbor for lymphomas. -3. **Include grading when available** - Tumor grade provides important prognostic information. -4. **Document metastasis** - Use `characteristics[metastasis site]` for metastatic samples. - -== Additional Terms - -This section contains optional metadata terms that may be useful in specific contexts. - -=== Smoking Status - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[smoking status]NCIT:C19796Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[smoking status]` |NCIT:C19796 |Optional -|=== -endif::[] - -|=== -|Value |NCIT ID |Description - -|never smoker |NCIT:C65108 |Never smoked -|former smoker |NCIT:C65107 |Previously smoked, now quit -|current smoker |NCIT:C65106 |Currently smoking -|=== - -=== Menopausal Status - -ifdef::backend-html5[] -++++ - - - - - - - - - - - -
    TermOntologyRequirement
    characteristics[menopausal status]NCIT:C16151Optional
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="1,1,1"] -|=== -|Term |Ontology |Requirement - -|`characteristics[menopausal status]` |NCIT:C16151 |Optional -|=== -endif::[] - -For female patients. Values: `pre-menopausal`, `peri-menopausal`, `post-menopausal`. - -== References - -=== Disease and Clinical Ontologies -- MONDO Disease Ontology: https://mondo.monarchinitiative.org/ -- NCI Thesaurus (NCIT): https://ncithesaurus.nci.nih.gov/ -- EFO Experimental Factor Ontology: https://www.ebi.ac.uk/efo/ - -=== Anatomy and Cell Ontologies -- UBERON Anatomy Ontology: https://obofoundry.org/ontology/uberon.html -- Cell Ontology (CL): https://obofoundry.org/ontology/cl.html - -=== Phenotype and Quality Ontologies -- PATO Phenotype Ontology: https://obofoundry.org/ontology/pato.html - -=== Chemical and Treatment Ontologies -- ChEBI Chemical Entities: https://www.ebi.ac.uk/chebi/ - -=== Population and Ancestry -- Human Ancestry Ontology (HANCESTRO): https://www.ebi.ac.uk/ols4/ontologies/hancestro - -=== Staging Systems -- TNM Classification: AJCC Cancer Staging Manual -- Ann Arbor Staging: Lymphoma staging system - -[[template-file]] -== Template File - -The human SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/human/1.1.0/human.sdrf.tsv[human.sdrf.tsv] diff --git a/sdrf-proteomics/templates/immunopeptidomics/README.adoc b/sdrf-proteomics/templates/immunopeptidomics/README.adoc deleted file mode 100644 index 436ca704d..000000000 --- a/sdrf-proteomics/templates/immunopeptidomics/README.adoc +++ /dev/null @@ -1,319 +0,0 @@ -= SDRF-Proteomics: Immunopeptidomics Template -:sectnums: -:toc: left -:doctype: book -//only works on some backends, not HTML -:showcomments: -//use style like Section 1 when referencing within the document. -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -//GitHub specific settings -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides a template for annotating immunopeptidomics experiments in SDRF-Proteomics format. This template defines additional columns that can be combined with any core template (human, vertebrates, etc.) to capture immunopeptidomics-specific metadata. - -**Type:** Specialized Template (used in combination with core templates) - -**Status:** Draft - This template is under active development and may change significantly. - -**Version:** 1.0.0-dev - 2026-01 - -[[abstract]] -== Abstract - -Immunopeptidomics focuses on the identification of peptides presented by major histocompatibility complex (MHC) molecules on the cell surface. These MHC-bound peptides are essential for understanding T-cell immune responses, antigen presentation, tumor-associated antigens for cancer immunotherapy, and vaccine development. - -Immunopeptidomics experiments have unique characteristics: specialized MHC enrichment methods, naturally processed short peptides (8-15 aa for MHC-I, 12-30 aa for MHC-II), MHC polymorphism requiring typing information, and no enzymatic digestion. This template defines the additional metadata requirements for annotating immunopeptidomics datasets. - -[[connections]] -== Connections to Other Omics Fields - -Immunopeptidomics data is often integrated with: - -- **Genomics/Exome sequencing**: For neoantigen identification in cancer research -- **Transcriptomics**: To correlate peptide presentation with gene expression -- **HLA typing databases**: IMGT/HLA database for allele information -- **Immunological databases**: IEDB (Immune Epitope Database) for epitope information - -When available, linking SDRF files to related genomic or transcriptomic data through BioSamples accession numbers is highly RECOMMENDED. - -[[additional-ontologies]] -== Additional Ontologies - -In addition to the ontologies supported by the core SDRF-Proteomics specification, immunopeptidomics templates utilize: - -- **IMGT/HLA nomenclature**: For HLA allele naming (https://www.ebi.ac.uk/ipd/imgt/hla/) -- **MHC Restriction Ontology (MRO)**: For MHC molecule classification -- **Vaccine Ontology (VO)**: For immunization-related terms when applicable - -[[checklist]] -== Checklist - -This section defines the metadata columns required and recommended for immunopeptidomics experiments. - -=== Required Columns - -The following columns are REQUIRED for immunopeptidomics experiments in addition to the core SDRF-Proteomics requirements: - -|=== -|Column Name |Description |Cardinality |Ontology/CV |Example Values - -|characteristics[immunopeptidome enrichment method] -|Method used to enrich for MHC-bound peptides from cell surface -|1 -|EFO, PRIDE CV -|immunoaffinity purification, immunoaffinity purification (iodoacetamide), mild acid elution, anti-pan MHC class I antibody (W6/32) - -|characteristics[MHC class] -|Class of MHC molecules being studied -|1 -|Controlled vocabulary -|MHC class I, MHC class II, MHC class I and II, non-canonical -|=== - -=== Recommended Columns - -The following columns are RECOMMENDED for immunopeptidomics experiments: - -|=== -|Column Name |Description |Cardinality |Ontology/CV |Example Values - -|characteristics[MHC typing] -|MHC allelic composition of the sample following appropriate nomenclature (IMGT/HLA for human) -|0..* -|IMGT/HLA nomenclature for human, appropriate nomenclature for other species -|HLA-A*02:01, HLA-B*07:02, HLA-C*07:02, H-2Kb, H-2Db - -|characteristics[MHC typing method] -|Method used to determine MHC alleles -|0..1 -|Free text or controlled vocabulary -|sequence-based typing, PCR-SSO, NGS-based typing, inferred from mass spectrometry - -|comment[cell number] -|Number of cells used for immunopeptidome extraction -|0..1 -|Numeric value with unit -|1e8 cells, 5e7 cells, 2e9 cells - -|comment[tissue mass] -|Mass of tissue used for immunopeptidome extraction when applicable -|0..1 -|Numeric value with unit -|500 mg, 1 g - -|comment[elution conditions] -|Conditions used for peptide elution from MHC molecules -|0..1 -|Free text description -|0.1% TFA at room temperature, 10% acetic acid, mild acid elution pH 2.5 - -|comment[antibody used] -|Specific antibody clone used for immunoaffinity purification -|0..1 -|Free text or MRO (MHC Restriction Ontology) (https://www.ebi.ac.uk/ols4/ontologies/mro) -|W6/32 (pan-HLA class I), L243 (HLA-DR), BB7.2 (HLA-A2) - -|comment[MHC binding prediction] -|Whether MHC binding predictions were performed and with which tool -|0..1 -|Free text description -|NetMHCpan 4.1, MHCflurry 2.0, not performed -|=== - -=== Sample Preparation Context - -Immunopeptidomics samples often do NOT use enzymatic digestion. When no enzyme is used: - -- Set `comment[cleavage agent details]` to `not applicable` -- This indicates peptides were naturally processed - -For samples that include an additional enzymatic digestion step (e.g., for database construction): - -- Annotate the enzyme used following standard SDRF-Proteomics conventions - -[[mhc-annotation]] -== MHC Typing Annotation - -MHC typing information is critical for immunopeptidomics data interpretation. When annotating MHC types: - -=== Nomenclature - -Follow the appropriate MHC nomenclature standard for your organism: - -**For Human (HLA):** - -- Format: `HLA-Gene*Allele_group:Protein` -- Example: `HLA-A*02:01` - -For multiple alleles, use multiple `characteristics[MHC typing]` columns or separate alleles with semicolons: - -|=== -|source name |characteristics[MHC typing] |characteristics[MHC typing] |characteristics[MHC typing] -|sample_001 |HLA-A*02:01 |HLA-A*03:01 |HLA-B*07:02 -|=== - -Or alternatively: - -|=== -|source name |characteristics[MHC typing] -|sample_001 |HLA-A*02:01;HLA-A*03:01;HLA-B*07:02;HLA-B*44:02;HLA-C*07:02;HLA-C*05:01 -|=== - -=== Resolution Levels - -For human HLA types, different resolution levels can be reported: - -- **Two-field** (protein level): `HLA-A*02:01` - RECOMMENDED minimum -- **Three-field** (synonymous variants): `HLA-A*02:01:01` -- **Four-field** (intronic variants): `HLA-A*02:01:01:01` - -Use the highest resolution available from your typing method. - -=== Unknown MHC Types - -When MHC typing is not available: - -- Use `not available` if typing was not performed -- Use `not determined` if typing was attempted but failed - -[[example-sdrf]] -== Example SDRF File - -A minimal example for an immunopeptidomics experiment: - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[cell line]characteristics[MHC class]characteristics[MHC typing]...comment[cell number]comment[antibody used]comment[cleavage agent details]comment[data file]factor value[cell line]
    JY_cells_rep1JYMHC class IHLA-A*02:01;HLA-B*07:02;HLA-C*07:02...1e8 cellsW6/32not applicableJY_rep1.rawJY
    JY_cells_rep2JYMHC class IHLA-A*02:01;HLA-B*07:02;HLA-C*07:02...1e8 cellsW6/32not applicableJY_rep2.rawJY
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |characteristics[cell line] |characteristics[MHC class] |characteristics[MHC typing] |... |comment[cell number] |comment[antibody used] |comment[cleavage agent details] |comment[data file] |factor value[cell line] - -|JY_cells_rep1 |JY |MHC class I |HLA-A*02:01;HLA-B*07:02;HLA-C*07:02 |... |1e8 cells |W6/32 |not applicable |JY_rep1.raw |JY -|JY_cells_rep2 |JY |MHC class I |HLA-A*02:01;HLA-B*07:02;HLA-C*07:02 |... |1e8 cells |W6/32 |not applicable |JY_rep2.raw |JY -|=== -endif::[] - -NOTE: The `...` column indicates omitted columns (organism, disease, immunopeptidome enrichment method, biological replicate, assay name, technology type, fraction identifier, label, instrument). - -[[best-practices]] -== Best Practices for Immunopeptidomics Annotation - -1. **Always specify MHC class**: Indicate whether the experiment targets MHC class I, class II, or both. - -2. **Provide MHC typing when available**: MHC information is essential for interpreting binding motifs and comparing datasets. - -3. **Document enrichment protocol details**: Include antibody clone names, elution conditions, and any modifications to standard protocols. - -4. **Report cell or tissue quantities**: This information is crucial for assessing sensitivity and comparing yields across experiments. - -5. **Link to patient/sample metadata**: Use `characteristics[individual]` and `characteristics[biosample accession number]` when working with clinical samples. - -6. **Note when enzyme is not used**: Set cleavage agent to "not applicable" for naturally processed immunopeptides. - -7. **Consider factor values**: Use `factor value` columns to indicate the experimental variables under study (e.g., disease state, treatment, cell type). - -[[annotated-examples]] -== Annotated Project Examples - -Examples of immunopeptidomics datasets annotated with SDRF-Proteomics: - -- https://github.com/bigbio/proteomics-metadata-standard/tree/master/annotated-projects/PXD002255[PXD002255] - Immunopeptidome analysis - -[[template-file]] -== Template File - -The immunopeptidomics SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/immunopeptidomics/1.0.0-dev/immunopeptidomics.sdrf.tsv[immunopeptidomics.sdrf.tsv] - -[[validation]] -== Validation - -Immunopeptidomics SDRF files should be validated using the sdrf-pipelines tool with the immunopeptidomics template: - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template immunopeptidomics ----- - -[[authors]] -== Authors and Maintainers - -This template was developed by the SDRF-Proteomics community with contributions from immunopeptidomics researchers: - -- [Yasset Priverol](https://github.com/ypriverol) -- [Jonas Scheid](https://github.com/jonasscheid) -- [Joshua Klein](https://github.com/mobiusklein) - -For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository]. - -[[references]] -== References - -- Bassani-Sternberg M, et al. (2015) Mass spectrometry-based antigen discovery for cancer immunotherapy. Current Opinion in Immunology. -- Purcell AW, et al. (2019) Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics. Nature Protocols. -- IEDB: Immune Epitope Database (https://www.iedb.org/) -- IMGT/HLA Database (https://www.ebi.ac.uk/ipd/imgt/hla/) diff --git a/sdrf-proteomics/templates/invertebrates/README.adoc b/sdrf-proteomics/templates/invertebrates/README.adoc deleted file mode 100644 index a70c842ae..000000000 --- a/sdrf-proteomics/templates/invertebrates/README.adoc +++ /dev/null @@ -1,349 +0,0 @@ -= SDRF-Proteomics: Invertebrates Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -The invertebrates template provides standardized metadata fields for invertebrate proteomics experiments. This includes model organisms like Drosophila melanogaster and Caenorhabditis elegans, as well as other insects, worms, and invertebrate species. - -This template is appropriate for: - -* Drosophila (fruit fly) proteomics studies -* C. elegans proteomics studies -* Insect proteomics (bees, mosquitoes, etc.) -* Marine invertebrate studies - -[[extends]] -== Template Hierarchy - -[source] ----- -base (construction artifact) - └── invertebrates (SAMPLE layer - must combine with TECHNOLOGY template) ----- - -The invertebrates template extends the **base** template, adding disease annotation and invertebrate-specific fields. - -[IMPORTANT] -==== -The invertebrates template **cannot be used alone**. You must combine it with a technology template: - -* `ms-proteomics` + `invertebrates` - For MS-based proteomics of invertebrate samples -* `affinity-proteomics` + `invertebrates` - For affinity proteomics of invertebrate samples -==== - -[[checklist]] -== Checklist - -=== Inherited Columns - -All columns from the base template are inherited (source name, organism, organism part, biological replicate, assay name, technology type, instrument, technical replicate, data file). Technology-specific columns come from the technology template (`ms-proteomics` or `affinity-proteomics`). - -=== Invertebrates-Specific Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    characteristics[disease]REQUIREDDisease state of the sampleMONDO, EFO, DOID, PATOnormal, breast cancer, diabetes mellitus
    characteristics[developmental stage]RECOMMENDEDDevelopmental stage of the organismFBdv (Drosophila), WBls (C. elegans), EFO, UBERONadult stage, larval stage, pupal stage, embryonic stage
    characteristics[strain/breed]OPTIONALStrain of the organismNCBITaxonOregon-R, w1118, N2, Canton-S
    characteristics[genotype]OPTIONALGenotype of the organism—wild type, daf-2(e1370), w[*]; P{GAL4}
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|characteristics[disease] |REQUIRED |Disease state of the sample |MONDO, EFO, DOID, PATO |normal, breast cancer, diabetes mellitus -|characteristics[developmental stage] |RECOMMENDED |Developmental stage of the organism |FBdv, WBls, EFO, UBERON |adult stage, larval stage, pupal stage, embryonic stage -|characteristics[strain/breed] |OPTIONAL |Strain of the organism |NCBITaxon |Oregon-R, w1118, N2, Canton-S -|characteristics[genotype] |OPTIONAL |Genotype of the organism |— |wild type, daf-2(e1370), w[*]; P{GAL4} -|=== -endif::[] - -[[common-organisms]] -== Common Invertebrate Organisms - -|=== -|Common Name |Scientific Name |NCBITaxon ID |Common Strains |Developmental Stage Ontology - -|Fruit fly |Drosophila melanogaster |NCBITaxon:7227 |Oregon-R, Canton-S, w1118 |FBdv -|Nematode |Caenorhabditis elegans |NCBITaxon:6239 |N2, CB4856 |WBls -|Honey bee |Apis mellifera |NCBITaxon:7460 |— |— -|Mosquito |Anopheles gambiae |NCBITaxon:7165 |— |— -|=== - -[[developmental-stages]] -== Developmental Stages - -=== Drosophila Stages (FBdv) - -|=== -|Stage |FBdv Term |Description - -|embryonic stage |FBdv:00005289 |Embryo development -|larval stage |FBdv:00005336 |Larval instar stages (L1, L2, L3) -|pupal stage |FBdv:00005349 |Metamorphosis -|adult stage |FBdv:00005369 |Sexually mature adult -|=== - -=== C. elegans Stages (WBls) - -|=== -|Stage |WBls Term |Description - -|embryo Ce |WBls:0000003 |Embryonic development -|L1 larva Ce |WBls:0000024 |First larval stage -|L2 larva Ce |WBls:0000027 |Second larval stage -|L3 larva Ce |WBls:0000035 |Third larval stage -|L4 larva Ce |WBls:0000038 |Fourth larval stage -|dauer larva Ce |WBls:0000032 |Dauer stage -|adult Ce |WBls:0000041 |Adult stage -|=== - -[[genotype-notation]] -== Genotype Notation - -=== Drosophila Genotype Format - -Drosophila genotypes follow a specific notation: - -[source] ----- -# Wild type -wild type - -# Single mutation -w[1118] - -# Multiple alleles with GAL4/UAS system -w[*]; P{GAL4-da.G32} ----- - -=== C. elegans Genotype Format - -C. elegans genotypes use allele notation: - -[source] ----- -# Wild type -wild type - -# Single mutation (gene-allele format) -daf-2(e1370) - -# Multiple mutations -daf-2(e1370); daf-16(mgDf50) ----- - -[[validation]] -== Validation - -Validate SDRF files using sdrf-pipelines: - -[source,bash] ----- -pip install sdrf-pipelines -sdrf_validate --sdrf_file your_file.sdrf.tsv --template invertebrates ----- - -[[template-file]] -== Template File - -The invertebrates SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/invertebrates/1.1.0/invertebrates.sdrf.tsv[invertebrates.sdrf.tsv] - -[[examples]] -== Examples - -=== Drosophila Study Example - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]characteristics[developmental stage]characteristics[strain/breed]characteristics[genotype]characteristics[biological replicate]
    sample_1drosophila melanogasterwhole organismnormaladult stageOregon-Rwild type1
    sample_2drosophila melanogasterwhole organismnormaladult stageOregon-Rwild type2
    sample_3drosophila melanogasterwhole organismnormaladult stagew1118w[1118]1
    -
    - Sample metadata -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[developmental stage] |characteristics[strain/breed] |characteristics[genotype] |characteristics[biological replicate] - -|sample_1 |drosophila melanogaster |whole organism |normal |adult stage |Oregon-R |wild type |1 -|sample_2 |drosophila melanogaster |whole organism |normal |adult stage |Oregon-R |wild type |2 -|sample_3 |drosophila melanogaster |whole organism |normal |adult stage |w1118 |w[1118] |1 -|=== -endif::[] - -=== C. elegans Study Example - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]characteristics[developmental stage]characteristics[strain/breed]characteristics[genotype]characteristics[biological replicate]
    sample_1caenorhabditis eleganswhole organismnormaladult CeN2wild type1
    sample_2caenorhabditis eleganswhole organismnormaladult CeN2wild type2
    sample_3caenorhabditis eleganswhole organismnormaladult CeCB1370daf-2(e1370)1
    -
    - Sample metadata -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[developmental stage] |characteristics[strain/breed] |characteristics[genotype] |characteristics[biological replicate] - -|sample_1 |caenorhabditis elegans |whole organism |normal |adult Ce |N2 |wild type |1 -|sample_2 |caenorhabditis elegans |whole organism |normal |adult Ce |N2 |wild type |2 -|sample_3 |caenorhabditis elegans |whole organism |normal |adult Ce |CB1370 |daf-2(e1370) |1 -|=== -endif::[] diff --git a/sdrf-proteomics/templates/metaproteomics/README.adoc b/sdrf-proteomics/templates/metaproteomics/README.adoc deleted file mode 100644 index eeb73cb02..000000000 --- a/sdrf-proteomics/templates/metaproteomics/README.adoc +++ /dev/null @@ -1,539 +0,0 @@ -= SDRF-Proteomics: Metaproteomics Template -:sectnums: -:toc: left -:doctype: book -//only works on some backends, not HTML -:showcomments: -//use style like Section 1 when referencing within the document. -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -//GitHub specific settings -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides guidelines for annotating metaproteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with metaproteomics-specific metadata fields. - -**Status:** Draft - This template is under active development and may change significantly. - -**Version:** 1.0.0-dev - 2026-01 - -[[abstract]] -== Abstract - -Metaproteomics is the study of proteins expressed by microbial communities, analyzing complex samples containing proteins from many different organisms simultaneously. Key applications include gut microbiome characterization, environmental microbiology, host-microbiome interactions, and industrial biotechnology. - -Metaproteomics experiments have unique characteristics: multi-organism samples, complex sample matrices, databases constructed from metagenomics data, taxonomic attribution challenges, and critical environmental context metadata. This template defines the additional metadata requirements for annotating metaproteomics datasets. - -[[connections]] -== Connections to Other Omics Fields - -Metaproteomics data is typically integrated with: - -- **Metagenomics**: For database construction and taxonomic context -- **Metatranscriptomics**: For gene expression correlation -- **16S/ITS amplicon sequencing**: For community composition -- **Metabolomics**: For functional interpretation -- **Environmental databases**: ENVO, MIxS standards - -When available, linking to related omics datasets is highly RECOMMENDED. - -[[additional-ontologies]] -== Additional Ontologies - -In addition to the ontologies supported by the core SDRF-Proteomics specification, metaproteomics templates utilize: - -- **Environment Ontology (ENVO)**: For environmental sample classification (http://www.obofoundry.org/ontology/envo.html) -- **Gazetteer (GAZ)**: For geographic locations -- **MIxS**: Minimum Information about any (x) Sequence standards -- **NCBI Taxonomy**: For organism classification - -[[checklist]] -== Checklist - -This section defines the metadata columns required and recommended for metaproteomics experiments. - -=== Required Columns - -The following columns are REQUIRED for metaproteomics experiments in addition to the core SDRF-Proteomics requirements: - -|=== -|Column Name |Description |Cardinality |Ontology/CV |Example Values - -|characteristics[environmental sample type] -|Type of environmental or biological sample being analyzed -|1 -|ENVO, EFO -|soil, marine sediment, human gut, wastewater, rhizosphere, oral cavity, skin -|=== - -=== Recommended Columns - -The following columns are RECOMMENDED for metaproteomics experiments: - -|=== -|Column Name |Description |Cardinality |Ontology/CV |Example Values - -|characteristics[sample collection method] -|Method used to collect the sample -|0..1 -|Controlled vocabulary or free text -|grab sample, core sampling, swab collection, filtration, fecal collection, biopsy - -|characteristics[geographic location] -|Geographic location where sample was collected -|0..1 -|GAZ or free text with coordinates -|Baltic Sea, Amazon rainforest, lat:52.5 lon:13.4, GAZ:00002459 - -|characteristics[collection date] -|Date when sample was collected -|0..1 -|ISO 8601 date format -|2024-03-15, 2024-03, March 2024 - -|characteristics[depth] -|Depth at which sample was collected (for water/sediment) -|0..1 -|Numeric value with unit -|10 m, 0-5 cm, surface - -|characteristics[altitude] -|Altitude/elevation for terrestrial samples -|0..1 -|Numeric value with unit -|500 m, 1200 m above sea level - -|characteristics[temperature] -|Environmental temperature at collection -|0..1 -|Numeric value with unit (Celsius) -|25 C, 4 C, 37 C - -|characteristics[pH] -|pH of the sample or environment -|0..1 -|Numeric value -|7.4, 5.5, 8.2 - -|characteristics[host organism] -|Host organism for host-associated microbiomes -|0..1 -|NCBITaxon -|homo sapiens, mus musculus, zea mays - -|characteristics[host disease] -|Disease state of host if applicable -|0..1 -|MONDO, EFO -|inflammatory bowel disease, normal, colorectal cancer - -|characteristics[host age] -|Age of host organism -|0..1 -|Standard age format -|45Y, 8W, 3M - -|comment[database search strategy] -|Strategy for sequence database construction -|0..1 -|Free text description -|matched metagenome, RefSeq bacteria, GTDB, UniRef90, custom assembly - -|comment[metagenome accession] -|Accession number for associated metagenome data -|0..1 -|Database accession -|SRR12345678, ERR12345678, PRJNA123456 - -|comment[sample storage] -|How sample was stored before processing -|0..1 -|Free text description -|flash frozen, -80C, RNAlater, 4C for 24h -|=== - -=== Environmental Context Columns - -==== Aquatic Samples - -|=== -|Column Name |Description |Example Values - -|characteristics[water body type] -|Type of water body -|ocean, lake, river, estuary, pond - -|characteristics[salinity] -|Salinity measurement -|35 PSU, freshwater, brackish - -|characteristics[dissolved oxygen] -|Dissolved oxygen concentration -|8.5 mg/L, hypoxic, anoxic - -|characteristics[chlorophyll] -|Chlorophyll concentration if measured -|2.5 ug/L - -|characteristics[sampling depth zone] -|Ecological depth zone -|epipelagic, mesopelagic, benthic -|=== - -==== Soil Samples - -|=== -|Column Name |Description |Example Values - -|characteristics[soil type] -|Soil classification -|sandy loam, clay, peat - -|characteristics[soil horizon] -|Soil horizon sampled -|A horizon, O horizon, B horizon - -|characteristics[land use] -|Land use type -|agricultural, forest, urban, grassland - -|characteristics[vegetation] -|Dominant vegetation -|deciduous forest, corn field, prairie -|=== - -==== Host-Associated Samples - -|=== -|Column Name |Description |Example Values - -|characteristics[body site] -|Specific body site for host-associated samples -|stool, oral cavity, skin, vaginal - -|characteristics[host diet] -|Diet information for host -|omnivore, vegan, western diet, high-fiber - -|characteristics[antibiotic treatment] -|Recent antibiotic exposure -|none, amoxicillin 7 days prior, broad-spectrum -|=== - -[[organism-annotation]] -== Organism Annotation in Metaproteomics - -The `characteristics[organism]` column presents a unique challenge in metaproteomics because samples contain multiple organisms. Several approaches are supported: - -=== Option 1: Use "metagenome" or Environment-Specific Term - -For samples where the community composition is unknown or highly complex: - -|=== -|characteristics[organism] |Example Samples - -|metagenome -|General environmental samples - -|human gut metagenome -|Human fecal samples, gut biopsies - -|soil metagenome -|Soil samples - -|marine metagenome -|Ocean water, marine sediment - -|mouse gut metagenome -|Mouse fecal samples -|=== - -These terms have corresponding NCBITaxon identifiers (e.g., NCBITaxon:749906 for "gut metagenome"). - -=== Option 2: Specify Host Organism - -For host-associated microbiomes where host context is important: - -|=== -|characteristics[organism] |characteristics[microbiome source] - -|homo sapiens -|gut microbiome - -|mus musculus -|gut microbiome - -|arabidopsis thaliana -|rhizosphere microbiome -|=== - -=== Option 3: Multiple Organism Columns - -For controlled or known communities (e.g., defined consortia, mock communities): - -|=== -|characteristics[organism] |characteristics[organism] |characteristics[organism] - -|escherichia coli -|bacteroides fragilis -|lactobacillus acidophilus -|=== - -NOTE: The approach should be chosen based on the experimental context and database search strategy used. - -[[database-annotation]] -== Database Search Strategy Annotation - -Metaproteomics database construction is critical and should be documented: - -|=== -|Strategy |Description |When to Use - -|Matched metagenome -|Database from metagenome of same sample -|When metagenome sequencing was performed - -|Reference database -|Public reference database (RefSeq, UniProt) -|When no metagenome available - -|Custom assembly -|De novo assembled from sample metagenome -|For novel environments - -|GTDB/UHGG -|Genome-resolved metagenome databases -|For gut microbiome studies - -|Hybrid approach -|Combination of reference and sample-specific -|Complex communities with some known members -|=== - -Document the strategy in `comment[database search strategy]`. - -[[mock-communities]] -== Mock Community Samples - -For defined/mock microbial communities used as standards: - -|=== -|Column Name |Description |Example Values - -|characteristics[mock community] -|Identifier or name of mock community standard -|ZymoBIOMICS Microbial Community Standard, ATCC MSA-1000 - -|characteristics[mock community composition] -|Description of community composition -|8 bacteria + 2 yeasts at defined ratios, even mix of 10 species - -|comment[expected organism list] -|List of organisms expected in mock community -|E. coli;B. subtilis;S. cerevisiae;L. fermentum -|=== - -[[example-sdrf]] -== Example SDRF Files - -=== Human Gut Microbiome Example - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[environmental sample type]characteristics[host disease]...comment[database search strategy]comment[metagenome accession]comment[data file]
    subject_001_stoolhuman gut metagenomehuman gutinflammatory bowel disease...matched metagenomeSRR12345678IBD_001.raw
    subject_002_stoolhuman gut metagenomehuman gutnormal...matched metagenomeSRR12345679healthy_002.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |characteristics[organism] |characteristics[environmental sample type] |characteristics[host disease] |... |comment[database search strategy] |comment[metagenome accession] |comment[data file] - -|subject_001_stool |human gut metagenome |human gut |inflammatory bowel disease |... |matched metagenome |SRR12345678 |IBD_001.raw -|subject_002_stool |human gut metagenome |human gut |normal |... |matched metagenome |SRR12345679 |healthy_002.raw -|=== -endif::[] - -=== Environmental Sample Example - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[environmental sample type]characteristics[geographic location]characteristics[depth]...comment[database search strategy]comment[data file]
    baltic_station1_summermarine metagenomemarine sedimentBaltic Sea50 m...GTDB marine subsetbaltic_sed_001.raw
    soil_farm_plot1soil metagenomeagricultural soilIowa, USA0-10 cm...custom assemblysoil_plot1.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |characteristics[organism] |characteristics[environmental sample type] |characteristics[geographic location] |characteristics[depth] |... |comment[database search strategy] |comment[data file] - -|baltic_station1_summer |marine metagenome |marine sediment |Baltic Sea |50 m |... |GTDB marine subset |baltic_sed_001.raw -|soil_farm_plot1 |soil metagenome |agricultural soil |Iowa, USA |0-10 cm |... |custom assembly |soil_plot1.raw -|=== -endif::[] - -[[quality-considerations]] -== Quality Control Annotations - -For metaproteomics, consider documenting: - -|=== -|Column Name |Description |Example Values - -|comment[biomass estimation] -|Estimated microbial biomass in sample -|1e9 cells/g, high biomass, low biomass - -|comment[host contamination] -|Level of host protein contamination if known -|low (<5%), moderate (5-20%), high (>20%) - -|comment[contaminant database] -|Contaminant databases used in search -|cRAP, MaxQuant contaminants -|=== - -[[best-practices]] -== Best Practices for Metaproteomics Annotation - -1. **Use appropriate organism terms**: Choose between metagenome terms, host organism, or explicit multi-organism annotation based on your experimental design. - -2. **Document database strategy**: The sequence database used dramatically affects results - always document construction strategy. - -3. **Link to metagenomics data**: When available, provide accession numbers for related metagenome/metatranscriptome data. - -4. **Include environmental context**: Geographic location, collection date, and environmental parameters enhance data reusability. - -5. **Specify host information**: For host-associated microbiomes, document host species, health status, and relevant metadata. - -6. **Note sample handling**: Storage conditions and processing time can affect community composition. - -7. **Consider MIxS standards**: Align with Minimum Information about any (x) Sequence standards where applicable. - -8. **Use controlled vocabularies**: Prefer ENVO terms for environmental classification and NCBITaxon for organisms. - -[[template-file]] -== Template File - -The metaproteomics SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/metaproteomics/1.0.0-dev/metaproteomics.sdrf.tsv[metaproteomics.sdrf.tsv] - -[[validation]] -== Validation - -Metaproteomics SDRF files should be validated using the sdrf-pipelines tool: - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv ----- - -NOTE: Metaproteomics-specific validation rules are under development. - -[[authors]] -== Authors and Maintainers - -This template was developed by the SDRF-Proteomics community with contributions from metaproteomics researchers. - -For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository]. - -[[references]] -== References - -- Wilmes P, Bond PL. (2004) The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms. Environmental Microbiology. -- Muth T, et al. (2015) The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation. Journal of Proteome Research. -- Chatterjee S, et al. (2023) A comprehensive and scalable database search system for metaproteomics. Nature Communications. -- ENVO: Environment Ontology (http://www.obofoundry.org/ontology/envo.html) -- MIxS: Minimum Information about any (x) Sequence (https://genomicsstandardsconsortium.github.io/mixs/) diff --git a/sdrf-proteomics/templates/ms-proteomics/README.adoc b/sdrf-proteomics/templates/ms-proteomics/README.adoc deleted file mode 100644 index 9a8bea3f4..000000000 --- a/sdrf-proteomics/templates/ms-proteomics/README.adoc +++ /dev/null @@ -1,488 +0,0 @@ -= SDRF-Proteomics: MS-Proteomics Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -The MS-Proteomics template is the **minimum valid SDRF template** for mass spectrometry-based proteomics experiments. It includes all columns necessary to describe an MS proteomics dataset. - -This template is appropriate for: - -* DDA (Data-Dependent Acquisition) proteomics -* DIA (Data-Independent Acquisition) proteomics -* Targeted proteomics (SRM/MRM/PRM) -* Any experiment using mass spectrometry for protein/peptide detection - -[[hierarchy]] -== Template Hierarchy - -[source] ----- -base - └── ms-proteomics (THIS TEMPLATE) - │ - ├── dda-acquisition (DDA-specific columns) - ├── dia-acquisition (DIA-specific columns) - ├── crosslinking (XL-MS columns) - ├── single-cell (SCP columns) - └── immunopeptidomics (MHC-MS columns) ----- - -[[checklist]] -== Checklist - -=== Inherited Columns (from base) - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescription
    source nameREQUIREDUnique identifier for the biological sample
    characteristics[organism]REQUIREDSpecies (NCBI Taxonomy)
    characteristics[organism part]REQUIREDAnatomical part
    characteristics[cell type]RECOMMENDEDCell type
    characteristics[biological replicate]REQUIREDBiological replicate number
    assay nameREQUIREDUnique identifier for the MS run
    technology typeREQUIRED"proteomic profiling by mass spectrometry"
    comment[technical replicate]RECOMMENDEDTechnical replicate number
    comment[data file]REQUIREDRaw data file name
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,3", options="header"] -|=== -|Column Name |Requirement |Description - -|source name |REQUIRED |Unique identifier for the biological sample -|characteristics[organism] |REQUIRED |Species (NCBI Taxonomy) -|characteristics[organism part] |REQUIRED |Anatomical part -|characteristics[cell type] |RECOMMENDED |Cell type -|characteristics[biological replicate] |REQUIRED |Biological replicate number -|assay name |REQUIRED |Unique identifier for the MS run -|technology type |REQUIRED |"proteomic profiling by mass spectrometry" -|comment[technical replicate] |RECOMMENDED |Technical replicate number -|comment[data file] |REQUIRED |Raw data file name -|=== -endif::[] - -=== MS-Specific Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    comment[instrument]REQUIREDMass spectrometer usedMSQ Exactive HF, Orbitrap Fusion Lumos, timsTOF Pro
    comment[proteomics data acquisition method]REQUIREDMS acquisition methodPRIDEData-dependent acquisition, Data-independent acquisition
    comment[cleavage agent details]REQUIREDEnzyme used for digestionMSNT=Trypsin;AC=MS:1001251
    comment[label]REQUIREDLabeling strategyPRIDElabel free sample, TMT126, SILAC heavy
    comment[fraction identifier]REQUIREDFraction number (1 for non-fractionated)—1, 2, 3
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|comment[instrument] |REQUIRED |Mass spectrometer used |MS |Q Exactive HF, Orbitrap Fusion Lumos, timsTOF Pro -|comment[proteomics data acquisition method] |REQUIRED |MS acquisition method |PRIDE |Data-dependent acquisition, Data-independent acquisition -|comment[cleavage agent details] |REQUIRED |Enzyme used for digestion |MS |NT=Trypsin;AC=MS:1001251 -|comment[label] |REQUIRED |Labeling strategy |PRIDE |label free sample, TMT126, SILAC heavy -|comment[fraction identifier] |REQUIRED |Fraction number (1 for non-fractionated) |— |1, 2, 3 -|=== -endif::[] - -[[field-guidelines]] -== Field Guidelines - -=== CV Term Format - -For data file metadata columns that reference ontology terms, use the structured CV term format: - -`NT={term name};AC={accession}` - -**Examples:** - -- Dissociation method: `NT=HCD;AC=PRIDE:0000590` -- Instrument: `NT=Q Exactive HF;AC=MS:1002523` -- Label: `NT=TMT126;AC=PRIDE:0000285` - -NOTE: Data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files. - -=== Label - -**Column:** `comment[label]` - -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000514[PRIDE:0000514 - Sample label] - -Describes the isotopic label applied to each sample. All label values MUST be children of PRIDE:0000514 (label free sample, TMT, iTRAQ, SILAC, etc.). link:../../sdrf-explorer.html?view=PXD004683[Open example SDRF] - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - -
    source namecomment[label]comment[data file]
    sample_1TMT126run1.raw
    sample_2TMT127Nrun1.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -=== Cleavage Agents - -**Column:** `comment[cleavage agent details]` - -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/ms/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMS_1001045[PSI-MS - Cleavage agent name (MS:1001045)] - -**Format:** `NT=EnzymeName;AC=Accession` - -|=== -|Enzyme |Value |OLS Link - -|Trypsin |NT=Trypsin;AC=MS:1001251 |https://www.ebi.ac.uk/ols4/ontologies/ms/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMS_1001251[MS:1001251] -|Trypsin/P |NT=Trypsin/P;AC=MS:1001313 |https://www.ebi.ac.uk/ols4/ontologies/ms/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMS_1001313[MS:1001313] -|Lys-C |NT=Lys-C;AC=MS:1001309 |https://www.ebi.ac.uk/ols4/ontologies/ms/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMS_1001309[MS:1001309] -|=== - -For top-down/intact proteins, use `not applicable`. For multiple enzymes, add multiple columns. link:../../sdrf-explorer.html?view=PXD002395[Open example SDRF] - -=== Protein Modifications - -**Column:** `comment[modification parameters]` - -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/unimod[UNIMOD] or https://www.ebi.ac.uk/ols4/ontologies/mod[PSI-MOD] - -**Format:** `NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position` link:../../sdrf-explorer.html?view=PXD001725[Open example SDRF] - -|=== -|Property |Key |Values - -|Name |NT |UNIMOD or PSI-MOD term name -|Accession |AC |UNIMOD:X or MOD:X -|Type |MT |`Fixed`, `Variable` -|Target Amino Acid |TA |Single letter codes (e.g., `S,T,Y`) -|Position |PP |`Anywhere`, `Protein N-term`, `Protein C-term` -|=== - -**Common modifications:** - -|=== -|Modification |Value |OLS Link - -|Carbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C;PP=Anywhere |https://www.ebi.ac.uk/ols4/ontologies/unimod/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FUNIMOD_4[UNIMOD:4] -|Oxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M;PP=Anywhere |https://www.ebi.ac.uk/ols4/ontologies/unimod/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FUNIMOD_35[UNIMOD:35] -|Phosphorylation (variable) |NT=Phospho;AC=UNIMOD:21;MT=Variable;TA=S,T,Y;PP=Anywhere |https://www.ebi.ac.uk/ols4/ontologies/unimod/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FUNIMOD_21[UNIMOD:21] -|=== - -=== Mass Tolerances - -**Columns:** `comment[precursor mass tolerance]`, `comment[fragment mass tolerance]` - -**Format:** `{value} {unit}` where unit is `Da` or `ppm`. - -|=== -|Precursor |Fragment |Instrument Type - -|10 ppm |20 ppm |Orbitrap MS1/MS2 -|20 ppm |0.6 Da |Orbitrap MS1, Ion trap MS2 -|=== - -=== Fractionation - -**Column:** `comment[fractionation method]` - -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/pride/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPRIDE_0000550[PRIDE - Fractionation method] - -Use with `comment[fraction identifier]` to number fractions. - -|=== -|Method |OLS Link - -|High-pH reversed-phase chromatography |https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000564[PRIDE:0000564] -|Strong cation-exchange chromatography |https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000561[PRIDE:0000561] -|=== - -NOTE: For single-shot experiments without fractionation, this column can be omitted or set to `not applicable`. link:../../sdrf-explorer.html?view=MSV000078494[Open example SDRF] - -=== Dissociation Method - -**Column:** `comment[dissociation method]` - -**Ontology:** https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMS_1000044[PRIDE - dissociation method (MS:1000044)] - -All values MUST be children of MS:1000044 from the PRIDE ontology. Use the short acronyms (HCD, CID, ETD, etc.) as term names. - -|=== -|Term (Acronym) |OLS Link - -|HCD |https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000590[PRIDE:0000590] -|CID |https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000591[PRIDE:0000591] -|ETD |https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000593[PRIDE:0000593] -|EThcD |https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000594[PRIDE:0000594] -|=== - -**CV term format:** `NT=HCD;AC=PRIDE:0000590` link:../../sdrf-explorer.html?view=PMID25043054[Open example SDRF] - -=== Collision Energy - -**Column:** `comment[collision energy]` - -**Format:** `{value} {unit}` - -|=== -|Format |Example |Description - -|Normalized |27 NCE |Normalized collision energy -|Absolute |30 eV |Absolute energy in electron volts -|Stepped |22 NCE;26 NCE;30 NCE |Multiple energies (semicolon-separated) -|=== - -TIP: For DIA experiments with stepped collision energy, see the link:../dia-acquisition/README.adoc[DIA template] for detailed guidance. - -=== Sample Preparation - -**Reduction Reagent:** `comment[reduction reagent]` - DTT, TCEP, beta-mercaptoethanol - -**Alkylation Reagent:** `comment[alkylation reagent]` - IAA, chloroacetamide - -**Depletion:** `comment[depletion]` - no depletion, depletion, depleted fraction, bound fraction - -[[usage]] -== Usage - -=== File Metadata Columns - -SDRF files SHOULD include metadata columns to specify version and template information. Only list leaf templates; parent templates are implied by inheritance. Place these columns at the end of the file. - -=== Minimal MS Proteomics (non-organism-specific) - -|=== -|... |comment[sdrf version] |comment[sdrf template] - -|... |v1.1.0 |ms-proteomics v1.1.0 -|=== - -=== Human Samples (Recommended) - -|=== -|... |comment[sdrf version] |comment[sdrf template] - -|... |v1.1.0 |human v1.1.0 -|=== - -NOTE: The `human` template inherits from `ms-proteomics`, so you only need to specify `human`. - -=== With Acquisition-Specific Parameters (multiple templates) - -When using multiple templates, add multiple `comment[sdrf template]` columns: - -|=== -|... |comment[sdrf version] |comment[sdrf template] |comment[sdrf template] - -|... |v1.1.0 |human v1.1.0 |dda-acquisition v1.1.0 -|=== - -Each template declares its own version, allowing templates to evolve independently. - -[[validation]] -== Validation - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template ms-proteomics ----- - -[[example]] -== Example - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[biological replicate]assay nametechnology typecomment[instrument]comment[proteomics data acquisition method]comment[cleavage agent details]comment[label]comment[fraction identifier]comment[data file]
    sample_1homo sapiensliver1run_1proteomic profiling by mass spectrometryQ Exactive HFData-dependent acquisitionNT=Trypsin;AC=MS:1001251label free sample1sample1.raw
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[biological replicate] |assay name |technology type |comment[instrument] |comment[proteomics data acquisition method] |comment[cleavage agent details] |comment[label] |comment[fraction identifier] |comment[data file] - -|sample_1 |homo sapiens |liver |1 |run_1 |proteomic profiling by mass spectrometry |Q Exactive HF |Data-dependent acquisition |NT=Trypsin;AC=MS:1001251 |label free sample |1 |sample1.raw -|=== -endif::[] - -[[related]] -== Related Templates - -* link:../../README.adoc[Main Specification] - Core SDRF-Proteomics documentation -* link:../dda-acquisition/README.adoc[DDA Acquisition] - DDA-specific columns -* link:../dia-acquisition/README.adoc[DIA Acquisition] - DIA-specific columns -* link:../human/README.adoc[Human Template] - Human sample metadata - -[[template-file]] -== Template File - -The MS-Proteomics SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/ms-proteomics/1.1.0/ms-proteomics.sdrf.tsv[ms-proteomics.sdrf.tsv] - -== Ontologies - -- PRIDE Ontology: https://www.ebi.ac.uk/ols4/ontologies/pride -- PSI-MS Ontology: https://www.ebi.ac.uk/ols4/ontologies/ms -- UNIMOD: https://www.ebi.ac.uk/ols4/ontologies/unimod -- PSI-MOD: https://www.ebi.ac.uk/ols4/ontologies/mod diff --git a/sdrf-proteomics/templates/olink/README.adoc b/sdrf-proteomics/templates/olink/README.adoc deleted file mode 100644 index 719d6c39e..000000000 --- a/sdrf-proteomics/templates/olink/README.adoc +++ /dev/null @@ -1,305 +0,0 @@ -= SDRF-Proteomics: Olink Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides guidelines for annotating Olink Proximity Extension Assay (PEA) experiments in SDRF-Proteomics format. - -**Type:** Platform-Specific Template (extends affinity-proteomics) - -**Status:** Released - -**Version:** 1.0.0 - 2026-01 - -[[abstract]] -== Abstract - -Olink proteomics uses Proximity Extension Assay (PEA) technology to measure protein levels in biological samples. This template extends the affinity-proteomics template with Olink-specific metadata fields for panel information, NPX normalization, and quality control. - -[[hierarchy]] -== Template Hierarchy - -[source] ----- -base - └── affinity-proteomics - └── olink (THIS TEMPLATE) ----- - -[[usage]] -== Usage - -=== File Metadata Columns - -SDRF files SHOULD include metadata columns to specify version and template information. Only list leaf templates; parent templates are implied by inheritance (olink inherits from affinity-proteomics). Place these columns at the end of the file. - -**Non-human samples:** - -|=== -|... |comment[sdrf version] |comment[sdrf template] - -|... |v1.1.0 |olink v1.0.0 -|=== - -**Human samples** - use multiple template columns: - -|=== -|... |comment[sdrf version] |comment[sdrf template] |comment[sdrf template] - -|... |v1.1.0 |human v1.1.0 |olink v1.0.0 -|=== - -[[checklist]] -== Olink-Specific Columns - -In addition to all columns from link:../affinity-proteomics/README.adoc[affinity-proteomics], the following Olink-specific columns are available: - -=== Required for Olink - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionExample Values
    comment[olink panel]REQUIREDSpecific Olink panel nameTarget 96 Inflammation, Explore 384 Cardiometabolic, Explore 1536
    comment[olink platform]REQUIREDOlink instrument/platform versionOlink Target 96, Olink Explore 384, Olink Explore HT
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column |Requirement |Description |Example Values - -|comment[olink panel] |REQUIRED |Specific Olink panel name |Target 96 Inflammation, Explore 1536 -|comment[olink platform] |REQUIRED |Olink instrument/platform version |Olink Target 96, Olink Explore HT -|=== -endif::[] - -=== Recommended for Olink - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionExample Values
    comment[NPX normalization]RECOMMENDEDNormalization method applied to NPX valuesplate control normalized, intensity normalized, bridge normalized
    comment[QC warning]OPTIONALQuality control warnings if anyQC pass, below LOD, plate effect warning
    comment[olink lot number]OPTIONALReagent lot number for traceabilitylot_2023_001, B12345
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column |Requirement |Description |Example Values - -|comment[NPX normalization] |RECOMMENDED |Normalization method applied |plate control normalized, intensity normalized -|comment[QC warning] |OPTIONAL |Quality control warnings |QC pass, below LOD -|comment[olink lot number] |OPTIONAL |Reagent lot number |lot_2023_001 -|=== -endif::[] - -[[olink-panels]] -== Olink Panels - -=== Target 96 Panels - -Individual panels measuring 92 proteins each: - -* Target 96 Inflammation -* Target 96 Cardiovascular II -* Target 96 Cardiovascular III -* Target 96 Neurology -* Target 96 Oncology II -* Target 96 Oncology III -* Target 96 Metabolism - -=== Explore Panels - -High-throughput panels: - -* Olink Explore 384 (384 proteins) -* Olink Explore 1536 (1536 proteins) -* Olink Explore 3072 (3072 proteins) -* Olink Explore HT (5400+ proteins) - -[[technology-type]] -== Technology Type - -For Olink experiments, use: - -`technology type` = `protein expression profiling by antibody array` - -[[quantification]] -== Quantification - -Olink uses **NPX (Normalized Protein eXpression)** units: - -* NPX is a log2 scale relative quantification -* Higher NPX = higher protein concentration -* NPX values are comparable within a study after proper normalization -* Cross-study comparisons require bridge normalization - -Always set: - -`comment[quantification unit]` = `NPX` - -[[example]] -== Example SDRF - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]assay nametechnology typecomment[instrument]comment[olink panel]comment[olink platform]comment[quantification unit]comment[NPX normalization]comment[data file]
    patient_001homo sapiensblood plasmarheumatoid arthritisXB6protein expression profiling by antibody arrayOlink Explore HTOlink Explore 1536Olink Explore HTNPXplate control normalizedolink_npx.csv
    patient_002homo sapiensblood plasmanormalXB65protein expression profiling by antibody arrayOlink Explore HTOlink Explore 1536Olink Explore HTNPXplate control normalizedolink_npx.csv
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -[cols="1,1,1,1,1,1,1,1,1,1,1,1", options="header"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |assay name |technology type |comment[instrument] |comment[olink panel] |comment[olink platform] |comment[quantification unit] |comment[NPX normalization] |comment[data file] - -|patient_001 |homo sapiens |blood plasma |rheumatoid arthritis |XB6 |protein expression profiling by antibody array |Olink Explore HT |Olink Explore 1536 |Olink Explore HT |NPX |plate control normalized |olink_npx.csv -|patient_002 |homo sapiens |blood plasma |normal |XB65 |protein expression profiling by antibody array |Olink Explore HT |Olink Explore 1536 |Olink Explore HT |NPX |plate control normalized |olink_npx.csv -|=== -endif::[] - -[[data-files]] -== Data File Formats - -Olink data files typically contain: - -* **NPX CSV/Excel**: Normalized protein expression values -* **Parquet**: Large datasets in efficient columnar format - -The `assay name` column must match the **Sample ID** column in the Olink output file. - -[[validation]] -== Validation - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template olink ----- - -[[template-file]] -== Template File - -The Olink SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/olink/1.0.0/olink.sdrf.tsv[olink.sdrf.tsv] - -[[related-templates]] -== Related Templates - -* link:../affinity-proteomics/README.adoc[Affinity Proteomics] - Parent template -* link:../human/README.adoc[Human Template] - Human sample metadata - -[[references]] -== References - -- Assarsson E, et al. (2014) Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. -- Olink Proteomics: https://www.olink.com/ -- Olink NPX Documentation: https://olink.com/knowledge/documents diff --git a/sdrf-proteomics/templates/plants/README.adoc b/sdrf-proteomics/templates/plants/README.adoc deleted file mode 100644 index 617f6e745..000000000 --- a/sdrf-proteomics/templates/plants/README.adoc +++ /dev/null @@ -1,379 +0,0 @@ -= SDRF-Proteomics: Plants Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -The plants template provides standardized metadata fields for plant proteomics experiments. This includes model organisms like Arabidopsis thaliana, as well as crop species, trees, and other plant systems. - -This template is appropriate for: - -* Arabidopsis proteomics studies -* Crop proteomics (rice, maize, wheat, soybean) -* Plant stress response studies -* Agricultural and plant biology research - -[[extends]] -== Template Hierarchy - -[source] ----- -base (construction artifact) - └── plants (SAMPLE layer - must combine with TECHNOLOGY template) ----- - -The plants template extends the **base** template, adding disease annotation and plant-specific fields. - -[IMPORTANT] -==== -The plants template **cannot be used alone**. You must combine it with a technology template: - -* `ms-proteomics` + `plants` - For MS-based proteomics of plant samples -* `affinity-proteomics` + `plants` - For affinity proteomics of plant samples -==== - -[[checklist]] -== Checklist - -=== Inherited Columns - -All columns from the base template are inherited (source name, organism, organism part, biological replicate, assay name, technology type, instrument, technical replicate, data file). Technology-specific columns come from the technology template (`ms-proteomics` or `affinity-proteomics`). - -=== Plants-Specific Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    characteristics[disease]REQUIREDDisease state of the sampleMONDO, EFO, DOID, PATOnormal, breast cancer, diabetes mellitus
    characteristics[developmental stage]RECOMMENDEDDevelopmental stage of the plantPlant Ontology (PO), EFOseedling stage, flowering stage, rosette growth stage, senescent stage
    characteristics[strain/breed]OPTIONALCultivar, ecotype, or accession of the plant—Col-0, Ler-0, Nipponbare, B73
    characteristics[growth conditions]OPTIONALGrowth conditions for the plant—long day (16h light/8h dark), short day (8h light/16h dark), continuous light, greenhouse
    characteristics[treatment]OPTIONALTreatment applied to the plantEFO, ChEBIdrought stress, salt stress, pathogen infection, hormone treatment
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|characteristics[disease] |REQUIRED |Disease state of the sample |MONDO, EFO, DOID, PATO |normal, breast cancer, diabetes mellitus -|characteristics[developmental stage] |RECOMMENDED |Developmental stage of the plant |Plant Ontology (PO), EFO |seedling stage, flowering stage, rosette growth stage, senescent stage -|characteristics[strain/breed] |OPTIONAL |Cultivar, ecotype, or accession of the plant |— |Col-0, Ler-0, Nipponbare, B73 -|characteristics[growth conditions] |OPTIONAL |Growth conditions for the plant |— |long day (16h light/8h dark), short day (8h light/16h dark), continuous light, greenhouse -|characteristics[treatment] |OPTIONAL |Treatment applied to the plant |EFO, ChEBI |drought stress, salt stress, pathogen infection, hormone treatment -|=== -endif::[] - -[[common-organisms]] -== Common Plant Organisms - -|=== -|Common Name |Scientific Name |NCBITaxon ID |Common Ecotypes/Cultivars - -|Arabidopsis |Arabidopsis thaliana |NCBITaxon:3702 |Col-0, Ler-0, Ws-0, C24 -|Rice |Oryza sativa |NCBITaxon:4530 |Nipponbare, IR64, Kasalath -|Maize |Zea mays |NCBITaxon:4577 |B73, Mo17, W22 -|Wheat |Triticum aestivum |NCBITaxon:4565 |Chinese Spring -|Soybean |Glycine max |NCBITaxon:3847 |Williams 82 -|Tomato |Solanum lycopersicum |NCBITaxon:4081 |M82, Micro-Tom -|=== - -[[developmental-stages]] -== Developmental Stages - -Common developmental stages from the Plant Ontology (PO): - -|=== -|Stage |PO Term |Description - -|seedling stage |PO:0007131 |Plant after germination before mature vegetative growth -|rosette growth stage |PO:0007113 |Arabidopsis-specific rosette development -|vegetative growth stage |PO:0007134 |Mature vegetative plant -|reproductive growth stage |PO:0007130 |Flowering and fruiting -|flowering stage |PO:0007616 |Active flowering -|fruit formation stage |PO:0007042 |Fruit/seed development -|senescent stage |PO:0025337 |Aging and senescence -|=== - -[[organism-parts]] -== Plant Organism Parts - -Common plant tissue/organ terms: - -|=== -|Organ/Tissue |Ontology Term |Description - -|leaf |PO:0025034 |Photosynthetic organ -|root |PO:0009005 |Underground organ -|stem |PO:0009047 |Main axis -|flower |PO:0009046 |Reproductive structure -|seed |PO:0009010 |Mature ovule -|fruit |PO:0009001 |Mature ovary -|shoot |PO:0009006 |Aerial part -|whole plant |PO:0000003 |Entire organism -|=== - -[[growth-conditions]] -== Growth Conditions - -Document growth conditions using standard descriptions: - -|=== -|Condition |Format |Example - -|Photoperiod |{light}h light/{dark}h dark |16h light/8h dark -|Temperature |{temp}°C |22°C -|Light intensity |{value} μmol m⁻² s⁻¹ |120 μmol m⁻² s⁻¹ -|Growth medium |{medium name} |1/2 MS medium -|=== - -[[treatments]] -== Common Plant Treatments - -|=== -|Treatment Type |Example Values |Ontology - -|Abiotic stress |drought stress, salt stress, cold stress, heat stress |EFO -|Biotic stress |pathogen infection, herbivore attack |EFO -|Hormone treatment |auxin treatment, ABA treatment, jasmonic acid |ChEBI -|Nutrient stress |nitrogen starvation, phosphate starvation |EFO -|=== - -[[validation]] -== Validation - -Validate SDRF files using sdrf-pipelines: - -[source,bash] ----- -pip install sdrf-pipelines -sdrf_validate --sdrf_file your_file.sdrf.tsv --template plants ----- - -[[template-file]] -== Template File - -The plants SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/plants/1.1.0/plants.sdrf.tsv[plants.sdrf.tsv] - -[[examples]] -== Examples - -=== Arabidopsis Stress Study Example - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]characteristics[developmental stage]characteristics[strain/breed]characteristics[growth conditions]characteristics[treatment]characteristics[biological replicate]
    sample_1arabidopsis thalianaleafnormalrosette growth stageCol-0long day (16h light/8h dark)control1
    sample_2arabidopsis thalianaleafnormalrosette growth stageCol-0long day (16h light/8h dark)control2
    sample_3arabidopsis thalianaleafnormalrosette growth stageCol-0long day (16h light/8h dark)drought stress1
    sample_4arabidopsis thalianaleafnormalrosette growth stageCol-0long day (16h light/8h dark)drought stress2
    -
    - Sample metadata -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[developmental stage] |characteristics[strain/breed] |characteristics[growth conditions] |characteristics[treatment] |characteristics[biological replicate] - -|sample_1 |arabidopsis thaliana |leaf |normal |rosette growth stage |Col-0 |long day (16h light/8h dark) |control |1 -|sample_2 |arabidopsis thaliana |leaf |normal |rosette growth stage |Col-0 |long day (16h light/8h dark) |control |2 -|sample_3 |arabidopsis thaliana |leaf |normal |rosette growth stage |Col-0 |long day (16h light/8h dark) |drought stress |1 -|sample_4 |arabidopsis thaliana |leaf |normal |rosette growth stage |Col-0 |long day (16h light/8h dark) |drought stress |2 -|=== -endif::[] - -=== Rice Proteomics Example - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]characteristics[developmental stage]characteristics[strain/breed]characteristics[biological replicate]
    sample_1oryza sativaleafnormalseedling stageNipponbare1
    sample_2oryza sativaleafnormalseedling stageNipponbare2
    sample_3oryza sativarootnormalseedling stageNipponbare1
    sample_4oryza sativarootnormalseedling stageNipponbare2
    -
    - Sample metadata -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[developmental stage] |characteristics[strain/breed] |characteristics[biological replicate] - -|sample_1 |oryza sativa |leaf |normal |seedling stage |Nipponbare |1 -|sample_2 |oryza sativa |leaf |normal |seedling stage |Nipponbare |2 -|sample_3 |oryza sativa |root |normal |seedling stage |Nipponbare |1 -|sample_4 |oryza sativa |root |normal |seedling stage |Nipponbare |2 -|=== -endif::[] diff --git a/sdrf-proteomics/templates/single-cell/README.adoc b/sdrf-proteomics/templates/single-cell/README.adoc deleted file mode 100644 index f4be032c4..000000000 --- a/sdrf-proteomics/templates/single-cell/README.adoc +++ /dev/null @@ -1,583 +0,0 @@ -= SDRF-Proteomics: Single Cell Proteomics Template -:sectnums: -:toc: left -:doctype: book -//only works on some backends, not HTML -:showcomments: -//use style like Section 1 when referencing within the document. -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -//GitHub specific settings -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides guidelines for annotating single cell proteomics (SCP) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with single-cell-specific metadata fields. - -**Status:** Released - This template is aligned with community guidelines and stable for production use. - -**Version:** 1.0.0 - 2026-01 - -[[guidelines]] -== Alignment with Community Guidelines - -This template is aligned with the **Nature Methods single-cell proteomics guidelines**: - -**** -Gatto L, Aebersold R, Cox J, et al. (2023). **Initial recommendations for performing, benchmarking and reporting single-cell proteomics experiments.** _Nature Methods_, 20(3), 375-386. https://doi.org/10.1038/s41592-023-01785-3 -**** - -The metadata columns and requirements in this template follow the recommendations from this community consensus paper for standardizing SCP experiment reporting. - -[[abstract]] -== Abstract - -Single cell proteomics (SCP) characterizes the proteome at the level of individual cells, providing insights into cellular heterogeneity, rare cell populations, cellular state transitions, and protein expression dynamics at single-cell resolution. - -SCP experiments have unique characteristics: cell isolation methods (FACS, microfluidics, cellenONE), ultra-low sample input (picogram to nanogram), carrier proteome strategies, cell-level metadata requirements, and high-throughput multiplexing (SCoPE-MS, TMT). This template defines the additional metadata requirements for annotating single cell proteomics datasets. - -[[connections]] -== Connections to Other Omics Fields - -Single cell proteomics data is often integrated with: - -- **Single-cell RNA sequencing (scRNA-seq)**: For multi-omic cellular characterization -- **Single-cell ATAC-seq**: For chromatin accessibility correlation -- **Spatial transcriptomics**: When cells have spatial context -- **Flow cytometry data**: For pre-sorting characterization (FSC, SSC, sorting markers) - -When available, linking to related single-cell omics datasets through BioSamples accession numbers or shared cell identifiers is highly RECOMMENDED. - -[[additional-ontologies]] -== Additional Ontologies - -In addition to the ontologies supported by the core SDRF-Proteomics specification, single cell proteomics templates utilize: - -- **Cell Ontology (CL)**: For cell type classification (https://obofoundry.org/ontology/cl.html) -- **Human Cell Atlas ontologies**: For standardized cell annotations -- **EDAM ontology**: For bioinformatics data types and operations -- **Human/Mouse Developmental Stage ontologies (HsapDv, MmusDv)**: For developmental stage annotation - -[[checklist]] -== Checklist - -This section defines the metadata columns required and recommended for single cell proteomics experiments, following the Nature Methods SCP guidelines. - -=== Required Columns - -The following columns are REQUIRED for single cell proteomics experiments in addition to the core SDRF-Proteomics requirements: - -|=== -|Column Name |Description |Cardinality |Controlled Values |Example Values - -|comment[sample type] -|Classification of the sample - distinguishes single cells from carriers, references, and controls. **Critical for proper data analysis.** -|1 -|single cell, carrier, reference, empty, negative control, bulk control, not applicable -|single cell, carrier, reference, empty - -|characteristics[single cell isolation method] -|Technique used to isolate individual cells -|1 -|FACS, cellenONE, CellenONE, microfluidics, laser capture microdissection, LCM, manual picking, nanoPOTS, droplet microfluidics, acoustic droplet ejection, not applicable -|FACS, cellenONE, laser capture microdissection - -|characteristics[cell identifier] -|Unique identifier for each single cell within the experiment. Required per SCP guidelines for tracking cells through analysis. -|1 -|Alphanumeric identifier (use `carrier`, `reference`, `empty` for non-single-cell samples) -|cell_001, SC_A1, well_B3, barcode_ATCGATCG, carrier, reference -|=== - -=== Recommended Columns - -The following columns are RECOMMENDED for single cell proteomics experiments per the Nature Methods guidelines: - -|=== -|Column Name |Description |Cardinality |Ontology/CV |Example Values - -|characteristics[individual] -|Unique identifier for the donor/patient individual. Important for studies with multiple donors. -|0..1 -|Alphanumeric identifier -|patient_001, donor_A, C1, T1 - -|comment[sample preparation batch] -|Batch identifier for sample preparation (plate, chip, processing batch). **Critical for batch effect correction.** -|0..1 -|Free text identifier -|plate1, plate2, chip_A, batch_20220601 - -|comment[cells per well] -|Number of cells per well/reaction. Use 1 for true single cells, higher numbers for small pools. -|0..1 -|Numeric value -|1, 5, 10, 100 - -|characteristics[developmental stage] -|Developmental stage of the organism at sample collection -|0..1 -|EFO, HsapDv, MmusDv, UBERON -|adult, embryonic stage, fetal stage, neonate -|=== - -=== Optional Columns - Flow Cytometry Data - -Per the Nature Methods guidelines, flow cytometry data should be reported when available: - -|=== -|Column Name |Description |Example Values - -|characteristics[forward scatter] -|Forward scatter (FSC) value from flow cytometry - proxy for cell size -|316.0, 250, not applicable - -|characteristics[side scatter] -|Side scatter (SSC) value from flow cytometry - proxy for cell granularity/complexity -|301.0, 184, not applicable - -|characteristics[sorting marker] -|Markers used for cell sorting/selection with optional intensity values -|CD45+, GFP+, CD3+CD4+, CD34:APC-Cy7-A=276.0, PI- -|=== - -=== Optional Columns - Cell State and Quality - -|=== -|Column Name |Description |Example Values - -|characteristics[cell viability] -|Viability status of the cell at isolation -|live, viable, dead, unknown - -|characteristics[cell cycle phase] -|Cell cycle phase if determined (e.g., by FACS or computational inference) -|G1, S, G2, G2/M, M, G0, not determined - -|characteristics[cell diameter] -|Physical diameter of the isolated cell if measured (in micrometers) -|15 um, 20.5 um, 12 μm - -|comment[single cell quality] -|Quality assessment of the single cell preparation (pass/fail based on QC criteria) -|pass, fail, OK, not OK -|=== - -=== Optional Columns - Model Organisms - -|=== -|Column Name |Description |Example Values - -|characteristics[genotype] -|Genotype of the organism (especially for model organisms) -|wild type genotype, Pitx2-/-, GFP+, daf-2(e1370) - -|characteristics[strain] -|Strain or genetic background of model organisms -|C57BL/6, BALB/c, CD1, Sprague-Dawley -|=== - -=== Optional Columns - Carrier and Multiplexing (SCoPE-MS type methods) - -|=== -|Column Name |Description |Example Values - -|comment[carrier proteome] -|Description of carrier proteome used in carrier-assisted SCP methods -|200x HeLa carrier, 100 ng bovine serum albumin, no carrier - -|comment[carrier channel] -|TMT/iTRAQ channel used for carrier proteome -|TMT131C, TMT126, not applicable - -|comment[reference channel] -|TMT/iTRAQ channel used for reference/booster sample -|TMT127N, TMT134N, not applicable -|=== - -=== Optional Columns - Batch and Technical Tracking - -|=== -|Column Name |Description |Example Values - -|comment[LC batch] -|Liquid chromatography batch identifier for batch effect tracking -|LC1, LC2, column_A - -|comment[acquisition date] -|Date and time of MS data acquisition (ISO 8601 format recommended) -|2022-06-01_18:28:37, 2022-06-01, 20220601 -|=== - -=== Optional Columns - Spatial Information - -For spatially-resolved single-cell proteomics (e.g., laser capture microdissection from tissue): - -|=== -|Column Name |Description |Example Values - -|comment[spatial coordinates] -|X,Y coordinates if cells were isolated from a spatial context -|X=100;Y=250, X=50.5;Y=120.3, not applicable - -|comment[tissue section] -|Tissue section identifier for spatially resolved single-cell proteomics -|section_001, slide_A_section_3 -|=== - -[[sample-type]] -== Sample Type Classification - -The `comment[sample type]` column is critical for distinguishing the different sample types commonly used in SCP experiments: - -|=== -|Sample Type |Description |Use Case - -|single cell -|An individual cell isolated for proteomics analysis -|The primary analyte in SCP experiments - -|carrier -|Carrier proteome channel (e.g., 200x HeLa lysate) used to boost signal in carrier-assisted methods -|SCoPE-MS, SCoPE2, and similar methods - -|reference -|Reference channel used for normalization across runs -|TMT-based experiments requiring cross-run normalization - -|empty -|Control well with no cells - used to estimate background and noise -|QC for cell isolation efficiency - -|negative control -|Negative control sample to assess technical artifacts -|Method validation and QC - -|bulk control -|Bulk sample (many cells) for comparison with single-cell data -|Benchmarking single-cell vs. bulk measurements -|=== - -[[cell-identifier]] -== Cell Identifier Annotation - -Each cell in a single cell proteomics experiment MUST have a unique identifier. The `characteristics[cell identifier]` serves as the primary cell-level identifier within the dataset. - -=== Naming Conventions - -Recommended naming conventions for cell identifiers: - -- **Well-based**: `well_A01`, `plate1_A01`, `96wp_A01` -- **Sequential**: `cell_001`, `cell_002`, `SC_0001` -- **Barcode-based**: `barcode_ATCGATCG` (for methods using molecular barcodes) -- **Combined**: `plate1_well_A01_cell1` - -For non-single-cell channels, use descriptive identifiers: - -- **Carrier**: `carrier` -- **Reference**: `reference` -- **Empty**: `empty` - -=== Uniqueness Requirements - -- Cell identifiers MUST be unique within the SDRF file -- When combining multiple plates/batches, include batch information in the identifier -- The combination of `source name` + `assay name` + `comment[label]` + `characteristics[cell identifier]` should uniquely identify each row - -[[multiplexed-scp]] -== Multiplexed Single Cell Proteomics Checklist - -Many SCP methods use TMT or similar labeling to multiplex multiple cells in a single MS run. For these experiments: - -=== SCoPE-MS and Similar Methods - -|=== -|source name |comment[sample type] |characteristics[cell identifier] |characteristics[individual] |characteristics[cell type] |comment[sample preparation batch] |comment[label] |comment[carrier channel] |comment[data file] - -|PBMC_patient1 -|single cell -|cell_001 -|patient_001 -|T cell -|plate1 -|TMT127N -|TMT131C -|run001.raw - -|PBMC_patient1 -|single cell -|cell_002 -|patient_001 -|B cell -|plate1 -|TMT127C -|TMT131C -|run001.raw - -|PBMC_patient1 -|single cell -|cell_003 -|patient_001 -|monocyte -|plate1 -|TMT128N -|TMT131C -|run001.raw - -|carrier_reference -|carrier -|carrier -|not applicable -|mixed -|plate1 -|TMT131C -|TMT131C -|run001.raw - -|empty_well -|empty -|empty -|not applicable -|not applicable -|plate1 -|TMT126 -|TMT131C -|run001.raw -|=== - -=== Carrier and Reference Channels - -When using carrier proteome strategies: - -- Use `comment[sample type]` to clearly indicate which rows are carriers, references, or single cells -- Annotate the carrier channel with `comment[carrier channel]` -- Use `characteristics[cell identifier]` = `carrier`, `reference`, or `empty` for non-single-cell channels -- Set `characteristics[cell type]` to `mixed` or specify the carrier source for carrier channels - -[[label-free-scp]] -== Label-Free Single Cell Proteomics Checklist - -For label-free SCP methods (nanoPOTS, direct injection, etc.): - -- Set `comment[label]` to `label free sample` -- Each cell corresponds to one MS run -- Cell identifier still required for tracking - -Example: - -|=== -|source name |comment[sample type] |characteristics[cell identifier] |characteristics[individual] |characteristics[cell type] |assay name |comment[label] |comment[data file] - -|tissue_section_1 -|single cell -|cell_LCM_001 -|donor_A -|epithelial cell -|LCM_cell_001_run -|label free sample -|cell001.raw - -|tissue_section_1 -|single cell -|cell_LCM_002 -|donor_A -|stromal cell -|LCM_cell_002_run -|label free sample -|cell002.raw -|=== - -[[example-sdrf]] -== Example SDRF File - -A complete example for a TMT-based single cell proteomics experiment aligned with Nature Methods guidelines: - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecomment[sample type]characteristics[cell identifier]characteristics[individual]characteristics[cell type]characteristics[forward scatter]characteristics[side scatter]...comment[sample preparation batch]comment[label]comment[data file]
    PBMC_donor1single cellcell_T001patient_001T cell316.0301.0...plate1TMT127Nbatch1_set1.raw
    PBMC_donor1single cellcell_B001patient_001B cell250.0184.0...plate1TMT127Cbatch1_set1.raw
    carrier_HeLacarriercarriernot applicableepithelial cellnot applicablenot applicable...plate1TMT131Cbatch1_set1.raw
    empty_controlemptyemptynot applicablenot applicablenot applicablenot applicable...plate1TMT126batch1_set1.raw
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -|=== -|source name |comment[sample type] |characteristics[cell identifier] |characteristics[individual] |characteristics[cell type] |characteristics[forward scatter] |characteristics[side scatter] |... |comment[sample preparation batch] |comment[label] |comment[data file] - -|PBMC_donor1 |single cell |cell_T001 |patient_001 |T cell |316.0 |301.0 |... |plate1 |TMT127N |batch1_set1.raw -|PBMC_donor1 |single cell |cell_B001 |patient_001 |B cell |250.0 |184.0 |... |plate1 |TMT127C |batch1_set1.raw -|carrier_HeLa |carrier |carrier |not applicable |epithelial cell |not applicable |not applicable |... |plate1 |TMT131C |batch1_set1.raw -|empty_control |empty |empty |not applicable |not applicable |not applicable |not applicable |... |plate1 |TMT126 |batch1_set1.raw -|=== -endif::[] - -NOTE: The `...` column indicates omitted columns (organism, disease, biological replicate, assay name, technology type, carrier proteome, fraction identifier, cleavage agent details, instrument). - -[[quality-metrics]] -== Quality Control Annotations - -For single cell proteomics, the following quality-related annotations are RECOMMENDED: - -|=== -|Column Name |Description |Example Values - -|comment[proteins identified] -|Number of proteins identified per cell (post-analysis) -|500, 1200, 2500 - -|comment[peptides identified] -|Number of peptides identified per cell (post-analysis) -|1500, 3500, 8000 - -|comment[MS2 identification rate] -|Percentage of MS2 spectra resulting in identifications -|25%, 40%, 55% - -|comment[missing value percentage] -|Percentage of missing values for this cell -|30%, 45%, 60% -|=== - -NOTE: These columns may be added after data analysis and are not required at submission time. - -[[best-practices]] -== Best Practices for Single Cell Proteomics Annotation - -Following the Nature Methods SCP guidelines: - -1. **Always classify sample types**: Use `comment[sample type]` to distinguish single cells from carriers, references, and controls. - -2. **Provide unique cell identifiers**: Each cell MUST have a unique identifier enabling tracking through analysis. - -3. **Document isolation method**: Specify the exact technique used for cell isolation (FACS, LCM, cellenONE, etc.). - -4. **Track individual/donor information**: Use `characteristics[individual]` to identify which donor/patient each cell came from. - -5. **Record batch information**: Document `comment[sample preparation batch]` and `comment[LC batch]` for batch effect correction. - -6. **Include flow cytometry data when available**: Report FSC, SSC, and sorting marker values. - -7. **Annotate carrier channels**: When using carrier proteome, clearly identify which channels contain carrier vs. single cells. - -8. **Include cell type information**: Annotate cell types using Cell Ontology terms when possible. - -9. **Report cell numbers**: Use `comment[cells per well]` to indicate whether measurements are truly single cells or small pools. - -10. **Use factor values**: Use `factor value` columns to indicate experimental variables (treatment, time point, cell type comparisons). - -[[template-file]] -== Template File - -The single cell proteomics SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/single-cell/1.0.0/single-cell.sdrf.tsv[single-cell.sdrf.tsv] - -[[validation]] -== Validation - -Single cell proteomics SDRF files should be validated using the sdrf-pipelines tool: - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template single-cell ----- - -[[authors]] -== Authors and Maintainers - -This template was developed by the SDRF-Proteomics community with contributions from single cell proteomics researchers, aligned with the Nature Methods SCP consensus guidelines. - -For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository]. - -[[references]] -== References - -- **Gatto L, Aebersold R, Cox J, et al.** (2023). Initial recommendations for performing, benchmarking and reporting single-cell proteomics experiments. _Nature Methods_, 20(3), 375-386. https://doi.org/10.1038/s41592-023-01785-3 -- Slavov N. (2021) Single-cell protein analysis by mass spectrometry. _Current Opinion in Chemical Biology_. -- Specht H, et al. (2021) Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2. _Genome Biology_. -- Kelly RT. (2020) Single-cell Proteomics: Progress and Prospects. _Molecular & Cellular Proteomics_. -- Budnik B, et al. (2018) SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation. _Genome Biology_. diff --git a/sdrf-proteomics/templates/somascan/README.adoc b/sdrf-proteomics/templates/somascan/README.adoc deleted file mode 100644 index 5562f7b26..000000000 --- a/sdrf-proteomics/templates/somascan/README.adoc +++ /dev/null @@ -1,337 +0,0 @@ -= SDRF-Proteomics: SomaScan Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status of this Template - -This document provides guidelines for annotating SomaScan aptamer-based proteomics experiments in SDRF-Proteomics format. - -**Type:** Platform-Specific Template (extends affinity-proteomics) - -**Status:** Released - -**Version:** 1.0.0 - 2026-01 - -[[abstract]] -== Abstract - -SomaScan is an aptamer-based proteomics platform developed by SomaLogic that uses Slow Off-rate Modified Aptamers (SOMAmer) reagents to measure protein levels. This template extends the affinity-proteomics template with SomaScan-specific metadata fields for menu version, sample matrix, and normalization methods. - -[[hierarchy]] -== Template Hierarchy - -[source] ----- -base - └── affinity-proteomics - └── somascan (THIS TEMPLATE) ----- - -[[usage]] -== Usage - -=== File Metadata Columns - -SDRF files SHOULD include metadata columns to specify version and template information. Only list leaf templates; parent templates are implied by inheritance (somascan inherits from affinity-proteomics). Place these columns at the end of the file. - -**Non-human samples:** - -|=== -|... |comment[sdrf version] |comment[sdrf template] - -|... |v1.1.0 |somascan v1.0.0 -|=== - -**Human samples** - use multiple template columns: - -|=== -|... |comment[sdrf version] |comment[sdrf template] |comment[sdrf template] - -|... |v1.1.0 |human v1.1.0 |somascan v1.0.0 -|=== - -[[checklist]] -== SomaScan-Specific Columns - -In addition to all columns from link:../affinity-proteomics/README.adoc[affinity-proteomics], the following SomaScan-specific columns are available: - -=== Required for SomaScan - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionExample Values
    comment[somascan menu]REQUIREDSomaScan assay menu (number of aptamers)SomaScan 5K, SomaScan 7K, SomaScan 11K
    comment[somascan platform]REQUIREDSomaScan platform versionSomaScan Assay v4, SomaScan Assay v4.1
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column |Requirement |Description |Example Values - -|comment[somascan menu] |REQUIRED |SomaScan assay menu |SomaScan 5K, SomaScan 7K, SomaScan 11K -|comment[somascan platform] |REQUIRED |SomaScan platform version |SomaScan Assay v4, SomaScan Assay v4.1 -|=== -endif::[] - -=== Recommended for SomaScan - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionExample Values
    comment[sample matrix]RECOMMENDEDSample matrix type (affects calibration)plasma, serum, EDTA plasma, CSF
    comment[dilution]RECOMMENDEDSample dilution factor used0.005%, 0.5%, 20%, 40%
    comment[normalization method]RECOMMENDEDNormalization method applied to RFU valueshybridization control normalized, median normalized, ANML
    comment[QC flag]OPTIONALQuality control flagPASS, FLAG, FAIL
    comment[somascan lot number]OPTIONALReagent lot numberSS-2023-001
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,2", options="header"] -|=== -|Column |Requirement |Description |Example Values - -|comment[sample matrix] |RECOMMENDED |Sample matrix type |plasma, serum, EDTA plasma -|comment[dilution] |RECOMMENDED |Dilution factor |0.005%, 0.5%, 20%, 40% -|comment[normalization method] |RECOMMENDED |Normalization method |median normalized, ANML -|comment[QC flag] |OPTIONAL |Quality control flag |PASS, FLAG, FAIL -|comment[somascan lot number] |OPTIONAL |Reagent lot number |SS-2023-001 -|=== -endif::[] - -[[somascan-menus]] -== SomaScan Assay Menus - -SomaScan offers different menu sizes based on the number of protein targets: - -=== Current Menus - -* **SomaScan 7K**: ~7,000 protein targets (current standard) -* **SomaScan 11K**: ~11,000 protein targets (expanded panel) - -=== Legacy Menus - -* **SomaScan 1.1K**: ~1,100 protein targets -* **SomaScan 1.3K**: ~1,300 protein targets -* **SomaScan 5K**: ~5,000 protein targets - -[[technology-type]] -== Technology Type - -For SomaScan experiments, use: - -`technology type` = `protein expression profiling by aptamer array` - -[[quantification]] -== Quantification - -SomaScan uses **RFU (Relative Fluorescence Units)**: - -* RFU is a measure of fluorescence intensity proportional to protein concentration -* Higher RFU = higher protein concentration -* RFU values require normalization for cross-sample comparisons -* Standard normalization includes hybridization control, median, and plate scaling - -Always set: - -`comment[quantification unit]` = `RFU` - -[[sample-matrix]] -== Sample Matrix - -The sample matrix is critical for SomaScan assays because calibration and expected ranges differ by matrix type: - -* **EDTA plasma**: Preferred matrix, most validated -* **Serum**: Commonly used alternative -* **Citrate/Heparin plasma**: Less common -* **CSF**: Specialized protocols -* **Cell/Tissue lysates**: Research applications - -[[normalization]] -== Normalization Methods - -SomaScan data typically undergoes multiple normalization steps: - -1. **Hybridization control normalization**: Corrects for hybridization variation -2. **Median normalization**: Scales samples to common median -3. **Plate scale normalization**: Corrects for plate-to-plate variation -4. **Calibration**: Applies standard curve corrections -5. **ANML (Adaptive Normalization by Maximum Likelihood)**: Advanced cross-study normalization - -[[example]] -== Example SDRF - -ifndef::env-github[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]assay nametechnology typecomment[instrument]comment[somascan menu]comment[somascan platform]comment[quantification unit]comment[sample matrix]comment[normalization method]comment[data file]
    patient_001homo sapiensblood plasmatype 2 diabetes mellitusSL0001protein expression profiling by aptamer arraySomaScan Assay 7KSomaScan 7KSomaScan Assay v4.1RFUEDTA plasmaadaptive normalization by maximum likelihood (ANML)somascan_results.adat
    patient_002homo sapiensblood plasmanormalSL0002protein expression profiling by aptamer arraySomaScan Assay 7KSomaScan 7KSomaScan Assay v4.1RFUEDTA plasmaadaptive normalization by maximum likelihood (ANML)somascan_results.adat
    -
    - Sample metadata - Data file metadata -
    -
    -++++ -endif::[] - -ifdef::env-github[] -[cols="1,1,1,1,1,1,1,1,1,1,1,1,1", options="header"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |assay name |technology type |comment[instrument] |comment[somascan menu] |comment[somascan platform] |comment[quantification unit] |comment[sample matrix] |comment[normalization method] |comment[data file] - -|patient_001 |homo sapiens |blood plasma |type 2 diabetes mellitus |SL0001 |protein expression profiling by aptamer array |SomaScan Assay 7K |SomaScan 7K |SomaScan Assay v4.1 |RFU |EDTA plasma |adaptive normalization by maximum likelihood (ANML) |somascan_results.adat -|patient_002 |homo sapiens |blood plasma |normal |SL0002 |protein expression profiling by aptamer array |SomaScan Assay 7K |SomaScan 7K |SomaScan Assay v4.1 |RFU |EDTA plasma |adaptive normalization by maximum likelihood (ANML) |somascan_results.adat -|=== -endif::[] - -[[data-files]] -== Data File Formats - -SomaScan data files: - -* **ADAT**: Native SomaScan format (annotated data file) -* **CSV/TSV**: Tabular exports of RFU values - -The `assay name` column must match the **SampleId** column in the ADAT file. - -[[validation]] -== Validation - -[source,bash] ----- -pip install sdrf-pipelines -parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template somascan ----- - -[[template-file]] -== Template File - -The SomaScan SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/somascan/1.0.0/somascan.sdrf.tsv[somascan.sdrf.tsv] - -[[related-templates]] -== Related Templates - -* link:../affinity-proteomics/README.adoc[Affinity Proteomics] - Parent template -* link:../olink/README.adoc[Olink Template] - Alternative affinity platform -* link:../human/README.adoc[Human Template] - Human sample metadata - -[[references]] -== References - -- Gold L, et al. (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. -- SomaLogic: https://somalogic.com/ -- SomaScan Technical Documentation: https://somalogic.com/somascan-platform/ diff --git a/sdrf-proteomics/templates/vertebrates/README.adoc b/sdrf-proteomics/templates/vertebrates/README.adoc deleted file mode 100644 index f5296f2ff..000000000 --- a/sdrf-proteomics/templates/vertebrates/README.adoc +++ /dev/null @@ -1,245 +0,0 @@ -= SDRF-Proteomics: Vertebrates Template -:sectnums: -:toc: left -:doctype: book -:showcomments: -:xrefstyle: short -:figure-caption: Figure -:pdf-page-size: A4 - -ifdef::env-github[] -:tip-caption: :bulb: -:note-caption: :information_source: -:important-caption: :heavy_exclamation_mark: -:caution-caption: :fire: -:warning-caption: :warning: -endif::[] - -[[status]] -== Status - -**Status:** Released - -**Version:** 1.1.0 - 2026-01 - -[[abstract]] -== Abstract - -The vertebrates template provides standardized metadata fields for non-human vertebrate proteomics experiments. This includes mammals (mouse, rat, etc.), birds, fish, reptiles, and amphibians. - -This template is appropriate for: - -* Mouse and rat proteomics studies -* Model organism research (zebrafish, Xenopus) -* Livestock and agricultural animal studies -* Wildlife and comparative proteomics - -[[extends]] -== Template Hierarchy - -[source] ----- -base (construction artifact) - └── vertebrates (SAMPLE layer - must combine with TECHNOLOGY template) ----- - -The vertebrates template extends the **base** template, adding disease annotation and vertebrate-specific fields. - -[IMPORTANT] -==== -The vertebrates template **cannot be used alone**. You must combine it with a technology template: - -* `ms-proteomics` + `vertebrates` - For MS-based proteomics of vertebrate samples -* `affinity-proteomics` + `vertebrates` - For affinity proteomics of vertebrate samples -==== - -[[checklist]] -== Checklist - -=== Inherited Columns - -All columns from the base template are inherited (source name, organism, organism part, biological replicate, assay name, technology type, instrument, technical replicate, data file). Technology-specific columns come from the technology template (`ms-proteomics` or `affinity-proteomics`). - -=== Vertebrates-Specific Columns - -ifdef::backend-html5[] -++++ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnRequirementDescriptionOntologyExample Values
    characteristics[disease]REQUIREDDisease state of the sampleMONDO, EFO, DOID, PATOnormal, breast cancer, diabetes mellitus
    characteristics[developmental stage]RECOMMENDEDDevelopmental stage of the organismEFO, UBERONadult, embryo, juvenile, larval stage
    characteristics[strain/breed]OPTIONALStrain or breed of the organismNCBITaxonC57BL/6, Sprague-Dawley, BALB/c
    characteristics[sex]OPTIONALBiological sex of the organism—male, female, hermaphrodite, not available, not applicable
    -++++ -endif::[] - -ifndef::backend-html5[] -[cols="2,1,2,1,2", options="header"] -|=== -|Column Name |Requirement |Description |Ontology |Example Values - -|characteristics[disease] |REQUIRED |Disease state of the sample |MONDO, EFO, DOID, PATO |normal, breast cancer, diabetes mellitus -|characteristics[developmental stage] |RECOMMENDED |Developmental stage of the organism |EFO, UBERON |adult, embryo, juvenile, larval stage -|characteristics[strain/breed] |OPTIONAL |Strain or breed of the organism |NCBITaxon |C57BL/6, Sprague-Dawley, BALB/c -|characteristics[sex] |OPTIONAL |Biological sex of the organism |— |male, female, hermaphrodite, not available, not applicable -|=== -endif::[] - -[[common-organisms]] -== Common Vertebrate Organisms - -|=== -|Common Name |Scientific Name |NCBITaxon ID |Common Strains/Breeds - -|Mouse |Mus musculus |NCBITaxon:10090 |C57BL/6, BALB/c, 129S1 -|Rat |Rattus norvegicus |NCBITaxon:10116 |Sprague-Dawley, Wistar, Lewis -|Zebrafish |Danio rerio |NCBITaxon:7955 |AB, TL, WIK -|Pig |Sus scrofa |NCBITaxon:9823 |Large White, Duroc -|Chicken |Gallus gallus |NCBITaxon:9031 |— -|Xenopus |Xenopus laevis |NCBITaxon:8355 |— -|=== - -[[developmental-stages]] -== Developmental Stages - -Common developmental stage terms for vertebrates: - -|=== -|Stage |EFO/UBERON Term |Description - -|adult |EFO:0001272 |Sexually mature organism -|embryo |UBERON:0000068 |Organism in early development -|juvenile |EFO:0001303 |Post-embryonic, pre-adult -|neonate |EFO:0001375 |Newborn -|fetus |UBERON:0000323 |Late embryonic stage (mammals) -|=== - -[[validation]] -== Validation - -Validate SDRF files using sdrf-pipelines: - -[source,bash] ----- -pip install sdrf-pipelines -sdrf_validate --sdrf_file your_file.sdrf.tsv --template vertebrates ----- - -[[template-file]] -== Template File - -The vertebrates SDRF template file is available in the sdrf-templates repository: - -- link:https://github.com/bigbio/sdrf-templates/blob/main/vertebrates/1.1.0/vertebrates.sdrf.tsv[vertebrates.sdrf.tsv] - -[[examples]] -== Examples - -=== Mouse Study Example - -ifdef::backend-html5[] -++++ -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    source namecharacteristics[organism]characteristics[organism part]characteristics[disease]characteristics[developmental stage]characteristics[strain/breed]characteristics[sex]characteristics[biological replicate]
    sample_1mus musculuslivernormaladultC57BL/6male1
    sample_2mus musculuslivernormaladultC57BL/6male2
    sample_3mus musculuslivernormaladultC57BL/6female1
    sample_4mus musculuslivernormaladultC57BL/6female2
    -
    - Sample metadata -
    -
    -++++ -endif::[] - -ifndef::backend-html5[] -[%header,cols="1,1,1,1,1,1,1,1"] -|=== -|source name |characteristics[organism] |characteristics[organism part] |characteristics[disease] |characteristics[developmental stage] |characteristics[strain/breed] |characteristics[sex] |characteristics[biological replicate] - -|sample_1 |mus musculus |liver |normal |adult |C57BL/6 |male |1 -|sample_2 |mus musculus |liver |normal |adult |C57BL/6 |male |2 -|sample_3 |mus musculus |liver |normal |adult |C57BL/6 |female |1 -|sample_4 |mus musculus |liver |normal |adult |C57BL/6 |female |2 -|=== -endif::[] diff --git a/site/build-search-index.py b/site/build-search-index.py index a592e20a4..34cfcfa20 100644 --- a/site/build-search-index.py +++ b/site/build-search-index.py @@ -7,6 +7,7 @@ import json import os import re +import sys from pathlib import Path def extract_text_from_adoc(filepath): @@ -152,11 +153,79 @@ def parse_sdrf_terms_tsv(filepath): return entries +def _index_yaml_templates(docs_dir): + """Index YAML template definitions for search. + + Uses resolve_templates to get full template data including inherited columns, + then creates search entries for each template. + """ + scripts_dir = Path(docs_dir) / 'scripts' + templates_dir = Path(docs_dir) / 'sdrf-proteomics' / 'sdrf-templates' + + if not templates_dir.exists(): + print("Warning: sdrf-templates directory not found, skipping YAML template indexing") + return [] + + # Import resolve_templates + sys.path.insert(0, str(scripts_dir)) + try: + from resolve_templates import resolve_all + except ImportError: + print("Warning: Could not import resolve_templates, skipping YAML template indexing") + return [] + + entries = [] + all_templates = resolve_all(templates_dir) + + for name, tpl in all_templates.items(): + # Build searchable content from template metadata and columns + parts = [ + tpl.get('description', ''), + tpl.get('documentation', ''), + ] + + # Add column names and descriptions + column_keywords = [] + for col in tpl.get('all_columns', []): + col_name = col.get('name', '') + parts.append(col_name) + parts.append(col.get('description', '')) + column_keywords.append(col_name) + + # Extract ontology references from validators + for v in col.get('validators', []): + if v.get('params'): + ontology = v['params'].get('ontology', '') + if ontology: + column_keywords.append(ontology) + + content = ' '.join(p for p in parts if p) + + # Build keywords + kw = set(column_keywords) + kw.update(extract_keywords(content)) + if tpl.get('layer'): + kw.add(tpl['layer']) + # Add the template name parts as keywords + kw.update(name.replace('-', ' ').split()) + + entries.append({ + 'title': f"{name.replace('-', ' ').title()} Template", + 'content': content[:3000], + 'url': f'./templates/{name}.html', + 'section': f'{(tpl.get("layer") or "internal").title()} Template', + 'keywords': ' '.join(kw) + }) + + print(f" Indexed {len(entries)} YAML template entries") + return entries + + def build_index(docs_dir, output_file): """Build search index from documentation files.""" index = [] - # Define documents to index (use relative paths for file:// compatibility) + # Define AsciiDoc documents to index documents = [ { 'file': 'sdrf-proteomics/README.adoc', @@ -164,32 +233,33 @@ def build_index(docs_dir, output_file): 'section': 'Core Specification' }, { - 'file': 'sdrf-proteomics/metadata-guidelines/sample-metadata.adoc', - 'url': './metadata-guidelines/sample-metadata.html', - 'section': 'Sample Metadata Guidelines' + 'file': 'sdrf-proteomics/TEMPLATES.adoc', + 'url': './templates.html', + 'section': 'Templates Guide' }, { - 'file': 'sdrf-proteomics/tool-support.adoc', - 'url': './tool-support.html', + 'file': 'sdrf-proteomics/TOOLS.adoc', + 'url': './tools.html', 'section': 'Tool Support' }, + { + 'file': 'sdrf-proteomics/SAMPLE-GUIDELINES.adoc', + 'url': './sample-guidelines.html', + 'section': 'Sample Metadata Guidelines' + }, ] - # Add template documents - templates_dir = Path(docs_dir) / 'templates' - if templates_dir.exists(): - for template_dir in templates_dir.iterdir(): - if template_dir.is_dir(): - readme = template_dir / 'README.adoc' - if readme.exists(): - template_name = template_dir.name - documents.append({ - 'file': str(readme.relative_to(docs_dir)), - 'url': f'./templates/{template_name}.html', - 'section': f'{template_name.replace("-", " ").title()} Template' - }) - - # Process each document + # Add metadata-guidelines .adoc files if they exist + mg_dir = Path(docs_dir) / 'sdrf-proteomics' / 'metadata-guidelines' + if mg_dir.exists(): + for adoc_file in sorted(mg_dir.glob('*.adoc')): + documents.append({ + 'file': str(adoc_file.relative_to(docs_dir)), + 'url': f'./metadata-guidelines/{adoc_file.stem}.html', + 'section': adoc_file.stem.replace('-', ' ').title() + }) + + # Process AsciiDoc documents for doc in documents: filepath = Path(docs_dir) / doc['file'] if not filepath.exists(): @@ -204,10 +274,12 @@ def build_index(docs_dir, output_file): title, content = extract_text_from_adoc(filepath) keywords = extract_keywords(raw_content) - # Split large documents into chunks for better search results chunks = split_into_chunks(content, title, doc['url'], doc['section'], keywords) index.extend(chunks) + # Index YAML-generated template pages + index.extend(_index_yaml_templates(docs_dir)) + # Index sdrf-terms.tsv for column definitions and ontology mappings sdrf_terms_path = Path(docs_dir) / 'sdrf-proteomics' / 'metadata-guidelines' / 'sdrf-terms.tsv' if sdrf_terms_path.exists(): diff --git a/site/css/style.css b/site/css/style.css index 530afc052..721d68d27 100644 --- a/site/css/style.css +++ b/site/css/style.css @@ -1697,7 +1697,7 @@ body.has-doc-header.toc2 #toc { } .term-metadata-table a { - color: var(--primary); + color: var(--primary-color); text-decoration: none; } @@ -1878,3 +1878,272 @@ hr { border-top: 1px solid var(--border-light); margin: 40px 0; } + +/* ===== Template Page Styles ===== */ + +/* Badges */ +.badge { display: inline-block; padding: 0.2em 0.6em; border-radius: 4px; font-size: 0.8rem; font-weight: 600; vertical-align: middle; } +.badge-version { background: var(--bg-alt); color: var(--text-light); border: 1px solid var(--border); } +.badge-layer-sample { background: #ddf4ff; color: #0550ae; } +.badge-layer-technology { background: #dafbe1; color: #116329; } +.badge-layer-experiment { background: #fff8c5; color: #6a5700; } +.badge-internal { background: var(--bg-alt); color: var(--text-light); } +.badge-required { background: #cf222e; color: white; } +.badge-recommended { background: #9a6700; color: white; } +.badge-optional { background: var(--bg-alt); color: var(--text-light); } +.badge-source { background: var(--bg-alt); color: var(--text-light); font-size: 0.75rem; } +.badge-source-own { background: #dafbe1; color: #116329; } + +/* Inheritance chain breadcrumb */ +.inheritance-chain { margin: 1.5rem 0; } +.inheritance-chain a { text-decoration: none; color: var(--accent); } +.inheritance-chain a:hover { text-decoration: underline; } +.inheritance-chain .chain-sep { margin: 0 0.3em; color: var(--text-light); } + +/* Combination rules */ +.combination-rules { margin: 1rem 0; } +.combination-rules ul { margin-left: 1.5rem; } + +/* Documentation section */ +.documentation-section { margin: 1.5rem 0; line-height: 1.7; } +.documentation-section p { margin-bottom: 0.5rem; } + +/* Toggle button for inherited columns */ +.toggle-inherited { margin-bottom: 1rem; } +.toggle-inherited button { padding: 0.4em 0.8em; border: 1px solid var(--border); border-radius: 4px; background: var(--bg); cursor: pointer; font-size: 0.85rem; } +.toggle-inherited button:hover { background: var(--bg-alt); } + +/* Column table */ +.columns-table { width: 100%; border-collapse: collapse; font-size: 0.9rem; } +.columns-table th { background: var(--bg-alt); text-align: left; padding: 0.6rem; border-bottom: 2px solid var(--border); font-weight: 600; } +.columns-table td { padding: 0.6rem; border-bottom: 1px solid var(--border-light); vertical-align: top; } +.columns-table tr.inherited { background: #fafbfc; } +.columns-table tr.inherited.hidden { display: none; } +.columns-table .col-name { font-family: 'JetBrains Mono', monospace; font-size: 0.85rem; white-space: nowrap; } +.columns-table .col-validators { font-size: 0.8rem; color: var(--text-light); } +.columns-table .col-examples { font-size: 0.8rem; color: var(--text-light); font-style: italic; } +.ontology-link { font-family: 'JetBrains Mono', monospace; font-size: 0.8rem; } + +/* Contributors on template pages */ +.contributors-section { margin-top: 2rem; } +.contributors-section ul { list-style: none; padding: 0; } +.contributors-section li { padding: 0.3rem 0; } + +/* =========================== + SDRF Builder + =========================== */ + +.builder-section { + margin-top: 3rem; + padding-top: 2rem; + border-top: 2px solid var(--border); +} + +.builder-step { margin-bottom: 2rem; } +.builder-step.hidden { display: none; } +.builder-step h3 { margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem; } + +.step-number { + display: inline-flex; align-items: center; justify-content: center; + width: 28px; height: 28px; border-radius: 50%; + background: var(--accent); color: white; + font-size: 0.85rem; font-weight: 600; flex-shrink: 0; +} +.step-number.completed { background: #16a34a; } + +/* Option cards */ +.option-grid { + display: grid; + grid-template-columns: repeat(auto-fill, minmax(220px, 1fr)); + gap: 12px; margin-top: 0.75rem; +} + +.option-card { + border: 2px solid var(--border); border-radius: 8px; + padding: 16px; cursor: pointer; + transition: all 0.2s ease; background: white; +} +.option-card:hover { border-color: var(--accent); box-shadow: 0 2px 8px rgba(0,0,0,0.08); } +.option-card.selected { border-color: var(--accent); background: #eff6ff; } +.option-card.disabled { opacity: 0.5; cursor: not-allowed; } +.option-card.disabled:hover { border-color: var(--border); box-shadow: none; } +.option-card h4 { margin: 0 0 4px 0; font-size: 0.95rem; } +.option-card p { margin: 0; font-size: 0.8rem; color: var(--text-light); line-height: 1.4; } +.option-card .disabled-reason { font-size: 0.75rem; color: #dc2626; margin-top: 6px; font-style: italic; } +.option-card .column-count { + display: inline-block; margin-top: 8px; font-size: 0.75rem; + padding: 2px 8px; background: var(--bg-alt); border-radius: 12px; color: var(--text-light); +} + +/* Expandable "Why?" sections */ +.why-toggle { + display: inline-block; margin-top: 8px; font-size: 0.8rem; + color: var(--accent); cursor: pointer; + border: none; background: none; padding: 0; text-decoration: underline; +} +.why-content { + display: none; margin-top: 8px; padding: 12px; + background: var(--bg-alt); border-radius: 6px; + font-size: 0.85rem; line-height: 1.5; +} +.why-content.open { display: block; } +.why-content a { color: var(--accent); } + +/* Live preview table */ +.builder-preview { + margin-top: 2rem; border: 1px solid var(--border); + border-radius: 8px; overflow: hidden; +} +.builder-preview-header { + display: flex; justify-content: space-between; align-items: center; + padding: 12px 16px; background: var(--bg-alt); + border-bottom: 1px solid var(--border); +} +.builder-preview-header h3 { margin: 0; font-size: 1rem; } +.column-stats { font-size: 0.85rem; color: var(--text-light); } +.builder-preview .table-container { overflow-x: auto; max-height: 400px; overflow-y: auto; } +.builder-preview table { width: 100%; border-collapse: collapse; font-size: 0.8rem; } +.builder-preview th { + padding: 8px 12px; font-weight: 600; text-align: left; + white-space: nowrap; position: sticky; top: 0; z-index: 1; +} +.builder-preview td { + padding: 8px 12px; white-space: nowrap; + color: var(--text-light); font-style: italic; + border: 1px solid var(--border); +} +.builder-preview th, .builder-preview td { border: 1px solid var(--border); } +.builder-preview th.sample-col { background: #dbeafe; color: #1e40af; } +.builder-preview td.sample-col { background: #eff6ff; } +.builder-preview th.data-col { background: #dcfce7; color: #166534; } +.builder-preview td.data-col { background: #f0fdf4; } +.builder-preview th.factor-col { background: #fef3c7; color: #92400e; } +.builder-preview td.factor-col { background: #fffbeb; } +.builder-preview tbody tr:hover td { filter: brightness(0.97); } +.builder-preview .sdrf-legend { + padding: 10px 16px; background: var(--bg-alt); + border-top: 1px solid var(--border); +} + +/* Column picker */ +.column-picker { margin-top: 1.5rem; } +.column-picker-search { + width: 100%; max-width: 400px; + padding: 8px 12px; border: 1px solid var(--border); + border-radius: 6px; font-size: 0.9rem; margin-bottom: 12px; +} +.column-picker-search:focus { outline: none; border-color: var(--accent); box-shadow: 0 0 0 3px rgba(37,99,235,0.1); } +.column-picker-group { margin-bottom: 1rem; } +.column-picker-group h4 { + font-size: 0.85rem; color: var(--text-light); + text-transform: uppercase; letter-spacing: 0.05em; margin-bottom: 8px; +} +.column-picker-item { + display: flex; align-items: center; gap: 10px; + padding: 8px 12px; border: 1px solid var(--border); + border-radius: 6px; margin-bottom: 6px; cursor: pointer; + transition: background 0.15s; +} +.column-picker-item:hover { background: var(--bg-alt); } +.column-picker-item.included { background: #eff6ff; border-color: var(--accent); } +.column-picker-item.locked { opacity: 0.7; cursor: default; background: #f3f4f6; border-color: #d1d5db; } +.column-picker-item.locked:hover { background: #f3f4f6; } +.col-lock { + font-size: 0.65rem; padding: 1px 6px; border-radius: 8px; + background: #e5e7eb; color: #6b7280; white-space: nowrap; flex-shrink: 0; +} +.column-picker-item .col-name { font-weight: 500; font-size: 0.85rem; } +.column-picker-item .col-desc { font-size: 0.75rem; color: var(--text-light); flex: 1; } +.col-type-badge { + font-size: 0.6rem; padding: 2px 6px; border-radius: 8px; + text-transform: uppercase; letter-spacing: 0.03em; + white-space: nowrap; flex-shrink: 0; font-weight: 600; +} +.col-type-badge.sample-col { background: #dbeafe; color: #1e40af; } +.col-type-badge.data-col { background: #dcfce7; color: #166534; } +.col-type-badge.factor-col { background: #fef3c7; color: #92400e; } +.column-picker-group h4 { + text-transform: capitalize; +} + +.toggle-btn { + width: 36px; height: 20px; border-radius: 10px; + border: none; background: #d1d5db; position: relative; + cursor: pointer; transition: background 0.2s; flex-shrink: 0; +} +.toggle-btn.active { background: var(--accent); } +.toggle-btn::after { + content: ''; position: absolute; top: 2px; left: 2px; + width: 16px; height: 16px; border-radius: 50%; + background: white; transition: transform 0.2s; +} +.toggle-btn.active::after { transform: translateX(16px); } + +/* Download bar */ +.download-bar { + position: sticky; bottom: 0; background: white; + border-top: 2px solid var(--border); + padding: 12px 24px; display: flex; + align-items: center; justify-content: space-between; + gap: 16px; z-index: 10; + box-shadow: 0 -2px 8px rgba(0,0,0,0.06); +} +.download-bar.hidden { display: none; } +.download-bar .download-info { font-size: 0.9rem; color: var(--text-light); } +.download-bar .download-actions { display: flex; gap: 10px; } + +.btn-download { + display: inline-flex; align-items: center; gap: 6px; + padding: 10px 20px; background: var(--accent); color: white; + border: none; border-radius: 6px; font-size: 0.9rem; + font-weight: 500; cursor: pointer; transition: background 0.2s; +} +.btn-download:hover { background: #1d4ed8; } +.btn-download:disabled { background: #9ca3af; cursor: not-allowed; } + +.btn-secondary { + display: inline-flex; align-items: center; gap: 6px; + padding: 10px 20px; background: white; color: var(--accent); + border: 2px solid var(--accent); border-radius: 6px; + font-size: 0.9rem; font-weight: 500; cursor: pointer; transition: all 0.2s; +} +.btn-secondary:hover { background: #eff6ff; } + +/* CTA arrow */ +.cta-builder { + text-align: center; margin: 2rem 0; padding: 1.5rem; + background: linear-gradient(135deg, #eff6ff, #dbeafe); + border-radius: 12px; +} +.cta-builder p { font-size: 1.1rem; font-weight: 500; margin: 0; } +.cta-builder .arrow-down { font-size: 1.5rem; display: block; margin-top: 8px; animation: bounce 2s infinite; } +@keyframes bounce { 0%, 100% { transform: translateY(0); } 50% { transform: translateY(6px); } } + +/* Factor value picker */ +.factor-picker { + display: flex; flex-wrap: wrap; gap: 8px; margin: 1rem 0; +} +.factor-chip { + display: inline-flex; align-items: center; gap: 4px; + padding: 6px 14px; border-radius: 20px; + border: 2px solid #e5e7eb; background: #fff; + font-size: 0.85rem; font-weight: 500; color: var(--text); + cursor: pointer; transition: all 0.2s; +} +.factor-chip:hover { + border-color: #f59e0b; background: #fffbeb; +} +.factor-chip.active { + border-color: #f59e0b; background: #fef3c7; color: #92400e; + box-shadow: 0 0 0 1px #f59e0b; +} +.factor-chip.active::before { + content: '\2713 '; font-weight: 700; +} + +/* Responsive */ +@media (max-width: 768px) { + .option-grid { grid-template-columns: 1fr; } + .download-bar { flex-direction: column; text-align: center; } + .download-bar .download-actions { width: 100%; justify-content: center; } +} diff --git a/site/index.html b/site/index.html index 5d1152f2c..7a6463be3 100644 --- a/site/index.html +++ b/site/index.html @@ -207,12 +207,12 @@

    Metadata Guidelines

    Sample Metadata

    Age, sex, disease, organism part

    - View Guidelines + View Guidelines
    -

    Human Metadata

    -

    Disease staging, treatment, demographics

    - View Guidelines +

    Templates Guide

    +

    Inheritance, layers, combination rules

    + View Guide

    SDRF Terms

    @@ -222,6 +222,108 @@

    SDRF Terms

    +
    +

    Example SDRF Files

    +

    Curated examples covering different experiment types, labeling strategies, and organisms. Download and use as starting points for your own annotations.

    +
    + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
    AccessionDescriptionOrganismLabelTemplatesRows
    PXD004684Label-free, DDAHomo sapienslabel freems-proteomics, human15
    PXD008934Label-free, human proteomeHomo sapienslabel freems-proteomics, human35
    PXD003772TMT labelingMus musculusTMTms-proteomics, vertebrates13
    PDC000126TMT labeling, large cohortHomo sapiensTMTms-proteomics, human2041
    PXD013923SILAC, phosphoproteomicsHomo sapiensSILACms-proteomics, human21
    PXD012667DIA acquisitionHomo sapienslabel freems-proteomics, human, dia-acquisition49
    PXD019515Single-cell proteomicsHomo sapienslabel freems-proteomics, human, single-cell7
    PXD003791Metaproteomics, guthuman gut metagenomelabel freemetaproteomics109
    PXD006439Label-free, mouseMus musculuslabel freems-proteomics, vertebrates68
    PXD013868Label-free, plantArabidopsis thalianalabel freems-proteomics, plants21
    +
    +

    Browse all examples on GitHub →

    +
    +

    Tool Support

    A growing ecosystem of tools supports the SDRF-Proteomics format for creating, validating, and analyzing proteomics data.

    @@ -234,17 +336,17 @@

    SDRF Editor

    Annotators

    Web-based tools for creating and editing SDRF files with ontology support.

    - View Tools + View Tools

    Validators

    Validate your SDRF files against the specification and check ontology terms.

    - View Tools + View Tools

    Analysis Pipelines

    Proteomics workflows that use SDRF as input for automated analysis.

    - View Tools + View Tools
    diff --git a/site/js/sdrf-builder.js b/site/js/sdrf-builder.js new file mode 100644 index 000000000..ad9951974 --- /dev/null +++ b/site/js/sdrf-builder.js @@ -0,0 +1,957 @@ +/** + * SDRF Interactive Builder + * Guides users through template selection and generates SDRF files. + */ +(function () { + 'use strict'; + + /* --------------------------------------------------------------- + Constants – step option definitions + --------------------------------------------------------------- */ + var TECHNOLOGY_OPTIONS = [ + { id: 'ms-proteomics', label: 'MS-based Proteomics', desc: 'Mass spectrometry experiments (DDA, DIA, PRM, SRM)' }, + { id: 'affinity-proteomics', label: 'Affinity-based Proteomics', desc: 'Protein-level assays (Olink, SomaScan)' } + ]; + + var ORGANISM_OPTIONS = [ + { id: 'human', label: 'Human', desc: 'Homo sapiens \u2014 adds ancestry, age, sex columns' }, + { id: 'vertebrates', label: 'Other Vertebrate', desc: 'Mouse, rat, zebrafish, etc. \u2014 adds strain, developmental stage' }, + { id: 'invertebrates', label: 'Invertebrate', desc: 'Drosophila, C. elegans, insects \u2014 adds strain, developmental stage' }, + { id: 'plants', label: 'Plant', desc: 'Arabidopsis, crops \u2014 adds cultivar, growth conditions' }, + { id: null, label: 'Skip', desc: 'No organism-specific columns needed' } + ]; + + var MS_EXPERIMENT_OPTIONS = [ + { id: 'dia-acquisition', label: 'DIA', desc: 'Data-independent acquisition \u2014 adds isolation window columns' }, + { id: 'single-cell', label: 'Single-cell', desc: 'Single-cell proteomics \u2014 adds cell-level annotations' }, + { id: 'crosslinking', label: 'Crosslinking MS', desc: 'XL-MS \u2014 adds crosslinker chemistry columns' }, + { id: 'immunopeptidomics', label: 'Immunopeptidomics', desc: 'MHC-bound peptides \u2014 adds HLA/MHC typing' }, + { id: 'metaproteomics', label: 'Metaproteomics', desc: 'Microbial communities \u2014 adds environment metadata' } + ]; + + var AFFINITY_OPTIONS = [ + { id: 'olink', label: 'Olink', desc: 'Proximity Extension Assay (PEA)' }, + { id: 'somascan', label: 'SomaScan', desc: 'Aptamer-based proteomics' }, + { id: null, label: 'Generic', desc: 'Other affinity platform \u2014 base columns only' } + ]; + + /* --------------------------------------------------------------- + Application state + --------------------------------------------------------------- */ + var state = { + technology: null, + organism: null, + experiments: [], + affinitySubtype: null, + extraColumns: [], // columns from sdrf-terms.tsv added by user + addedOptionals: [], // optional template columns the user opted into + factorValues: [] // characteristics chosen as factor values + }; + + var builderData = null; + + /* --------------------------------------------------------------- + Helpers + --------------------------------------------------------------- */ + + function classifyColumn(name) { + if (name === 'source name' || name.indexOf('characteristics[') === 0) { + return 'sample-col'; + } + if (name.indexOf('factor value[') === 0) { + return 'factor-col'; + } + return 'data-col'; + } + + function showStep(id) { + var el = document.getElementById(id); + if (el) el.classList.remove('hidden'); + } + + function hideStep(id) { + var el = document.getElementById(id); + if (el) el.classList.add('hidden'); + } + + function scrollTo(id) { + var el = document.getElementById(id); + if (el) { + setTimeout(function () { + el.scrollIntoView({ behavior: 'smooth', block: 'start' }); + }, 120); + } + } + + /* --------------------------------------------------------------- + Combination rules + --------------------------------------------------------------- */ + + function isDisabledByRules(templateId) { + if (!builderData || !builderData.combination_rules) return null; + var groups = builderData.combination_rules.mutually_exclusive; + if (!groups) return null; + for (var i = 0; i < groups.length; i++) { + var group = groups[i]; + var members = group.templates || group; + if (members.indexOf(templateId) === -1) continue; + // check if another member is already selected + for (var j = 0; j < members.length; j++) { + var m = members[j]; + if (m === templateId) continue; + if (state.experiments.indexOf(m) !== -1) { + return group.reason || ('Cannot combine with ' + m); + } + } + } + return null; + } + + /* --------------------------------------------------------------- + Organism-specific example overrides + --------------------------------------------------------------- */ + var ORGANISM_EXAMPLES = { + 'human': { + 'characteristics[organism]': 'Homo sapiens', + 'characteristics[organism part]': 'liver', + 'characteristics[cell type]': 'hepatocyte' + }, + 'vertebrates': { + 'characteristics[organism]': 'Mus musculus', + 'characteristics[organism part]': 'brain', + 'characteristics[cell type]': 'neuron' + }, + 'invertebrates': { + 'characteristics[organism]': 'Drosophila melanogaster', + 'characteristics[organism part]': 'whole organism', + 'characteristics[cell type]': 'not applicable' + }, + 'plants': { + 'characteristics[organism]': 'Arabidopsis thaliana', + 'characteristics[organism part]': 'leaf', + 'characteristics[cell type]': 'not applicable' + } + }; + + /* --------------------------------------------------------------- + Column resolution + --------------------------------------------------------------- */ + + function resolveColumns() { + if (!builderData || !state.technology) return []; + + var templateIds = [state.technology]; + if (state.organism) templateIds.push(state.organism); + if (state.technology === 'ms-proteomics') { + for (var i = 0; i < state.experiments.length; i++) { + templateIds.push(state.experiments[i]); + } + } + if (state.technology === 'affinity-proteomics' && state.affinitySubtype) { + templateIds.push(state.affinitySubtype); + } + + // Collect ALL template columns (for picker) and build resolved column set + var allColMap = {}; // all columns from templates (for picker reference) + var allColOrder = []; + for (var t = 0; t < templateIds.length; t++) { + var tid = templateIds[t]; + var tmpl = builderData.templates[tid]; + if (!tmpl || !tmpl.columns) continue; + for (var c = 0; c < tmpl.columns.length; c++) { + var col = tmpl.columns[c]; + if (!allColMap[col.name]) { + allColOrder.push(col.name); + } + allColMap[col.name] = col; + } + } + + // Store full template column map for the picker to use + resolveColumns._allTemplateColumns = allColMap; + resolveColumns._allTemplateOrder = allColOrder; + + // Build result: required/recommended by default, optional only if user opted in + var result = []; + for (var k = 0; k < allColOrder.length; k++) { + var colName = allColOrder[k]; + var col2 = allColMap[colName]; + var req = col2.requirement || 'optional'; + if (req === 'optional') { + // Only include if user explicitly added it + if (state.addedOptionals.indexOf(colName) === -1) continue; + } + result.push(col2); + } + + // Append extra columns from terms + for (var e = 0; e < state.extraColumns.length; e++) { + var extraName = state.extraColumns[e]; + var alreadyIn = false; + for (var r = 0; r < result.length; r++) { + if (result[r].name === extraName) { alreadyIn = true; break; } + } + if (!alreadyIn) { + var termInfo = findTerm(extraName); + result.push({ + name: extraName, + description: termInfo ? termInfo.description : '', + example_value: termInfo ? (termInfo.example_value || '') : '', + requirement: 'optional', + source_template: 'user' + }); + } + } + + // Apply organism-specific example overrides (shallow copy to avoid mutating JSON) + var orgExamples = state.organism ? ORGANISM_EXAMPLES[state.organism] : null; + if (orgExamples) { + for (var oe = 0; oe < result.length; oe++) { + if (orgExamples[result[oe].name]) { + var copy = {}; + for (var key in result[oe]) { + copy[key] = result[oe][key]; + } + copy.example_value = orgExamples[result[oe].name]; + result[oe] = copy; + } + } + } + + // Build factor value columns + var factorCols = []; + for (var fv = 0; fv < state.factorValues.length; fv++) { + var charName = state.factorValues[fv]; // e.g. "characteristics[disease]" + var bare = charName.replace(/^characteristics\[/, '').replace(/\]$/, ''); + var fvName = 'factor value[' + bare + ']'; + // Find matching characteristics column for example value + var fvExample = ''; + for (var fx = 0; fx < result.length; fx++) { + if (result[fx].name === charName) { + fvExample = result[fx].example_value || ''; + break; + } + } + factorCols.push({ + name: fvName, + description: 'Experimental variable: ' + bare, + example_value: fvExample, + requirement: 'required', + source_template: 'factor' + }); + } + + // Sort into proper SDRF column order: + // 1. source name + // 2. characteristics[...] (sample metadata) + // 3. assay name, technology type + // 4. comment[...] (data/method) + // 5. factor value[...] + function sdrfOrder(col) { + var n = col.name; + if (n === 'source name') return 0; + if (n.indexOf('characteristics[') === 0) return 1; + if (n === 'assay name') return 2; + if (n === 'technology type') return 3; + if (n.indexOf('comment[') === 0) return 4; + if (n.indexOf('factor value[') === 0) return 6; + return 5; // other columns (e.g. extras without prefix) + } + + // Stable sort: preserve relative order within each group + var indexed = []; + for (var si = 0; si < result.length; si++) { + indexed.push({ col: result[si], idx: si }); + } + // Add factor columns with indices after result + for (var fi = 0; fi < factorCols.length; fi++) { + indexed.push({ col: factorCols[fi], idx: result.length + fi }); + } + indexed.sort(function (a, b) { + var oa = sdrfOrder(a.col); + var ob = sdrfOrder(b.col); + if (oa !== ob) return oa - ob; + return a.idx - b.idx; + }); + + var sorted = []; + for (var sj = 0; sj < indexed.length; sj++) { + sorted.push(indexed[sj].col); + } + + return sorted; + } + + function findTerm(name) { + if (!builderData || !builderData.terms) return null; + for (var i = 0; i < builderData.terms.length; i++) { + if (builderData.terms[i].term === name) return builderData.terms[i]; + } + return null; + } + + /* --------------------------------------------------------------- + Rendering – option cards + --------------------------------------------------------------- */ + + function renderOptionGrid(containerId, options, onSelect, isMulti) { + var container = document.getElementById(containerId); + if (!container) return; + container.innerHTML = ''; + + for (var i = 0; i < options.length; i++) { + (function (opt) { + var card = document.createElement('div'); + card.className = 'option-card'; + card.setAttribute('data-id', opt.id === null ? '__null__' : opt.id); + + var h4 = document.createElement('h4'); + h4.textContent = opt.label; + card.appendChild(h4); + + var p = document.createElement('p'); + p.textContent = opt.desc; + card.appendChild(p); + + // column count badge + if (opt.id && builderData && builderData.templates[opt.id]) { + var ownCols = builderData.templates[opt.id].own_columns; + if (ownCols && ownCols.length > 0) { + var badge = document.createElement('span'); + badge.className = 'column-count'; + badge.textContent = '+ ' + ownCols.length + ' columns'; + card.appendChild(badge); + } + } + + // disabled check + var reason = isDisabledByRules(opt.id); + if (reason) { + card.classList.add('disabled'); + var reasonDiv = document.createElement('div'); + reasonDiv.className = 'disabled-reason'; + reasonDiv.textContent = reason; + card.appendChild(reasonDiv); + } + + card.addEventListener('click', function () { + if (card.classList.contains('disabled')) return; + onSelect(opt.id, card, container, isMulti); + }); + + container.appendChild(card); + })(options[i]); + } + } + + /* --------------------------------------------------------------- + Selection logic + --------------------------------------------------------------- */ + + function selectOption(id, card, container, isMulti) { + if (isMulti) { + card.classList.toggle('selected'); + } else { + var cards = container.querySelectorAll('.option-card'); + for (var i = 0; i < cards.length; i++) { + cards[i].classList.remove('selected'); + } + card.classList.add('selected'); + } + } + + function getSelectedIds(container) { + var ids = []; + var selected = container.querySelectorAll('.option-card.selected'); + for (var i = 0; i < selected.length; i++) { + var raw = selected[i].getAttribute('data-id'); + if (raw !== '__null__') ids.push(raw); + } + return ids; + } + + /* --------------------------------------------------------------- + Step handlers + --------------------------------------------------------------- */ + + function onTechnologySelect(id, card, container) { + selectOption(id, card, container, false); + state.technology = id; + state.experiments = []; + state.affinitySubtype = null; + state.addedOptionals = []; + state.extraColumns = []; + state.factorValues = []; + + showStep('step-organism'); + renderOptionGrid('organism-options', ORGANISM_OPTIONS, onOrganismSelect, false); + + if (id === 'ms-proteomics') { + showStep('step-experiment'); + hideStep('step-affinity-subtype'); + renderOptionGrid('experiment-options', MS_EXPERIMENT_OPTIONS, onExperimentSelect, true); + } else { + showStep('step-affinity-subtype'); + hideStep('step-experiment'); + renderOptionGrid('affinity-options', AFFINITY_OPTIONS, onAffinitySelect, false); + } + + scrollTo('step-organism'); + updatePreview(); + } + + function onOrganismSelect(id, card, container) { + selectOption(id, card, container, false); + state.organism = id; // null for Skip + showStep('step-customize'); + showStep('step-factors'); + scrollTo('step-customize'); + updatePreview(); + } + + function onExperimentSelect(id, card, container) { + selectOption(id, card, container, true); + state.experiments = getSelectedIds(container); + + // re-render to update disabled states + var currentSelected = state.experiments.slice(); + renderOptionGrid('experiment-options', MS_EXPERIMENT_OPTIONS, onExperimentSelect, true); + // restore selections + var cards = container.querySelectorAll('.option-card'); + for (var i = 0; i < cards.length; i++) { + var cid = cards[i].getAttribute('data-id'); + if (currentSelected.indexOf(cid) !== -1) { + cards[i].classList.add('selected'); + } + } + + showStep('step-customize'); + showStep('step-factors'); + scrollTo('step-customize'); + updatePreview(); + } + + function onAffinitySelect(id, card, container) { + selectOption(id, card, container, false); + state.affinitySubtype = id; + showStep('step-customize'); + showStep('step-factors'); + scrollTo('step-customize'); + updatePreview(); + } + + /* --------------------------------------------------------------- + Preview table + --------------------------------------------------------------- */ + + function updatePreview() { + var columns = resolveColumns(); + var downloadBar = document.getElementById('download-bar'); + var previewTable = document.getElementById('preview-table'); + var colStats = document.getElementById('column-stats'); + var downloadInfo = document.getElementById('download-info'); + + if (!columns.length) { + if (downloadBar) downloadBar.classList.add('hidden'); + if (previewTable) previewTable.innerHTML = ''; + if (colStats) colStats.textContent = ''; + return; + } + + if (downloadBar) downloadBar.classList.remove('hidden'); + + // Stats + var required = 0; + var optional = 0; + for (var i = 0; i < columns.length; i++) { + if (columns[i].requirement === 'required' || columns[i].requirement === 'mandatory') { + required++; + } else { + optional++; + } + } + if (colStats) { + colStats.textContent = columns.length + ' columns (' + required + ' required, ' + optional + ' optional)'; + } + if (downloadInfo) { + downloadInfo.innerHTML = 'Your SDRF template is ready! ' + + '' + columns.length + ' columns — download the TSV or open in the editor.'; + } + + // Build table + if (previewTable) { + previewTable.innerHTML = ''; + var thead = document.createElement('thead'); + var headerRow = document.createElement('tr'); + headerRow.id = 'preview-header'; + var tbody = document.createElement('tbody'); + var dataRow = document.createElement('tr'); + dataRow.id = 'preview-row'; + + for (var j = 0; j < columns.length; j++) { + var col = columns[j]; + var cls = classifyColumn(col.name); + + var th = document.createElement('th'); + th.className = cls; + th.textContent = col.name; + if (col.description) th.title = col.description; + headerRow.appendChild(th); + + var td = document.createElement('td'); + td.className = cls; + td.textContent = col.example_value || ''; + dataRow.appendChild(td); + } + + thead.appendChild(headerRow); + tbody.appendChild(dataRow); + previewTable.appendChild(thead); + previewTable.appendChild(tbody); + } + + // Enable buttons + var btnDownload = document.getElementById('btn-download'); + var btnEditor = document.getElementById('btn-editor'); + if (btnDownload) btnDownload.disabled = false; + if (btnEditor) btnEditor.disabled = false; + + renderColumnPicker(columns); + renderFactorPicker(columns); + } + + /* --------------------------------------------------------------- + Factor value picker + --------------------------------------------------------------- */ + + function renderFactorPicker(columns) { + var container = document.getElementById('factor-picker'); + if (!container) return; + + // Collect characteristics columns (candidates for factor values) + var candidates = []; + for (var i = 0; i < columns.length; i++) { + var name = columns[i].name; + if (name.indexOf('characteristics[') === 0 && name.indexOf('factor value[') === -1) { + candidates.push(columns[i]); + } + } + + container.innerHTML = ''; + + if (!candidates.length) { + container.innerHTML = '

    No characteristics columns available yet.

    '; + return; + } + + for (var c = 0; c < candidates.length; c++) { + (function (col) { + var bare = col.name.replace(/^characteristics\[/, '').replace(/\]$/, ''); + var chip = document.createElement('button'); + chip.type = 'button'; + chip.className = 'factor-chip'; + if (state.factorValues.indexOf(col.name) !== -1) { + chip.classList.add('active'); + } + chip.textContent = bare; + if (col.description) chip.title = col.description; + + chip.addEventListener('click', function () { + var idx = state.factorValues.indexOf(col.name); + if (idx !== -1) { + state.factorValues.splice(idx, 1); + } else { + state.factorValues.push(col.name); + } + updatePreview(); + }); + + container.appendChild(chip); + })(candidates[c]); + } + } + + /* --------------------------------------------------------------- + Column picker + --------------------------------------------------------------- */ + + function renderColumnPicker(currentColumns) { + var list = document.getElementById('column-picker-list'); + if (!list || !builderData) return; + + var searchInput = document.getElementById('column-search'); + var filter = searchInput ? searchInput.value.toLowerCase() : ''; + + // All template columns (including optionals that aren't in currentColumns) + var allTmplCols = resolveColumns._allTemplateColumns || {}; + var allTmplOrder = resolveColumns._allTemplateOrder || []; + + // Current included column names + var includedNames = {}; + for (var i = 0; i < currentColumns.length; i++) { + includedNames[currentColumns[i].name] = true; + } + + // Categorize template columns + var includedGroups = {}; // source_template -> [cols] (required/recommended that are included) + var includedGroupOrder = []; + var optionalCols = []; // optional template columns NOT yet enabled + + for (var o = 0; o < allTmplOrder.length; o++) { + var colName = allTmplOrder[o]; + var col = allTmplCols[colName]; + var req = col.requirement || 'optional'; + + // Apply search filter + if (filter && colName.toLowerCase().indexOf(filter) === -1 && + (!col.description || col.description.toLowerCase().indexOf(filter) === -1)) { + continue; + } + + if (req === 'optional' && !includedNames[colName]) { + // Optional and not enabled -> goes in "optional" section + optionalCols.push(col); + } else if (includedNames[colName] && state.extraColumns.indexOf(colName) === -1) { + // Included from template (not user-added extra) + var source = col.source_template || 'base'; + if (!includedGroups[source]) { + includedGroups[source] = []; + includedGroupOrder.push(source); + } + includedGroups[source].push(col); + } + } + + // Extra columns added by user (from terms, not from template) + var extraCols = []; + for (var e = 0; e < state.extraColumns.length; e++) { + var extraName = state.extraColumns[e]; + if (allTmplCols[extraName]) continue; // It's a template optional, handled above + if (filter && extraName.toLowerCase().indexOf(filter) === -1) continue; + for (var ci = 0; ci < currentColumns.length; ci++) { + if (currentColumns[ci].name === extraName) { + extraCols.push(currentColumns[ci]); + break; + } + } + } + + // Build a set of bare names from all template columns for dedup + // e.g. "characteristics[organism]" -> "organism", "comment[data file]" -> "data file" + var tmplBareNames = {}; + for (var bn = 0; bn < allTmplOrder.length; bn++) { + var fullName = allTmplOrder[bn]; + tmplBareNames[fullName] = true; + var match = fullName.match(/^(?:characteristics|comment|factor value)\[(.+)\]$/); + if (match) tmplBareNames[match[1]] = true; + } + + // Terms not in any template column (truly new additions) + var addable = []; + if (builderData.terms) { + for (var t = 0; t < builderData.terms.length; t++) { + var term = builderData.terms[t]; + if (tmplBareNames[term.term]) continue; // Already a template column (exact or bare name match) + if (includedNames[term.term]) continue; // Already included as extra + if (filter && term.term.toLowerCase().indexOf(filter) === -1 && + (!term.description || term.description.toLowerCase().indexOf(filter) === -1)) { + continue; + } + addable.push(term); + } + } + + list.innerHTML = ''; + + // ---- Section 1: Included template columns (grouped by source) ---- + for (var g = 0; g < includedGroupOrder.length; g++) { + var groupName = includedGroupOrder[g]; + var items = includedGroups[groupName]; + if (!items || !items.length) continue; + + var groupDiv = document.createElement('div'); + groupDiv.className = 'column-picker-group'; + var groupTitle = document.createElement('h4'); + groupTitle.textContent = groupName.replace(/-/g, ' '); + groupDiv.appendChild(groupTitle); + + for (var m = 0; m < items.length; m++) { + groupDiv.appendChild(renderPickerItem(items[m], true, false)); + } + list.appendChild(groupDiv); + } + + // ---- Section 1b: User-added extra columns ---- + if (extraCols.length) { + var extraDiv = document.createElement('div'); + extraDiv.className = 'column-picker-group'; + var extraTitle = document.createElement('h4'); + extraTitle.textContent = 'Added by you'; + extraDiv.appendChild(extraTitle); + for (var x = 0; x < extraCols.length; x++) { + extraDiv.appendChild(renderPickerItem(extraCols[x], false, true)); + } + list.appendChild(extraDiv); + } + + // ---- Section 2: Optional template columns (off by default) ---- + if (optionalCols.length) { + var optDiv = document.createElement('div'); + optDiv.className = 'column-picker-group'; + var optTitle = document.createElement('h4'); + optTitle.textContent = 'Optional template columns'; + optDiv.appendChild(optTitle); + + for (var p = 0; p < optionalCols.length; p++) { + (function (col) { + var item = document.createElement('div'); + item.className = 'column-picker-item'; + item.style.cursor = 'pointer'; + + var badge = document.createElement('span'); + badge.className = 'col-type-badge ' + classifyColumn(col.name); + badge.textContent = getColumnTypeLabel(col.name); + item.appendChild(badge); + + var nameSpan = document.createElement('span'); + nameSpan.className = 'col-name'; + nameSpan.textContent = col.name; + item.appendChild(nameSpan); + + var srcBadge = document.createElement('span'); + srcBadge.className = 'col-lock'; + srcBadge.textContent = col.source_template || ''; + item.appendChild(srcBadge); + + var descSpan = document.createElement('span'); + descSpan.className = 'col-desc'; + descSpan.textContent = col.description || ''; + item.appendChild(descSpan); + + var toggleBtn = document.createElement('button'); + toggleBtn.className = 'toggle-btn'; + toggleBtn.type = 'button'; + item.appendChild(toggleBtn); + + item.addEventListener('click', function () { + state.addedOptionals.push(col.name); + updatePreview(); + }); + optDiv.appendChild(item); + })(optionalCols[p]); + } + list.appendChild(optDiv); + } + + // ---- Section 3: Available from sdrf-terms.tsv ---- + if (addable.length) { + var addDiv = document.createElement('div'); + addDiv.className = 'column-picker-group'; + var addTitle2 = document.createElement('h4'); + addTitle2.textContent = 'Other available columns'; + addDiv.appendChild(addTitle2); + + var showCount = filter ? addable.length : Math.min(addable.length, 20); + for (var a = 0; a < showCount; a++) { + (function (term) { + var item = document.createElement('div'); + item.className = 'column-picker-item'; + item.style.cursor = 'pointer'; + + var badge = document.createElement('span'); + badge.className = 'col-type-badge ' + classifyColumn(term.term); + badge.textContent = getColumnTypeLabel(term.term); + item.appendChild(badge); + + var nameSpan = document.createElement('span'); + nameSpan.className = 'col-name'; + nameSpan.textContent = term.term; + item.appendChild(nameSpan); + + var descSpan = document.createElement('span'); + descSpan.className = 'col-desc'; + descSpan.textContent = term.description || ''; + item.appendChild(descSpan); + + var toggleBtn = document.createElement('button'); + toggleBtn.className = 'toggle-btn'; + toggleBtn.type = 'button'; + item.appendChild(toggleBtn); + + item.addEventListener('click', function () { + state.extraColumns.push(term.term); + updatePreview(); + }); + addDiv.appendChild(item); + })(addable[a]); + } + if (!filter && addable.length > 20) { + var moreMsg = document.createElement('p'); + moreMsg.style.cssText = 'font-size:0.8rem;color:var(--text-light);padding:8px 12px;'; + moreMsg.textContent = 'Showing 20 of ' + addable.length + ' — use search to find more'; + addDiv.appendChild(moreMsg); + } + list.appendChild(addDiv); + } + } + + function renderPickerItem(col, isFromTemplate, isExtra) { + var isRequired = col.requirement === 'required'; + var isHardLocked = isFromTemplate && isRequired; + + var item = document.createElement('div'); + item.className = 'column-picker-item included' + (isHardLocked ? ' locked' : ''); + + var badge = document.createElement('span'); + badge.className = 'col-type-badge ' + classifyColumn(col.name); + badge.textContent = getColumnTypeLabel(col.name); + item.appendChild(badge); + + var nameSpan = document.createElement('span'); + nameSpan.className = 'col-name'; + nameSpan.textContent = col.name; + item.appendChild(nameSpan); + + // Show requirement badge for template columns + if (isFromTemplate) { + var reqBadge = document.createElement('span'); + reqBadge.className = 'col-lock'; + reqBadge.textContent = col.requirement || 'optional'; + item.appendChild(reqBadge); + } + + var descSpan = document.createElement('span'); + descSpan.className = 'col-desc'; + descSpan.textContent = col.description || ''; + item.appendChild(descSpan); + + var toggleBtn = document.createElement('button'); + toggleBtn.className = 'toggle-btn active'; + toggleBtn.type = 'button'; + + if (isHardLocked) { + toggleBtn.disabled = true; + toggleBtn.style.opacity = '0.4'; + toggleBtn.title = 'Required by template — cannot be removed'; + } + item.appendChild(toggleBtn); + + // Optional template columns and extra columns can be toggled + if (!isHardLocked) { + var colName = col.name; + item.addEventListener('click', function () { + if (isExtra) { + // Remove from extra + var idx = state.extraColumns.indexOf(colName); + if (idx !== -1) state.extraColumns.splice(idx, 1); + } else { + // Toggle optional template column off (remove from addedOptionals) + var idx2 = state.addedOptionals.indexOf(colName); + if (idx2 !== -1) state.addedOptionals.splice(idx2, 1); + } + updatePreview(); + }); + item.style.cursor = 'pointer'; + } + + return item; + } + + function getColumnTypeLabel(name) { + if (name === 'source name' || name.startsWith('characteristics[')) return 'sample'; + if (name.startsWith('factor value[')) return 'factor'; + if (name.startsWith('comment[')) return 'method'; + return 'data'; + } + + /* --------------------------------------------------------------- + Download / Editor + --------------------------------------------------------------- */ + + function downloadTSV() { + var columns = resolveColumns(); + if (!columns.length) return; + + var headers = []; + var values = []; + for (var i = 0; i < columns.length; i++) { + headers.push(columns[i].name); + values.push(columns[i].example_value || ''); + } + + var tsv = headers.join('\t') + '\n' + values.join('\t') + '\n'; + var blob = new Blob([tsv], { type: 'text/tab-separated-values;charset=utf-8' }); + var url = URL.createObjectURL(blob); + + var a = document.createElement('a'); + a.href = url; + a.download = 'sdrf-template.sdrf.tsv'; + document.body.appendChild(a); + a.click(); + document.body.removeChild(a); + URL.revokeObjectURL(url); + } + + function openInEditor() { + var columns = resolveColumns(); + if (!columns.length) return; + + var names = []; + for (var i = 0; i < columns.length; i++) { + names.push(columns[i].name); + } + window.open('sdrf-editor.html?columns=' + encodeURIComponent(names.join(','))); + } + + /* --------------------------------------------------------------- + Initialization + --------------------------------------------------------------- */ + + function loadBuilderData() { + var container = document.getElementById('sdrf-builder'); + if (!container) return; + + fetch('sdrf-builder-data.json') + .then(function (resp) { + if (!resp.ok) throw new Error('HTTP ' + resp.status); + return resp.json(); + }) + .then(function (data) { + builderData = data; + initBuilder(); + }) + .catch(function (err) { + container.innerHTML = + '

    Failed to load builder data: ' + + err.message + '

    '; + }); + } + + function initBuilder() { + renderOptionGrid('technology-options', TECHNOLOGY_OPTIONS, onTechnologySelect, false); + + // Wire up column search + var searchInput = document.getElementById('column-search'); + if (searchInput) { + var debounceTimer = null; + searchInput.addEventListener('input', function () { + clearTimeout(debounceTimer); + debounceTimer = setTimeout(function () { + var columns = resolveColumns(); + if (columns.length) renderColumnPicker(columns); + }, 200); + }); + } + } + + /* Expose global handlers for onclick attributes */ + window.downloadTSV = downloadTSV; + window.openInEditor = openInEditor; + + /* Entry point */ + if (document.readyState === 'loading') { + document.addEventListener('DOMContentLoaded', loadBuilderData); + } else { + loadBuilderData(); + } +})(); diff --git a/site/quickstart.html b/site/quickstart.html index e0f0ba1bb..ea6441da8 100644 --- a/site/quickstart.html +++ b/site/quickstart.html @@ -3,8 +3,24 @@ - Quick Start Tutorial - SDRF-Proteomics + Quick Start - SDRF-Proteomics +
    @@ -12,1531 +28,249 @@
    -
    - -
    -

    Create Your SDRF File

    -

    Answer a few questions about your experiment and we'll guide you to the right template and examples.

    -
    - - -
    -
    - -
    -
    - 1 -

    What acquisition method did you use?

    -
    -
    - - - -
    -
    - - - - - - - - - -
    -
    - -
    - - -
    -

    What is SDRF?

    -

    SDRF (Sample and Data Relationship Format) is a simple tab-separated file (like Excel) that describes your proteomics experiment. It connects your biological samples to your mass spectrometry data files.

    - -
    -

    The Core Concept

    -

    Think of SDRF as a table where:

    -
      -
    • Each row = one sample-to-file relationship
      • -
    • Each column = one piece of information about that sample or file
      • -
    -
    - -
    - Why use SDRF? When you submit data to repositories like PRIDE, SDRF ensures your experiment is fully described and can be reanalyzed by others. It's becoming a standard requirement for proteomics data submission. - Learn more in the specification → -
    -
    - - -
    -

    Learn from Real Examples

    -

    The best way to learn is by example. Browse real SDRF files from published proteomics datasets and use them as templates for your own experiments.

    - -
    - Tip: Find datasets similar to yours by organism, instrument, or acquisition method. You can view the complete SDRF structure and use it as a starting point. - Browse Examples in SDRF Explorer → -
    -
    - - -
    -

    Step 1: Choose Your Template

    -

    Templates are pre-made SDRF files with the right columns already set up for your experiment type. Pick one based on your organism and experiment:

    - -
    -
    -

    Core Templates (by organism)

    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    Your SamplesTemplateIncludes
    Human sampleshumanage, sex, ancestry, ethnicity
    Mouse, rat, zebrafishvertebratesdevelopmental stage, strain
    Insects, wormsinvertebratesdevelopmental stage
    Plantsplantscultivar, growth conditions
    Other / Not surems-proteomicsminimal required columns
    -
    - -
    -

    Specialized Templates (by experiment type)

    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    Experiment TypeTemplateAdds
    Cell line studiescell-linescell line name, Cellosaurus ID
    DIA acquisitiondia-acquisitionDIA isolation window
    ImmunopeptidomicsimmunopeptidomicsHLA alleles, MHC class
    Cross-linking MScrosslinkingcrosslinker, cleavability
    Single-cell proteomicssingle-cellsingle cell identifier
    -
    -
    - -
    - Tip: You can combine templates! Start with a core template (e.g., "human") and add columns from specialized templates as needed. -
    -
    - - -
    -

    Step 2: Understand Column Types

    -

    SDRF columns follow a naming pattern that tells you what kind of information they contain:

    - -
    -
    -

    characteristics[...]

    -

    Describe the biological sample

    - characteristics[organism] - characteristics[disease] - characteristics[organism part] - Sample Metadata -
    -
    -

    comment[...]

    -

    Describe the data file or MS run

    - comment[data file] - comment[instrument] - comment[label] - Data File Metadata -
    -
    -

    factor value[...]

    -

    The experimental variable you're comparing

    - factor value[disease] - factor value[compound] - factor value[time] - What You're Studying -
    -
    - -
    - Important: Column names are case-sensitive and spacing matters! -
      -
    • characteristics[organism] — Correct
      • -
    • Characteristics[organism] — Wrong (capital C)
      • -
    • characteristics [organism] — Wrong (space before bracket)
      • -
    -
    -
    - - -
    -

    Step 3: Fill in Sample Information

    -

    Open your template in Excel, Google Sheets, or any spreadsheet software. For each sample, fill in the biological information:

    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnWhat to WriteExampleNotes
    source nameA unique identifier for your biological samplepatient_001Unique to the sample; repeats for fractions/replicates
    characteristics[organism]Species name (lowercase)homo sapiensUse scientific name from NCBI Taxonomy
    characteristics[organism part]Tissue or body partliverUse terms from UBERON
    characteristics[disease]Disease name, or "normal"hepatocellular carcinomaUse "normal" for healthy samples
    - -
    - Tip: Don't stress about finding exact ontology terms. Write the common name (e.g., "liver", "breast cancer") and the validator will check it for you. You can always refine later. -
    -
    - - -
    -

    Step 4: Add Data File Information

    -

    For each row, also specify information about the raw file and how it was acquired:

    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    ColumnWhat to WriteExampleNotes
    assay nameA name for this MS runrun_001Often same as source name
    comment[label]Type of labelinglabel free sampleOr TMT126, TMT127N, etc.
    comment[instrument]Mass spectrometer usedQ Exactive HFFrom PSI-MS ontology
    comment[data file]Your raw file namesample_001.rawExact filename including extension
    - -
    - One row = one sample-to-file relationship. In multiplexed experiments (TMT/iTRAQ), multiple samples share the same file, so you'll have multiple rows pointing to the same raw file. In fractionated experiments, one sample spans multiple files, so you'll have multiple rows for the same sample. - More about SDRF structure → -
    -
    - - -
    -

    Step 5: Define Your Experimental Variables

    -

    Factor values tell analysis tools what you're comparing in your experiment. This is crucial for downstream analysis!

    - -
    -

    What is a Factor Value?

    -

    A factor value is the experimental variable you're studying. If your experiment compares cancer vs. healthy tissue, then disease is your factor. The values would be "hepatocellular carcinoma" and "normal".

    -
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    Experiment TypeFactor Value ColumnExample Values
    Disease vs. healthyfactor value[disease]cancer, normal
    Drug treatmentfactor value[compound]aspirin, DMSO
    Time coursefactor value[time]0 hour, 6 hour, 24 hour
    Tissue comparisonfactor value[organism part]liver, kidney, heart
    Multiple variablesMultiple factor columnsBoth disease AND time
    - -
    - Common mistake: Factor values often duplicate information from characteristics columns — and that's correct! The factor value explicitly marks which characteristic is the experimental variable. -
    -
    - - -
    -

    Complete Example

    -

    Here's a minimum valid SDRF file for a human liver cancer study, including all required columns from the human template:

    - -
    - +
    + + +
    +

    What is an SDRF file?

    +

    + SDRF (Sample and Data Relationship Format) is a tab-delimited file that + describes your proteomics samples and links them to data files. Every row + is one sample-to-file relationship, and every column captures a piece of + metadata — from the organism you studied to the instrument that acquired the data. +

    +

    + Columns fall into three categories: +

    + +
    +
    - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + +
    source name characteristics[organism]characteristics[organism part] characteristics[disease]characteristics[biological replicate]characteristics[age]characteristics[sex] assay nametechnology typecomment[proteomics data acquisition method]comment[label] comment[instrument]comment[cleavage agent details]comment[fraction identifier]comment[technical replicate] comment[data file] factor value[disease]
    patient_001homo sapiensliverhepatocellular carcinoma155Ymalerun_001proteomic profiling by mass spectrometryData-dependent acquisitionlabel free sampleQ Exactive HFNT=Trypsin;AC=MS:100125111patient_001.rawhepatocellular carcinoma
    patient_002homo sapiensliverhepatocellular carcinoma262Yfemalerun_002proteomic profiling by mass spectrometryData-dependent acquisitionlabel free sampleQ Exactive HFNT=Trypsin;AC=MS:100125111patient_002.rawhepatocellular carcinomaSample-1Homo sapienslung cancerrun_01Orbitrap Exploris 480sample1.rawlung cancer
    control_001homo sapienslivernormal148Ymalerun_003proteomic profiling by mass spectrometryData-dependent acquisitionlabel free sampleQ Exactive HFNT=Trypsin;AC=MS:100125111control_001.rawnormal
    control_002homo sapienslivernormal251Yfemalerun_004proteomic profiling by mass spectrometryData-dependent acquisitionlabel free sampleQ Exactive HFNT=Trypsin;AC=MS:100125111control_002.rawnormalSample-2Homo sapiensnormalrun_02Orbitrap Exploris 480sample2.rawnormal
    -

    Scroll horizontally to see all columns →

    -
    - Sample metadata (characteristics) - Data file metadata (comment) - Experimental variable (factor value) + +
    + Sample metadata + Data / instrument + Experimental factors
    -
    -

    Required columns in this example:

    -
      -
    • Sample metadata: source name, organism, organism part, disease, biological replicate, age, sex
      • -
    • Data file metadata: assay name, technology type, proteomics data acquisition method, label, instrument, cleavage agent, fraction identifier, technical replicate, data file
      • -
    • Factor value: the experimental variable being compared (disease)
      • -
    -

    What this example tells us:

    -
      -
    • 2 biological replicates per condition (numbered 1-2 within each factor value group)
      • -
    • No fractionation (fraction identifier = 1 for all)
      • -
    • Single injection per sample (technical replicate = 1)
      • -
    • Label-free DDA proteomics with trypsin digestion on Q Exactive HF
      • -
    +
    +

    Build your own SDRF below

    + ▼
    - -
    -

    Step 6: Validate Your File

    -

    Before submission, validate your SDRF to catch errors early:

    + +
    -
    -
    -

    Option 1: Command Line (Recommended)

    -
    - 
    # Install the validator
-pip install sdrf-pipelines
-
-# Validate your file
-parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv
    -
    -

    Best for batch validation and integration into pipelines.

    + +
    +

    1 What type of proteomics experiment?

    +

    Choose the technology platform used in your study.

    +
    +
    +
    + Why does this matter? ▾ +
    +
    +

    + MS-based and affinity-based proteomics have fundamentally different data types. + MS experiments produce spectra files and need columns for instrument settings, + fragmentation, and search parameters. Affinity experiments (Olink, SomaScan) + produce protein-level measurements and need panel/assay identifiers. + They cannot be combined in a single SDRF. +

    +

    Read the full specification →

    +
    +
    -
    -

    Option 2: With Template Check

    -
    - 
    # Validate against a specific template
-parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv --template human
    -
    -

    Checks that all required columns for your template are present.

    + + -
    - Validation checks for: -
      -
    • Correct column names and formatting
      • -
    • Valid ontology terms (organism, disease, etc.)
      • -
    • Required columns present
      • -
    • No empty cells where values are required
      • -
    + + -
    - -
    -

    Common Scenarios

    + + -
    -
    - TMT/iTRAQ Multiplexed Samples -
    -

    For multiplexed experiments, multiple samples share the same raw file. Each sample gets its own row with a different label:

    - - - - - - - - - - - - - - - - - - - - - -
    source namecomment[label]comment[data file]
    sample_ATMT126multiplex_1.raw
    sample_BTMT127Nmultiplex_1.raw
    sample_CTMT127Cmultiplex_1.raw
    - Full TMT documentation → -
    -
    + + -
    - - -
    -

    Common Mistakes to Avoid

    - -
    -
    -
    - Wrong - Source Name -
    -
    - Correct - source name -
    -

    Column names must be lowercase

    -
    -
    - Wrong - characteristics [organism] -
    -
    - Correct - characteristics[organism] -
    -

    No space before the bracket

    +
    +

    Add or remove columns

    + +
    +
    -
    -
    - Wrong - control for healthy -
    -
    - Correct - normal for healthy -
    -

    Use "normal" for healthy tissue/samples

    + +
    - - -
    -

    Finding the Right Terms

    -

    SDRF uses ontology terms to ensure consistency. Here's where to find them:

    - -
    - -

    NCBI Taxonomy

    -

    Organism names

    - homo sapiens, mus musculus -     - -

    UBERON

    -

    Tissues and organs

    - liver, brain, blood -     - -

    MONDO

    -

    Disease names

    - breast cancer, diabetes -     - -

    Cell Ontology

    -

    Cell types

    - T cell, hepatocyte -     - -

    PSI-MS

    -

    Instruments & methods

    - Q Exactive, Orbitrap -     - -

    Cellosaurus

    -

    Cell line identifiers

    - HeLa, HEK293 -     -
    -
    - -
    -

    Next Steps

    -
    -
    -

    Browse Examples

    -

    See real SDRF files from published datasets in ProteomeXchange

    - SDRF Explorer -
    -
    -

    All SDRF Terms

    -

    Complete reference of all columns, their requirements, and valid values

    - SDRF Terms Reference -
    -
    -

    Full Specification

    -

    Detailed documentation for advanced use cases and edge cases

    - Read Specification + +
    -
    - -
    -
    -

    SDRF-Proteomics is developed by the HUPO-PSI community.

    -

    Copyright © Proteomics Standards Initiative. Licensed under Apache 2.0.

    -
    -
    - - + - + diff --git a/site/sdrf-data.json b/site/sdrf-data.json index 20bdecf48..33f8cd622 100644 --- a/site/sdrf-data.json +++ b/site/sdrf-data.json @@ -1,12 +1,12 @@ { "statistics": { - "total_datasets": 299, - "total_samples": 80305, - "generated_at": "2026-01-26T10:03:35.642694Z", + "total_datasets": 298, + "total_samples": 80289, + "generated_at": "2026-03-09T06:16:51.796049Z", "organisms": { "Homo sapiens": 51421, "homo sapiens": 10167, - "Mus musculus": 4476, + "Mus musculus": 4460, "Homo Sapiens": 3873, "plasmodium falciparum": 3461, "Escherichia coli": 1695, @@ -41,13 +41,13 @@ "bone marrow": 2411, "Muscle": 2316, "liver": 2142, - "brain": 2085, + "brain": 2069, "Heart": 1777, "colorectal": 1755, "Cell lysate": 1505, "colon": 1239, "stomach": 1170, - "cerebrospinal fluid": 1132, + "cerebrospinal fluid": 1150, "primary human medulloblastomas": 1028, "cervix": 901, "human erythrocytes": 844, @@ -64,12 +64,12 @@ "Brain": 412, "Hippocampus": 400, "rectum": 379, - "\"middle temporal lobe, BA21 region\"": 378, + "middle temporal lobe, BA21 region": 378, "Ascending Colon": 345, "Liver": 323, "leaf": 282, "flower": 248, - "floral bud": 240, + "flower bud": 240, "medial frontal gyrus": 240, "Caco-2 cells": 240, "root": 220, @@ -89,7 +89,7 @@ "Breast Invasive Carcinoma": 3775, "metastatic cutaneous melanoma": 3600, "breast cancer": 2355, - "high-grade serous ovarian adenocarcinoma": 2231, + "ovarian high grade serous adenocarcinoma": 2231, "chronic myelogenous leukemia": 2197, "melanoma": 1904, "colorectal cancer": 1755, @@ -196,8 +196,8 @@ "Q Exactive HF": 8662, "Orbitrap Fusion": 4610, "orbitrap": 4359, - "LTQ Orbitrap Elite": 3910, - "Q Exactive HF-X": 2178, + "Orbitrap Elite": 3998, + "Q Exactive HF-X": 2162, "LTQ Orbitrap": 1664, "LTQ Orbitrap Velos Pro": 1528, "LTQ Orbitrap XL": 1442, @@ -207,7 +207,6 @@ "Orbitrap Eclipse": 152, "Orbitrap Fusion ETD": 138, "3200 QTRAP": 116, - "Orbitrap Elite": 88, "LTQ": 84, "LTQ FT Ultra": 71, "Orbitrap Exploris 480": 64, @@ -215,7 +214,7 @@ "TSQ Vantage": 34, "SCIEX instrument model": 33, " Q Exactive Plus": 30, - " LTQ Orbitrap Elite": 27, + " Orbitrap Elite": 27, " Orbitrap Fusion Lumos": 24, "timsTOF Pro 2": 24, "LTQ Velos": 10, @@ -223,7 +222,7 @@ " Q Exactive": 6 }, "labels": { - "label free sample": 34053, + "label free sample": 34037, "Label free": 4395, "TMT126": 3702, "TMT131": 3111, @@ -245,18 +244,18 @@ "SILAC light": 929 }, "acquisition_methods": { - "Data-dependent acquisition": 78534, + "Data-dependent acquisition": 78518, "data-dependent acquisition": 898, "Data-independent acquisition": 662, "selected reaction monitoring": 205, "DDA": 6 }, "modifications": { - "Oxidation": 12016, - "TMT6plex": 11605, + "Oxidation": 11866, + "TMT6plex": 11389, "Acetyl": 9167, - "Phospho": 8060, - "Carbamidomethyl": 5197, + "Phospho": 8044, + "Carbamidomethyl": 5347, " TMT6plex": 4176, "TMT": 2424, "Deamidated": 2375, @@ -270,6 +269,7 @@ "iTRAQ4plex": 328, "Deamidation": 235, "Glu->pyro-Glu": 216, + "13C6-15N4": 216, "iTRAQ": 210, "Propionamide": 185, "Biotin:Thermo-21341": 130, @@ -279,14 +279,13 @@ "not aplicable": 107, "Label:13C(6)15N(4)": 106, "Oxidation ": 89, - "\"NT = Phosphorylation ": 84, - "Ubiquitination": 78, - "Label:13C(6)15N(2)": 72 + "NT = Phosphorylation ": 84, + "Ubiquitination": 78 }, "cleavage_agents": { "Trypsin": 60748, "Lys-C": 10184, - "Trypsin/P": 6468, + "Trypsin/P": 6452, "unspecific cleavage": 1248, "N-glycosidase F": 474, "trypsin": 351, @@ -302,19 +301,18 @@ "no cleavage": 5 }, "experiment_types": { - "DDA": 291, + "DDA": 290, "SRM/MRM": 3, "DIA": 5 }, "label_types": { - "Label-free": 230, + "Label-free": 229, "TMT": 36, "SILAC": 23, "iTRAQ": 10 }, "templates": { - "ms-proteomics,version=v1.1.0": 298, - "crosslinking,version=v1.0.0": 1 + "unknown": 298 } }, "datasets": [ @@ -326,26 +324,26 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/COMBINEDPX0000001/COMBINEDPX0000001.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/COMBINEDPX0000001/COMBINEDPX0000001.sdrf.tsv", "num_samples": 35, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], "diseases": [ - "non-small cell lung cancer", - "small cell lung cancer" + "small cell lung cancer", + "non-small cell lung cancer" ], "instruments": [ - "LTQ Orbitrap Elite", - "LTQ Orbitrap Velos", - " Orbitrap Fusion Lumos" + "Orbitrap Elite", + " Orbitrap Fusion Lumos", + "LTQ Orbitrap Velos" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "MSV000078494", @@ -355,10 +353,10 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/MSV000078494/MSV000078494.sdrf.tsv", "num_samples": 96, - "num_columns": 33, + "num_columns": 35, "organisms": [ - "homo sapiens", - "mus musculus" + "mus musculus", + "homo sapiens" ], "diseases": [ "melanoma" @@ -371,8 +369,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "MSV000078535", @@ -382,7 +380,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/MSV000078535/MSV000078535.sdrf.tsv", "num_samples": 44, - "num_columns": 35, + "num_columns": 37, "organisms": [ "homo sapiens" ], @@ -397,8 +395,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "MSV000078555", @@ -408,7 +406,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/MSV000078555/MSV000078555.sdrf.tsv", "num_samples": 176, - "num_columns": 35, + "num_columns": 37, "organisms": [ "homo sapiens" ], @@ -424,8 +422,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "MSV000080451", @@ -435,7 +433,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/MSV000080451/MSV000080451.sdrf.tsv", "num_samples": 71, - "num_columns": 31, + "num_columns": 33, "organisms": [ "homo sapiens" ], @@ -444,16 +442,16 @@ "multiple myeloma" ], "instruments": [ - "LTQ Orbitrap XL", - "LTQ Orbitrap Elite" + "Orbitrap Elite", + "LTQ Orbitrap XL" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "MSV000086206", @@ -463,7 +461,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/MSV000086206/MSV000086206.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/MSV000086206/MSV000086206.sdrf.tsv", "num_samples": 6, - "num_columns": 19, + "num_columns": 21, "organisms": [ "Escherichia coli" ], @@ -476,8 +474,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PMID21183079", @@ -487,7 +485,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PMID21183079/PMID21183079.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PMID21183079/PMID21183079.sdrf.tsv", "num_samples": 347, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Mus musculus" ], @@ -500,8 +498,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PMID25043054", @@ -511,7 +509,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PMID25043054/PMID25043054.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PMID25043054/PMID25043054.sdrf.tsv", "num_samples": 1425, - "num_columns": 39, + "num_columns": 41, "organisms": [ "Homo sapiens" ], @@ -529,8 +527,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PMID28625833", @@ -540,7 +538,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PMID28625833/PMID28625833.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PMID28625833/PMID28625833.sdrf.tsv", "num_samples": 660, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -555,8 +553,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PMID31975593", @@ -566,7 +564,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PMID31975593/PMID31975593.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PMID31975593/PMID31975593.sdrf.tsv", "num_samples": 10, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -581,8 +579,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PMID33086064", @@ -592,13 +590,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PMID33086064/PMID33086064.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PMID33086064/PMID33086064.sdrf.tsv", "num_samples": 3120, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Homo sapiens" ], "diseases": [ - "high-grade serous ovarian adenocarcinoma", - "Non-Tumor" + "Non-Tumor", + "ovarian high grade serous adenocarcinoma" ], "instruments": [ "Q Exactive" @@ -608,8 +606,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PMID33212010", @@ -619,7 +617,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PMID33212010/PMID33212010.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PMID33212010/PMID33212010.sdrf.tsv", "num_samples": 4250, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -635,8 +633,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000070", @@ -646,7 +644,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000070/PXD000070.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000070/PXD000070.sdrf.tsv", "num_samples": 6, - "num_columns": 29, + "num_columns": 31, "organisms": [ "plasmodium falciparum" ], @@ -659,8 +657,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000228", @@ -670,7 +668,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000228/PXD000228.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000228/PXD000228.sdrf.tsv", "num_samples": 270, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -683,8 +681,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000288", @@ -694,7 +692,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000288/PXD000288.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000288/PXD000288.sdrf.tsv", "num_samples": 72, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Mus musculus" ], @@ -707,8 +705,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000312", @@ -718,7 +716,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000312/PXD000312.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000312/PXD000312.sdrf.tsv", "num_samples": 30, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Mus musculus" ], @@ -733,8 +731,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000396", @@ -744,7 +742,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000396/PXD000396.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000396/PXD000396.sdrf.tsv", "num_samples": 40, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -759,8 +757,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000498", @@ -770,7 +768,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000498/PXD000498.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000498/PXD000498.sdrf.tsv", "num_samples": 84, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Escherichia coli" ], @@ -783,8 +781,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000527", @@ -794,7 +792,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000527/PXD000527.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000527/PXD000527.sdrf.tsv", "num_samples": 240, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Citrus maxima" ], @@ -807,8 +805,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000534", @@ -818,7 +816,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000534/PXD000534.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000534/PXD000534.sdrf.tsv", "num_samples": 16, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -826,15 +824,15 @@ "cholangiocellular carcinoma" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000547", @@ -844,14 +842,14 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000547/PXD000547.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000547/PXD000547.sdrf.tsv", "num_samples": 160, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], "diseases": [ + "lung embolism", "cardiopulmonary insufficiency", - "heart infarction", - "lung embolism" + "heart infarction" ], "instruments": [ "LTQ Orbitrap XL" @@ -861,8 +859,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000548", @@ -872,14 +870,14 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000548/PXD000548.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000548/PXD000548.sdrf.tsv", "num_samples": 160, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], "diseases": [ + "lung embolism", "cardiopulmonary insufficiency", - "heart infarction", - "lung embolism" + "heart infarction" ], "instruments": [ "LTQ Orbitrap XL" @@ -889,8 +887,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000561", @@ -900,22 +898,22 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000561/PXD000561.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000561/PXD000561.sdrf.tsv", "num_samples": 2212, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Homo sapiens" ], "diseases": [], "instruments": [ - "LTQ Orbitrap Velos", - "LTQ Orbitrap Elite" + "Orbitrap Elite", + "LTQ Orbitrap Velos" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000612", @@ -925,7 +923,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000612/PXD000612.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000612/PXD000612.sdrf.tsv", "num_samples": 273, - "num_columns": 35, + "num_columns": 37, "organisms": [ "homo sapiens" ], @@ -940,8 +938,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000651", @@ -951,7 +949,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000651/PXD000651.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000651/PXD000651.sdrf.tsv", "num_samples": 37, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -966,8 +964,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000652", @@ -977,7 +975,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000652/PXD000652.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000652/PXD000652.sdrf.tsv", "num_samples": 46, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -992,8 +990,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000759", @@ -1003,7 +1001,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000759/PXD000759.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000759/PXD000759.sdrf.tsv", "num_samples": 336, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -1011,15 +1009,15 @@ "epithelial cervix carcinoma" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000790", @@ -1029,7 +1027,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000790/PXD000790.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000790/PXD000790.sdrf.tsv", "num_samples": 1, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Mus musculus" ], @@ -1042,8 +1040,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000792", @@ -1053,7 +1051,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000792/PXD000792.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000792/PXD000792.sdrf.tsv", "num_samples": 4, - "num_columns": 21, + "num_columns": 23, "organisms": [ "Saccharomyces cerevisiae" ], @@ -1066,8 +1064,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000793", @@ -1077,7 +1075,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000793/PXD000793.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000793/PXD000793.sdrf.tsv", "num_samples": 116, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Mus musculus" ], @@ -1090,8 +1088,8 @@ ], "experiment_type": "SRM/MRM", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000815", @@ -1101,7 +1099,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000815/PXD000815.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000815/PXD000815.sdrf.tsv", "num_samples": 454, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -1116,8 +1114,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000857", @@ -1127,7 +1125,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000857/PXD000857.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000857/PXD000857.sdrf.tsv", "num_samples": 1, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Oryza sativa" ], @@ -1140,8 +1138,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000895", @@ -1151,7 +1149,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000895/PXD000895.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000895/PXD000895.sdrf.tsv", "num_samples": 32, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], @@ -1166,8 +1164,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000923", @@ -1177,7 +1175,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000923/PXD000923.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000923/PXD000923.sdrf.tsv", "num_samples": 10, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Oryza sativa" ], @@ -1190,8 +1188,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD000999", @@ -1201,7 +1199,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD000999/PXD000999.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD000999/PXD000999.sdrf.tsv", "num_samples": 7, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], @@ -1216,8 +1214,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001061", @@ -1227,7 +1225,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001061/PXD001061.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001061/PXD001061.sdrf.tsv", "num_samples": 32, - "num_columns": 36, + "num_columns": 38, "organisms": [ "Homo sapiens" ], @@ -1242,8 +1240,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001168", @@ -1253,7 +1251,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001168/PXD001168.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001168/PXD001168.sdrf.tsv", "num_samples": 6, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Oryza sativa" ], @@ -1266,8 +1264,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001224", @@ -1277,7 +1275,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001224/PXD001224.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001224/PXD001224.sdrf.tsv", "num_samples": 108, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -1290,8 +1288,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001325", @@ -1301,7 +1299,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001325/PXD001325.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001325/PXD001325.sdrf.tsv", "num_samples": 48, - "num_columns": 29, + "num_columns": 31, "organisms": [ "homo sapiens" ], @@ -1316,8 +1314,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001381", @@ -1327,7 +1325,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001381/PXD001281.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001381/PXD001281.sdrf.tsv", "num_samples": 84, - "num_columns": 16, + "num_columns": 18, "organisms": [ "Homo sapiens" ], @@ -1342,8 +1340,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001404", @@ -1353,7 +1351,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001404/PXD001404.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001404/PXD001404.sdrf.tsv", "num_samples": 154, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Mus musculus" ], @@ -1366,8 +1364,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001468", @@ -1377,7 +1375,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001468/PXD001468.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001468/PXD001468.sdrf.tsv", "num_samples": 24, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Homo sapiens" ], @@ -1390,8 +1388,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001474", @@ -1401,7 +1399,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001474/PXD001474.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001474/PXD001474.sdrf.tsv", "num_samples": 27, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -1409,15 +1407,15 @@ "HCV-related hepatic fibrosis" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001487", @@ -1427,7 +1425,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001487/PXD001487.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001487/PXD001487.sdrf.tsv", "num_samples": 72, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -1442,8 +1440,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001558", @@ -1453,7 +1451,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001558/PXD001558.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001558/PXD001558.sdrf.tsv", "num_samples": 123, - "num_columns": 19, + "num_columns": 21, "organisms": [ "homo sapiens" ], @@ -1468,8 +1466,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001684", @@ -1479,7 +1477,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001684/PXD001684.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001684/PXD001684.sdrf.tsv", "num_samples": 71, - "num_columns": 29, + "num_columns": 31, "organisms": [ "plasmodium falciparum" ], @@ -1492,8 +1490,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001725", @@ -1503,7 +1501,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001725/PXD001725.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001725/PXD001725.sdrf.tsv", "num_samples": 30, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -1518,8 +1516,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001736", @@ -1529,7 +1527,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001736/PXD001736.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001736/PXD001736.sdrf.tsv", "num_samples": 84, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -1544,8 +1542,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001774", @@ -1555,7 +1553,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001774/PXD001774.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001774/PXD001774.sdrf.tsv", "num_samples": 18, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Oryza sativa" ], @@ -1568,8 +1566,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD001819", @@ -1579,7 +1577,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD001819/PXD001819.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD001819/PXD001819.sdrf.tsv", "num_samples": 27, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Saccharomyces cerevisiae" ], @@ -1592,8 +1590,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002029", @@ -1603,7 +1601,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002029/PXD002029.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002029/PXD002029.sdrf.tsv", "num_samples": 24, - "num_columns": 32, + "num_columns": 34, "organisms": [ "homo sapiens" ], @@ -1618,8 +1616,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002049", @@ -1629,7 +1627,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002049/PXD002049.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002049/PXD002049.sdrf.tsv", "num_samples": 150, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -1644,8 +1642,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002080", @@ -1655,7 +1653,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002080/PXD002080.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002080/PXD002080.sdrf.tsv", "num_samples": 150, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -1670,8 +1668,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002081", @@ -1681,7 +1679,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002081/PXD002081.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002081/PXD002081.sdrf.tsv", "num_samples": 150, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -1696,8 +1694,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002082", @@ -1707,7 +1705,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002082/PXD002082.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002082/PXD002082.sdrf.tsv", "num_samples": 150, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -1722,8 +1720,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002084", @@ -1733,7 +1731,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002084/PXD002084.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002084/PXD002084.sdrf.tsv", "num_samples": 150, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -1748,8 +1746,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002086", @@ -1759,7 +1757,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002086/PXD002086.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002086/PXD002086.sdrf.tsv", "num_samples": 153, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -1775,8 +1773,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002087", @@ -1786,7 +1784,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002087/PXD002087.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002087/PXD002087.sdrf.tsv", "num_samples": 150, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -1801,8 +1799,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002088", @@ -1812,13 +1810,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002088/PXD002088.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002088/PXD002088.sdrf.tsv", "num_samples": 150, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Homo sapiens" ], "diseases": [ - "rectum adenocarcinoma", - "rectal mucinous adenocarcinoma" + "rectal mucinous adenocarcinoma", + "rectum adenocarcinoma" ], "instruments": [ "LTQ Orbitrap Velos" @@ -1828,8 +1826,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002171", @@ -1839,7 +1837,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002171/PXD002171.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002171/PXD002171.sdrf.tsv", "num_samples": 38, - "num_columns": 33, + "num_columns": 35, "organisms": [ "homo sapiens" ], @@ -1847,15 +1845,15 @@ "hepatocellular carcinoma" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002192", @@ -1865,16 +1863,16 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002192/PXD002192.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002192/PXD002192.sdrf.tsv", "num_samples": 276, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], "diseases": [ - "Mlignant Melanoma", "Breast Adenocarcinoma", - "Glioblastoma", "Pancreatic Carcinoma", - "Breast Cancer" + "Mlignant Melanoma", + "Breast Cancer", + "Glioblastoma" ], "instruments": [ "LTQ Orbitrap Velos" @@ -1884,8 +1882,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002222", @@ -1895,7 +1893,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002222/PXD002222.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002222/PXD002222.sdrf.tsv", "num_samples": 6, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Oryza sativa" ], @@ -1910,8 +1908,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002255", @@ -1921,7 +1919,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002255/PXD002255.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002255/PXD002255.sdrf.tsv", "num_samples": 428, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -1936,8 +1934,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002266", @@ -1947,7 +1945,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002266/PXD002266.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002266/PXD002266.sdrf.tsv", "num_samples": 216, - "num_columns": 26, + "num_columns": 28, "organisms": [ "plasmodium falciparum" ], @@ -1960,8 +1958,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002370", @@ -1971,7 +1969,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002370/PXD002370.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002370/PXD002370.sdrf.tsv", "num_samples": 9, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Saccharomyces cerevisiae" ], @@ -1984,8 +1982,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002395", @@ -1995,21 +1993,21 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002395/PXD002395.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002395/PXD002395.sdrf.tsv", "num_samples": 198, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Homo sapiens" ], "diseases": [ - "Childhood T acute lymphoblastic leukemia", + "Colon carcinoma", "Prostate carcinoma", - "Human papillomavirus-related endocervical adenocarcinoma", - "Osteosarcoma", + "Invasive ductal carcinoma, not otherwise specified", "Hepatoblastoma", - "Glioblastoma", - "Colon carcinoma", "Chronic myelogenous leukemia, BCR-ABL1 positive", - "Lung adenocarcinoma", - "Invasive ductal carcinoma, not otherwise specified" + "Osteosarcoma", + "Human papillomavirus-related endocervical adenocarcinoma", + "Childhood T acute lymphoblastic leukemia", + "Glioblastoma", + "Lung adenocarcinoma" ], "instruments": [ "LTQ Orbitrap Velos" @@ -2019,8 +2017,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002756", @@ -2030,21 +2028,21 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002756/PXD002756.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002756/PXD002756.sdrf.tsv", "num_samples": 8, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Oryza sativa" ], "diseases": [], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002815", @@ -2054,7 +2052,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002815/PXD002815.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002815/PXD002815.sdrf.tsv", "num_samples": 4311, - "num_columns": 19, + "num_columns": 21, "organisms": [ "Homo sapiens", "Mus musculus" @@ -2068,8 +2066,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD002870", @@ -2079,21 +2077,21 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD002870/PXD002870.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD002870/PXD002870.sdrf.tsv", "num_samples": 1477, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Mus musculus" ], "diseases": [], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003028", @@ -2103,7 +2101,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003028/PXD003028.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003028/PXD003028.sdrf.tsv", "num_samples": 89, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -2116,8 +2114,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003133", @@ -2127,7 +2125,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003133/PXD003133.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003133/PXD003133.sdrf.tsv", "num_samples": 4, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Homo sapiens" ], @@ -2140,8 +2138,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003209", @@ -2151,7 +2149,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003209/PXD003209.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003209/PXD003209.sdrf.tsv", "num_samples": 3, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], @@ -2166,8 +2164,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003430", @@ -2177,13 +2175,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003430/PXD003430.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003430/PXD003430.sdrf.tsv", "num_samples": 36, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], "diseases": [ - "control", - "Prostate adenocarcinoma" + "Prostate adenocarcinoma", + "control" ], "instruments": [ "Q Exactive" @@ -2193,8 +2191,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003452", @@ -2204,13 +2202,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003452/PXD003452.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003452/PXD003452.sdrf.tsv", "num_samples": 36, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], "diseases": [ - "control", - "Prostate adenocarcinoma" + "Prostate adenocarcinoma", + "control" ], "instruments": [ "Q Exactive" @@ -2220,8 +2218,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003469", @@ -2231,32 +2229,32 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003469/PXD003469.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003469/PXD003469.sdrf.tsv", "num_samples": 382, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], "diseases": [ - "Nodular lymphocyte predominant Hodgkin lymphoma", - "Mantle cell lymphoma", - "Burkitt lymphoma", - "Classical Hodgkin lymphoma", + "Transformed follicular lymphoma", "Burkitt's lymphoma (American)", + "plasmacytoma", + "Nodular lymphocyte predominant Hodgkin lymphoma", + "follicular lymphoma", + "malignant non-Hodgkin's lymphoma", + "Anaplastic large cell lymphoma", + "diffuse histiocytic lymphoma", + "Burkitt's lymphoma", "Primary mediastinal large B-cell lymphoma", - "Aggressive NK-cell leukemia", + "Anaplastic large cell lymphoma,", "cutaneous T cell lymphoma", - "Transformed follicular lymphoma", - "Multiple Myeloma", - "Burkitt's lymphoma", "acute T cell leukemia", - "Anaplastic large cell lymphoma", - "malignant non-Hodgkin's lymphoma", - "Sezary Syndrome", - "plasmacytoma", - "Diffuse large B-cell lymphoma", + "Multiple Myeloma", + "Classical Hodgkin lymphoma", + "Mantle cell lymphoma", "lymphoma", - "\"Anaplastic large cell lymphoma,\"", - "diffuse histiocytic lymphoma", - "follicular lymphoma" + "Diffuse large B-cell lymphoma", + "Burkitt lymphoma", + "Aggressive NK-cell leukemia", + "Sezary Syndrome" ], "instruments": [ "LTQ Orbitrap XL" @@ -2266,8 +2264,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003515", @@ -2277,13 +2275,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003515/PXD003515.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003515/PXD003515.sdrf.tsv", "num_samples": 40, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], "diseases": [ - "control", - "Prostate adenocarcinoma" + "Prostate adenocarcinoma", + "control" ], "instruments": [ "Q Exactive" @@ -2293,8 +2291,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003531", @@ -2304,13 +2302,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003531/PXD003531.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003531/PXD003531.sdrf.tsv", "num_samples": 59, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Homo sapiens" ], "diseases": [ - "high grade serous ovarian cancer", - "epithelial ovarian cancer" + "epithelial ovarian cancer", + "high grade serous ovarian cancer" ], "instruments": [ "Q Exactive", @@ -2321,8 +2319,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003539", @@ -2332,42 +2330,42 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003539/PXD003539.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003539/PXD003539.sdrf.tsv", "num_samples": 120, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], "diseases": [ - "immunoblastic large cell lymphoma", - "large cell lung carcinoma", - "chronic myelogenic leukemia", - "renal cell carcinoma", - "colon carcinoma", - "malignant melanoma", - "melanoma", - "renal clear cell adenocarcinoma", - "prostate adenocarcinoma", - "promyelocytic leukemia", - "skin cutaneous melanoma", - "clear cell renal carcinoma", - "B-cell plasmacytoma; myeloma", - "acute T lymphoblastic leukaemia", - "renal adenocarcinoma", - "lung carcinoma", - "ovarian carcinoma", "ovarian adenocarcinoma", - "acute lymphoblastic leukemia", - "breast carcinoma", - "renal carcinoma", - "breast ductal adenocarcinoma", - "colon adenocarcinoma", "mesothelioma", - "breast adenocarcinoma", + "renal adenocarcinoma", + "plasmacytoma", "non-small cell lung carcinoma", + "colon adenocarcinoma", + "acute T lymphoblastic leukaemia", + "clear cell renal carcinoma", + "lung carcinoma", "ovarian serous cystadenocarcinoma", + "breast carcinoma", + "renal carcinoma", + "melanoma", "astrocytoma", - "glioma", + "breast adenocarcinoma", + "skin cutaneous melanoma", + "glioblastoma", + "renal cell carcinoma", + "prostate adenocarcinoma", + "malignant melanoma", + "chronic myelogenic leukemia", + "acute lymphoblastic leukemia", + "immunoblastic large cell lymphoma", "renal cell adenocarcinoma", - "glioblastoma" + "promyelocytic leukemia", + "ovarian carcinoma", + "large cell lung carcinoma", + "colon carcinoma", + "glioma", + "renal clear cell adenocarcinoma", + "breast ductal adenocarcinoma" ], "instruments": [ "TripleTOF 5600" @@ -2377,8 +2375,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003615", @@ -2388,7 +2386,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003615/PXD003615.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003615/PXD003615.sdrf.tsv", "num_samples": 36, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -2403,8 +2401,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003636", @@ -2414,13 +2412,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003636/PXD003636.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003636/PXD003636.sdrf.tsv", "num_samples": 30, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], "diseases": [ - "control", - "Prostate adenocarcinoma" + "Prostate adenocarcinoma", + "control" ], "instruments": [ "Q Exactive" @@ -2430,8 +2428,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003668", @@ -2441,7 +2439,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003668/PXD003668.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003668/PXD003668.sdrf.tsv", "num_samples": 101, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -2456,8 +2454,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD003977", @@ -2467,7 +2465,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD003977/PXD003977.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD003977/PXD003977.sdrf.tsv", "num_samples": 120, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -2482,8 +2480,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004132", @@ -2493,13 +2491,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004132/PXD004132.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004132/PXD004132.sdrf.tsv", "num_samples": 23, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], "diseases": [ - "control", - "Prostate adenocarcinoma" + "Prostate adenocarcinoma", + "control" ], "instruments": [ "Q Exactive" @@ -2509,8 +2507,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004143", @@ -2520,7 +2518,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004143/PXD004143.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004143/PXD004143.sdrf.tsv", "num_samples": 4, - "num_columns": 29, + "num_columns": 31, "organisms": [ "homo sapiens" ], @@ -2533,8 +2531,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004159", @@ -2544,7 +2542,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004159/PXD004159.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004159/PXD004159.sdrf.tsv", "num_samples": 12, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -2559,8 +2557,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004242", @@ -2570,13 +2568,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004242/PXD004242.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004242/PXD004242.sdrf.tsv", "num_samples": 1290, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], "diseases": [ - "obesity", - "uninfected" + "uninfected", + "obesity" ], "instruments": [ "Q Exactive HF" @@ -2586,8 +2584,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004332", @@ -2597,7 +2595,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004332/PXD004332.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004332/PXD004332.sdrf.tsv", "num_samples": 61, - "num_columns": 30, + "num_columns": 32, "organisms": [ "homo sapiens" ], @@ -2610,8 +2608,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004436", @@ -2621,7 +2619,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004436/PXD004436.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004436/PXD004436.sdrf.tsv", "num_samples": 27, - "num_columns": 22, + "num_columns": 24, "organisms": [ "mus musculus" ], @@ -2629,16 +2627,16 @@ "none" ], "instruments": [ - "LTQ Velos", - "Q Exactive Plus" + "Q Exactive Plus", + "LTQ Velos" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004452", @@ -2648,16 +2646,16 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004452/PXD004452-celllines.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004452/PXD004452-celllines.sdrf.tsv", "num_samples": 761, - "num_columns": 36, + "num_columns": 38, "organisms": [ "Homo sapiens" ], "diseases": [ + "lung adenocarcinoma", "breast cancer", "neuroblastoma", "epithelial cervix carcinoma", - "colon cancer", - "lung adenocarcinoma" + "colon cancer" ], "instruments": [ "Q Exactive" @@ -2667,8 +2665,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004452", @@ -2678,7 +2676,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004452/PXD004452-tissues.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004452/PXD004452-tissues.sdrf.tsv", "num_samples": 216, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -2691,8 +2689,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004528", @@ -2702,7 +2700,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004528/PXD004528.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004528/PXD004528.sdrf.tsv", "num_samples": 5, - "num_columns": 22, + "num_columns": 24, "organisms": [ "Homo sapiens" ], @@ -2715,8 +2713,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004603", @@ -2726,7 +2724,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004603/PXD004603.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004603/PXD004603.sdrf.tsv", "num_samples": 23, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Oryza sativa" ], @@ -2739,8 +2737,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004604", @@ -2750,7 +2748,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004604/PXD004604.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004604/PXD004604.sdrf.tsv", "num_samples": 10, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Mus musculus" ], @@ -2763,8 +2761,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004605", @@ -2774,7 +2772,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004605/PXD004605.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004605/PXD004605.sdrf.tsv", "num_samples": 30, - "num_columns": 21, + "num_columns": 23, "organisms": [ "Escherichia coli" ], @@ -2787,8 +2785,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004613", @@ -2798,7 +2796,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004613/PXD004613.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004613/PXD004613.sdrf.tsv", "num_samples": 8, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -2813,8 +2811,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004616", @@ -2824,7 +2822,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004616/PXD004616.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004616/PXD004616.sdrf.tsv", "num_samples": 15, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Homo sapiens" ], @@ -2837,8 +2835,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004617", @@ -2848,7 +2846,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004617/PXD004617.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004617/PXD004617.sdrf.tsv", "num_samples": 15, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Homo sapiens" ], @@ -2861,8 +2859,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004618", @@ -2872,7 +2870,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004618/PXD004618.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004618/PXD004618.sdrf.tsv", "num_samples": 15, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Homo sapiens" ], @@ -2885,8 +2883,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004624", @@ -2896,7 +2894,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004624/PXD004624.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004624/PXD004624.sdrf.tsv", "num_samples": 6, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -2911,8 +2909,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004682", @@ -2922,13 +2920,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004682/PXD004682.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004682/PXD004682.sdrf.tsv", "num_samples": 192, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], "diseases": [ - "control", - "squamous cell carcinoma" + "squamous cell carcinoma", + "control" ], "instruments": [ "Q Exactive Plus" @@ -2938,8 +2936,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004683", @@ -2949,7 +2947,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004683/PXD004683.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004683/PXD004683.sdrf.tsv", "num_samples": 192, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], @@ -2964,8 +2962,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004684", @@ -2975,13 +2973,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004684/PXD004684.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004684/PXD004684.sdrf.tsv", "num_samples": 16, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], "diseases": [ - "control", - "squamous cell carcinoma" + "squamous cell carcinoma", + "control" ], "instruments": [ "Q Exactive Plus" @@ -2991,8 +2989,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004705", @@ -3002,7 +3000,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004705/PXD004705.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004705/PXD004705.sdrf.tsv", "num_samples": 9, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Oryza sativa" ], @@ -3015,8 +3013,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004732", @@ -3026,7 +3024,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004732/PXD004732.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004732/PXD004732.sdrf.tsv", "num_samples": 1460, - "num_columns": 38, + "num_columns": 40, "organisms": [ "Homo sapiens" ], @@ -3039,8 +3037,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004903", @@ -3050,7 +3048,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004903/PXD004903.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004903/PXD004903.sdrf.tsv", "num_samples": 27, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], @@ -3065,8 +3063,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004939", @@ -3076,7 +3074,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004939/PXD004939.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004939/PXD004939.sdrf.tsv", "num_samples": 9, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Oryza sativa" ], @@ -3089,8 +3087,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD004987", @@ -3100,21 +3098,21 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD004987/PXD004987.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD004987/PXD004987.sdrf.tsv", "num_samples": 9, - "num_columns": 23, + "num_columns": 25, "organisms": [ "Homo sapiens" ], "diseases": [], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005163", @@ -3124,7 +3122,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005163/PXD005163.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005163/PXD005163.sdrf.tsv", "num_samples": 72, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -3139,8 +3137,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005171", @@ -3150,7 +3148,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005171/PXD005171.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005171/PXD005171.sdrf.tsv", "num_samples": 100, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -3165,8 +3163,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005172", @@ -3176,7 +3174,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005172/PXD005172.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005172/PXD005172.sdrf.tsv", "num_samples": 100, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -3191,8 +3189,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005173", @@ -3202,7 +3200,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005173/PXD005173.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005173/PXD005173.sdrf.tsv", "num_samples": 59, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Homo sapiens" ], @@ -3218,8 +3216,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005174", @@ -3229,7 +3227,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005174/PXD005174.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005174/PXD005174.sdrf.tsv", "num_samples": 128, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -3244,8 +3242,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005175", @@ -3255,7 +3253,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005175/PXD005175.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005175/PXD005175.sdrf.tsv", "num_samples": 120, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], @@ -3270,8 +3268,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005176", @@ -3281,7 +3279,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005176/PXD005176.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005176/PXD005176.sdrf.tsv", "num_samples": 114, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -3296,8 +3294,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005177", @@ -3307,7 +3305,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005177/PXD005177.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005177/PXD005177.sdrf.tsv", "num_samples": 136, - "num_columns": 29, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -3322,8 +3320,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005207", @@ -3333,7 +3331,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005207/PXD005207.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005207/PXD005207.sdrf.tsv", "num_samples": 258, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo Sapiens" ], @@ -3346,8 +3344,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005241", @@ -3357,7 +3355,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005241/PXD005241.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005241/PXD005241.sdrf.tsv", "num_samples": 18, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Oryza sativa" ], @@ -3370,8 +3368,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005300", @@ -3381,7 +3379,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005300/PXD005300.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005300/PXD005300.sdrf.tsv", "num_samples": 128, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Mus musculus" ], @@ -3394,8 +3392,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005354", @@ -3405,7 +3403,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005354/PXD005354.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005354/PXD005354.sdrf.tsv", "num_samples": 1560, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -3420,8 +3418,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005355", @@ -3431,7 +3429,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005355/PXD005355.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005355/PXD005355.sdrf.tsv", "num_samples": 195, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -3439,15 +3437,15 @@ "colorectal cancer" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005366", @@ -3457,7 +3455,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005366/PXD005366-hela.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005366/PXD005366-hela.sdrf.tsv", "num_samples": 48, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Homo sapiens" ], @@ -3472,8 +3470,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005366", @@ -3483,7 +3481,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005366/PXD005366-rattus.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005366/PXD005366-rattus.sdrf.tsv", "num_samples": 28, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Rattus norvegicus" ], @@ -3496,8 +3494,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005366", @@ -3507,7 +3505,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005366/PXD005366.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005366/PXD005366.sdrf.tsv", "num_samples": 48, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Homo sapiens" ], @@ -3522,8 +3520,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005445", @@ -3533,7 +3531,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005445/PXD005445.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005445/PXD005445.sdrf.tsv", "num_samples": 196, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -3548,8 +3546,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005463", @@ -3559,7 +3557,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005463/PXD005463.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005463/PXD005463.sdrf.tsv", "num_samples": 6, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Saccharomyces cerevisiae" ], @@ -3572,8 +3570,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005507", @@ -3583,7 +3581,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005507/PXD005507.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005507/PXD005507.sdrf.tsv", "num_samples": 18, - "num_columns": 30, + "num_columns": 32, "organisms": [ "homo sapiens" ], @@ -3591,15 +3589,15 @@ "hepatocellular carcinoma" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005539", @@ -3609,7 +3607,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005539/PXD005539.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005539/PXD005539.sdrf.tsv", "num_samples": 27, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -3618,15 +3616,15 @@ "amelanotic melanoma" ], "instruments": [ - " LTQ Orbitrap Elite" + " Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005554", @@ -3636,13 +3634,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005554/PXD005554.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005554/PXD005554.sdrf.tsv", "num_samples": 142, - "num_columns": 37, + "num_columns": 39, "organisms": [ "homo sapiens" ], "diseases": [ - "triple-negative breast cancer", - "metastatic ovarian high grade serous adenocarcinoma" + "metastatic ovarian high grade serous adenocarcinoma", + "triple-negative breast cancer" ], "instruments": [ "Q Exactive" @@ -3652,8 +3650,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005780", @@ -3663,7 +3661,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005780/PXD005780.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005780/PXD005780.sdrf.tsv", "num_samples": 15, - "num_columns": 29, + "num_columns": 31, "organisms": [ "feces metagenome" ], @@ -3676,8 +3674,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005819", @@ -3687,7 +3685,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005819/PXD005819.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005819/PXD005819.sdrf.tsv", "num_samples": 32, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -3700,8 +3698,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005940", @@ -3711,31 +3709,31 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005940/PXD005940.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005940/PXD005940.sdrf.tsv", "num_samples": 216, - "num_columns": 34, + "num_columns": 36, "organisms": [ "homo sapiens" ], "diseases": [ + "amelanotic melanoma", + "childhood T acute lymphoblastic leukemia", + "colon adenocarcinoma", "prostate carcinoma", + "renal cell carcinoma", "ovarian serous cystadenocarcinoma", "invasive ductal carcinoma", - "colon adenocarcinoma", - "childhood T acute lymphoblastic leukemia", - "renal cell carcinoma", - "astrocytoma", "non-small cell lung adenocarcinoma", - "amelanotic melanoma" + "astrocytoma" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005942", @@ -3745,39 +3743,39 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005942/PXD005942.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005942/PXD005942.sdrf.tsv", "num_samples": 59, - "num_columns": 29, + "num_columns": 31, "organisms": [ "homo sapiens" ], "diseases": [ - "anaplastic large cell lymphoma", - "prostate carcinoma", - "renal cell carcinoma", - "colon carcinoma", - "adult acute myeloid leukemia", - "melanoma", - "Colon adenocarcinoma", - "amelanotic melanoma", "lung adenocarcinoma", - "invasive ductal carcinoma", - "high grade ovarian serous adenocarcinoma", "childhood T acute lymphoblastic leukemia", - "adult T acute lymphoblastic leukemia", - "clear cell renal carcinoma", + "Pleural Epithelioid Mesothelioma", + "metastatic melanoma", + "Colon adenocarcinoma", "non-small cell lung adenocarcinoma", - "chronic myelogenous leukemia", - "multiple myeloma", - "colon adenocarcinoma", - "brain glioblastoma", - "gliosarcoma", - "breast adenocarcinoma", + "amelanotic melanoma", "non-small cell lung carcinoma", + "colon adenocarcinoma", "cutaneous melanoma", - "Ovarian Endometrioid Adenocarcinoma", + "clear cell renal carcinoma", "ovarian serous cystadenocarcinoma", - "Pleural Epithelioid Mesothelioma", + "invasive ductal carcinoma", + "gliosarcoma", + "melanoma", + "adult T acute lymphoblastic leukemia", "astrocytoma", - "metastatic melanoma" + "breast adenocarcinoma", + "prostate carcinoma", + "renal cell carcinoma", + "high grade ovarian serous adenocarcinoma", + "chronic myelogenous leukemia", + "anaplastic large cell lymphoma", + "adult acute myeloid leukemia", + "multiple myeloma", + "colon carcinoma", + "Ovarian Endometrioid Adenocarcinoma", + "brain glioblastoma" ], "instruments": [ "LTQ Orbitrap XL ETD" @@ -3787,8 +3785,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD005946", @@ -3798,39 +3796,39 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD005946/PXD005946.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD005946/PXD005946.sdrf.tsv", "num_samples": 732, - "num_columns": 33, + "num_columns": 35, "organisms": [ "homo sapiens" ], "diseases": [ - "anaplastic large cell lymphoma", - "prostate carcinoma", - "rectosigmoid adenocarcinoma", - "renal cell carcinoma", - "colon carcinoma", - "adult acute myeloid leukemia", - "melanoma", - "amelanotic melanoma", "lung adenocarcinoma", - "invasive ductal carcinoma", - "high grade ovarian serous adenocarcinoma", "childhood T acute lymphoblastic leukemia", - "clear cell renal carcinoma", - "adult T acute lymphoblastic leukemia", + "Pleural Epithelioid Mesothelioma", + "metastatic melanoma", "non-small cell lung adenocarcinoma", - "chronic myelogenous leukemia", - "multiple myeloma", + "amelanotic melanoma", + "non-small cell lung carcinoma", "colon adenocarcinoma", - "brain glioblastoma", - "gliosarcoma", - "breast adenocarcinoma", "cutaneous melanoma", + "clear cell renal carcinoma", "ovarian serous cystadenocarcinoma", - "Ovarian Endometrioid Adenocarcinoma", - "non-small cell lung carcinoma", - "Pleural Epithelioid Mesothelioma", + "invasive ductal carcinoma", + "gliosarcoma", + "melanoma", + "rectosigmoid adenocarcinoma", + "adult T acute lymphoblastic leukemia", + "breast adenocarcinoma", "astrocytoma", - "metastatic melanoma" + "prostate carcinoma", + "renal cell carcinoma", + "high grade ovarian serous adenocarcinoma", + "chronic myelogenous leukemia", + "anaplastic large cell lymphoma", + "adult acute myeloid leukemia", + "multiple myeloma", + "colon carcinoma", + "Ovarian Endometrioid Adenocarcinoma", + "brain glioblastoma" ], "instruments": [ "LTQ Orbitrap XL ETD" @@ -3840,8 +3838,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006003", @@ -3851,7 +3849,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006003/PXD006003.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006003/PXD006003.sdrf.tsv", "num_samples": 1346, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Mus musculus" ], @@ -3866,8 +3864,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006132", @@ -3877,7 +3875,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006132/PXD006132.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006132/PXD006132.sdrf.tsv", "num_samples": 49, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Homo sapiens" ], @@ -3892,8 +3890,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006195", @@ -3903,21 +3901,21 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006195/PXD006195.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006195/PXD006195.sdrf.tsv", "num_samples": 72, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Escherichia coli" ], "diseases": [], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006233", @@ -3927,7 +3925,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006233/PXD006233.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006233/PXD006233.sdrf.tsv", "num_samples": 378, - "num_columns": 27, + "num_columns": 29, "organisms": [ "homo sapiens" ], @@ -3942,8 +3940,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006401", @@ -3953,10 +3951,10 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006401/PXD006401.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006401/PXD006401.sdrf.tsv", "num_samples": 28, - "num_columns": 30, + "num_columns": 32, "organisms": [ - "homo sapiens", - "mus musculus" + "mus musculus", + "homo sapiens" ], "diseases": [], "instruments": [ @@ -3967,8 +3965,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006430", @@ -3978,7 +3976,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006430/PXD006430-silac.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006430/PXD006430-silac.sdrf.tsv", "num_samples": 576, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Homo sapiens" ], @@ -3994,8 +3992,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006430", @@ -4005,7 +4003,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006430/PXD006430-tmt.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006430/PXD006430-tmt.sdrf.tsv", "num_samples": 720, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -4020,8 +4018,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006482", @@ -4031,7 +4029,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006482/PXD006482.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006482/PXD006482.sdrf.tsv", "num_samples": 192, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Homo sapiens" ], @@ -4046,8 +4044,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006542", @@ -4057,7 +4055,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006542/PXD006542.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006542/PXD006542.sdrf.tsv", "num_samples": 1488, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -4072,8 +4070,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006607", @@ -4083,7 +4081,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006607/PXD006607.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006607/PXD006607.sdrf.tsv", "num_samples": 1028, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -4098,8 +4096,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006675", @@ -4109,7 +4107,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006675/PXD006675.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006675/PXD006675.sdrf.tsv", "num_samples": 594, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -4125,8 +4123,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006877", @@ -4136,7 +4134,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006877/PXD006877.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006877/PXD006877.sdrf.tsv", "num_samples": 112, - "num_columns": 23, + "num_columns": 25, "organisms": [ "Haloferax volcanii DS2" ], @@ -4149,8 +4147,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD006914", @@ -4160,7 +4158,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD006914/PXD006914.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD006914/PXD006914.sdrf.tsv", "num_samples": 24, - "num_columns": 27, + "num_columns": 29, "organisms": [ "homo sapiens" ], @@ -4177,8 +4175,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD007073", @@ -4188,7 +4186,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD007073/PXD007073.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD007073/PXD007073.sdrf.tsv", "num_samples": 136, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -4203,8 +4201,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD007160", @@ -4214,47 +4212,47 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD007160/PXD007160.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD007160/PXD007160.sdrf.tsv", "num_samples": 1687, - "num_columns": 30, + "num_columns": 32, "organisms": [ "homo sapiens" ], "diseases": [ - "control4", - "Alzheimer's disease/Parkinson's disease5", - "Parkinson's disease3", - "Parkinson's disease9", - "control9", - "control7", - "control5", - "Alzheimer's disease 3", - "control0", - "Parkinson's disease0", - "Alzheimer's disease0", + "Parkinson's disease4", + "Alzheimer's disease/Parkinson's disease7", "Alzheimer's disease/Parkinson's disease9", "Alzheimer's disease 9", - "Parkinson's disease4", - "Alzheimer's disease/Parkinson's disease", - "Alzheimer's disease 7", - "Parkinson's disease5", "Alzheimer's disease", - "Alzheimer's disease 8", - "control6", - "Alzheimer's disease 6", - "Parkinson's disease8", - "control3", - "Alzheimer's disease/Parkinson's disease3", + "control0", + "control4", + "Alzheimer's disease0", + "Alzheimer's disease 7", + "Parkinson's disease0", "control", + "Alzheimer's disease 5", + "Parkinson's disease7", + "Parkinson's disease9", + "Alzheimer's disease/Parkinson's disease0", + "Alzheimer's disease/Parkinson's disease5", "Alzheimer's disease/Parkinson's disease8", - "control8", "Alzheimer's disease 4", - "Alzheimer's disease/Parkinson's disease6", - "Alzheimer's disease 5", + "control7", + "control5", + "Alzheimer's disease 6", + "Parkinson's disease6", + "control9", "Alzheimer's disease/Parkinson's disease4", - "Parkinson's disease7", + "Parkinson's disease5", + "Alzheimer's disease/Parkinson's disease", + "Parkinson's disease3", + "control6", + "Alzheimer's disease 8", "Parkinson's disease", - "Alzheimer's disease/Parkinson's disease7", - "Parkinson's disease6", - "Alzheimer's disease/Parkinson's disease0" + "Alzheimer's disease 3", + "control3", + "Parkinson's disease8", + "Alzheimer's disease/Parkinson's disease6", + "control8", + "Alzheimer's disease/Parkinson's disease3" ], "instruments": [ "Orbitrap Fusion" @@ -4264,8 +4262,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD007555", @@ -4275,7 +4273,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD007555/PXD007555.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD007555/PXD007555.sdrf.tsv", "num_samples": 36, - "num_columns": 28, + "num_columns": 30, "organisms": [ "homo sapiens" ], @@ -4290,8 +4288,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD007662", @@ -4301,7 +4299,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD007662/PXD007662.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD007662/PXD007662.sdrf.tsv", "num_samples": 48, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -4316,8 +4314,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD007864", @@ -4327,7 +4325,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD007864/PXD007864.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD007864/PXD007864.sdrf.tsv", "num_samples": 2, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Escherichia coli" ], @@ -4340,8 +4338,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008012", @@ -4351,7 +4349,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008012/PXD008012.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008012/PXD008012.sdrf.tsv", "num_samples": 141, - "num_columns": 38, + "num_columns": 40, "organisms": [ "Homo sapiens" ], @@ -4359,15 +4357,15 @@ "Triple-negative breast cancer" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008222", @@ -4377,19 +4375,19 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008222/PXD008222.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008222/PXD008222.sdrf.tsv", "num_samples": 456, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], "diseases": [ - "breast carcinoma", "primary breast tumor", - "fibrocystic disease", + "medulallary carcinoma", "ductal carcinoma", - "primary acantholytic squamous cell carcinoma", "metastatic carcinoma", + "fibrocystic disease", + "breast carcinoma", "primary ductal carcinoma", - "medulallary carcinoma" + "primary acantholytic squamous cell carcinoma" ], "instruments": [ "Q Exactive" @@ -4399,8 +4397,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008355", @@ -4410,7 +4408,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008355/PXD008355.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008355/PXD008355.sdrf.tsv", "num_samples": 40, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Arabidopsis thaliana" ], @@ -4423,8 +4421,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008369", @@ -4434,7 +4432,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008369/PXD008369.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008369/PXD008369.sdrf.tsv", "num_samples": 18, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Escherichia coli" ], @@ -4447,8 +4445,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008440", @@ -4458,7 +4456,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008440/PXD008440.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008440/PXD008440.sdrf.tsv", "num_samples": 200, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -4473,8 +4471,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008722", @@ -4484,7 +4482,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008722/PXD008722.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008722/PXD008722.sdrf.tsv", "num_samples": 252, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -4499,8 +4497,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008840", @@ -4510,7 +4508,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008840/PXD008840.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008840/PXD008840.sdrf.tsv", "num_samples": 1016, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], @@ -4525,8 +4523,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008841", @@ -4536,17 +4534,17 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008841/PXD008841.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008841/PXD008841.sdrf.tsv", "num_samples": 3600, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo Sapiens" ], "diseases": [ - "luminal B breast carcinoma", "Normal Breast-Like Subtype of Breast Carcinoma", - "basal-like breast carcinoma", - "HER2 Positive Breast Carcinoma", "luminal A breast carcinoma", - "breast cancer" + "HER2 Positive Breast Carcinoma", + "breast cancer", + "luminal B breast carcinoma", + "basal-like breast carcinoma" ], "instruments": [ "Q Exactive" @@ -4556,8 +4554,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008921", @@ -4567,7 +4565,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008921/PXD008921.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008921/PXD008921.sdrf.tsv", "num_samples": 36, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Escherichia coli" ], @@ -4580,8 +4578,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD008934", @@ -4591,14 +4589,14 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD008934/PXD008934.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD008934/PXD008934.sdrf.tsv", "num_samples": 34, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], "diseases": [ "dilated cardiomyopathy", - "ischemic cardiomyopathy", "cardiac hypertrophy", + "ischemic cardiomyopathy", "compensated hypertrophy" ], "instruments": [ @@ -4609,8 +4607,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009157", @@ -4620,7 +4618,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009157/PXD009157.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009157/PXD009157.sdrf.tsv", "num_samples": 66, - "num_columns": 27, + "num_columns": 29, "organisms": [ "plasmodium falciparum" ], @@ -4633,8 +4631,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009203", @@ -4644,24 +4642,24 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009203/PXD009203.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009203/PXD009203.sdrf.tsv", "num_samples": 20, - "num_columns": 27, + "num_columns": 29, "organisms": [ "homo sapiens" ], "diseases": [ - "invasive high-grade bladder cancer", - "severe cystitis with reactive urothelial atypia" + "severe cystitis with reactive urothelial atypia", + "invasive high-grade bladder cancer" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009465", @@ -4671,7 +4669,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009465/PXD009465.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009465/PXD009465.sdrf.tsv", "num_samples": 60, - "num_columns": 27, + "num_columns": 29, "organisms": [ "plasmodium falciparum" ], @@ -4684,8 +4682,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009602", @@ -4695,7 +4693,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009602/PXD009602.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009602/PXD009602.sdrf.tsv", "num_samples": 528, - "num_columns": 31, + "num_columns": 33, "organisms": [ "homo sapiens" ], @@ -4710,8 +4708,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009623", @@ -4721,7 +4719,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009623/PXD009623-dda.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009623/PXD009623-dda.sdrf.tsv", "num_samples": 3, - "num_columns": 25, + "num_columns": 27, "organisms": [ "homo sapiens" ], @@ -4734,8 +4732,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009623", @@ -4745,7 +4743,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009623/PXD009623-dia.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009623/PXD009623-dia.sdrf.tsv", "num_samples": 3, - "num_columns": 25, + "num_columns": 27, "organisms": [ "homo sapiens" ], @@ -4758,8 +4756,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009630", @@ -4769,18 +4767,18 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009630/PXD009630.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009630/PXD009630.sdrf.tsv", "num_samples": 111, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], "diseases": [ "unknown", - "lentigo maligna melanoma", "nodular melanoma", "acral lentiginous melanoma", - "superficial spreading melanoma", "other", - "mucosal" + "mucosal", + "superficial spreading melanoma", + "lentigo maligna melanoma" ], "instruments": [ "Q Exactive", @@ -4791,8 +4789,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009815", @@ -4802,7 +4800,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009815/PXD009815.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009815/PXD009815.sdrf.tsv", "num_samples": 40, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Saccharomyces cerevisiae" ], @@ -4815,8 +4813,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD009909", @@ -4826,7 +4824,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD009909/PXD009909.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD009909/PXD009909.sdrf.tsv", "num_samples": 12, - "num_columns": 25, + "num_columns": 27, "organisms": [ "mus musculus" ], @@ -4839,8 +4837,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010154", @@ -4850,23 +4848,23 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010154/PXD010154.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010154/PXD010154.sdrf.tsv", "num_samples": 1800, - "num_columns": 30, + "num_columns": 32, "organisms": [ "homo sapiens" ], "diseases": [], "instruments": [ - "Q Exactive HF", + "Orbitrap Fusion Lumos", "Q Exactive Plus", - "Orbitrap Fusion Lumos" + "Q Exactive HF" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010271", @@ -4876,7 +4874,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010271/PXD010271.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010271/PXD010271.sdrf.tsv", "num_samples": 252, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -4892,8 +4890,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010357", @@ -4903,7 +4901,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010357/PXD010357.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010357/PXD010357.sdrf.tsv", "num_samples": 116, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Homo sapiens" ], @@ -4918,8 +4916,8 @@ ], "experiment_type": "DIA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010371", @@ -4929,19 +4927,19 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010371/PXD010371.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010371/PXD010371.sdrf.tsv", "num_samples": 77, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], "diseases": [ - "Healthy control", - "Ulcerative Colitis remission stage", "'Crohn''s Disease Irritable Bowel Syndrome'", + "Irritable Bowel Syndrome", "Gastric Carcinoma", "'Crohn''s Disease'", - "Colon Adenoma", - "Irritable Bowel Syndrome", - "Ulcerative Colitis active stage" + "Ulcerative Colitis active stage", + "Healthy control", + "Ulcerative Colitis remission stage", + "Colon Adenoma" ], "instruments": [ "Q Exactive HF" @@ -4951,8 +4949,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010429", @@ -4962,7 +4960,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010429/PXD010429.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010429/PXD010429.sdrf.tsv", "num_samples": 4176, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], @@ -4977,8 +4975,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010595", @@ -4988,7 +4986,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010595/PXD010595.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010595/PXD010595.sdrf.tsv", "num_samples": 888, - "num_columns": 38, + "num_columns": 40, "organisms": [ "Homo sapiens" ], @@ -5001,8 +4999,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010603", @@ -5012,7 +5010,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010603/PXD010603.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010603/PXD010603.sdrf.tsv", "num_samples": 311, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -5027,8 +5025,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010698", @@ -5038,7 +5036,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010698/PXD010698.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010698/PXD010698.sdrf.tsv", "num_samples": 5, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Homo sapiens" ], @@ -5053,8 +5051,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010705", @@ -5064,7 +5062,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010705/PXD010705.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010705/PXD010705.sdrf.tsv", "num_samples": 3, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Homo sapiens" ], @@ -5079,8 +5077,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010708", @@ -5090,12 +5088,12 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010708/PXD010708.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010708/PXD010708.sdrf.tsv", "num_samples": 15, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Homo Sapiens" ], "diseases": [ - "\"NT:hydrocephalus,AC:DOID:10908\"" + "hydrocephalus" ], "instruments": [ "Q Exactive" @@ -5105,8 +5103,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD010981", @@ -5116,7 +5114,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD010981/PXD010981.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD010981/PXD010981.sdrf.tsv", "num_samples": 12, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Saccharomyces cerevisiae" ], @@ -5129,8 +5127,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD011023", @@ -5140,7 +5138,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD011023/PXD011023.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD011023/PXD011023.sdrf.tsv", "num_samples": 32, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Escherichia coli" ], @@ -5153,8 +5151,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD011050", @@ -5164,7 +5162,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD011050/PXD011050.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD011050/PXD011050.sdrf.tsv", "num_samples": 16, - "num_columns": 22, + "num_columns": 24, "organisms": [ "Haloferax volcanii DS2" ], @@ -5177,8 +5175,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD011153", @@ -5188,7 +5186,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD011153/PXD011153.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD011153/PXD011153.sdrf.tsv", "num_samples": 6, - "num_columns": 23, + "num_columns": 26, "organisms": [ "Mus musculus" ], @@ -5203,8 +5201,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD011175", @@ -5214,7 +5212,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD011175/PXD011175.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD011175/PXD011175.sdrf.tsv", "num_samples": 28, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -5229,8 +5227,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD011799", @@ -5240,7 +5238,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD011799/PXD011799.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD011799/PXD011799.sdrf.tsv", "num_samples": 480, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -5255,8 +5253,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD011839", @@ -5266,13 +5264,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD011839/PXD011839.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD011839/PXD011839.sdrf.tsv", "num_samples": 399, - "num_columns": 36, + "num_columns": 38, "organisms": [ "homo sapiens" ], "diseases": [ - "cirrhosis of liver", "non-alcoholic fatty liver disease", + "cirrhosis of liver", "type II diabetes mellitus" ], "instruments": [ @@ -5283,8 +5281,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD011967", @@ -5294,7 +5292,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD011967/PXD011967.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD011967/PXD011967.sdrf.tsv", "num_samples": 2316, - "num_columns": 29, + "num_columns": 31, "organisms": [ "homo sapiens" ], @@ -5307,8 +5305,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012131", @@ -5318,7 +5316,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012131/PXD012131.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012131/PXD012131.sdrf.tsv", "num_samples": 326, - "num_columns": 35, + "num_columns": 37, "organisms": [ "homo sapiens" ], @@ -5334,8 +5332,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012143", @@ -5345,7 +5343,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012143/PXD012143.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012143/PXD012143.sdrf.tsv", "num_samples": 320, - "num_columns": 28, + "num_columns": 30, "organisms": [ "plasmodium falciparum" ], @@ -5358,8 +5356,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012203", @@ -5369,14 +5367,14 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012203/PXD012203.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012203/PXD012203.sdrf.tsv", "num_samples": 240, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], "diseases": [ - "Non-demented control", "Alzheimer's disease", - "Alzheimer's diseasemedial" + "Alzheimer's diseasemedial", + "Non-demented control" ], "instruments": [ "Q Exactive" @@ -5386,8 +5384,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012243", @@ -5397,7 +5395,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012243/PXD012243.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012243/PXD012243.sdrf.tsv", "num_samples": 128, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -5412,8 +5410,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012255", @@ -5423,7 +5421,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012255/PXD012255.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012255/PXD012255.sdrf.tsv", "num_samples": 40, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -5438,8 +5436,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012277", @@ -5449,7 +5447,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012277/PXD012277.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012277/PXD012277.sdrf.tsv", "num_samples": 42, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -5462,8 +5460,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012307", @@ -5473,7 +5471,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012307/PXD012307.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012307/PXD012307.sdrf.tsv", "num_samples": 32, - "num_columns": 26, + "num_columns": 28, "organisms": [ "mus musculus" ], @@ -5486,8 +5484,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012431", @@ -5497,7 +5495,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012431/PXD012431.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012431/PXD012431.sdrf.tsv", "num_samples": 69, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -5512,8 +5510,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012593", @@ -5523,7 +5521,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012593/PXD012593-rat.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012593/PXD012593-rat.sdrf.tsv", "num_samples": 24, - "num_columns": 20, + "num_columns": 22, "organisms": [ "Rattus norvegicus" ], @@ -5536,8 +5534,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012593", @@ -5547,22 +5545,22 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012593/PXD012593-srm.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012593/PXD012593-srm.sdrf.tsv", "num_samples": 55, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Homo sapiens" ], "diseases": [], "instruments": [ - "Q Exactive Plus", - "TSQ Quantiva" + "TSQ Quantiva", + "Q Exactive Plus" ], "acquisition_methods": [ "selected reaction monitoring" ], "experiment_type": "SRM/MRM", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012611", @@ -5572,7 +5570,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012611/PXD012611.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012611/PXD012611.sdrf.tsv", "num_samples": 34, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -5585,8 +5583,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012755", @@ -5596,7 +5594,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012755/PXD012755.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012755/PXD012755.sdrf.tsv", "num_samples": 32, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], @@ -5605,15 +5603,15 @@ "Autism Spectrum Disorder" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012764", @@ -5623,7 +5621,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012764/PXD012764.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012764/PXD012764.sdrf.tsv", "num_samples": 6, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Oryza sativa" ], @@ -5636,8 +5634,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012923", @@ -5647,7 +5645,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012923/PXD012923.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012923/PXD012923.sdrf.tsv", "num_samples": 78, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -5662,8 +5660,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD012986", @@ -5673,7 +5671,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD012986/PXD012986.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD012986/PXD012986.sdrf.tsv", "num_samples": 15, - "num_columns": 41, + "num_columns": 43, "organisms": [ "Mus musculus" ], @@ -5686,8 +5684,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013234", @@ -5697,7 +5695,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013234/PXD013234.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013234/PXD013234.sdrf.tsv", "num_samples": 54, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -5713,8 +5711,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013273", @@ -5724,7 +5722,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013273/PXD013273.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013273/PXD013273.sdrf.tsv", "num_samples": 28, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Escherichia coli" ], @@ -5737,8 +5735,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013523", @@ -5748,7 +5746,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013523/PXD013523.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013523/PXD013523.sdrf.tsv", "num_samples": 198, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -5763,8 +5761,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013610", @@ -5774,7 +5772,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013610/PXD013610.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013610/PXD013610.sdrf.tsv", "num_samples": 6, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Escherichia coli" ], @@ -5787,8 +5785,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013737", @@ -5798,7 +5796,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013737/PXD013737.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013737/PXD013737.sdrf.tsv", "num_samples": 96, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -5811,8 +5809,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013753", @@ -5822,7 +5820,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013753/PXD013753.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013753/PXD013753.sdrf.tsv", "num_samples": 160, - "num_columns": 35, + "num_columns": 37, "organisms": [ "homo sapiens" ], @@ -5838,8 +5836,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013765", @@ -5849,7 +5847,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013765/PXD013765.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013765/PXD013765.sdrf.tsv", "num_samples": 144, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], @@ -5864,8 +5862,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013868", @@ -5875,7 +5873,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013868/PXD013868.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013868/PXD013868.sdrf.tsv", "num_samples": 1560, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Arabidopsis thaliana" ], @@ -5888,8 +5886,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD013923", @@ -5899,7 +5897,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD013923/PXD013923.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD013923/PXD013923.sdrf.tsv", "num_samples": 372, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Homo sapiens" ], @@ -5914,8 +5912,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014058", @@ -5925,14 +5923,14 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014058/PXD014058.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014058/PXD014058.sdrf.tsv", "num_samples": 323, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], "diseases": [ + "Colorectal cancer", "gastric carcinoma", "epithelial cervix carcinoma", - "Colorectal cancer", "Hepatoblastoma" ], "instruments": [ @@ -5943,8 +5941,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014145", @@ -5954,7 +5952,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014145/PXD014145.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014145/PXD014145.sdrf.tsv", "num_samples": 132, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -5969,8 +5967,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014458", @@ -5980,13 +5978,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014458/PXD14458.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014458/PXD14458.sdrf.tsv", "num_samples": 44, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Homo sapiens" ], "diseases": [ - "nontumorigenic", - "breast cancer" + "breast cancer", + "nontumorigenic" ], "instruments": [ "LTQ" @@ -5996,8 +5994,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014502", @@ -6007,7 +6005,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014502/PXD014502.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014502/PXD014502.sdrf.tsv", "num_samples": 240, - "num_columns": 21, + "num_columns": 23, "organisms": [ "Homo sapiens" ], @@ -6020,8 +6018,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014525", @@ -6031,7 +6029,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014525/PXD014525-dda.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014525/PXD014525-dda.sdrf.tsv", "num_samples": 224, - "num_columns": 36, + "num_columns": 38, "organisms": [ "Homo sapiens", "Saccharomyces cerevisiae" @@ -6047,8 +6045,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014525", @@ -6058,7 +6056,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014525/PXD014525-dia.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014525/PXD014525-dia.sdrf.tsv", "num_samples": 427, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens", "Saccharomyces cerevisiae" @@ -6074,8 +6072,8 @@ ], "experiment_type": "DIA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014528", @@ -6085,7 +6083,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014528/PXD014528.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014528/PXD014528.sdrf.tsv", "num_samples": 48, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Mus musculus" ], @@ -6098,8 +6096,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014557", @@ -6109,7 +6107,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014557/PXD014557.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014557/PXD014557.sdrf.tsv", "num_samples": 400, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], @@ -6124,8 +6122,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD014565", @@ -6135,7 +6133,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD014565/PXD014565.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD014565/PXD014565.sdrf.tsv", "num_samples": 80, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -6150,8 +6148,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015093", @@ -6161,7 +6159,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015093/PXD015093-LFQ.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015093/PXD015093-LFQ.sdrf.tsv", "num_samples": 148, - "num_columns": 27, + "num_columns": 29, "organisms": [ "plasmodium falciparum" ], @@ -6174,8 +6172,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015093", @@ -6185,7 +6183,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015093/PXD015093-TMT.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015093/PXD015093-TMT.sdrf.tsv", "num_samples": 1380, - "num_columns": 30, + "num_columns": 32, "organisms": [ "plasmodium falciparum" ], @@ -6198,8 +6196,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015270", @@ -6209,13 +6207,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015270/PXD015270.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015270/PXD015270.sdrf.tsv", "num_samples": 12, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], "diseases": [ - "non-small cell lung cancer", - "small cell lung cancer" + "small cell lung cancer", + "non-small cell lung cancer" ], "instruments": [ " Orbitrap Fusion Lumos" @@ -6225,8 +6223,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015578", @@ -6236,7 +6234,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015578/PXD015578.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015578/PXD015578.sdrf.tsv", "num_samples": 34, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -6249,8 +6247,8 @@ ], "experiment_type": "SRM/MRM", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015744", @@ -6260,7 +6258,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015744/PXD015744.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015744/PXD015744.sdrf.tsv", "num_samples": 100, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -6275,8 +6273,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015833", @@ -6286,7 +6284,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015833/PXD015833-Exp1.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015833/PXD015833-Exp1.sdrf.tsv", "num_samples": 360, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens", "plasmodium knowlesi", @@ -6294,16 +6292,16 @@ ], "diseases": [], "instruments": [ - "Q Exactive", - "Orbitrap Fusion Lumos" + "Orbitrap Fusion Lumos", + "Q Exactive" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015833", @@ -6313,7 +6311,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015833/PXD015833-Exp2.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015833/PXD015833-Exp2.sdrf.tsv", "num_samples": 120, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens", "plasmodium falciparum" @@ -6327,8 +6325,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015833", @@ -6338,7 +6336,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015833/PXD015833-Exp3.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015833/PXD015833-Exp3.sdrf.tsv", "num_samples": 240, - "num_columns": 29, + "num_columns": 31, "organisms": [ "plasmodium falciparum" ], @@ -6351,8 +6349,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015833", @@ -6362,7 +6360,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015833/PXD015833-Exp4.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015833/PXD015833-Exp4.sdrf.tsv", "num_samples": 160, - "num_columns": 29, + "num_columns": 31, "organisms": [ "plasmodium knowlesi", "plasmodium falciparum" @@ -6376,8 +6374,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015833", @@ -6387,7 +6385,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015833/PXD015833-Exp5.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015833/PXD015833-Exp5.sdrf.tsv", "num_samples": 160, - "num_columns": 29, + "num_columns": 31, "organisms": [ "plasmodium knowlesi", "plasmodium falciparum" @@ -6401,8 +6399,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015833", @@ -6412,7 +6410,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015833/PXD015833-Exp6.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015833/PXD015833-Exp6.sdrf.tsv", "num_samples": 160, - "num_columns": 29, + "num_columns": 31, "organisms": [ "plasmodium knowlesi", "plasmodium falciparum" @@ -6426,8 +6424,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD015957", @@ -6437,13 +6435,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD015957/PXD015957.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD015957/PXD015957.sdrf.tsv", "num_samples": 30, - "num_columns": 34, + "num_columns": 36, "organisms": [ "Homo sapiens" ], "diseases": [ - "malignant melanoma", - "metastatic melanoma tumor" + "metastatic melanoma tumor", + "malignant melanoma" ], "instruments": [ " Q Exactive Plus" @@ -6453,8 +6451,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD016001", @@ -6464,7 +6462,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD016001/PXD016001.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD016001/PXD016001.sdrf.tsv", "num_samples": 61, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Escherichia coli" ], @@ -6477,8 +6475,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD016002", @@ -6488,7 +6486,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD016002/PXD016002.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD016002/PXD016002.sdrf.tsv", "num_samples": 1008, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Homo sapiens" ], @@ -6503,8 +6501,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD016074", @@ -6514,7 +6512,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD016074/PXD016074.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD016074/PXD016074.sdrf.tsv", "num_samples": 24, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Escherichia coli" ], @@ -6527,8 +6525,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD016669", @@ -6538,7 +6536,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD016669/PXD016669.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD016669/PXD016669.sdrf.tsv", "num_samples": 20, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -6552,8 +6550,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD016772", @@ -6563,7 +6561,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD016772/PXD016772.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD016772/PXD016772.sdrf.tsv", "num_samples": 22, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Saccharomyces cerevisiae" ], @@ -6576,8 +6574,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD016837", @@ -6587,7 +6585,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD016837/PXD016837.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD016837/PXD016837.sdrf.tsv", "num_samples": 8, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -6595,15 +6593,15 @@ "ductal carcinoma" ], "instruments": [ - "LTQ Orbitrap Elite" + "Orbitrap Elite" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017035", @@ -6613,16 +6611,16 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017035/PXD017035.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017035/PXD017035.sdrf.tsv", "num_samples": 720, - "num_columns": 28, + "num_columns": 30, "organisms": [ - "Anaerostipes caccae", - "Escherichia coli K-12", - "lactobacillus", - "Bacteroides thetaiotaomicron", "Blautia producta", "clostridium", + "Bacteroides thetaiotaomicron", + "Escherichia coli K-12", + "lactobacillus", "Bifidobacterium longum", - "Clostridium butyricum" + "Clostridium butyricum", + "Anaerostipes caccae" ], "diseases": [], "instruments": [ @@ -6633,8 +6631,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017201", @@ -6644,7 +6642,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017201/PXD017201.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017201/PXD017201.sdrf.tsv", "num_samples": 3600, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Homo sapiens" ], @@ -6659,8 +6657,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017291", @@ -6670,7 +6668,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017291/PXD017291-mixed-label.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017291/PXD017291-mixed-label.sdrf.tsv", "num_samples": 1584, - "num_columns": 38, + "num_columns": 40, "organisms": [ "Homo sapiens" ], @@ -6678,16 +6676,16 @@ "chronic myelogenous leukemia" ], "instruments": [ - "Q Exactive Plus", - "Orbitrap Fusion Lumos" + "Orbitrap Fusion Lumos", + "Q Exactive Plus" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017291", @@ -6697,7 +6695,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017291/PXD017291-tmt.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017291/PXD017291-tmt.sdrf.tsv", "num_samples": 600, - "num_columns": 36, + "num_columns": 38, "organisms": [ "Homo sapiens" ], @@ -6712,8 +6710,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017602", @@ -6723,7 +6721,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017602/PXD017602.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017602/PXD017602.sdrf.tsv", "num_samples": 64, - "num_columns": 16, + "num_columns": 18, "organisms": [ "Mycolicibacterium smegmatis" ], @@ -6738,8 +6736,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017618", @@ -6749,22 +6747,22 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017618/PXD017618.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017618/PXD017618.sdrf.tsv", "num_samples": 6, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Escherichia coli" ], "diseases": [], "instruments": [ - "Q Exactive Plus", - "Orbitrap Fusion Lumos" + "Orbitrap Fusion Lumos", + "Q Exactive Plus" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017710", @@ -6774,13 +6772,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017710/PXD017710-silac.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017710/PXD017710-silac.sdrf.tsv", "num_samples": 264, - "num_columns": 36, + "num_columns": 38, "organisms": [ "Homo sapiens" ], "diseases": [ - "colon cancer", - "adenocarcinoma" + "adenocarcinoma", + "colon cancer" ], "instruments": [ "Q Exactive HF" @@ -6790,8 +6788,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD017710", @@ -6801,7 +6799,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD017710/PXD017710-tmt.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD017710/PXD017710-tmt.sdrf.tsv", "num_samples": 216, - "num_columns": 33, + "num_columns": 35, "organisms": [ "Homo sapiens" ], @@ -6816,8 +6814,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018117", @@ -6827,7 +6825,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018117/PXD018117.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018117/PXD018117.sdrf.tsv", "num_samples": 98, - "num_columns": 31, + "num_columns": 33, "organisms": [ "homo sapiens" ], @@ -6840,8 +6838,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018241", @@ -6851,7 +6849,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018241/PXD018241-phosphoproteomics.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018241/PXD018241-phosphoproteomics.sdrf.tsv", "num_samples": 2, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Cercopithecus" ], @@ -6864,8 +6862,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018241", @@ -6875,7 +6873,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018241/PXD018241.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018241/PXD018241.sdrf.tsv", "num_samples": 20, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Cercopithecus" ], @@ -6888,8 +6886,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018357", @@ -6899,13 +6897,13 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018357/PXD018357.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018357/PXD018357.sdrf.tsv", "num_samples": 240, - "num_columns": 31, + "num_columns": 33, "organisms": [ "homo sapiens" ], "diseases": [ - "Control", - "SARS-Cov2_infected" + "SARS-Cov2_infected", + "Control" ], "instruments": [ "Orbitrap Fusion Lumos" @@ -6915,8 +6913,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018581", @@ -6926,7 +6924,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018581/PXD018581.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018581/PXD018581.sdrf.tsv", "num_samples": 481, - "num_columns": 35, + "num_columns": 37, "organisms": [ "Homo sapiens" ], @@ -6941,8 +6939,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018594", @@ -6952,7 +6950,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018594/PXD018594.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018594/PXD018594.sdrf.tsv", "num_samples": 20, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Chlorocebus sabaeus" ], @@ -6965,8 +6963,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018678", @@ -6976,7 +6974,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018678/PXD018678-dda.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018678/PXD018678-dda.sdrf.tsv", "num_samples": 12, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -6991,8 +6989,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018678", @@ -7002,7 +7000,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018678/PXD018678-dia.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018678/PXD018678-dia.sdrf.tsv", "num_samples": 46, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Homo sapiens" ], @@ -7017,8 +7015,8 @@ ], "experiment_type": "DIA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018830", @@ -7028,7 +7026,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018830/PXD018830-DIA.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018830/PXD018830-DIA.sdrf.tsv", "num_samples": 25, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -7044,8 +7042,8 @@ ], "experiment_type": "DIA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD018970", @@ -7055,7 +7053,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD018970/PXD018970.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD018970/PXD018970.sdrf.tsv", "num_samples": 54, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -7070,8 +7068,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD019113", @@ -7081,7 +7079,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD019113/PXD019113.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD019113/PXD019113.sdrf.tsv", "num_samples": 64, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Chlorocebus sabaeus" ], @@ -7095,8 +7093,8 @@ ], "experiment_type": "DIA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD019123", @@ -7106,7 +7104,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD019123/PXD019123.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD019123/PXD019123.sdrf.tsv", "num_samples": 99, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Homo sapiens" ], @@ -7121,8 +7119,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD019140", @@ -7132,7 +7130,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD019140/PXD019140.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD019140/PXD019140.sdrf.tsv", "num_samples": 21, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Escherichia coli" ], @@ -7145,8 +7143,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD019185_PXD018883", @@ -7156,7 +7154,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD019185_PXD018883/PXD019185_PXD018883.sdrf.tsv", "num_samples": 13, - "num_columns": 39, + "num_columns": 41, "organisms": [ "homo sapiens" ], @@ -7171,8 +7169,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD019288", @@ -7182,7 +7180,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD019288/PXD019288.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD019288/PXD019288.sdrf.tsv", "num_samples": 18, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -7195,8 +7193,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD019291", @@ -7206,7 +7204,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD019291/PXD019291.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD019291/PXD019291.sdrf.tsv", "num_samples": 4, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Oryza sativa" ], @@ -7219,8 +7217,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD020187", @@ -7230,21 +7228,21 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD020187/PXD020187.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD020187/PXD020187.sdrf.tsv", "num_samples": 10, - "num_columns": 27, + "num_columns": 29, "organisms": [ "homo sapiens" ], "diseases": [ - "decellularized_5", - "native_1", - "native_3", + "decellularized_2", "decellularized_4", - "decellularized_1", + "native_3", "native_2", - "native_5", + "native_1", "native_4", + "decellularized_1", + "native_5", "decellularized_3", - "decellularized_2" + "decellularized_5" ], "instruments": [ "LTQ" @@ -7254,8 +7252,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD020192", @@ -7265,7 +7263,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD020192/PXD020192.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD020192/PXD020192.sdrf.tsv", "num_samples": 92, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Homo sapiens" ], @@ -7280,8 +7278,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD020207", @@ -7291,7 +7289,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD020207/PXD020207.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD020207/PXD020207.sdrf.tsv", "num_samples": 15, - "num_columns": 24, + "num_columns": 26, "organisms": [ "Escherichia coli" ], @@ -7304,8 +7302,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD020249", @@ -7315,7 +7313,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD020249/PXD020249.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD020249/PXD020249.sdrf.tsv", "num_samples": 130, - "num_columns": 37, + "num_columns": 39, "organisms": [ "Escherichia coli" ], @@ -7328,8 +7326,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD020381", @@ -7339,7 +7337,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD020381/PXD020381.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD020381/PXD020381.sdrf.tsv", "num_samples": 370, - "num_columns": 26, + "num_columns": 28, "organisms": [ "plasmodium falciparum" ], @@ -7352,8 +7350,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD020394", @@ -7363,7 +7361,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD020394/PXD020394.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD020394/PXD020394.sdrf.tsv", "num_samples": 20, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Severe acute respiratory syndrome coronavirus 2" ], @@ -7378,8 +7376,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD020785", @@ -7389,7 +7387,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD020785/PXD020785.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD020785/PXD020785.sdrf.tsv", "num_samples": 209, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Escherichia coli" ], @@ -7403,8 +7401,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD021874", @@ -7414,7 +7412,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD021874/PXD021874.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD021874/PXD021874.sdrf.tsv", "num_samples": 62, - "num_columns": 22, + "num_columns": 24, "organisms": [ "Haloferax volcanii DS2" ], @@ -7427,8 +7425,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD022070", @@ -7438,7 +7436,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD022070/PXD022070.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD022070/PXD022070.sdrf.tsv", "num_samples": 186, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Escherichia coli" ], @@ -7451,8 +7449,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD022526", @@ -7462,7 +7460,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD022526/PXD022526.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD022526/PXD022526.sdrf.tsv", "num_samples": 9, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Escherichia coli" ], @@ -7475,8 +7473,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD023158", @@ -7486,7 +7484,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD023158/PXD023158.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD023158/PXD023158.sdrf.tsv", "num_samples": 90, - "num_columns": 31, + "num_columns": 33, "organisms": [ "Escherichia coli" ], @@ -7499,8 +7497,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD023650", @@ -7510,7 +7508,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD023650/PXD023650.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD023650/PXD023650.sdrf.tsv", "num_samples": 123, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Homo sapiens" ], @@ -7525,8 +7523,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD023707", @@ -7536,7 +7534,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD023707/PXD023707.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD023707/PXD023707.sdrf.tsv", "num_samples": 3, - "num_columns": 34, + "num_columns": 36, "organisms": [ "homo sapiens" ], @@ -7551,8 +7549,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD024138", @@ -7562,7 +7560,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD024138/PXD024138.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD024138/PXD024138.sdrf.tsv", "num_samples": 8, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Escherichia coli" ], @@ -7575,8 +7573,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD025088", @@ -7586,7 +7584,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD025088/PXD025088.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD025088/PXD025088.sdrf.tsv", "num_samples": 16, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -7599,8 +7597,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD025706", @@ -7610,7 +7608,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD025706/PXD025706.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD025706/PXD025706.sdrf.tsv", "num_samples": 12, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -7624,8 +7622,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD026474", @@ -7635,7 +7633,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD026474/PXD026474.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD026474/PXD026474.sdrf.tsv", "num_samples": 8, - "num_columns": 30, + "num_columns": 32, "organisms": [ "plasmodium falciparum" ], @@ -7648,8 +7646,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD029347", @@ -7659,7 +7657,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD029347/PXD029347.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD029347/PXD029347.sdrf.tsv", "num_samples": 6, - "num_columns": 26, + "num_columns": 28, "organisms": [ "Escherichia coli" ], @@ -7672,8 +7670,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD029931", @@ -7683,7 +7681,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD029931/PXD029931.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD029931/PXD029931.sdrf.tsv", "num_samples": 21, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -7696,8 +7694,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD030345", @@ -7707,7 +7705,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD030345/PXD030345.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD030345/PXD030345.sdrf.tsv", "num_samples": 12, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -7720,8 +7718,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD030346", @@ -7731,7 +7729,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD030346/PXD030346.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD030346/PXD030346.sdrf.tsv", "num_samples": 12, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -7744,8 +7742,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD030650", @@ -7755,7 +7753,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD030650/PXD030650.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD030650/PXD030650.sdrf.tsv", "num_samples": 60, - "num_columns": 29, + "num_columns": 31, "organisms": [ "Escherichia coli" ], @@ -7768,8 +7766,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD030690", @@ -7779,7 +7777,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD030690/PXD030690.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD030690/PXD030690.sdrf.tsv", "num_samples": 10, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Escherichia coli" ], @@ -7792,8 +7790,8 @@ ], "experiment_type": "DDA", "label_type": "iTRAQ", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD031694", @@ -7803,7 +7801,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD031694/PXD031694.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD031694/PXD031694.sdrf.tsv", "num_samples": 18, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Escherichia coli" ], @@ -7816,8 +7814,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD032954", @@ -7827,7 +7825,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD032954/PXD032954.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD032954/PXD032954.sdrf.tsv", "num_samples": 4, - "num_columns": 32, + "num_columns": 34, "organisms": [ "Escherichia coli" ], @@ -7840,8 +7838,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD035590", @@ -7851,7 +7849,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD035590/PXD035590.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD035590/PXD035590.sdrf.tsv", "num_samples": 6, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Escherichia coli" ], @@ -7864,8 +7862,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD036749", @@ -7875,7 +7873,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD036749/PXD036749.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD036749/PXD036749.sdrf.tsv", "num_samples": 4, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Escherichia coli" ], @@ -7888,8 +7886,8 @@ ], "experiment_type": "DDA", "label_type": "SILAC", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD037221", @@ -7899,7 +7897,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD037221/PXD037221.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD037221/PXD037221.sdrf.tsv", "num_samples": 90, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Escherichia coli" ], @@ -7912,8 +7910,8 @@ ], "experiment_type": "DDA", "label_type": "TMT", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD040621", @@ -7923,7 +7921,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD040621/PXD040621.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD040621/PXD040621.sdrf.tsv", "num_samples": 8, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Escherichia coli" ], @@ -7936,8 +7934,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD041301", @@ -7947,7 +7945,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD041301/PXD041301.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD041301/PXD041301.sdrf.tsv", "num_samples": 18, - "num_columns": 30, + "num_columns": 32, "organisms": [ "Escherichia coli" ], @@ -7960,8 +7958,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD042173", @@ -7971,7 +7969,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD042173/PXD042173.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD042173/PXD042173.sdrf.tsv", "num_samples": 30, - "num_columns": 24, + "num_columns": 27, "organisms": [ "homo sapiens" ], @@ -7984,8 +7982,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "crosslinking,version=v1.0.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD043473", @@ -7995,22 +7993,22 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD043473/PXD043473.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD043473/PXD043473.sdrf.tsv", "num_samples": 129, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Escherichia coli" ], "diseases": [], "instruments": [ - "Q Exactive HF", - "Orbitrap Eclipse" + "Orbitrap Eclipse", + "Q Exactive HF" ], "acquisition_methods": [ "Data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD045084", @@ -8020,7 +8018,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD045084/PXD045084.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD045084/PXD045084.sdrf.tsv", "num_samples": 4, - "num_columns": 25, + "num_columns": 27, "organisms": [ "Escherichia coli" ], @@ -8033,8 +8031,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD050358", @@ -8044,7 +8042,7 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD050358/PXD050358.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD050358/PXD050358.sdrf.tsv", "num_samples": 72, - "num_columns": 27, + "num_columns": 29, "organisms": [ "Escherichia coli" ], @@ -8057,32 +8055,8 @@ ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" - }, - { - "id": "PXD051889", - "file": "PXD051889.sdrf.tsv", - "filename": "PXD051889.sdrf.tsv", - "path": "annotated-projects/PXD051889/PXD051889.sdrf.tsv", - "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD051889/PXD051889.sdrf.tsv", - "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD051889/PXD051889.sdrf.tsv", - "num_samples": 16, - "num_columns": 29, - "organisms": [ - "Mus musculus" - ], - "diseases": [], - "instruments": [ - "Q Exactive HF-X" - ], - "acquisition_methods": [ - "Data-dependent acquisition" - ], - "experiment_type": "DDA", - "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" }, { "id": "PXD058808", @@ -8092,22 +8066,22 @@ "github_url": "https://github.com/bigbio/proteomics-metadata-standard/blob/master/annotated-projects/PXD058808/PXD058808.sdrf.tsv", "raw_url": "https://raw.githubusercontent.com/bigbio/proteomics-metadata-standard/master/annotated-projects/PXD058808/PXD058808.sdrf.tsv", "num_samples": 48, - "num_columns": 28, + "num_columns": 30, "organisms": [ "Escherichia coli" ], "diseases": [], "instruments": [ - "Q Exactive HF-X", - "timsTOF Pro 2" + "timsTOF Pro 2", + "Q Exactive HF-X" ], "acquisition_methods": [ "data-dependent acquisition" ], "experiment_type": "DDA", "label_type": "Label-free", - "template": "ms-proteomics,version=v1.1.0", - "version": "v1.1.0" + "template": "unknown", + "version": "unknown" } ] } \ No newline at end of file diff --git a/site/sdrf-terms.html b/site/sdrf-terms.html index 6a0036f5f..059632f10 100644 --- a/site/sdrf-terms.html +++ b/site/sdrf-terms.html @@ -475,19 +475,19 @@

    SDRF Terms Reference

    const data = [ // Core anchor columns - REQUIRED {term: "source name", type: "other", requirement: "required", ontology_term_accession: "PRIDE:0000623", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "free text", description: "Unique identifier for the biological sample", allow_not_available: false, allow_not_applicable: false}, - {term: "assay name", type: "other", requirement: "required", ontology_term_accession: "NCIT:C178857", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "free text", description: "Unique identifier for the MS run", allow_not_available: false, allow_not_applicable: false}, + {term: "assay name", type: "other", requirement: "required", ontology_term_accession: "NCIT:C178857", usage: "minimum, ms-proteomics, affinity-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "free text", description: "Unique identifier for the assay or sample within a study (e.g. MS run name for mass spectrometry, sample ID from platform data file for affinity proteomics)", allow_not_available: false, allow_not_applicable: false}, {term: "technology type", type: "other", requirement: "required", ontology_term_accession: "EFO:0002772", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "fixed: proteomic profiling by mass spectrometry", description: "Type of technology used", allow_not_available: false, allow_not_applicable: false}, // Core sample characteristics - {term: "organism", type: "characteristics", requirement: "required", ontology_term_accession: "OBI:0100026", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "NCBITaxon", description: "Species of the sample", allow_not_available: false, allow_not_applicable: true, spec_link: "metadata-guidelines/sample-metadata.html#_organism"}, - {term: "organism part", type: "characteristics", requirement: "recommended", ontology_term_accession: "EFO:0000635", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "UBERON, BTO", description: "Anatomical part of the organism", allow_not_available: true, allow_not_applicable: true, spec_link: "metadata-guidelines/sample-metadata.html#_organism_part_tissue"}, - {term: "disease", type: "characteristics", requirement: "recommended", ontology_term_accession: "OGMS:0000031", usage: "ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition, dda-acquisition", values: "MONDO, EFO, DOID, PATO", description: "Disease state of the sample", allow_not_available: true, allow_not_applicable: true, spec_link: "metadata-guidelines/sample-metadata.html#disease-annotation"}, - {term: "cell type", type: "characteristics", requirement: "recommended", ontology_term_accession: "EFO:0000324", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "CL, BTO, CLO", description: "Cell type of the sample", allow_not_available: true, allow_not_applicable: true, spec_link: "metadata-guidelines/sample-metadata.html#cell-type-annotation"}, + {term: "organism", type: "characteristics", requirement: "required", ontology_term_accession: "OBI:0100026", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "NCBITaxon", description: "Species of the sample", allow_not_available: false, allow_not_applicable: true, spec_link: "sample-guidelines.html#_organism"}, + {term: "organism part", type: "characteristics", requirement: "recommended", ontology_term_accession: "EFO:0000635", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "UBERON, BTO", description: "Anatomical part of the organism", allow_not_available: true, allow_not_applicable: true, spec_link: "sample-guidelines.html#_organism_part_tissue"}, + {term: "disease", type: "characteristics", requirement: "recommended", ontology_term_accession: "OGMS:0000031", usage: "ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, dia-acquisition, dda-acquisition", values: "MONDO, EFO, DOID, PATO", description: "Disease state of the sample", allow_not_available: true, allow_not_applicable: true, spec_link: "sample-guidelines.html#disease-annotation"}, + {term: "cell type", type: "characteristics", requirement: "recommended", ontology_term_accession: "EFO:0000324", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "CL, BTO, CLO", description: "Cell type of the sample", allow_not_available: true, allow_not_applicable: true, spec_link: "sample-guidelines.html#cell-type-annotation"}, {term: "biological replicate", type: "characteristics", requirement: "required", ontology_term_accession: "MS:1001809", usage: "minimum, ms-proteomics, human, cell-lines, single-cell, immunopeptidomics, crosslinking, metaproteomics, dia-acquisition, dda-acquisition", values: "integer or pooled", description: "Identifier for the biological replicate", allow_not_available: false, allow_not_applicable: false}, // Human-specific characteristics {term: "ancestry category", type: "characteristics", requirement: "recommended", ontology_term_accession: "HANCESTRO:0004", usage: "human, cell-lines", values: "HANCESTRO, EFO", description: "Ancestry or ethnic background of the donor", allow_not_available: true, allow_not_applicable: true}, - {term: "age", type: "characteristics", requirement: "recommended", ontology_term_accession: "EFO:0000246", usage: "human, cell-lines", values: "pattern: {Number}{Unit} (Y/M/W/D)", description: "Age of the donor at sample collection", allow_not_available: true, allow_not_applicable: true, spec_link: "metadata-guidelines/sample-metadata.html#age-annotation"}, - {term: "sex", type: "characteristics", requirement: "recommended", ontology_term_accession: "PATO:0000047", usage: "human, cell-lines", values: "fixed: male, female, intersex, not available, not applicable", description: "Biological sex of the donor", allow_not_available: true, allow_not_applicable: true, spec_link: "metadata-guidelines/sample-metadata.html#sex-annotation"}, - {term: "developmental stage", type: "characteristics", requirement: "optional", ontology_term_accession: "EFO:0000399", usage: "human, cell-lines, single-cell", values: "HsapDv, EFO, MmusDv, UBERON", description: "Developmental stage of the donor", allow_not_available: true, allow_not_applicable: true, spec_link: "metadata-guidelines/sample-metadata.html#developmental-stage"}, + {term: "age", type: "characteristics", requirement: "recommended", ontology_term_accession: "EFO:0000246", usage: "human, cell-lines", values: "pattern: {Number}{Unit} (Y/M/W/D)", description: "Age of the donor at sample collection", allow_not_available: true, allow_not_applicable: true, spec_link: "sample-guidelines.html#age-annotation"}, + {term: "sex", type: "characteristics", requirement: "recommended", ontology_term_accession: "PATO:0000047", usage: "human, cell-lines", values: "fixed: male, female, intersex, not available, not applicable", description: "Biological sex of the donor", allow_not_available: true, allow_not_applicable: true, spec_link: "sample-guidelines.html#sex-annotation"}, + {term: "developmental stage", type: "characteristics", requirement: "optional", ontology_term_accession: "EFO:0000399", usage: "human, cell-lines, single-cell", values: "HsapDv, EFO, MmusDv, UBERON", description: "Developmental stage of the donor", allow_not_available: true, allow_not_applicable: true, spec_link: "sample-guidelines.html#developmental-stage"}, {term: "individual", type: "characteristics", requirement: "optional", ontology_term_accession: "to be filled", usage: "human, cell-lines", values: "free text pattern", description: "Unique identifier for the donor individual", allow_not_available: true, allow_not_applicable: true}, // Cell line characteristics {term: "cell line", type: "characteristics", requirement: "required", ontology_term_accession: "CLO:0000031", usage: "cell-lines, immunopeptidomics", values: "CLO, BTO, EFO", description: "Name of the cell line", allow_not_available: false, allow_not_applicable: true}, @@ -499,14 +499,14 @@

    SDRF Terms Reference

    {term: "cell identifier", type: "characteristics", requirement: "recommended", ontology_term_accession: "EFO:0010197", usage: "single-cell", values: "free text pattern", description: "Unique identifier for the single cell", allow_not_available: false, allow_not_applicable: false}, {term: "cell viability", type: "characteristics", requirement: "optional", ontology_term_accession: "to be filled", usage: "single-cell", values: "fixed: live, dead, unknown", description: "Viability status of the cell at isolation", allow_not_available: true, allow_not_applicable: true}, {term: "cell cycle phase", type: "characteristics", requirement: "optional", ontology_term_accession: "GO:0022403", usage: "single-cell", values: "fixed: G1, S, G2, M, G0", description: "Cell cycle phase of the isolated cell", allow_not_available: true, allow_not_applicable: true}, - {term: "sorting marker", type: "characteristics", requirement: "optional", ontology_term_accession: "to be filled", usage: "single-cell", values: "free text", description: "Markers used for cell sorting/selection", allow_not_available: true, allow_not_applicable: true}, + {term: "enrichment marker", type: "characteristics", requirement: "optional", ontology_term_accession: "to be filled", usage: "single-cell", values: "free text", description: "Markers used for cell sorting/enrichment", allow_not_available: true, allow_not_applicable: true}, {term: "genotype", type: "characteristics", requirement: "optional", ontology_term_accession: "EFO:0000513", usage: "single-cell", values: "free text", description: "Genotype of the organism (for model organisms)", allow_not_available: true, allow_not_applicable: true}, - {term: "strain", type: "characteristics", requirement: "optional", ontology_term_accession: "EFO:0005135", usage: "single-cell", values: "free text", description: "Strain or genetic background of model organisms", allow_not_available: true, allow_not_applicable: true}, + {term: "strain or breed", type: "characteristics", requirement: "optional", ontology_term_accession: "GENO:0000112", usage: "vertebrates, invertebrates, plants, single-cell", values: "free text", description: "Strain, breed, cultivar, or ecotype of the organism", allow_not_available: true, allow_not_applicable: true}, // Immunopeptidomics characteristics - {term: "MHC class", type: "characteristics", requirement: "required", ontology_term_accession: "to be filled", usage: "immunopeptidomics", values: "fixed: MHC class I, MHC class II, MHC class I and II", description: "MHC class targeted for immunopeptidome enrichment", allow_not_available: false, allow_not_applicable: false}, + {term: "MHC protein complex", type: "characteristics", requirement: "required", ontology_term_accession: "GO:0042611", usage: "immunopeptidomics", values: "fixed: MHC class I protein complex, MHC class II protein complex, non-classical MHC protein complex, mutant MHC protein complex, MHC protein complex with serotype", description: "MHC protein complex targeted for immunopeptidome enrichment (MRO terms under GO:0042611)", allow_not_available: false, allow_not_applicable: false}, {term: "immunopeptidome enrichment method", type: "characteristics", requirement: "required", ontology_term_accession: "to be filled", usage: "immunopeptidomics", values: "fixed: immunoaffinity purification, mild acid elution, detergent lysis", description: "Method used to enrich MHC-bound peptides", allow_not_available: false, allow_not_applicable: false}, - {term: "HLA typing", type: "characteristics", requirement: "recommended", ontology_term_accession: "NCIT:C71329", usage: "immunopeptidomics", values: "HLA nomenclature pattern", description: "HLA alleles expressed by the sample", allow_not_available: true, allow_not_applicable: true}, - {term: "HLA typing method", type: "characteristics", requirement: "optional", ontology_term_accession: "to be filled", usage: "immunopeptidomics", values: "fixed: NGS-based typing, SSO typing, SSP typing, SBT typing, predicted from RNA-seq", description: "Method used for HLA typing", allow_not_available: true, allow_not_applicable: true}, + {term: "MHC typing", type: "characteristics", requirement: "recommended", ontology_term_accession: "PRIDE:0000893", usage: "immunopeptidomics", values: "IPD-MHC nomenclature (https://www.ebi.ac.uk/ipd/mhc/); IPD-IMGT/HLA for human", description: "MHC allelic composition of the sample following IPD-MHC nomenclature", allow_not_available: true, allow_not_applicable: true}, + {term: "MHC typing method", type: "characteristics", requirement: "optional", ontology_term_accession: "PRIDE:0000894", usage: "immunopeptidomics", values: "fixed: NGS-based typing (NCIT:C101293), sequence-based typing (NCIT:C130180), PCR-SSO (NCIT:C130181), PCR-SSP (NCIT:C130179), PCR-based genotyping (NCIT:C17003), predicted from RNA-seq, inferred from mass spectrometry, inbred strain (known genotype)", description: "Method used to determine MHC alleles", allow_not_available: true, allow_not_applicable: true}, // Crosslinking characteristics {term: "crosslinking reagent", type: "characteristics", requirement: "required", ontology_term_accession: "to be filled", usage: "crosslinking", values: "XLMOD, ChEBI", description: "Name of the cross-linking reagent used", allow_not_available: false, allow_not_applicable: false}, {term: "enrichment process", type: "characteristics", requirement: "required", ontology_term_accession: "to be filled", usage: "crosslinking", values: "fixed: enrichment of cross-linked peptides, not applicable", description: "Indicates if the sample was enriched for cross-linked peptides", allow_not_available: false, allow_not_applicable: true}, diff --git a/site/templates/index-templates.html.j2 b/site/templates/index-templates.html.j2 new file mode 100644 index 000000000..0bca6518d --- /dev/null +++ b/site/templates/index-templates.html.j2 @@ -0,0 +1,26 @@ +

    Templates

    +

    SDRF templates define the columns and validation rules for different types of proteomics experiments. + See the Templates Guide for details on inheritance and combination rules.

    + +
    + + + + + + + + + + + {% for t in all_templates %} + + + + + + + {% endfor %} + +
    TemplateLayerDescriptionVersion
    {{ t.name | replace('-', ' ') | title }}{{ t.layer or 'internal' }}{{ t.description | truncate(120, true, '...') }}{{ t.version }}
    +
    diff --git a/site/templates/template-page.html.j2 b/site/templates/template-page.html.j2 new file mode 100644 index 000000000..19e4f225d --- /dev/null +++ b/site/templates/template-page.html.j2 @@ -0,0 +1,476 @@ + + + + + + {{ template.name }} - SDRF Template + + + + +
    + + {# ── 1. Header ── #} +
    +

    {{ template.name }}

    +
    + {% if template.version %} + v{{ template.version }} + {% endif %} + {% if template.layer %} + {{ template.layer }} + {% else %} + internal + {% endif %} + {% if template.usable_alone %} + usable alone + {% endif %} +
    +
    + + {# ── 2. Description ── #} + {% if template.description %} +
    +

    {{ template.description }}

    +
    + {% endif %} + + {# ── 3. Documentation / Key Guidance ── #} + {% if template.documentation_html is defined and template.documentation_html %} +
    +

    Key Guidance

    +
    + {{ template.documentation_html }} +
    +
    + {% elif template.documentation %} +
    +

    Key Guidance

    +
    + {% for block in template.documentation.split('\n\n') %} + {% set lines = block.strip().split('\n') %} + {% set list_lines = [] %} + {% set para_lines = [] %} + {% for line in lines %} + {% if line.strip().startswith('- ') %} + {% if list_lines.append(line.strip()[2:]) %}{% endif %} + {% else %} + {% if para_lines.append(line.strip()) %}{% endif %} + {% endif %} + {% endfor %} + {% if para_lines %} +

    {{ para_lines | join(' ') }}

    + {% endif %} + {% if list_lines %} +
      + {% for item in list_lines %} +
    • {{ item }}
      • + {% endfor %} +
    + {% endif %} + {% endfor %} +
    +
    + {% endif %} + + {# ── 4. Inheritance Chain ── #} + {% if template.inheritance_chain and template.inheritance_chain | length > 1 %} +
    +

    Inheritance

    +
    + {% for ancestor in template.inheritance_chain %} + {% if not loop.first %}→{% endif %} + {% if ancestor == template.name %} + {{ ancestor }} + {% else %} + {{ ancestor }} + {% endif %} + {% endfor %} +
    +
    + {% endif %} + + {# ── 5. Combination Rules ── #} + {% if template.requires or template.mutually_exclusive_with or template.excludes %} +
    +

    Combination Rules

    +
    +
      + {% if template.requires %} + {% for req in template.requires %} +
    • Requires a {{ req.layer }} layer template.
      • + {% endfor %} + {% endif %} + {% if template.mutually_exclusive_with %} +
    • Mutually exclusive with: + {% for t in template.mutually_exclusive_with %} + {{ t }}{% if not loop.last %}, {% endif %} + {% endfor %} +
      • + {% endif %} + {% if template.excludes and template.excludes.templates %} +
    • Excludes: + {% for t in template.excludes.templates %} + {{ t }}{% if not loop.last %}, {% endif %} + {% endfor %} +
      • + {% endif %} +
    +
    +
    + {% endif %} + + {# ── 6. Column Table ── #} + {% if template.all_columns %} + {% set inherited_cols = template.all_columns | selectattr('source_template', 'ne', template.name) | list %} + {% set own_cols = template.all_columns | selectattr('source_template', 'eq', template.name) | list %} +
    +

    Columns

    +
    + {% if inherited_cols %} + + {% endif %} + + {{ own_cols | length }} own{% if inherited_cols %} + {{ inherited_cols | length }} inherited{% endif %} = {{ template.all_columns | length }} total + · click a row for details + +
    +
    + + + + + + + + + + + + {% for col in template.all_columns %} + {% set is_inherited = col.source_template != template.name %} + {% set row_id = "col-" ~ loop.index %} + + + + + + + + + + + {% endfor %} + +
    ColumnRequirementSourceDescription
    ▶{{ col.name }} + {% if col.requirement == 'required' %} + required + {% elif col.requirement == 'recommended' %} + recommended + {% else %} + optional + {% endif %} + {{ col.source_template }}{{ col.description | default('', true) | truncate(100, true, '...') }}
    +
    + {% if col.description %} +
    + +
    {{ col.description }}
    +
    + {% endif %} + + {% if col.ontology_accession %} +
    + +
    + {{ col.ontology_accession }} +
    +
    + {% endif %} + +
    + +
    + {% if col.allow_not_applicable %}allows N/A{% endif %} + {% if col.allow_not_available %}allows not available{% endif %} + {% if col.cardinality is defined and col.cardinality %}{{ col.cardinality }} cardinality{% endif %} + {% if col.type is defined and col.type %}type: {{ col.type }}{% endif %} +
    +
    + + {% if col.validators %} +
    + +
    + {% for v in col.validators %} +
    + {{ v.validator_name }} + {% if v.params %} + {% if v.params.ontologies is defined %} + — ontologies: {{ v.params.ontologies | join(', ') }} + {% endif %} + {% if v.params.pattern is defined %} + — pattern: {{ v.params.pattern }} + {% endif %} + {% if v.params.allowed_values is defined %} + — values: {% for val in v.params.allowed_values[:6] %}{{ val }}{% if not loop.last %}, {% endif %}{% endfor %}{% if v.params.allowed_values | length > 6 %}, …{% endif %} + {% endif %} + {% if v.params.description is defined %} +
    {{ v.params.description }}
    + {% endif %} + {% endif %} +
    + {% endfor %} +
    +
    + {% endif %} + + {% set examples = [] %} + {% if col.validators %} + {% for v in col.validators %} + {% if v.params and v.params.examples %} + {% for ex in v.params.examples %} + {% if examples.append(ex) %}{% endif %} + {% endfor %} + {% endif %} + {% endfor %} + {% endif %} + {% if examples %} +
    + +
    + {% for ex in examples[:8] %}{{ ex }}{% if not loop.last %}, {% endif %}{% endfor %} +
    +
    + {% endif %} +
    +
    +
    +
    + {% endif %} + + {# ── 7. Contributors ── #} + {% if template.contributors %} +
    +

    Contributors

    +
      + {% for contributor in template.contributors %} +
    • {{ contributor }}
      • + {% endfor %} +
    +
    + {% endif %} + +
    + + + +